LOCUS       AAB34917                  31 aa            linear   INV 28-OCT-1995
DEFINITION  mu-O conotoxin MrVIA=voltage-gated sodium channel blocker
            {C-terminal} [Conus marmoreus=marble cones, venom ducts, Peptide
            Partial, 31 aa].
ACCESSION   AAB34917
VERSION     AAB34917.1
DBSOURCE    accession AAB34917.1
KEYWORDS    .
SOURCE      Conus marmoreus
  ORGANISM  Conus marmoreus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Conus.
REFERENCE   1  (residues 1 to 31)
  AUTHORS   McIntosh,J.M., Hasson,A., Spira,M.E., Gray,W.R., Li,W., Marsh,M.,
            Hillyard,D.R. and Olivera,B.M.
  TITLE     A new family of conotoxins that blocks voltage-gated sodium
            channels
  JOURNAL   J. Biol. Chem. 270 (28), 16796-16802 (1995)
   PUBMED   7622492
  REMARK    GenBank staff at the National Library of Medicine created this
            entry [NCBI gibbsq 169871] from the original journal article.
COMMENT     Method: direct peptide sequencing.
FEATURES             Location/Qualifiers
     source          1..31
                     /organism="Conus marmoreus"
                     /db_xref="taxon:42752"
     Protein         <1..31
                     /product="mu-O conotoxin MrVIA"
                     /name="voltage-gated sodium channel blocker"
ORIGIN      
        1 acrkkweyci vpiigfiycc pglicgpfvc v
//

LOCUS       NDB4V_TITSE                8 aa            linear   INV 23-FEB-2022
DEFINITION  RecName: Full=Venom peptide 7.1; AltName: Full=Venom peptide 7;
            Contains: RecName: Full=Venom peptide 7.2.
ACCESSION   P86828
VERSION     P86828.1
DBSOURCE    UniProtKB: locus NDB4V_TITSE, accession P86828;
            class: standard.
            extra accessions:C0HJT3
            created: Nov 30, 2010.
            sequence updated: Nov 30, 2010.
            annotation updated: Feb 23, 2022.
            xrefs (non-sequence databases): GO:0005576, GO:0017080, GO:0090729
KEYWORDS    Direct protein sequencing; Ion channel impairing toxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Tityus serrulatus (Brazilian scorpion)
  ORGANISM  Tityus serrulatus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 8)
  AUTHORS   Rates,B., Ferraz,K.K., Borges,M.H., Richardson,M., De Lima,M.E. and
            Pimenta,A.M.
  TITLE     Tityus serrulatus venom peptidomics: assessing venom peptide
            diversity
  JOURNAL   Toxicon 52 (5), 611-618 (2008)
   PUBMED   18718845
  REMARK    PROTEIN SEQUENCE, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom {ECO:0000269|PubMed:18718845}
REFERENCE   2  (residues 1 to 8)
  AUTHORS   Pucca,M.B., Cerni,F.A., Pinheiro-Junior,E.L., Zoccal,K.F.,
            Bordon,K.C.F., Amorim,F.G., Peigneur,S., Vriens,K., Thevissen,K.,
            Cammue,B.P.A., Junior,R.B.M., Arruda,E., Faccioli,L.H., Tytgat,J.
            and Arantes,E.C.
  TITLE     Non-disulfide-bridged peptides from Tityus serrulatus venom:
            Evidence for proline-free ACE-inhibitors
  JOURNAL   Peptides 82, 44-51 (2016)
   PUBMED   27221550
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom {ECO:0000303|PubMed:27221550}
COMMENT     [FUNCTION] [Venom peptide 7.1]: Has a weak inhibitory effect on
            voltage-gated sodium channel Nav1.5/SCN5A. Inhibits acetylcholine
            esterase in vitro. Increases interleukin-6 secretion from
            macrophages in vitro. Has no antifungal, antiviral or cytotoxic
            activity. {ECO:0000269|PubMed:27221550}.
            [FUNCTION] [Venom peptide 7.2]: Strongly inhibits acetylcholine
            esterase in vitro. Increases Il-6 secretion from macrophages in
            vitro. Has no antifungal, antiviral or cytotoxic activity.
            {ECO:0000269|PubMed:27221550}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:18718845,
            ECO:0000269|PubMed:27221550}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [MISCELLANEOUS] No effect on voltage-gated potassium channels. No
            effect on voltage-gated sodium channels Nav1.2/SCN2A, Nav1.3/SCN3A,
            Nav1.4/SCN4A and a sodium channel from B.germanica.
            {ECO:0000269|PubMed:27221550}.
            [SIMILARITY] Belongs to the non-disulfide-bridged peptide (NDBP)
            superfamily. Short antimicrobial peptide (group 4) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..8
                     /organism="Tityus serrulatus"
                     /db_xref="taxon:6887"
     Protein         1..8
                     /product="Venom peptide 7.1"
                     /note="Venom peptide 7"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..8
                     /region_name="Processed active peptide"
                     /note="Venom peptide 7.1.
                     /evidence=ECO:0000269|PubMed:18718845.
                     /id=PRO_0000401156."
     Region          1..6
                     /region_name="Processed active peptide"
                     /note="Venom peptide 7.2.
                     /evidence=ECO:0000269|PubMed:27221550.
                     /id=PRO_0000438307."
     unsure          7
                     /note="K or Q. /evidence=ECO:0000269|PubMed:18718845."
     unsure          8
                     /note="K or Q. /evidence=ECO:0000269|PubMed:18718845."
ORIGIN      
        1 rlrskgkk
//

LOCUS       NP_001308534             185 aa            linear   PRI 02-AUG-2023
DEFINITION  sodium channel subunit beta-1 isoform c [Homo sapiens].
ACCESSION   NP_001308534 XP_005259201
VERSION     NP_001308534.1
DBSOURCE    REFSEQ: accession NM_001321605.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 185)
  AUTHORS   Li Y, Yuan T, Huang B, Zhou F, Peng C, Li X, Qiu Y, Yang B, Zhao Y,
            Huang Z and Jiang D.
  TITLE     Structure of human NaV1.6 channel reveals Na+ selectivity and pore
            blockade by 4,9-anhydro-tetrodotoxin
  JOURNAL   Nat Commun 14 (1), 1030 (2023)
   PUBMED   36823201
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 185)
  AUTHORS   Fan X, Huang J, Jin X and Yan N.
  TITLE     Cryo-EM structure of human voltage-gated sodium channel Nav1.6
  JOURNAL   Proc Natl Acad Sci U S A 120 (5), e2220578120 (2023)
   PUBMED   36696443
REFERENCE   3  (residues 1 to 185)
  AUTHORS   Alghamdi MA, Al-Eitan LN, Asiri A, Rababa'h DM, Alqahtani SA,
            Aldarami MS, Alsaeedi MA, Almuidh RS, Alzahrani AA, Sakah AH, El
            Nashar EM, Otaif MY and Abdel Ghaffar NF.
  TITLE     Association of sodium voltage-gated channel genes polymorphisms
            with epilepsy risk and prognosis in the Saudi population
  JOURNAL   Ann Med 54 (1), 1938-1951 (2022)
   PUBMED   35801810
  REMARK    GeneRIF: Association of sodium voltage-gated channel genes
            polymorphisms with epilepsy risk and prognosis in the Saudi
            population.
REFERENCE   4  (residues 1 to 185)
  AUTHORS   Ramos-Mondragon R, Edokobi N, Hodges SL, Wang S, Bouza AA, Canugovi
            C, Scheuing C, Juratli L, Abel WR, Noujaim SF, Madamanchi NR, Runge
            MS, Lopez-Santiago LF and Isom LL.
  TITLE     Neonatal Scn1b-null mice have sinoatrial node dysfunction, altered
            atrial structure, and atrial fibrillation
  JOURNAL   JCI Insight 7 (10), e152050 (2022)
   PUBMED   35603785
  REMARK    GeneRIF: Neonatal Scn1b-null mice have sinoatrial node dysfunction,
            altered atrial structure, and atrial fibrillation.
            Publication Status: Online-Only
REFERENCE   5  (residues 1 to 185)
  AUTHORS   Qin N, D'Andrea MR, Lubin ML, Shafaee N, Codd EE and Correa AM.
  TITLE     Molecular cloning and functional expression of the human sodium
            channel beta1B subunit, a novel splicing variant of the beta1
            subunit
  JOURNAL   Eur J Biochem 270 (23), 4762-4770 (2003)
   PUBMED   14622265
  REMARK    GeneRIF: identification and characterization of a novel splicing
            variant; functional studies in oocytes demonstrate that the beta1B
            subunit increases the ionic current when coexpressed with the
            tetrodotoxin sensitive channel, NaV1.2
REFERENCE   6  (residues 1 to 185)
  AUTHORS   Makita N, Sloan-Brown K, Weghuis DO, Ropers HH and George AL Jr.
  TITLE     Genomic organization and chromosomal assignment of the human
            voltage-gated Na+ channel beta 1 subunit gene (SCN1B)
  JOURNAL   Genomics 23 (3), 628-634 (1994)
   PUBMED   7851891
REFERENCE   7  (residues 1 to 185)
  AUTHORS   Makita N, Bennett PB Jr and George AL Jr.
  TITLE     Voltage-gated Na+ channel beta 1 subunit mRNA expressed in adult
            human skeletal muscle, heart, and brain is encoded by a single gene
  JOURNAL   J Biol Chem 269 (10), 7571-7578 (1994)
   PUBMED   8125980
REFERENCE   8  (residues 1 to 185)
  AUTHORS   McClatchey AI, Cannon SC, Slaugenhaupt SA and Gusella JF.
  TITLE     The cloning and expression of a sodium channel beta 1-subunit cDNA
            from human brain
  JOURNAL   Hum Mol Genet 2 (6), 745-749 (1993)
   PUBMED   8394762
REFERENCE   9  (residues 1 to 185)
  AUTHORS   Brugada,R., Campuzano,O., Sarquella-Brugada,G., Brugada,P.,
            Brugada,J. and Hong,K.
  TITLE     Brugada Syndrome
  JOURNAL   (in) Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW
            and Amemiya A (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   20301690
REFERENCE   10 (residues 1 to 185)
  AUTHORS   Hartshorne,R.P. and Catterall,W.A.
  TITLE     The sodium channel from rat brain. Purification and subunit
            composition
  JOURNAL   J Biol Chem 259 (3), 1667-1675 (1984)
   PUBMED   6319405
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC020907.6, DA062026.1 and
            BC067122.1.
            
            On Mar 29, 2016 this sequence version replaced XP_005259201.1.
            
            Summary: Voltage-gated sodium channels are heteromeric proteins
            that function in the generation and propagation of action
            potentials in muscle and neuronal cells. They are composed of one
            alpha and two beta subunits, where the alpha subunit provides
            channel activity and the beta-1 subunit modulates the kinetics of
            channel inactivation. This gene encodes a sodium channel beta-1
            subunit. Mutations in this gene result in generalized epilepsy with
            febrile seizures plus, Brugada syndrome 5, and defects in cardiac
            conduction. Multiple transcript variants encoding different
            isoforms have been found for this gene.[provided by RefSeq, Oct
            2009].
            
            Transcript Variant: This variant (c) encodes an isoform (c) that
            lacks a predicted signal peptide compared to isoforms a and b.
            
            Sequence Note: This RefSeq record was created from transcript and
            genomic sequence data to make the sequence consistent with the
            reference genome assembly. The genomic coordinates used for the
            transcript record were based on transcript alignments.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: SRR3476690.288786.1,
                                           SRR3476690.535438.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1968968, SAMEA2145313
                                           [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..185
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19q13.11"
     Protein         1..185
                     /product="sodium channel subunit beta-1 isoform c"
                     /note="sodium channel subunit beta-1; sodium channel,
                     voltage-gated, type I, beta; sodium channel, voltage
                     gated, type I beta subunit"
                     /calculated_mol_wt=21366
     Region          8..114
                     /region_name="V-set"
                     /note="Immunoglobulin V-set domain; pfam07686"
                     /db_xref="CDD:429596"
     Region          71..75
                     /region_name="Ig strand E"
                     /note="Ig strand E [structural motif]"
                     /db_xref="CDD:409353"
     Region          85..90
                     /region_name="Ig strand F"
                     /note="Ig strand F [structural motif]"
                     /db_xref="CDD:409353"
     CDS             1..185
                     /gene="SCN1B"
                     /gene_synonym="ATFB13; BRGDA5; DEE52; EIEE52; GEFSP1"
                     /coded_by="NM_001321605.2:570..1127"
                     /note="isoform c is encoded by transcript variant c"
                     /db_xref="CCDS:CCDS86744.1"
                     /db_xref="GeneID:6324"
                     /db_xref="HGNC:HGNC:10586"
                     /db_xref="MIM:600235"
ORIGIN      
        1 mtfkilcisc krrsetnaet ftewtfrqkg teefvkilry enevlqleed erfegrvvwn
       61 gsrgtkdlqd lsifitnvty nhsgdyechv yrllffenye hntsvvkkih ievvdkanrd
      121 masivseimm yvlivvltiw lvaemiycyk kiaaatetaa qenaseylai tseskenctg
      181 vqvae
//

LOCUS       CM3A_CONKI                22 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin KIIIB; Contains: RecName:
            Full=Mu-conotoxin KIIIA; Flags: Precursor.
ACCESSION   P0C195
VERSION     P0C195.2
DBSOURCE    UniProtKB: locus CM3A_CONKI, accession P0C195;
            class: standard.
            created: Apr 18, 2006.
            sequence updated: Nov 22, 2017.
            annotation updated: Feb 22, 2023.
            xrefs: 2LXG_A, 6J8E_D, 7SAV_A, 7SAW_A
            xrefs (non-sequence databases): PDBsum:2LXG, PDBsum:6J8E,
            PDBsum:7SAV, PDBsum:7SAW, AlphaFoldDB:P0C195, BMRB:P0C195,
            SMR:P0C195, TCDB:8.B.28.1.4, ConoServer:1694, GO:0005576,
            GO:0017080, GO:0090729
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues;
            Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Conus kinoshitai
  ORGANISM  Conus kinoshitai
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Afonsoconus.
REFERENCE   1  (residues 1 to 22)
  AUTHORS   Bulaj,G., West,P.J., Garrett,J.E., Watkins,M., Zhang,M.M.,
            Norton,R.S., Smith,B.J., Yoshikami,D. and Olivera,B.M.
  TITLE     Novel conotoxins from Conus striatus and Conus kinoshitai
            selectively block TTX-resistant sodium channels
  JOURNAL   Biochemistry 44 (19), 7259-7265 (2005)
   PUBMED   15882064
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 5-22, FUNCTION, SYNTHESIS OF 5-20,
            AND AMIDATION AT CYS-20.;
            TISSUE=Venom duct
            Erratum:[Biochemistry. 2006 Mar 7;45(9):3116. Marsh, Maren
            [corrected to Watkins, Maren]]
REFERENCE   2  (residues 1 to 22)
  AUTHORS   Bulaj,G., West,P.J., Garrett,J.E., Watkins,M., Zhang,M.-M.,
            Norton,R.S., Smith,B.J., Yoshikami,D. and Olivera,B.M.
  JOURNAL   Biochemistry 45, 3116-3116 (2006)
  REMARK    ERRATUM OF PUBMED:15882064.
            DOI: 10.1021/bi068001c
REFERENCE   3  (residues 1 to 22)
  AUTHORS   Zhang,M.M., Green,B.R., Catlin,P., Fiedler,B., Azam,L.,
            Chadwick,A., Terlau,H., McArthur,J.R., French,R.J., Gulyas,J.,
            Rivier,J.E., Smith,B.J., Norton,R.S., Olivera,B.M., Yoshikami,D.
            and Bulaj,G.
  TITLE     Structure/function characterization of micro-conotoxin KIIIA, an
            analgesic, nearly irreversible blocker of mammalian neuronal sodium
            channels
  JOURNAL   J Biol Chem 282 (42), 30699-30706 (2007)
   PUBMED   17724025
  REMARK    FUNCTION, SYNTHESIS OF 5-20, AND MUTAGENESIS OF LYS-11; TRP-12;
            ARG-14; ASP-15; HIS-16 AND ARG-18.
REFERENCE   4  (residues 1 to 22)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    FUNCTION, AND SYNTHESIS OF 5-20.
REFERENCE   5  (residues 1 to 22)
  AUTHORS   Zhang,M.M., McArthur,J.R., Azam,L., Bulaj,G., Olivera,B.M.,
            French,R.J. and Yoshikami,D.
  TITLE     Synergistic and antagonistic interactions between tetrodotoxin and
            mu-conotoxin in blocking voltage-gated sodium channels
  JOURNAL   Channels (Austin) 3 (1), 32-38 (2009)
   PUBMED   19221510
  REMARK    FUNCTION, AND MUTAGENESIS OF LYS-11.
REFERENCE   6  (residues 1 to 22)
  AUTHORS   Van Der Haegen,A., Peigneur,S. and Tytgat,J.
  TITLE     Importance of position 8 in mu-conotoxin KIIIA for voltage-gated
            sodium channel selectivity
  JOURNAL   FEBS J 278 (18), 3408-3418 (2011)
   PUBMED   21781281
  REMARK    FUNCTION, SYNTHESIS OF 5-20, AND MUTAGENESIS OF TRP-12.
REFERENCE   7  (residues 1 to 22)
  AUTHORS   McArthur,J.R., Singh,G., McMaster,D., Winkfein,R., Tieleman,D.P.
            and French,R.J.
  TITLE     Interactions of key charged residues contributing to selective
            block of neuronal sodium channels by mu-conotoxin KIIIA
  JOURNAL   Mol Pharmacol 80 (4), 573-584 (2011)
   PUBMED   21709136
  REMARK    FUNCTION, SYNTHESIS OF 5-20, AND MUTAGENESIS OF LYS-11; ARG-14;
            HIS-16 AND ARG-18.
REFERENCE   8  (residues 1 to 22)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION, AND SYNTHESIS OF 5-20.
REFERENCE   9  (residues 1 to 22)
  AUTHORS   Zhang,M.M., Wilson,M.J., Azam,L., Gajewiak,J., Rivier,J.E.,
            Bulaj,G., Olivera,B.M. and Yoshikami,D.
  TITLE     Co-expression of Na(V)beta subunits alters the kinetics of
            inhibition of voltage-gated sodium channels by pore-blocking
            mu-conotoxins
  JOURNAL   Br J Pharmacol 168 (7), 1597-1610 (2013)
   PUBMED   23146020
  REMARK    FUNCTION.
REFERENCE   10 (residues 1 to 22)
  AUTHORS   Murray,J.K., Ligutti,J., Liu,D., Zou,A., Poppe,L., Li,H.,
            Andrews,K.L., Moyer,B.D., McDonough,S.I., Favreau,P., Stocklin,R.
            and Miranda,L.P.
  TITLE     Engineering potent and selective analogues of GpTx-1, a tarantula
            venom peptide antagonist of the Na(V)1.7 sodium channel
  JOURNAL   J Med Chem 58 (5), 2299-2314 (2015)
   PUBMED   25658507
  REMARK    FUNCTION.
REFERENCE   11 (residues 1 to 22)
  AUTHORS   Khoo,K.K., Feng,Z.P., Smith,B.J., Zhang,M.M., Yoshikami,D.,
            Olivera,B.M., Bulaj,G. and Norton,R.S.
  TITLE     Structure of the analgesic mu-conotoxin KIIIA and effects on the
            structure and function of disulfide deletion
  JOURNAL   Biochemistry 48 (6), 1210-1219 (2009)
   PUBMED   19170536
  REMARK    STRUCTURE BY NMR OF 5-20 (MU-CONOTOXIN KIIIA), SYNTHESIS OF 5-20,
            SUBUNIT, AND MUTAGENESIS OF CYS-5 AND CYS-13.
REFERENCE   12 (residues 1 to 22)
  AUTHORS   Khoo,K.K., Gupta,K., Green,B.R., Zhang,M.M., Watkins,M.,
            Olivera,B.M., Balaram,P., Yoshikami,D., Bulaj,G. and Norton,R.S.
  TITLE     Distinct disulfide isomers of mu-conotoxins KIIIA and KIIIB block
            voltage-gated sodium channels
  JOURNAL   Biochemistry 51 (49), 9826-9835 (2012)
   PUBMED   23167564
  REMARK    STRUCTURE BY NMR OF 3-20 AND 5-20 (MU-CONOTOXIN KIIIA AND KIIIB),
            SYNTHESIS OF 3-20 AND 5-20, FUNCTION, AND DISULFIDE BOND OF
            SYNTHETIC PEPTIDES (P1 AND P2).
REFERENCE   13 (residues 1 to 22)
  AUTHORS   Pan,X., Li,Z., Huang,X., Huang,G., Gao,S., Shen,H., Liu,L., Lei,J.
            and Yan,N.
  TITLE     Molecular basis for pore blockade of human Na(+) channel Nav1.2 by
            the mu-conotoxin KIIIA
  JOURNAL   Science 363 (6433), 1309-1313 (2019)
   PUBMED   30765605
  REMARK    STRUCTURE BY ELECTRON MICROSCOPY (3.0 ANGSTROMS) OF 5-20
            (MU-CONOTOXIN KIIIA) IN COMPLEX WITH SUBUNITS ALPHA AND BETA-2 OF
            NAV1.2, AND DISULFIDE BOND.
REFERENCE   14 (residues 1 to 22)
  AUTHORS   Tran,H.N.T., McMahon,K.L., Deuis,J.R., Vetter,I. and Schroeder,C.I.
  TITLE     Structural and functional insights into the inhibition of human
            voltage-gated sodium channels by mu-conotoxin KIIIA disulfide
            isomers
  JOURNAL   J Biol Chem 298 (3), 101728 (2022)
   PUBMED   35167877
  REMARK    STRUCTURE BY NMR OF 5-20, FUNCTION, SYNTHESIS OF 5-20, DISULFIDE
            BOND OF SYNTHETIC PEPTIDES (P1; P2 AND N), AND 3D-STRUCTURE
            MODELING IN COMPLEX WITH SODIUM CHANNEL NAV12/SCN2A.
COMMENT     On Nov 24, 2017 this sequence version replaced P0C195.1.
            [FUNCTION] Mu-conotoxin KIIIA-P1: mu-conotoxins block voltage-gated
            sodium channels (Nav). This toxin potently blocks Nav1.2/SCN2A
            (IC(50)5-124 nM), Nav1.4/SCN4A (IC(50)=20-90 nM), and Nav1.7/SCN9A
            (IC(50)=290-413 nM) (PubMed:17724025, PubMed:19221510,
            PubMed:21781281, PubMed:21709136, PubMed:21652775, PubMed:23146020,
            PubMed:25658507, PubMed:35167877). It moderately blocks
            Nav1.1/SCN1A, and mNav1.6/SCN8A (PubMed:17724025, PubMed:21781281,
            PubMed:21709136, PubMed:21652775, PubMed:23146020, PubMed:25658507,
            PubMed:35167877). It also shows a very low activity on Nav1.3/SCN3A
            (PubMed:17724025, PubMed:21781281). This toxin binds a microsite
            within the pore different from the tetrodotoxin binding site 1
            (tested on Nav1.2) (PubMed:19221510). The block is partial, with a
            residual current that can be completely blocked by TTX
            (PubMed:19221510). The toxin probably docks at a more superficial
            site in the outer vestibule of the channel than does TTX
            (PubMed:19221510). On rNav1.2/SCN2A, it produces a block that is
            only partially reversible. The block of Nav1.7 is modified when
            beta-subunits are coexpressed with the alpha subunit
            (PubMed:23146020). Hence, blocks of channels containing beta-1 and
            beta-3 subunits are more potent (compared to channels without beta
            subunits), whereas blocks of channels containing beta-2 and beta-4
            subunits are less potent (compared to channels without beta
            subunits) (PubMed:23146020). {ECO:0000269|PubMed:15882064,
            ECO:0000269|PubMed:17724025, ECO:0000269|PubMed:18950653,
            ECO:0000269|PubMed:19221510, ECO:0000269|PubMed:21652775,
            ECO:0000269|PubMed:21709136, ECO:0000269|PubMed:21781281,
            ECO:0000269|PubMed:23146020, ECO:0000269|PubMed:25658507}.
            [FUNCTION] Mu-conotoxin KIIIA-P2: This toxin potently blocks
            Nav1.2/SCN2A (Kd=230 nM, IC(50)=1.37 uM) and Nav1.4/SCN4A (Kd=830
            nM, IC(50)=2 uM). It also moderately blocks Nav1.7/SCN9A (Kd=1.57
            uM, IC(50)=5.4 uM) (PubMed:35167877, PubMed:23167564). In addition,
            this toxin may also inhibit other sodium channels, as does
            Mu-conotoxin KIIIA-P1 (PubMed:23167564).
            {ECO:0000269|PubMed:23167564, ECO:0000269|PubMed:35167877}.
            [FUNCTION] Mu-conotoxin KIIIA-N: This toxin moderately blocks
            Nav1.2/SCN2A (IC(50)=875 nM), Nav1.4/SCN4A (IC(50)=472 nM), and
            Nav1.7/SCN9A (IC(50)=887 nM) (PubMed:35167877).
            {ECO:0000269|PubMed:35167877}.
            [FUNCTION] Mu-conotoxin KIIIB-P1: This toxin potently blocks
            Nav1.2/SCN2A (Kd=470 nM). In addition, this toxin may also inhibit
            other sodium channels, as does Mu-conotoxin KIIIA-P1.
            {ECO:0000269|PubMed:23167564}.
            [FUNCTION] Mu-conotoxin KIIIB-P2: This toxin potently blocks
            Nav1.2/SCN2A (Kd=26 nM). In addition, this toxin may also inhibit
            other sodium channels, as does Mu-conotoxin KIIIA-P1.
            {ECO:0000269|PubMed:23167564}.
            [SUBUNIT] Monomer. {ECO:0000269|PubMed:19170536}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:15882064}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:15882064}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [PTM] Toxins with three different disulfide connectivities have
            been synthesized (PubMed:35167877, PubMed:23167564). The conotoxin
            mu-KIIIA-P1 shows the connectivity C1-C5, C2-C4, and C3-C6, whereas
            mu-KIIIA-P2 shows the connectivity C1-C6, C2-C4, and C3-C5
            (PubMed:23167564). The conotoxin mu-KIIIA-N has the 'native' fold
            of the mu-conotoxin family (C1-C4, C2-C5, and C3-C6)
            (PubMed:35167877). Mu-KIIIA-P1 and mu-KIIIA-P2 are obtained by both
            thermodynamic oxidative folding and regioselective synthesis
            (PubMed:35167877, PubMed:23167564). Mu-KIIIA-P1 is the major
            oxidative folding product (PubMed:23167564). Mu-KIIIA-N is only
            obtained by regioselective synthesis (PubMed:35167877).
            {ECO:0000269|PubMed:23167564, ECO:0000269|PubMed:35167877}.
            [MISCELLANEOUS] Negative results: has no effect on hNav1.5/SCN5A
            (PubMed:17724025, PubMed:21781281, PubMed:25658507). Has no effect
            on hNav1.8/SCN10A (PubMed:21781281). {ECO:0000269|PubMed:21781281,
            ECO:0000269|PubMed:25658507}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..22
                     /organism="Conus kinoshitai"
                     /db_xref="taxon:376876"
     Protein         <1..22
                     /product="Mu-conotoxin KIIIB"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          <1..2
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:23167564.
                     /id=PRO_0000442339."
     Region          3..20
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin KIIIB.
                     /evidence=ECO:0000305|PubMed:23167564.
                     /id=PRO_0000442340."
     Region          5..20
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin KIIIA.
                     /evidence=ECO:0000305|PubMed:15882064.
                     /id=PRO_0000232662."
     Bond            bond(5,20)
                     /bond_type="disulfide"
                     /note="in KIIIA-P2 and KIIIB-P1; alternate.
                     /evidence=ECO:0000305|PubMed:23167564."
     Bond            bond(5,19)
                     /bond_type="disulfide"
                     /note="in KIIIA-P1 and KIIIB-P2; alternate.
                     /evidence=ECO:0000305|PubMed:23167564,
                     ECO:0000305|PubMed:30765605, ECO:0007744|PDB:2LXG,
                     ECO:0007744|PDB:6J8E."
     Bond            bond(5,13)
                     /bond_type="disulfide"
                     /note="in KIIIA-M; alternate.
                     /evidence=ECO:0000305|PubMed:35167877."
     Site            5
                     /site_type="mutagenized"
                     /note="C->A: Structure similar to wild-type toxin, even
                     with this disulfide bond deletion.
                     /evidence=ECO:0000269|PubMed:19170536."
     Bond            bond(6,19)
                     /bond_type="disulfide"
                     /note="in KIIIA-M; alternate.
                     /evidence=ECO:0000305|PubMed:35167877."
     Bond            bond(6,13)
                     /bond_type="disulfide"
                     /note="in KIIIA-P1, KIIIA-P2, KIIIB-P1 and KIIIB-P2;
                     alternate. /evidence=ECO:0000305|PubMed:23167564,
                     ECO:0000305|PubMed:30765605, ECO:0007744|PDB:2LXG,
                     ECO:0007744|PDB:6J8E."
     Site            7
                     /site_type="other"
                     /note="Pharmacophore key residue.
                     /evidence=ECO:0000305|PubMed:30765605."
     Bond            bond(8,20)
                     /bond_type="disulfide"
                     /note="in KIIIA-P1, KIIIB-P2 and KIIIA-M; alternate.
                     /evidence=ECO:0000305|PubMed:23167564,
                     ECO:0000305|PubMed:30765605, ECO:0007744|PDB:2LXG,
                     ECO:0007744|PDB:6J8E."
     Bond            bond(8,19)
                     /bond_type="disulfide"
                     /note="in KIIIA-P2 and KIIIB-P1; alternate.
                     /evidence=ECO:0000305|PubMed:23167564."
     Region          11..16
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6J8E."
     Site            11
                     /site_type="mutagenized"
                     /note="K->A: Decrease in ability to block Nav1.3, Nav1.4,
                     Nav1.6 and Nav1.7, but not Nav1.2. 21-fold decrease in
                     binding affinity for Nav1.2.
                     /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:19221510, ECO:0000269|PubMed:21709136."
     Site            11
                     /site_type="other"
                     /note="Pharmacophore key residue, the side chain functions
                     like a cork in the bottleneck, with the positively charged
                     amine group preventing the penetration of sodium.
                     /evidence=ECO:0000305|PubMed:30765605."
     Site            12
                     /site_type="other"
                     /note="Pharmacophore key residue.
                     /evidence=ECO:0000305|PubMed:30765605."
     Site            12
                     /site_type="mutagenized"
                     /note="W->A: Decrease in ability to block both Nav1.2 and
                     Nav1.4. Decrease in binding affinity for Nav1.2, Nav1.4,
                     and Nav1.7. /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21781281."
     Site            12
                     /site_type="mutagenized"
                     /note="W->E: 200-fold decrease in ability to block Nav1.4.
                     Block of Nav1.2 is completely reversible.
                     /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21781281."
     Site            12
                     /site_type="mutagenized"
                     /note="W->Q: 70-fold decrease in ability to block Nav1.4.
                     Block of Nav1.2 is completely reversible.
                     /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21781281."
     Site            12
                     /site_type="mutagenized"
                     /note="W->R: 40-fold decrease in ability to block Nav1.4.
                     Block of Nav1.2 is completely reversible.
                     /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21781281."
     Site            13
                     /site_type="mutagenized"
                     /note="C->A: Structure similar to wild-type toxin, even
                     with this disulfide bond deletion.
                     /evidence=ECO:0000269|PubMed:19170536."
     Region          14..16
                     /region_name="Region of interest in the sequence"
                     /note="Pharmacophore key residues.
                     /evidence=ECO:0000305|PubMed:17724025,
                     ECO:0000305|PubMed:30765605."
     Site            14
                     /site_type="mutagenized"
                     /note="R->A: Decrease in ability to block both Nav1.4 and
                     Nav1.2, and decrease in binding affinity for Nav1.2,
                     Nav1.4, and Nav1.7. /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21709136."
     Site            15
                     /site_type="mutagenized"
                     /note="D->A: Decrease in ability to inhibit both Nav1.4
                     and Nav1.2. /evidence=ECO:0000269|PubMed:17724025."
     Site            16
                     /site_type="mutagenized"
                     /note="H->A: Decrease in ability to inhibit both Nav1.4
                     and Nav1.2, and potently decreases the binding affinity
                     for Nav1.2, Nav1.4, and Nav1.7.
                     /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21709136."
     Region          18..19
                     /region_name="Region of interest in the sequence"
                     /note="Pharmacophore key residues.
                     /evidence=ECO:0000305|PubMed:17724025,
                     ECO:0000305|PubMed:30765605."
     Site            18
                     /site_type="mutagenized"
                     /note="R->A: Decrease in ability to inhibit both Nav1.4
                     and Nav1.2, and the binding affinity for Nav1.2, Nav1.4,
                     and Nav1.7. /evidence=ECO:0000269|PubMed:17724025,
                     ECO:0000269|PubMed:21709136."
     Site            20
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:15882064."
ORIGIN      
        1 krngccncss kwcrdhsrcc gr
//

LOCUS       SCX7_ANDCR                67 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Putative sodium channel alpha-toxin Acra7; Flags:
            Precursor.
ACCESSION   M1JB54
VERSION     M1JB54.1
DBSOURCE    UniProtKB: locus SCX7_ANDCR, accession M1JB54;
            class: standard.
            created: Apr 1, 2015.
            sequence updated: May 1, 2013.
            annotation updated: Feb 22, 2023.
            xrefs: JQ975129.1, AGE83106.1
            xrefs (non-sequence databases): AlphaFoldDB:M1JB54, SMR:M1JB54,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Androctonus crassicauda
  ORGANISM  Androctonus crassicauda
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
REFERENCE   1  (residues 1 to 67)
  AUTHORS   Caliskan,F., Quintero-Hernandez,V., Restano-Cassulini,R.,
            Coronas-Valderrama,F.I., Corzo,G. and Possani,L.D.
  TITLE     Molecular cloning and biochemical characterization of the first
            Na(+)-channel alpha-type toxin peptide (Acra4) from Androctonus
            crassicauda scorpion venom
  JOURNAL   Biochimie 95 (6), 1216-1222 (2013)
   PUBMED   23395751
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..67
                     /organism="Androctonus crassicauda"
                     /db_xref="taxon:122909"
     Protein         1..67
                     /product="Putative sodium channel alpha-toxin Acra7"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..66
                     /region_name="Mature chain"
                     /note="Putative sodium channel alpha-toxin Acra7.
                     /id=PRO_5001113086."
     Region          2..66
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..56
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,37)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(23,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(27,49)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          67
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000250|UniProtKB:P01480.
                     /id=PRO_0000432479."
ORIGIN      
        1 vrdgyivkpt ncvihcipfs pgcdkdckek gaasgycqaf gkhgngcwci dlpdkvpikd
       61 pnqdctr
//

LOCUS       SCX5_ANDCR                67 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Putative sodium channel alpha-toxin Acra5; Flags:
            Precursor.
ACCESSION   M1J7U4
VERSION     M1J7U4.1
DBSOURCE    UniProtKB: locus SCX5_ANDCR, accession M1J7U4;
            class: standard.
            created: Apr 1, 2015.
            sequence updated: May 1, 2013.
            annotation updated: Feb 22, 2023.
            xrefs: JQ975127.1, AGE83104.1
            xrefs (non-sequence databases): AlphaFoldDB:M1J7U4, SMR:M1J7U4,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Androctonus crassicauda
  ORGANISM  Androctonus crassicauda
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
REFERENCE   1  (residues 1 to 67)
  AUTHORS   Caliskan,F., Quintero-Hernandez,V., Restano-Cassulini,R.,
            Coronas-Valderrama,F.I., Corzo,G. and Possani,L.D.
  TITLE     Molecular cloning and biochemical characterization of the first
            Na(+)-channel alpha-type toxin peptide (Acra4) from Androctonus
            crassicauda scorpion venom
  JOURNAL   Biochimie 95 (6), 1216-1222 (2013)
   PUBMED   23395751
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..67
                     /organism="Androctonus crassicauda"
                     /db_xref="taxon:122909"
     Protein         1..67
                     /product="Putative sodium channel alpha-toxin Acra5"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..66
                     /region_name="Mature chain"
                     /note="Putative sodium channel alpha-toxin Acra5.
                     /id=PRO_5001112794."
     Region          2..65
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..54
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(13,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(17,40)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(30,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          67
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000250|UniProtKB:P01480.
                     /id=PRO_0000432478."
ORIGIN      
        1 vrdgyimikd tnckfscnif kkweycsplc qskgaetgyc ynfgcwcldl pddvpvygdr
       61 gvicrtr
//

LOCUS       TXPR2_THRPR               30 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta/omega-theraphotoxin-Tp2a;
            Short=Beta/omega-TRTX-Tp2a; AltName: Full=Protoxin-2;
            Short=ProTx-2; Short=ProTx2; AltName: Full=Protoxin-II;
            Short=PT-II; Short=ProTx-II.
ACCESSION   P83476
VERSION     P83476.1
DBSOURCE    UniProtKB: locus TXPR2_THRPR, accession P83476;
            class: standard.
            created: Nov 15, 2002.
            sequence updated: Nov 15, 2002.
            annotation updated: Feb 22, 2023.
            xrefs: 2N9T_A, 5O0U_A, 5TCZ_A, 6MK4_A, 6N4I_E, 6N4I_F, 6N4I_G,
            6N4I_H, 6N4Q_E, 6N4Q_F, 6N4Q_G, 6N4Q_H, 6N4R_E, 6N4R_F, 6N4R_G,
            6N4R_H
            xrefs (non-sequence databases): PDBsum:2N9T, PDBsum:5O0U,
            PDBsum:5TCZ, PDBsum:6MK4, PDBsum:6N4I, PDBsum:6N4Q, PDBsum:6N4R,
            AlphaFoldDB:P83476, BMRB:P83476, SMR:P83476, TCDB:8.B.5.2.1,
            ArachnoServer:AS000414, GO:0005576, GO:0005246, GO:0008289,
            GO:0017080, GO:0090729, SUPFAM:SSF57059
KEYWORDS    3D-structure; Calcium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Knottin;
            Lipid-binding; Neurotoxin; Pharmaceutical; Secreted; Toxin;
            Voltage-gated calcium channel impairing toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Thrixopelma pruriens
  ORGANISM  Thrixopelma pruriens
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Thrixopelma.
REFERENCE   1  (residues 1 to 30)
  AUTHORS   Middleton,R.E., Warren,V.A., Kraus,R.L., Hwang,J.C., Liu,C.J.,
            Dai,G., Brochu,R.M., Kohler,M.G., Gao,Y.D., Garsky,V.M.,
            Bogusky,M.J., Mehl,J.T., Cohen,C.J. and Smith,M.M.
  TITLE     Two tarantula peptides inhibit activation of multiple sodium
            channels
  JOURNAL   Biochemistry 41 (50), 14734-14747 (2002)
   PUBMED   12475222
  REMARK    PROTEIN SEQUENCE, SYNTHESIS, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND DISULFIDE BONDS.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 30)
  AUTHORS   Smith,J.J., Alphy,S., Seibert,A.L. and Blumenthal,K.M.
  TITLE     Differential phospholipid binding by site 3 and site 4 toxins.
            Implications for structural variability between voltage-sensitive
            sodium channel domains
  JOURNAL   J Biol Chem 280 (12), 11127-11133 (2005)
   PUBMED   15632158
  REMARK    FUNCTION.
REFERENCE   3  (residues 1 to 30)
  AUTHORS   Smith,J.J., Cummins,T.R., Alphy,S. and Blumenthal,K.M.
  TITLE     Molecular interactions of the gating modifier toxin ProTx-II with
            NaV 1.5: implied existence of a novel toxin binding site coupled to
            activation
  JOURNAL   J Biol Chem 282 (17), 12687-12697 (2007)
   PUBMED   17339321
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 30)
  AUTHORS   Priest,B.T., Blumenthal,K.M., Smith,J.J., Warren,V.A. and
            Smith,M.M.
  TITLE     ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium
            channels
  JOURNAL   Toxicon 49 (2), 194-201 (2007)
   PUBMED   17087985
  REMARK    FUNCTION, SYNTHESIS, AND MUTAGENESIS OF TYR-1; GLN-3; TRP-5; MET-6;
            TRP-7; THR-8; ASP-10; SER-11; GLU-12; LEU-23 AND TRP-24.
REFERENCE   5  (residues 1 to 30)
  AUTHORS   Sokolov,S., Kraus,R.L., Scheuer,T. and Catterall,W.A.
  TITLE     Inhibition of sodium channel gating by trapping the domain II
            voltage sensor with protoxin II
  JOURNAL   Mol Pharmacol 73 (3), 1020-1028 (2008)
   PUBMED   18156314
  REMARK    FUNCTION.
REFERENCE   6  (residues 1 to 30)
  AUTHORS   Schmalhofer,W.A., Calhoun,J., Burrows,R., Bailey,T., Kohler,M.G.,
            Weinglass,A.B., Kaczorowski,G.J., Garcia,M.L., Koltzenburg,M. and
            Priest,B.T.
  TITLE     ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks
            action potential propagation in nociceptors
  JOURNAL   Mol Pharmacol 74 (5), 1476-1484 (2008)
   PUBMED   18728100
  REMARK    FUNCTION.
REFERENCE   7  (residues 1 to 30)
  AUTHORS   Edgerton,G.B., Blumenthal,K.M. and Hanck,D.A.
  TITLE     Evidence for multiple effects of ProTxII on activation gating in
            Na(V)1.5
  JOURNAL   Toxicon 52 (3), 489-500 (2008)
   PUBMED   18657562
  REMARK    FUNCTION.
REFERENCE   8  (residues 1 to 30)
  AUTHORS   Xiao,Y., Blumenthal,K., Jackson,J.O. 2nd, Liang,S. and Cummins,T.R.
  TITLE     The tarantula toxins ProTx-II and huwentoxin-IV differentially
            interact with human Nav1.7 voltage sensors to inhibit channel
            activation and inactivation
  JOURNAL   Mol Pharmacol 78 (6), 1124-1134 (2010)
   PUBMED   20855463
  REMARK    FUNCTION.
REFERENCE   9  (residues 1 to 30)
  AUTHORS   Edgerton,G.B., Blumenthal,K.M. and Hanck,D.A.
  TITLE     Inhibition of the activation pathway of the T-type calcium channel
            Ca(V)3.1 by ProTxII
  JOURNAL   Toxicon 56 (4), 624-636 (2010)
   PUBMED   20600227
  REMARK    FUNCTION ON CAV3.1 CALCIUM CHANNEL.
REFERENCE   10 (residues 1 to 30)
  AUTHORS   Gilchrist,J., Das,S., Van Petegem,F. and Bosmans,F.
  TITLE     Crystallographic insights into sodium-channel modulation by the
            beta4 subunit
  JOURNAL   Proc Natl Acad Sci U S A 110 (51), E5016-E5024 (2013)
   PUBMED   24297919
  REMARK    FUNCTION.
REFERENCE   11 (residues 1 to 30)
  AUTHORS   Bladen,C., Hamid,J., Souza,I.A. and Zamponi,G.W.
  TITLE     Block of T-type calcium channels by protoxins I and II
  JOURNAL   Mol Brain 7, 36 (2014)
   PUBMED   24886690
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   12 (residues 1 to 30)
  AUTHORS   Kikuchi,K., Sugiura,M. and Kimura,T.
  TITLE     High Proteolytic Resistance of Spider-Derived Inhibitor Cystine
            Knots
  JOURNAL   Int J Pept 2015, 537508 (2015)
   PUBMED   26843868
  REMARK    DOMAIN.
REFERENCE   13 (residues 1 to 30)
  AUTHORS   Murray,J.K., Ligutti,J., Liu,D., Zou,A., Poppe,L., Li,H.,
            Andrews,K.L., Moyer,B.D., McDonough,S.I., Favreau,P., Stocklin,R.
            and Miranda,L.P.
  TITLE     Engineering potent and selective analogues of GpTx-1, a tarantula
            venom peptide antagonist of the Na(V)1.7 sodium channel
  JOURNAL   J Med Chem 58 (5), 2299-2314 (2015)
   PUBMED   25658507
  REMARK    FUNCTION.
REFERENCE   14 (residues 1 to 30)
  AUTHORS   Das,S., Gilchrist,J., Bosmans,F. and Van Petegem,F.
  TITLE     Binary architecture of the Nav1.2-beta2 signaling complex
  JOURNAL   Elife 5, e10960 (2016)
   PUBMED   26894959
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   15 (residues 1 to 30)
  AUTHORS   Flinspach,M., Xu,Q., Piekarz,A.D., Fellows,R., Hagan,R., Gibbs,A.,
            Liu,Y., Neff,R.A., Freedman,J., Eckert,W.A., Zhou,M., Bonesteel,R.,
            Pennington,M.W., Eddinger,K.A., Yaksh,T.L., Hunter,M., Swanson,R.V.
            and Wickenden,A.D.
  TITLE     Insensitivity to pain induced by a potent selective closed-state
            Nav1.7 inhibitor
  JOURNAL   Sci Rep 7, 39662 (2017)
   PUBMED   28045073
  REMARK    PHARMACEUTICAL, AND MUTAGENESIS OF TYR-1; TRP-7 AND TRP-30.
            Publication Status: Online-Only
REFERENCE   16 (residues 1 to 30)
  AUTHORS   Nicolas,S., Zoukimian,C., Bosmans,F., Montnach,J., Diochot,S.,
            Cuypers,E., De Waard,S., Beroud,R., Mebs,D., Craik,D., Boturyn,D.,
            Lazdunski,M., Tytgat,J. and De Waard,M.
  TITLE     Chemical Synthesis, Proper Folding, Nav Channel Selectivity Profile
            and Analgesic Properties of the Spider Peptide Phlotoxin 1
  JOURNAL   Toxins (Basel) 11 (6), E367 (2019)
   PUBMED   31234412
  REMARK    FUNCTION ON NAV1.7/SCN9A, AND SYNTHESIS.
            Publication Status: Online-Only
REFERENCE   17 (residues 1 to 30)
  AUTHORS   Park,J.H., Carlin,K.P., Wu,G., Ilyin,V.I., Musza,L.L., Blake,P.R.
            and Kyle,D.J.
  TITLE     Studies examining the relationship between the chemical structure
            of protoxin II and its activity on voltage gated sodium channels
  JOURNAL   J Med Chem 57 (15), 6623-6631 (2014)
   PUBMED   25026046
  REMARK    STRUCTURE BY NMR, FUNCTION, AND MUTAGENESIS OF GLU-12 AND MET-19.
REFERENCE   18 (residues 1 to 30)
  AUTHORS   Henriques,S.T., Deplazes,E., Lawrence,N., Cheneval,O., Chaousis,S.,
            Inserra,M., Thongyoo,P., King,G.F., Mark,A.E., Vetter,I.,
            Craik,D.J. and Schroeder,C.I.
  TITLE     Interaction of Tarantula Venom Peptide ProTx-II with Lipid
            Membranes Is a Prerequisite for Its Inhibition of Human
            Voltage-gated Sodium Channel NaV1.7
  JOURNAL   J Biol Chem 291 (33), 17049-17065 (2016)
   PUBMED   27311819
  REMARK    STRUCTURE BY NMR, DISULFIDE BOND, SYNTHESIS, AND MUTAGENESIS OF
            LYS-4; TRP-5; TRP-7; LYS-14; GLU-17; TRP-24; LYS-26; LYS-27; LYS-28
            AND TRP-30.
REFERENCE   19 (residues 1 to 30)
  AUTHORS   Xu,H., Li,T., Rohou,A., Arthur,C.P., Tzakoniati,F., Wong,E.,
            Estevez,A., Kugel,C., Franke,Y., Chen,J., Ciferri,C., Hackos,D.H.,
            Koth,C.M. and Payandeh,J.
  TITLE     Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider
            Toxin
  JOURNAL   Cell 176 (4), 702-715 (2019)
   PUBMED   30661758
  REMARK    X-RAY CRYSTALLOGRAPHY (3.54 ANGSTROMS) IN COMPLEX WITH
            VOLTAGE-SENSING DOMAIN OF HUMAN NAV1.7 (SCN9A) IN A MEMBRANE-LIKE
            ENVIRONMENT, STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS),
            MUTAGENESIS OF ARG-22 AND LYS-26, AND DISULFIDE BOND.
            Erratum:[Cell. 2019 Feb 21;176(5):1238-1239. PMID: 30794776]
REFERENCE   20 (residues 1 to 30)
  AUTHORS   Shen,H., Liu,D., Wu,K., Lei,J. and Yan,N.
  TITLE     Structures of human Nav1.7 channel in complex with auxiliary
            subunits and animal toxins
  JOURNAL   Science 363 (6433), 1303-1308 (2019)
   PUBMED   30765606
  REMARK    STRUCTURE BY ELECTRON MICROSCOPY (3.2 ANGSTROMS) IN COMPLEX WITH
            SCN9A; SCN1B AND SCN2B, AND FUNCTION.
COMMENT     [FUNCTION] Gating-modifier toxin that targets voltage-gated sodium
            channels with a selective activity on Nav1.7/SCN9A (IC(50)=1-1.5
            nM) (PubMed:25026046, PubMed:31234412). It inhibits both activation
            and inactivation (PubMed:20855463). For inhibition of activation,
            it is 100-fold more selective for Nav1.7/SCN9A (IC(50)=0.26-3) than
            for other sodium channels (Nav1.2/SCN2A (IC(50)=40-540 nM),
            Nav1.3/SCN3A (IC(50)=102 nM), Nav1.4/SCN4A (IC(50)=30-39 nM),
            Nav1.5/SCN5A (IC(50)=19-90 nM), Nav1.6/SCN8A (IC(50)=26 nM), and
            Nav1.8/SCN10A (IC(50)=146 nM)) (PubMed:12475222, PubMed:17087985,
            PubMed:18156314, PubMed:18728100, PubMed:20855463, PubMed:25658507,
            PubMed:27311819, PubMed:30661758). For inhibition of inactivation,
            it is 20-fold more potent in inhibiting inactivation on
            Nav1.7/SCN9A (IC(50)=250 nM) than other channels (about 4.6 uM for
            all channels) (PubMed:20855463). It also weakly inhibits
            Cav1.2/CACNA1C and Cav3.2/CACNA1H (29% block at 1 uM)
            (PubMed:17087985, PubMed:20600227, PubMed:24886690). It inhibits
            Nav1.7/SCN9A activation by interacting with DII and impairs
            Nav1.7/SCN9A inactivation by interacting with DIV
            (PubMed:20855463). It docks on top of the DII S3 helix Nav1.7/SCN9A
            (PubMed:30661758, PubMed:30765606). It is about 60-fold less active
            on Nav1.7/SCN9A at depolarized potential (0 mV; IC(50)=15 nM),
            compared to -120 mV potential (IC(50)=0.26 nM) (PubMed:30661758).
            This toxin binds to lipid membrane (PubMed:15632158,
            PubMed:27311819). This ability correlates with hNav1.7/SCN9A
            inhibition, showing that membrane binding is the first step in the
            inhibitory mechanism of this toxin (PubMed:27311819). It inhibits
            Nav1.2/SCN2A less potently when it is coexpressed with SCN2B or
            SCN4B than when it is expressed alone, showing that beta subunits
            (SCN2B and SCN4B) have a protective effect (PubMed:24297919,
            PubMed:26894959). {ECO:0000269|PubMed:12475222,
            ECO:0000269|PubMed:15632158, ECO:0000269|PubMed:17087985,
            ECO:0000269|PubMed:17339321, ECO:0000269|PubMed:18156314,
            ECO:0000269|PubMed:18657562, ECO:0000269|PubMed:18728100,
            ECO:0000269|PubMed:20855463, ECO:0000269|PubMed:24886690,
            ECO:0000269|PubMed:25658507, ECO:0000269|PubMed:26894959,
            ECO:0000269|PubMed:27311819, ECO:0000269|PubMed:30765606}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12475222}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:12475222}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:27311819}.
            [MASS SPECTROMETRY] Mass=3827; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12475222}.
            [MASS SPECTROMETRY] Mass=3827; Method=MALDI;
            Evidence={ECO:0000269|PubMed:12475222}.
            [PHARMACEUTICAL] The derivative JNJ63955918 (Y1GPY; W7Q; W30L) is
            under preclinical trial by Janssen Pharmaceutica as a non-opioid
            alternative for the pharmacological treatment of severe pain.
            {ECO:0000269|PubMed:28045073}.
            [MISCELLANEOUS] The ability to inhibit Nav1.7/SCN9A is greatly
            enhances by unatural modifications such as C-terminal amidation
            (5-fold) or C-terminal addition of -NHCH3 (25-fold). Such
            modifications also improve the ability to inhibit Nav1.2/SCN2A, but
            the selectivity for Nav1.7/SCN9A over Nav1.2/SCN2A is retained.
            {ECO:0000269|PubMed:25026046}.
            [MISCELLANEOUS] Highly resistant to proteases, such as pepsin,
            trypsin, chymotrypsin and elastase. The toxin is not degraded in
            the plasma and shows fast clearance from the circulation.
            {ECO:0000269|PubMed:26843868}.
            [MISCELLANEOUS] Negative results: does not inhibit Kv1.2/KCNA2,
            Kv1.3/KCNA3, Kv1.5/KCNA5, and Kv2.1/KCNB1 channels
            (PubMed:12475222). Weakly inhibits calcium channels hCav3.1/CACNA1G
            (9% inhibition at 1 uM or 81% at 5 uM) and hCav3.3/CACNA1I (8.9%
            inhibition at 1 uM) (PubMed:24886690).
            {ECO:0000269|PubMed:12475222, ECO:0000269|PubMed:24886690}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..30
                     /organism="Thrixopelma pruriens"
                     /db_xref="taxon:213387"
     Protein         1..30
                     /product="Beta/omega-theraphotoxin-Tp2a"
                     /note="Beta/omega-TRTX-Tp2a; Protoxin-2; Protoxin-II;
                     ProTx-2; ProTx2; PT-II; ProTx-II"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..30
                     /region_name="Processed active peptide"
                     /note="Beta/omega-theraphotoxin-Tp2a.
                     /evidence=ECO:0000269|PubMed:12475222.
                     /id=PRO_0000044556."
     Site            1
                     /site_type="mutagenized"
                     /note="Y->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            1
                     /site_type="mutagenized"
                     /note="Y->GPY: Important increase in selectivity for
                     Nav1.7/SCN9A; derivative JNJ63955918.
                     /evidence=ECO:0000269|PubMed:28045073."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12475222,
                     ECO:0000269|PubMed:27311819, ECO:0000269|PubMed:30661758,
                     ECO:0000312|PDB:2N9T, ECO:0000312|PDB:5O0U,
                     ECO:0000312|PDB:5TCZ, ECO:0000312|PDB:6N4I,
                     ECO:0000312|PDB:6N4Q, ECO:0000312|PDB:6N4R."
     Site            3
                     /site_type="mutagenized"
                     /note="Q->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            4
                     /site_type="mutagenized"
                     /note="K->R: In K/R, 30-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. In K/R,E17K, 110-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. /evidence=ECO:0000269|PubMed:27311819."
     Region          5..7
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2N9T."
     Site            5
                     /site_type="other"
                     /note="Part of an aromatic-rich surface that anchors the
                     toxin toward the membrane core relative to lipid
                     headgroups bound along the pore module of Nav1.7/SCN9A.
                     /evidence=ECO:0000305|PubMed:30661758."
     Site            5
                     /site_type="mutagenized"
                     /note="W->A: At least 10-fold decrease in affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            5
                     /site_type="mutagenized"
                     /note="W->Y: 290-fold decrease in ability to inhibit
                     Nav1.7/SCN9A, and decrease in ability to bind membranes.
                     /evidence=ECO:0000269|PubMed:27311819."
     Site            6
                     /site_type="mutagenized"
                     /note="M->A: At least 10-fold decrease in affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            7
                     /site_type="other"
                     /note="Part of an aromatic-rich surface that anchors the
                     toxin toward the membrane core relative to lipid
                     headgroups bound along the pore module of Nav1.7/SCN9A.
                     /evidence=ECO:0000305|PubMed:30661758."
     Site            7
                     /site_type="mutagenized"
                     /note="W->A: At least 10-fold decrease in affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            7
                     /site_type="mutagenized"
                     /note="W->Q: Important increase in selectivity for
                     Nav1.7/SCN9A; derivative JNJ63955918.
                     /evidence=ECO:0000269|PubMed:28045073."
     Site            7
                     /site_type="mutagenized"
                     /note="W->Y: 111-fold decrease in ability to inhibit
                     Nav1.7/SCN9A, and decrease in ability to bind membranes.
                     /evidence=ECO:0000269|PubMed:27311819."
     Site            8
                     /site_type="mutagenized"
                     /note="T->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12475222,
                     ECO:0000269|PubMed:27311819, ECO:0000269|PubMed:30661758,
                     ECO:0000312|PDB:2N9T, ECO:0000312|PDB:5O0U,
                     ECO:0000312|PDB:5TCZ, ECO:0000312|PDB:6N4I,
                     ECO:0000312|PDB:6N4Q, ECO:0000312|PDB:6N4R."
     Site            10
                     /site_type="mutagenized"
                     /note="D->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Region          11..13
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5O0U."
     Site            11
                     /site_type="mutagenized"
                     /note="S->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            12
                     /site_type="mutagenized"
                     /note="E->A: No change in binding affinity with
                     Nav1.5/SCN5A. 5-fold increase in ability to inhibit sodium
                     channel Nav1.7/SCN9A. No change in activity towards
                     Nav1.7/SCN9A; when associated with L-19.
                     /evidence=ECO:0000269|PubMed:17087985,
                     ECO:0000269|PubMed:25026046."
     Site            14
                     /site_type="mutagenized"
                     /note="K->R: In K/R, 30-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. In K/R,E17K, 110-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. /evidence=ECO:0000269|PubMed:27311819."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12475222,
                     ECO:0000269|PubMed:27311819, ECO:0000269|PubMed:30661758,
                     ECO:0000312|PDB:2N9T, ECO:0000312|PDB:5O0U,
                     ECO:0000312|PDB:5TCZ, ECO:0000312|PDB:6N4I,
                     ECO:0000312|PDB:6N4Q, ECO:0000312|PDB:6N4R."
     Region          16..18
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2N9T."
     Site            17
                     /site_type="mutagenized"
                     /note="E->K: No change in ability to inhibit Nav1.7/SCN9A,
                     and change in ability to bind membranes. In K/R,E17K,
                     110-fold decrease in ability to inhibit Nav1.7/SCN9A, and
                     change in ability to bind membranes.
                     /evidence=ECO:0000269|PubMed:27311819."
     Region          19..27
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5O0U."
     Site            19
                     /site_type="mutagenized"
                     /note="M->L: 1.7-fold decrease in ability to inhibit
                     sodium channel Nav1.7/SCN9A. No change in activity towards
                     Nav1.7/SCN9A; when associated with A-12.
                     /evidence=ECO:0000269|PubMed:25026046."
     Site            22
                     /site_type="other"
                     /note="Electrostatic gating-modifier of Nav1.7/SCN9A that
                     antagonizes outward gating-charge movement through direct
                     electrostatic repulsion; may also indirectly antagonize S4
                     gating-charge movement by neutralizing acidic side chains
                     within the extracellular vestibule of VSD2.
                     /evidence=ECO:0000305|PubMed:30661758."
     Site            22
                     /site_type="mutagenized"
                     /note="R->D,E: Important decrease in ability to inhibit
                     human Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:30661758."
     Site            22
                     /site_type="mutagenized"
                     /note="R->K: Small decrease in ability to inhibit human
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:30661758."
     Site            22
                     /site_type="mutagenized"
                     /note="R->Q: Moderate decrease in ability to inhibit human
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:30661758."
     Site            23
                     /site_type="mutagenized"
                     /note="L->A: No change in binding affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            24
                     /site_type="other"
                     /note="Part of an aromatic-rich surface that anchors the
                     toxin toward the membrane core relative to lipid
                     headgroups bound along the pore module of Nav1.7/SCN9A; it
                     also stabilizes the toxin for productive receptor site
                     engagement. /evidence=ECO:0000305|PubMed:30661758."
     Site            24
                     /site_type="mutagenized"
                     /note="W->A: At least 10-fold decrease in affinity with
                     Nav1.5/SCN5A. /evidence=ECO:0000269|PubMed:17087985."
     Site            24
                     /site_type="mutagenized"
                     /note="W->Y: 180-fold decrease in ability to inhibit
                     Nav1.7/SCN9A, and decrease in ability to bind membranes.
                     /evidence=ECO:0000269|PubMed:27311819."
     Region          26..30
                     /region_name="Region of interest in the sequence"
                     /note="Flexible tail region important for ability to
                     inhibit Nav channel.
                     /evidence=ECO:0000305|PubMed:25026046."
     Site            26
                     /site_type="other"
                     /note="Antagonizes outward gating-charge movement of
                     Nav1.7/SCN9A through direct electrostatic repulsion; may
                     also indirectly antagonize S4 gating-charge movement by
                     neutralizing acidic side chains within the extracellular
                     vestibule of VSD2. /evidence=ECO:0000305|PubMed:30661758."
     Site            26
                     /site_type="mutagenized"
                     /note="K->D: Important decrease in ability to inhibit
                     human Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:30661758."
     Site            26
                     /site_type="mutagenized"
                     /note="K->E: Almost complete loss in ability to inhibit
                     human Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:30661758."
     Site            26
                     /site_type="mutagenized"
                     /note="K->R: Small increase in ability to inhibit human
                     Nav1.7/SCN9A. In K/R, 30-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. In K/R,E17K, 110-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. /evidence=ECO:0000269|PubMed:27311819,
                     ECO:0000269|PubMed:30661758."
     Site            27
                     /site_type="mutagenized"
                     /note="K->R: In K/R, 30-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. In K/R,E17K, 110-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. /evidence=ECO:0000269|PubMed:27311819."
     Site            28
                     /site_type="mutagenized"
                     /note="K->R: In K/R, 30-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. In K/R,E17K, 110-fold decrease in ability to
                     inhibit Nav1.7/SCN9A, and change in ability to bind
                     membranes. /evidence=ECO:0000269|PubMed:27311819."
     Region          29..30
                     /region_name="Region of interest in the sequence"
                     /note="Hydrophobic dyad that anchors the toxin into the
                     membrane while positioning it over the S3 helix of
                     Nav1.7/SCN9A. /evidence=ECO:0000305|PubMed:30661758."
     Site            30
                     /site_type="other"
                     /note="Part of an aromatic-rich surface that anchors the
                     toxin toward the membrane core relative to lipid
                     headgroups bound along the pore module of Nav1.7/SCN9A.
                     /evidence=ECO:0000305|PubMed:30661758."
     Site            30
                     /site_type="mutagenized"
                     /note="W->L: Important increase in selectivity for
                     Nav1.7/SCN9A; derivative JNJ63955918.
                     /evidence=ECO:0000269|PubMed:28045073."
     Site            30
                     /site_type="mutagenized"
                     /note="W->Y: 6-fold decrease in ability to inhibit
                     Nav1.7/SCN9A, and decrease in ability to bind membranes.
                     /evidence=ECO:0000269|PubMed:27311819."
ORIGIN      
        1 ycqkwmwtcd serkccegmv crlwckkklw
//

LOCUS       TXPR1_THRPR               35 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta/omega-theraphotoxin-Tp1a;
            Short=Beta/omega-TRTX-Tp1a; AltName: Full=Protoxin-1;
            Short=ProTx-1; Short=ProTx1; AltName: Full=Protoxin-I;
            Short=ProTx-I.
ACCESSION   P83480
VERSION     P83480.1
DBSOURCE    UniProtKB: locus TXPR1_THRPR, accession P83480;
            class: standard.
            created: Nov 15, 2002.
            sequence updated: Nov 15, 2002.
            annotation updated: Feb 22, 2023.
            xrefs: 2M9L_A
            xrefs (non-sequence databases): PDBsum:2M9L, AlphaFoldDB:P83480,
            BMRB:P83480, SMR:P83480, TCDB:8.B.5.1.1, ArachnoServer:AS000413,
            GO:0005576, GO:0019855, GO:0015459, GO:0017080, GO:0090729,
            InterPro:IPR011696, Pfam:PF07740, SUPFAM:SSF57059
KEYWORDS    3D-structure; Calcium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Pharmaceutical; Potassium channel impairing toxin;
            Secreted; Toxin; Voltage-gated calcium channel impairing toxin;
            Voltage-gated potassium channel impairing toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Thrixopelma pruriens
  ORGANISM  Thrixopelma pruriens
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Thrixopelma.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Middleton,R.E., Warren,V.A., Kraus,R.L., Hwang,J.C., Liu,C.J.,
            Dai,G., Brochu,R.M., Kohler,M.G., Gao,Y.D., Garsky,V.M.,
            Bogusky,M.J., Mehl,J.T., Cohen,C.J. and Smith,M.M.
  TITLE     Two tarantula peptides inhibit activation of multiple sodium
            channels
  JOURNAL   Biochemistry 41 (50), 14734-14747 (2002)
   PUBMED   12475222
  REMARK    PROTEIN SEQUENCE, SYNTHESIS, FUNCTION, SUBCELLULAR LOCATION, AND
            MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Priest,B.T., Blumenthal,K.M., Smith,J.J., Warren,V.A. and
            Smith,M.M.
  TITLE     ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium
            channels
  JOURNAL   Toxicon 49 (2), 194-201 (2007)
   PUBMED   17087985
  REMARK    SYNTHESIS, AND FUNCTION.
REFERENCE   3  (residues 1 to 35)
  AUTHORS   Ohkubo,T., Yamazaki,J. and Kitamura,K.
  TITLE     Tarantula toxin ProTx-I differentiates between human T-type
            voltage-gated Ca2+ Channels Cav3.1 and Cav3.2
  JOURNAL   J Pharmacol Sci 112 (4), 452-458 (2010)
   PUBMED   20351484
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 35)
  AUTHORS   Bladen,C., Hamid,J., Souza,I.A. and Zamponi,G.W.
  TITLE     Block of T-type calcium channels by protoxins I and II
  JOURNAL   Mol Brain 7, 36 (2014)
   PUBMED   24886690
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   5  (residues 1 to 35)
  AUTHORS   Kikuchi,K., Sugiura,M. and Kimura,T.
  TITLE     High Proteolytic Resistance of Spider-Derived Inhibitor Cystine
            Knots
  JOURNAL   Int J Pept 2015, 537508 (2015)
   PUBMED   26843868
  REMARK    DOMAIN.
REFERENCE   6  (residues 1 to 35)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    FUNCTION, AND SYNTHESIS.
REFERENCE   7  (residues 1 to 35)
  AUTHORS   Nicolas,S., Zoukimian,C., Bosmans,F., Montnach,J., Diochot,S.,
            Cuypers,E., De Waard,S., Beroud,R., Mebs,D., Craik,D., Boturyn,D.,
            Lazdunski,M., Tytgat,J. and De Waard,M.
  TITLE     Chemical Synthesis, Proper Folding, Nav Channel Selectivity Profile
            and Analgesic Properties of the Spider Peptide Phlotoxin 1
  JOURNAL   Toxins (Basel) 11 (6), E367 (2019)
   PUBMED   31234412
  REMARK    FUNCTION ON NAV1.7/SCN9A, AND SYNTHESIS.
            Publication Status: Online-Only
REFERENCE   8  (residues 1 to 35)
  AUTHORS   Rupasinghe,D.B., Herzig,V., Vetter,I., Dekan,Z., Gilchrist,J.,
            Bosmans,F., Alewood,P.F., Lewis,R.J. and King,G.F.
  TITLE     Mutational analysis of ProTx-I and the novel venom peptide Pe1b
            provide insight into residues responsible for selective inhibition
            of the analgesic drug target NaV1.7
  JOURNAL   Biochem Pharmacol 181, 114080 (2020)
   PUBMED   32511987
  REMARK    RECOMBINANT EXPRESSION, FUNCTION, SUBCELLULAR LOCATION, AND
            MUTAGENESIS OF LEU-6; LYS-17; LEU-19; TRP-27; VAL-29; TRP-30 AND
            ASP-31.
REFERENCE   9  (residues 1 to 35)
  AUTHORS   Gui,J., Liu,B., Cao,G., Lipchik,A.M., Perez,M., Dekan,Z., Mobli,M.,
            Daly,N.L., Alewood,P.F., Parker,L.L., King,G.F., Zhou,Y.,
            Jordt,S.E. and Nitabach,M.N.
  TITLE     A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion
            channel by binding to the S1-S4 gating domain
  JOURNAL   Curr Biol 24 (5), 473-483 (2014)
   PUBMED   24530065
  REMARK    STRUCTURE BY NMR, DISULFIDE BONDS, FUNCTION, AND MUTAGENESIS OF
            ARG-3; TRP-5; GLN-13; LEU-19; SER-22; ARG-23; TRP-27; VAL-29;
            TRP-30; ASP-31; GLY-32; PHE-34 AND SER-35.
COMMENT     [FUNCTION] Ion channel impairing toxin that inhibits voltage-gated
            calcium channel Cav3.1/CACNA1G (IC(50)=53 nM), voltage-gated
            potassium channels Kv2.1/KCNB1 (IC(50)=411 nM), all sodium channels
            tested (Nav1.2/SCN2A (IC(50)=60-104 nM), Nav1.5/SCN5A
            (IC(50)=76-358 nM), Nav1.6/SCN8A (IC(50)=21-133 nM), Nav1.7/SCN9A
            (IC(50)=51-95 nM), and Nav1.8/SCN10A) and the nociceptor cation
            channel TRPA1 (IC(50)=389 nM) (PubMed:12475222, PubMed:17087985,
            PubMed:20351484, PubMed:24886690, PubMed:29703751, PubMed:31234412,
            PubMed:24530065). Acts as a potent and selective blocker of
            voltage-gated calcium channel Cav3.1/CACNA1G, but not of
            Cav3.2/CACNA1H, and Cav3.3/CACNA1I (PubMed:20351484,
            PubMed:24886690). On Nav1.7/SCN9A, primarily interacts with the DII
            and DIV voltage-sensor domains (PubMed:32511987). Also acts as an
            inhibitor of nociceptor cation channel TRPA1 (IC(50)
            389 nM) by binding to the S1-S4 gating domain of TRPA1
            (PubMed:24530065). It shows moderate affinity for lipid bilayers
            (PubMed:29703751). {ECO:0000269|PubMed:12475222,
            ECO:0000269|PubMed:17087985, ECO:0000269|PubMed:20351484,
            ECO:0000269|PubMed:24530065, ECO:0000269|PubMed:24886690,
            ECO:0000269|PubMed:29703751, ECO:0000269|PubMed:31234412}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12475222}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:12475222}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:24530065}.
            [PTM] An unnatural amidation at Ser-35 provokes a 14-fold increased
            toxin ability to inhibit Nav1.2/SCN2A and a
            2-fold decreased toxin ability to inhibit both Nav1.5/SCN5A and
            Nav1.6/SCN8A. {ECO:0000269|PubMed:32511987}.
            [MASS SPECTROMETRY] Mass=3988.3; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12475222}.
            [PHARMACEUTICAL] The amidated mutant G32A (ProTx-I-G32A-NH2) shows
            a decreased ability to inhibit all sodium channels tested, with a
            more pronounced reduction on Nav1.2/SCN2A and Nav1.5/SCN5A. As a
            consequence, this mutant shows an enhanced selectivity and potency
            for Nav1.7/SCN9A, and thus may provide a good starting point for
            second generation analogs to treat pain.
            {ECO:0000305|PubMed:32511987}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of Beta/omega-theraphotoxin-Bp1a from Bumba
            pulcherrimaklaasi (AC P0DQN3). {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 54
            (ProTx-1) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Thrixopelma pruriens"
                     /db_xref="taxon:213387"
     Protein         1..35
                     /product="Beta/omega-theraphotoxin-Tp1a"
                     /note="Beta/omega-TRTX-Tp1a; Protoxin-1; Protoxin-I;
                     ProTx-1; ProTx1; ProTx-I"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..35
                     /region_name="Processed active peptide"
                     /note="Beta/omega-theraphotoxin-Tp1a.
                     /evidence=ECO:0000303|PubMed:12475222.
                     /id=PRO_0000045029."
     Region          1..30
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24530065,
                     ECO:0007744|PDB:2M9L."
     Site            3
                     /site_type="mutagenized"
                     /note="R->A: Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Site            5
                     /site_type="mutagenized"
                     /note="W->A: Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Site            6
                     /site_type="mutagenized"
                     /note="L->A: Decrease in ability to inhibit Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            6
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24530065,
                     ECO:0007744|PDB:2M9L."
     Site            13
                     /site_type="mutagenized"
                     /note="Q->A: Reduced ability to inhibit nociceptor cation
                     channel TRPA1. /evidence=ECO:0000269|PubMed:24530065."
     Bond            bond(15,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24530065,
                     ECO:0007744|PDB:2M9L."
     Site            17
                     /site_type="mutagenized"
                     /note="K->E: Decrease in ability to inhibit Nav1.2/SCN2A,
                     Nav1.5/SCN5A, Nav1.6/SCN8A and Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Region          19..22
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2M9L."
     Site            19
                     /site_type="mutagenized"
                     /note="L->A: Decrease in ability to inhibit the channels
                     TRPA1, Nav1.2/SCN2A, and Nav1.7/SCN9A, probably due to
                     improper folding. /evidence=ECO:0000269|PubMed:24530065,
                     ECO:0000269|PubMed:32511987."
     Site            19
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            22
                     /site_type="mutagenized"
                     /note="S->A: Reduced ability to inhibit nociceptor cation
                     channel TRPA1. Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Region          23..26
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2M9L."
     Site            23
                     /site_type="mutagenized"
                     /note="R->A: Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Region          27..30
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2M9L."
     Site            27
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            27
                     /site_type="mutagenized"
                     /note="W->A: Decrease in ability to inhibit Nav1.2/SCN2A
                     and Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:24530065,
                     ECO:0000269|PubMed:32511987."
     Site            29
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            29
                     /site_type="mutagenized"
                     /note="V->A: Decrease in ability to inhibit Nav1.2/SCN2A
                     and Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:24530065,
                     ECO:0000269|PubMed:32511987."
     Site            30
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            30
                     /site_type="mutagenized"
                     /note="W->A: Decrease in ability to inhibit the channels
                     TRPA1, Nav1.2/SCN2A and Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:24530065,
                     ECO:0000269|PubMed:32511987."
     Region          31..33
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2M9L."
     Site            31
                     /site_type="mutagenized"
                     /note="D->A: Decrease in ability to inhibit Nav1.2/SCN2A
                     and Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:24530065,
                     ECO:0000269|PubMed:32511987."
     Site            31
                     /site_type="other"
                     /note="Pharmacophore for Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:32511987."
     Site            32
                     /site_type="mutagenized"
                     /note="G->A: Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Site            34
                     /site_type="mutagenized"
                     /note="F->A: Reduced ability to inhibit nociceptor cation
                     channel TRPA1. Reduced ability to inhibit sodium channel
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:24530065."
     Site            35
                     /site_type="mutagenized"
                     /note="S->A: Reduced ability to inhibit nociceptor cation
                     channel TRPA1. /evidence=ECO:0000269|PubMed:24530065."
ORIGIN      
        1 ecrywlggcs agqtcckhlv csrrhgwcvw dgtfs
//

LOCUS       TX36A_PHONI               82 aa            linear   INV 08-NOV-2023
DEFINITION  RecName: Full=Delta-ctenitoxin-Pn2a; Short=Delta-CNTX-Pn2a;
            AltName: Full=Delta-CNTX-Pn1c; AltName: Full=Neurotoxin Tx2-6;
            Short=PnTx2-6; Flags: Precursor.
ACCESSION   P29425
VERSION     P29425.2
DBSOURCE    UniProtKB: locus TX36A_PHONI, accession P29425;
            class: standard.
            extra accessions:Q95UF2
            created: Apr 1, 1993.
            sequence updated: Jan 23, 2002.
            annotation updated: Nov 8, 2023.
            xrefs: AY054746.1, AAL14349.1, S29216
            xrefs (non-sequence databases): AlphaFoldDB:P29425, SMR:P29425,
            ArachnoServer:AS000243, GO:0005576, GO:0017080, GO:0090729,
            InterPro:IPR035285, Pfam:PF17492
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Pharmaceutical; Secreted; Signal;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Phoneutria nigriventer (Brazilian armed spider)
  ORGANISM  Phoneutria nigriventer
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Entelegynae; Lycosoidea; Ctenidae;
            Phoneutria.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   Matavel,A., Cruz,J.S., Penaforte,C.L., Araujo,D.A.,
            Kalapothakis,E., Prado,V.F., Diniz,C.R., Cordeiro,M.N. and
            Beirao,P.S.
  TITLE     Electrophysiological characterization and molecular identification
            of the Phoneutria nigriventer peptide toxin PnTx2-6
  JOURNAL   FEBS Lett 523 (1-3), 219-223 (2002)
   PUBMED   12123835
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Cordeiro Mdo,N., Diniz,C.R., Valentim Ado,C., von Eickstedt,V.R.,
            Gilroy,J. and Richardson,M.
  TITLE     The purification and amino acid sequences of four Tx2 neurotoxins
            from the venom of the Brazilian 'armed' spider Phoneutria
            nigriventer (Keys)
  JOURNAL   FEBS Lett 310 (2), 153-156 (1992)
   PUBMED   1397265
  REMARK    PROTEIN SEQUENCE OF 35-82, FUNCTION, SUBCELLULAR LOCATION,
            BIOASSAY, AND MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 82)
  AUTHORS   Richardson,M., Pimenta,A.M., Bemquerer,M.P., Santoro,M.M.,
            Beirao,P.S., Lima,M.E., Figueiredo,S.G., Bloch,C. Jr.,
            Vasconcelos,E.A., Campos,F.A., Gomes,P.C. and Cordeiro,M.N.
  TITLE     Comparison of the partial proteomes of the venoms of Brazilian
            spiders of the genus Phoneutria
  JOURNAL   Comp. Biochem. Physiol. 142, 173-187 (2006)
   PUBMED   16278100
  REMARK    PROTEIN SEQUENCE OF 35-82, SUBCELLULAR LOCATION, MASS SPECTROMETRY,
            AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 82)
  AUTHORS   Matavel,A., Fleury,C., Oliveira,L.C., Molina,F., de Lima,M.E.,
            Cruz,J.S., Cordeiro,M.N., Richardson,M., Ramos,C.H. and Beirao,P.S.
  TITLE     Structure and activity analysis of two spider toxins that alter
            sodium channel inactivation kinetics
  JOURNAL   Biochemistry 48 (14), 3078-3088 (2009)
   PUBMED   19231838
  REMARK    PROTEIN SEQUENCE OF 35-82, FUNCTION, SUBCELLULAR LOCATION, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   5  (residues 1 to 82)
  AUTHORS   Nunes,K.P., Costa-Goncalves,A., Lanza,L.F., Cortes,S.F.,
            Cordeiro,M.N., Richardson,M., Pimenta,A.M., Webb,R.C., Leite,R. and
            De Lima,M.E.
  TITLE     Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat
            erectile function
  JOURNAL   Toxicon 51 (7), 1197-1206 (2008)
   PUBMED   18397797
  REMARK    FUNCTION.
REFERENCE   6  (residues 1 to 82)
  AUTHORS   Nunes,K.P., Cordeiro,M.N., Richardson,M., Borges,M.N., Diniz,S.O.,
            Cardoso,V.N., Tostes,R., De Lima,M.E., Webb,R.C. and Leite,R.
  TITLE     Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin
            from Phoneutria nigriventer spider in rat cavernosal tissue
  JOURNAL   J Sex Med 7 (12), 3879-3888 (2010)
   PUBMED   20722794
  REMARK    FUNCTION.
REFERENCE   7  (residues 1 to 82)
  AUTHORS   Nunes,K.P., Toque,H.A., Borges,M.H., Richardson,M., Webb,R.C. and
            de Lima,M.E.
  TITLE     Erectile function is improved in aged rats by PnTx2-6, a toxin from
            Phoneutria nigriventer spider venom
  JOURNAL   J Sex Med 9 (10), 2574-2581 (2012)
   PUBMED   22925420
  REMARK    FUNCTION.
REFERENCE   8  (residues 1 to 82)
  AUTHORS   Nunes,K.P., Wynne,B.M., Cordeiro,M.N., Borges,M.H., Richardson,M.,
            Leite,R., DeLima,M.E. and Webb,R.C.
  TITLE     Increased cavernosal relaxation by Phoneutria nigriventer toxin,
            PnTx2-6, via activation at NO/cGMP signaling
  JOURNAL   Int J Impot Res 24 (2), 69-76 (2012)
   PUBMED   21975567
  REMARK    FUNCTION.
REFERENCE   9  (residues 1 to 82)
  AUTHORS   Nunes,K.P., Torres,F.S., Borges,M.H., Matavel,A., Pimenta,A.M. and
            De Lima,M.E.
  TITLE     New insights on arthropod toxins that potentiate erectile function
  JOURNAL   Toxicon 69, 152-159 (2013)
   PUBMED   23583324
  REMARK    REVIEW (ERECTILE DYSFUNCTION).
REFERENCE   10 (residues 1 to 82)
  AUTHORS   Silva,C.N., Nunes,K.P., Torres,F.S., Cassoli,J.S., Santos,D.M.,
            Almeida Fde,M., Matavel,A., Cruz,J.S., Santos-Miranda,A.,
            Nunes,A.D., Castro,C.H., Machado de Avila,R.A.,
            Chavez-Olortegui,C., Lauar,S.S., Felicori,L., Resende,J.M.,
            Camargos,E.R., Borges,M.H., Cordeiro,M.N., Peigneur,S., Tytgat,J.
            and de Lima,M.E.
  TITLE     PnPP-19, a Synthetic and Nontoxic Peptide Designed from a
            Phoneutria nigriventer Toxin, Potentiates Erectile Function via
            NO/cGMP
  JOURNAL   J Urol 194 (5), 1481-1490 (2015)
   PUBMED   26119670
  REMARK    FUNCTION AS ERECTILE POTENTIATOR, PHARMACEUTICAL (ERECTILE
            DYSFUNCTION), AND MUTAGENESIS OF 1-MET--CYS-63; 64-ILE--GLY-68 AND
            CYS-80.
REFERENCE   11 (residues 1 to 82)
  AUTHORS   da Fonseca Pacheco,D., Freitas,A.C., Pimenta,A.M., Duarte,I.D. and
            de Lima,M.E.
  TITLE     A spider derived peptide, PnPP-19, induces central antinociception
            mediated by opioid and cannabinoid systems
  JOURNAL   J Venom Anim Toxins Incl Trop Dis 22, 34 (2016)
   PUBMED   28031732
  REMARK    PHARMACEUTICAL (PAIN), AND MUTAGENESIS OF 1-MET--CYS-63;
            64-ILE--GLY-68 AND CYS-80.
            Publication Status: Online-Only
REFERENCE   12 (residues 1 to 82)
  AUTHORS   Freitas,A.C., Silva,G.C., Pacheco,D.F., Pimenta,A.M., Lemos,V.S.,
            Duarte,I.D. and de Lima,M.E.
  TITLE     The synthetic peptide PnPP-19 induces peripheral antinociception
            via activation of NO/cGMP/KATP pathway: Role of eNOS and nNOS
  JOURNAL   Nitric Oxide 64, 31-38 (2017)
   PUBMED   28087360
  REMARK    PHARMACEUTICAL (PAIN), AND MUTAGENESIS OF 1-MET--CYS-63;
            64-ILE--GLY-68 AND CYS-80.
REFERENCE   13 (residues 1 to 82)
  AUTHORS   Freitas,A.C.N., Peigneur,S., Macedo,F.H.P., Menezes-Filho,J.E.,
            Millns,P., Medeiros,L.F., Arruda,M.A., Cruz,J., Holliday,N.D.,
            Tytgat,J., Hathway,G. and de Lima,M.E.
  TITLE     The Peptide PnPP-19, a Spider Toxin Derivative, Activates mu-Opioid
            Receptors and Modulates Calcium Channels
  JOURNAL   Toxins (Basel) 10 (1), E43 (2018)
   PUBMED   29342943
  REMARK    PHARMACEUTICAL (PAIN), AND MUTAGENESIS OF 1-MET--CYS-63;
            64-ILE--GLY-68 AND CYS-80.
            Publication Status: Online-Only
COMMENT     On or before Oct 25, 2005 this sequence version replaced gi:345429,
            gi:267181.
            [FUNCTION] Toxin that is known to potentiate erectile function
            (PubMed:18397797). It binds voltage-dependently to sodium channels
            (Nav), inhibits the inactivation of the activated channels and
            decreases the peak inward current (PubMed:19231838,
            PubMed:26119670). The toxin delays inactivation of Nav1.2/SCN2A,
            Nav1.3/SCN3A, Nav1.4/SCN4A and Nav1.8/SCN10A, slows the
            inactivation process and decreases the sodium peak amplitude of
            Nav1.5/SCN5A and Nav1.6/SCN8A (PubMed:26119670). In vivo, it
            enhances erectile function by inducing the release of nictric oxide
            (NO): it slows the sodium current, leading to depolarization, which
            leads to an increase in calcium influx (probably via activation of
            N-type calcium channels) which in turn activates neuronal NO
            synthase (nNOS/NOS1), inducing nitric oxide (NO) production
            (PubMed:20722794, PubMed:21975567). In a final step, NO activates
            soluble guanylate cyclase (GUCY1A1/GUCY1B1) which in turn increases
            cGMP formation, resulting in penile erection (PubMed:23583324). It
            is noteworthy that the toxin does not provoke erection by
            inhibiting phosphodiesterase type 5 (PDE5A), an enzyme that
            hydrolysis cGMP (PubMed:23583324). In vivo, it also causes
            scratching, lacrimation, hypersalivation, sweating and agitation
            followed by spastic paralysis of the anterior and posterior
            extremities and death at dose levels of 0.79 mg/mouse
            (PubMed:1397265, PubMed:16278100). It is insecticidal to the larval
            and adult forms of the house fly (PubMed:1397265). The toxin also
            improves cavernosal relaxation in different models where erectile
            dysfonction is observed, such as deoxycorticosterone-acetate
            (DOCA)-salt hypertensive rats, mice models for type-1 diabetes, as
            well as elderly rats (PubMed:18397797, PubMed:21975567,
            PubMed:22925420). {ECO:0000269|PubMed:1397265,
            ECO:0000269|PubMed:16278100, ECO:0000269|PubMed:18397797,
            ECO:0000269|PubMed:19231838, ECO:0000269|PubMed:20722794,
            ECO:0000269|PubMed:21975567, ECO:0000269|PubMed:22925420,
            ECO:0000269|PubMed:26119670, ECO:0000305|PubMed:23583324}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:1397265}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:1397265}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=5291.3; Method=Plasma desorption;
            Evidence={ECO:0000269|PubMed:1397265}.
            [MASS SPECTROMETRY] Mass=5289.0; Method=Unknown;
            Evidence={ECO:0000269|PubMed:16278100}.
            [MASS SPECTROMETRY] Mass=5289.31; Mass_error=0.03;
            Method=Electrospray; Evidence={ECO:0000269|PubMed:19231838}.
            [PHARMACEUTICAL] PnPP-19, a 19 AA-peptide that is N-terminally
            acetylated and C-terminally amidated, has been suggested to be a
            promising drug candidate for the treatment of erectile dysfunction
            (PubMed:26119670). The peptide potentiates erection through an
            increase in nitric oxide (NO)/cGMP production (PubMed:26119670). It
            has no apparent toxicity (when tested on brain, heart, lung, liver
            and kidney) and low immunogenicity in mice (PubMed:26119670). It
            acts by a different mechanism than the native toxin, since it does
            not affect sodium channels, has no effect on the rat heart, and is
            independent of extracellular calcium influx through N-type calcium
            channels (PubMed:26119670). In addition, it has a long half-life
            since its potentiating effect is observed 15 minutes after
            injection and lasts about one hour (PubMed:26119670).
            {ECO:0000269|PubMed:26119670}.
            [PHARMACEUTICAL] PnPP-19, a 19 AA-peptide that is N-terminally
            acetylated and C-terminally amidated, has been suggested to be a
            promising drug candidate for the treatment of pain
            (PubMed:29342943). The peptide induces both peripheral and central
            antinociception (PubMed:28031732, PubMed:28087360). This
            antinociceptive effect involves the activation of opioid and
            cannabinoid receptors along with the activation of the NO/cGMP/KATP
            pathway (PubMed:28031732, PubMed:28087360, PubMed:29342943).
            {ECO:0000269|PubMed:28031732, ECO:0000269|PubMed:28087360,
            ECO:0000269|PubMed:29342943}.
            [SIMILARITY] Belongs to the neurotoxin 03 (Tx2) family. 06
            subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Phoneutria nigriventer"
                     /db_xref="taxon:6918"
     Protein         1..82
                     /product="Delta-ctenitoxin-Pn2a"
                     /note="Delta-CNTX-Pn2a; Delta-CNTX-Pn1c; Neurotoxin Tx2-6;
                     PnTx2-6"
                     /UniProtKB_evidence="Evidence at protein level"
     Site            1..63
                     /site_type="mutagenized"
                     /note="Missing: In PnPP-19 (acetylated and amidated); loss
                     of activity on sodium channels.
                     /evidence=ECO:0000269|PubMed:26119670."
     Region          1..17
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          18..34
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:1397265,
                     ECO:0000269|PubMed:16278100, ECO:0000269|PubMed:19231838.
                     /id=PRO_0000035498."
     Region          35..82
                     /region_name="Mature chain"
                     /note="Delta-ctenitoxin-Pn2a.
                     /evidence=ECO:0000269|PubMed:1397265. /id=PRO_0000035499."
     Region          35..81
                     /region_name="D_CNTX"
                     /note="Delta Ctenitoxins; pfam17492"
                     /db_xref="CDD:340207"
     Bond            bond(37,51)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(44,57)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(48,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(50,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(59,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Site            64..68
                     /site_type="mutagenized"
                     /note="ICRQG->GERRQ: In PnPP-19 (acetylated and amidated);
                     loss of activity on sodium channels.
                     /evidence=ECO:0000269|PubMed:26119670."
     Site            80
                     /site_type="mutagenized"
                     /note="C->S: In PnPP-19 (acetylated and amidated); loss of
                     activity on sodium channels.
                     /evidence=ECO:0000269|PubMed:26119670."
ORIGIN      
        1 mkvailflsi lvlavasesi eesrddfave elgratcagq dqpcketcdc cgergecvcg
       61 gpcicrqgyf wiawyklanc kk
//

LOCUS       2M36_A                    38 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, U2-cyrtautoxin-As1a.
ACCESSION   2M36_A
VERSION     2M36_A
DBSOURCE    pdb: molecule 2M36, chain A, release May 8, 2013;
            deposition: Jan 10, 2013;
            class: TOXIN;
            source: Mmdb_id: 108540, Pdb_id 1: 2M36;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Apomastus schlingeri
  ORGANISM  Apomastus schlingeri
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Euctenizidae; Apomastus.
REFERENCE   1  (residues 1 to 38)
  AUTHORS   Skinner,W.S., Dennis,P.A., Li,J.P. and Quistad,G.B.
  TITLE     Identification of insecticidal peptides from venom of the trap-door
            spider, Aptostichus schlingeri (Ctenizidae)
  JOURNAL   Toxicon 30 (9), 1043-1050 (1992)
   PUBMED   1440641
REFERENCE   2  (residues 1 to 38)
  AUTHORS   Bende,N.S., Kang,E., Herzig,V., Bosmans,F., Nicholson,G.M.,
            Mobli,M. and King,G.F.
  TITLE     The insecticidal neurotoxin Aps III is an atypical knottin peptide
            that potently blocks insect voltage-gated sodium channels
  JOURNAL   Biochem. Pharmacol. 85 (10), 1542-1554 (2013)
   PUBMED   23473802
REFERENCE   3  (residues 1 to 38)
  AUTHORS   King,G.F., Bende,N.S. and Mobli,M.
  TITLE     Direct Submission
  JOURNAL   Submitted (10-JAN-2013)
COMMENT     On May 7, 2018 this sequence version replaced gi:471270287.
            Solution structure of the insecticidal spider-venom peptide Aps
            III.
FEATURES             Location/Qualifiers
     source          1..38
                     /organism="Apomastus schlingeri"
                     /db_xref="taxon:12944"
     Region          2..36
                     /region_name="Toxin_21"
                     /note="Spider insecticidal peptide; pfam08091"
                     /db_xref="CDD:400436"
     Bond            bond(2,16)
                     /bond_type="disulfide"
     Bond            bond(9,20)
                     /bond_type="disulfide"
     Bond            bond(15,36)
                     /bond_type="disulfide"
     SecStr          19..22
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(27,32)
                     /bond_type="disulfide"
     SecStr          34..37
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 scnskgtpct nadeccggkc aynvwncigg gcsktcgy
//

LOCUS       1AV3_A                    27 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, KAPPA-PVIIA.
ACCESSION   1AV3_A
VERSION     1AV3_A
DBSOURCE    pdb: molecule 1AV3, chain A, release Jul 13, 2011;
            deposition: Sep 24, 1997;
            class: POTASSIUM CHANNEL BLOCKER;
            source: Mmdb_id: 55373, Pdb_id 1: 1AV3;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Conus purpurascens
  ORGANISM  Conus purpurascens
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Chelyconus.
REFERENCE   1  (residues 1 to 27)
  AUTHORS   Terlau,H., Shon,K.J., Grilley,M., Stocker,M., Stuhmer,W. and
            Olivera,B.M.
  TITLE     Strategy for rapid immobilization of prey by a fish-hunting marine
            snail
  JOURNAL   Nature 381 (6578), 148-151 (1996)
   PUBMED   12074021
REFERENCE   2  (residues 1 to 27)
  AUTHORS   Scanlon,M.J., Naranjo,D., Thomas,L., Alewood,P.F., Lewis,R.J. and
            Craik,D.J.
  TITLE     Solution structure and proposed binding mechanism of a novel
            potassium channel toxin kappa-conotoxin PVIIA
  JOURNAL   Structure 5 (12), 1585-1597 (1997)
   PUBMED   9438859
REFERENCE   3  (residues 1 to 27)
  AUTHORS   Scanlon,M.J., Naranjo,D., Thomas,L., Alewood,P.F., Lewis,R.J. and
            Craik,D.J.
  TITLE     Direct Submission
  JOURNAL   Submitted (24-SEP-1997)
COMMENT     On Nov 7, 2007 this sequence version replaced gi:157830099.
            POTASSIUM CHANNEL BLOCKER KAPPA CONOTOXIN PVIIA FROM C.
            PURPURASCENS, NMR, 20 STRUCTURES.
FEATURES             Location/Qualifiers
     source          1..27
                     /organism="Conus purpurascens"
                     /db_xref="taxon:41690"
     NonStdRes       4
                     /non_std_residue="HYP"
     Bond            bond(8,20)
                     /bond_type="disulfide"
     Bond            bond(15,26)
                     /bond_type="disulfide"
     SecStr          19..22
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          24..27
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 crixnqkcfq hlddccsrkc nrfnkcv
//

LOCUS       CM3A_CONPU                73 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin PIIIA; AltName: Full=Mu-conotoxin P3.7;
            Flags: Precursor.
ACCESSION   P58925
VERSION     P58925.2
DBSOURCE    UniProtKB: locus CM3A_CONPU, accession P58925;
            class: standard.
            created: Jul 26, 2002.
            sequence updated: Jul 11, 2006.
            annotation updated: Feb 22, 2023.
            xrefs: 1R9I_A
            xrefs (non-sequence databases): PDBsum:1R9I, AlphaFoldDB:P58925,
            BMRB:P58925, SMR:P58925, TCDB:8.B.28.1.2, ConoServer:1407,
            EvolutionaryTrace:P58925, GO:0005576, GO:0019871, GO:0090729,
            InterPro:IPR004214, InterPro:IPR008036, Pfam:PF02950,
            PROSITE:PS60013
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues;
            Disulfide bond; Hydroxylation; Ion channel impairing toxin;
            Neurotoxin; Pyrrolidone carboxylic acid; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Conus purpurascens
  ORGANISM  Conus purpurascens
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Chelyconus.
REFERENCE   1  (residues 1 to 73)
  AUTHORS   Corpuz,G.P., Jacobsen,R.B., Jimenez,E.C., Watkins,M., Walker,C.,
            Colledge,C., Garrett,J.E., McDougal,O., Li,W., Gray,W.R.,
            Hillyard,D.R., Rivier,J., McIntosh,J.M., Cruz,L.J. and Olivera,B.M.
  TITLE     Definition of the M-conotoxin superfamily: characterization of
            novel peptides from molluscivorous Conus venoms
  JOURNAL   Biochemistry 44 (22), 8176-8186 (2005)
   PUBMED   15924437
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 73)
  AUTHORS   Shon,K.-J., Olivera,B.M., Watkins,M., Jacobsen,R.B., Gray,W.R.,
            Floresca,C.Z., Cruz,L.J., Hillyard,D.R., Brink,A., Terlau,H. and
            Yoshikami,D.
  TITLE     mu-Conotoxin PIIIA, a new peptide for discriminating among
            tetrodotoxin-sensitive Na channel subtypes
  JOURNAL   J Neurosci 18 (12), 4473-4481 (1998)
   PUBMED   9614224
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 47-73, SYNTHESIS OF 50-71,
            MUTAGENESIS OF ARG-63, PROBABLE PYROGLUTAMATE FORMATION AT GLN-50,
            PROBABLE HYDROXYLATION AT PRO-57 AND PRO-67, AND PROBABLE AMIDATION
            AT CYS-71.;
            TISSUE=Venom duct
REFERENCE   3  (residues 1 to 73)
  AUTHORS   Safo,P., Rosenbaum,T., Shcherbatko,A., Choi,D.Y., Han,E.,
            Toledo-Aral,J.J., Olivera,B.M., Brehm,P. and Mandel,G.
  TITLE     Distinction among neuronal subtypes of voltage-activated sodium
            channels by mu-conotoxin PIIIA
  JOURNAL   J Neurosci 20 (1), 76-80 (2000)
   PUBMED   10627583
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 73)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 73)
  AUTHORS   Favreau,P., Benoit,E., Hocking,H.G., Carlier,L., D' hoedt,D.,
            Leipold,E., Markgraf,R., Schlumberger,S., Cordova,M.A.,
            Gaertner,H., Paolini-Bertrand,M., Hartley,O., Tytgat,J.,
            Heinemann,S.H., Bertrand,D., Boelens,R., Stocklin,R. and Molgo,J.
  TITLE     A novel micro-conopeptide, CnIIIC, exerts potent and preferential
            inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic
            acetylcholine receptors
  JOURNAL   Br J Pharmacol 166 (5), 1654-1668 (2012)
   PUBMED   22229737
  REMARK    FUNCTION, AND SYNTHESIS OF 50-71.
REFERENCE   6  (residues 1 to 73)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION, AND SYNTHESIS OF 50-71.
REFERENCE   7  (residues 1 to 73)
  AUTHORS   Zhang,M.M., Wilson,M.J., Azam,L., Gajewiak,J., Rivier,J.E.,
            Bulaj,G., Olivera,B.M. and Yoshikami,D.
  TITLE     Co-expression of Na(V)beta subunits alters the kinetics of
            inhibition of voltage-gated sodium channels by pore-blocking
            mu-conotoxins
  JOURNAL   Br J Pharmacol 168 (7), 1597-1610 (2013)
   PUBMED   23146020
  REMARK    FUNCTION.
REFERENCE   8  (residues 1 to 73)
  AUTHORS   Tietze,A.A., Tietze,D., Ohlenschlager,O., Leipold,E., Ullrich,F.,
            Kuhl,T., Mischo,A., Buntkowsky,G., Gorlach,M., Heinemann,S.H. and
            Imhof,D.
  TITLE     Structurally diverse mu-conotoxin PIIIA isomers block sodium
            channel NaV 1.4
  JOURNAL   Angew. Chem. Int. Ed. 51, 4058-4061 (2012)
   PUBMED   22407516
  REMARK    STRUCTURE BY NMR OF 50-71, SYNTHESIS OF 50-71, FUNCTION, AND
            DISULFIDE BONDS FOR 3 SYNTHETIC ISOMERS.
REFERENCE   9  (residues 1 to 73)
  AUTHORS   Nielsen,K.J., Watson,M., Adams,D.J., Hammarstroem,A.K., Gage,P.W.,
            Hill,J.M., Craik,D.J., Thomas,L., Adams,D., Alewood,P.F. and
            Lewis,R.J.
  TITLE     Solution structure of mu-conotoxin PIIIA, a preferential inhibitor
            of persistent tetrodotoxin-sensitive sodium channels
  JOURNAL   J Biol Chem 277 (30), 27247-27255 (2002)
   PUBMED   12006587
  REMARK    STRUCTURE BY NMR OF 50-71, SYNTHESIS OF 50-71, AND DISULFIDE BONDS.
COMMENT     On Jul 11, 2006 this sequence version replaced gi:22001576.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin potently blocks rNav1.4/SCN4A (IC(50)=36-41 nM)
            (PubMed:10627583, PubMed:21652775). It also moderately blocks
            rNav1.1/SCN1A (IC(50)=120 nM), rNav1.2/SCN2A (IC(50)=620 nM),
            rNav1.3/SCN3A (IC(50)=3.2 uM), mNav1.6/SCN8A (IC(50)=100 nM)
            (PubMed:10627583, PubMed:21652775). This inhibition is reversible.
            The block of Nav1.1, Nav1.2, and Nav1.6 is modified when
            beta-subunits are coexpressed with alpha subunits. Hence, blocks of
            channels containing the beta-1 and beta-3 subunits are more potent
            (compared to channels without beta subunits), whereas blocks of
            channels containing the beta-2 and beta-4 are less potent (compared
            to channels without beta subunits). In vivo, this peptide causes
            flaccid paralysis in both mice and fish.
            {ECO:0000269|PubMed:10627583, ECO:0000269|PubMed:18950653,
            ECO:0000269|PubMed:21652775, ECO:0000269|PubMed:22229737,
            ECO:0000269|PubMed:22407516, ECO:0000269|PubMed:23146020}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250|UniProtKB:P01523}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:9614224}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-4 branch, since 4 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [PTM] 3D-structure of 3 disulfide-bond connectivities isomers is
            described (PIIIA-1 (C1-C5, C2-C6, C3-C4), PIIIA-2 (C1-C4, C2-C5,
            C3-C6) and PIIIA-3 (C1-C2, C3-C4, C5-C6)) (PubMed:22407516). Only
            PIIIA-2 contains the cysteine connectivity described as typical for
            native mu-conotoxins. However, PIIIA-1 is more potent than PIIIA-2,
            suggesting another possible disulfid connectivity. For this reason,
            both connectivities have been indicated in features.
            {ECO:0000269|PubMed:22407516}.
            [MISCELLANEOUS] Exists in two forms, due to cis-trans isomerization
            at Hyp-57. Adopts a predominately trans conformation (Probable).
            {ECO:0000305|PubMed:12006587}.
            [MISCELLANEOUS] Negative results: does not or only weakly blocks
            rNav1.5/SCN5A, rNav1.7/SCN9A (IC(50)=3.1-6.2 uM and >100 uM), and
            rNav1.8/SCN10A. {ECO:0000269|PubMed:10627583,
            ECO:0000269|PubMed:21652775}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..73
                     /organism="Conus purpurascens"
                     /db_xref="taxon:41690"
     Protein         1..73
                     /product="Mu-conotoxin PIIIA"
                     /note="Mu-conotoxin P3.7"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          2..72
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          20..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:9614224.
                     /id=PRO_0000035053."
     Region          50..71
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin PIIIA.
                     /evidence=ECO:0000305|PubMed:9614224. /id=PRO_0000035054."
     Site            50
                     /site_type="pyrrolidone-carboxylic-acid"
                     /note="Pyrrolidone carboxylic acid.
                     /evidence=ECO:0000305|PubMed:12006587,
                     ECO:0000305|PubMed:9614224."
     Region          52..55
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1R9I."
     Bond            bond(53,70)
                     /bond_type="disulfide"
                     /note="In PIIIA-1; alternate.
                     /evidence=ECO:0000250|UniProtKB:P01523."
     Bond            bond(53,65)
                     /bond_type="disulfide"
                     /note="In PIIIA-2; alternate.
                     /evidence=ECO:0000269|PubMed:12006587,
                     ECO:0000312|PDB:1R9I."
     Bond            bond(54,71)
                     /bond_type="disulfide"
                     /note="In PIIIA-1; alternate.
                     /evidence=ECO:0000250|UniProtKB:P01523."
     Bond            bond(54,70)
                     /bond_type="disulfide"
                     /note="In PIIIA-2; alternate.
                     /evidence=ECO:0000269|PubMed:12006587,
                     ECO:0000312|PDB:1R9I."
     Site            57
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000305|PubMed:9614224."
     Region          59..61
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1R9I."
     Bond            bond(60,71)
                     /bond_type="disulfide"
                     /note="In PIIIA-2; alternate.
                     /evidence=ECO:0000269|PubMed:12006587."
     Bond            bond(60,65)
                     /bond_type="disulfide"
                     /note="In PIIIA-1; alternate.
                     /evidence=ECO:0000250|UniProtKB:P01523."
     Region          63..67
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1R9I."
     Site            63
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000269|PubMed:9614224."
     Site            63
                     /site_type="mutagenized"
                     /note="R->A: Decrease in affinity to channel.
                     /evidence=ECO:0000269|PubMed:9614224."
     Site            67
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000305|PubMed:9614224."
     Site            71
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:9614224."
ORIGIN      
        1 msklgvllti clllfpital pmdgdqpadr laermqdnis seehpfekrq rlccgfpksc
       61 rsrqckphrc cgr
//

LOCUS       TX36B_PHONI               82 aa            linear   INV 08-NOV-2023
DEFINITION  RecName: Full=Delta-ctenitoxin-Pn2c; Short=Delta-CNTX-Pn2c;
            AltName: Full=Neurotoxin Pn2-5A; AltName: Full=Neurotoxin Tx2-5;
            Short=PnTx2-5; Flags: Precursor.
ACCESSION   O76199
VERSION     O76199.1
DBSOURCE    UniProtKB: locus TX36B_PHONI, accession O76199;
            class: standard.
            extra accessions:P29424
            created: Jan 23, 2002.
            sequence updated: Nov 1, 1998.
            annotation updated: Nov 8, 2023.
            xrefs: AF014463.1, AAC26165.1, S29215
            xrefs (non-sequence databases): AlphaFoldDB:O76199, SMR:O76199,
            TCDB:8.B.12.1.1, ArachnoServer:AS000242, ArachnoServer:AS000241,
            GO:0005576, GO:0017080, GO:0090729, InterPro:IPR035285,
            Pfam:PF17492
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Secreted; Signal; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Phoneutria nigriventer (Brazilian armed spider)
  ORGANISM  Phoneutria nigriventer
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Entelegynae; Lycosoidea; Ctenidae;
            Phoneutria.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   Kalapothakis,E., Penaforte,C.L., Beirao,P.S., Romano-Silva,M.A.,
            Cruz,J.S., Prado,M.A., Guimaraes,P.E., Gomez,M.V. and Prado,V.F.
  TITLE     Cloning of cDNAS encoding neurotoxic peptides from the spider
            Phoneutria nigriventer
  JOURNAL   Toxicon 36 (12), 1843-1850 (1998)
   PUBMED   9839668
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Cordeiro Mdo,N., Diniz,C.R., Valentim Ado,C., von Eickstedt,V.R.,
            Gilroy,J. and Richardson,M.
  TITLE     The purification and amino acid sequences of four Tx2 neurotoxins
            from the venom of the Brazilian 'armed' spider Phoneutria
            nigriventer (Keys)
  JOURNAL   FEBS Lett 310 (2), 153-156 (1992)
   PUBMED   1397265
  REMARK    PROTEIN SEQUENCE OF 35-82, FUNCTION, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 82)
  AUTHORS   Matavel,A., Fleury,C., Oliveira,L.C., Molina,F., de Lima,M.E.,
            Cruz,J.S., Cordeiro,M.N., Richardson,M., Ramos,C.H. and Beirao,P.S.
  TITLE     Structure and activity analysis of two spider toxins that alter
            sodium channel inactivation kinetics
  JOURNAL   Biochemistry 48 (14), 3078-3088 (2009)
   PUBMED   19231838
  REMARK    PROTEIN SEQUENCE OF 35-82, FUNCTION, SUBCELLULAR LOCATION, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 82)
  AUTHORS   Richardson,M., Pimenta,A.M., Bemquerer,M.P., Santoro,M.M.,
            Beirao,P.S., Lima,M.E., Figueiredo,S.G., Bloch,C. Jr.,
            Vasconcelos,E.A., Campos,F.A., Gomes,P.C. and Cordeiro,M.N.
  TITLE     Comparison of the partial proteomes of the venoms of Brazilian
            spiders of the genus Phoneutria
  JOURNAL   Comp. Biochem. Physiol. 142, 173-187 (2006)
   PUBMED   16278100
  REMARK    PROTEIN SEQUENCE OF 35-81, SUBCELLULAR LOCATION, MASS SPECTROMETRY,
            AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   5  (residues 1 to 82)
  AUTHORS   Rezende Junior,L., Cordeiro,M.N., Oliveira,E.B. and Diniz,C.R.
  TITLE     Isolation of neurotoxic peptides from the venom of the 'armed'
            spider Phoneutria nigriventer
  JOURNAL   Toxicon 29 (10), 1225-1233 (1991)
   PUBMED   1801316
  REMARK    PROTEIN SEQUENCE OF 35-44.;
            TISSUE=Venom
REFERENCE   6  (residues 1 to 82)
  AUTHORS   Yonamine,C.M., Troncone,L.R. and Camillo,M.A.
  TITLE     Blockade of neuronal nitric oxide synthase abolishes the toxic
            effects of Tx2-5, a lethal Phoneutria nigriventer spider toxin
  JOURNAL   Toxicon 44 (2), 169-172 (2004)
   PUBMED   15246765
  REMARK    PROTEIN SEQUENCE OF 35-39, FUNCTION, AND BIOASSAY.
COMMENT     On Jan 19, 2010 this sequence version replaced P29424.1.
            [FUNCTION] Reversible inhibitor of voltage-gated sodium channels
            (Nav). Delays the fast inactivation kinetics of neuronal-type
            sodium channels. In vivo, it induces rat penile erection
            (PubMed:15246765). This effect may be due to the neuronal nitric
            oxide synthase (NOS1), since one of its selective inhibitor
            completely abolishes all the toxic effects of the toxin
            (PubMed:15246765). This toxin also causes scratching, lacrimation,
            hypersalivation, sweating and agitation followed by spastic
            paralysis of the anterior and posterior extremities and death at
            dose levels of 0.24 mg/mouse (PubMed:1397265, PubMed:16278100,
            PubMed:15246765). It is also insecticidal to the larval and adult
            forms of the house fly (PubMed:1397265).
            {ECO:0000269|PubMed:1397265, ECO:0000269|PubMed:15246765,
            ECO:0000269|PubMed:16278100, ECO:0000269|PubMed:19231838}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:1397265,
            ECO:0000269|PubMed:16278100, ECO:0000269|PubMed:19231838}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:1397265, ECO:0000305|PubMed:16278100,
            ECO:0000305|PubMed:19231838}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=5116.6; Method=Unknown;
            Evidence={ECO:0000269|PubMed:16278100}.
            [MASS SPECTROMETRY] Mass=5112.31; Mass_error=0.41;
            Method=Electrospray; Evidence={ECO:0000269|PubMed:19231838}.
            [SIMILARITY] Belongs to the neurotoxin 03 (Tx2) family. 06
            subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Phoneutria nigriventer"
                     /db_xref="taxon:6918"
     Protein         1..82
                     /product="Delta-ctenitoxin-Pn2c"
                     /note="Delta-CNTX-Pn2c; Neurotoxin Pn2-5A; Neurotoxin
                     Tx2-5; PnTx2-5"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..17
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          18..34
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:1397265,
                     ECO:0000269|PubMed:16278100, ECO:0000269|PubMed:1801316,
                     ECO:0000269|PubMed:19231838. /id=PRO_0000035504."
     Region          35..82
                     /region_name="Mature chain"
                     /note="Delta-ctenitoxin-Pn2c.
                     /evidence=ECO:0000269|PubMed:1397265,
                     ECO:0000269|PubMed:19231838. /id=PRO_0000035505."
     Region          35..81
                     /region_name="D_CNTX"
                     /note="Delta Ctenitoxins; pfam17492"
                     /db_xref="CDD:340207"
     Bond            bond(37,51)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(44,57)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(48,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(50,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(59,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Region          74
                     /region_name="Conflict"
                     /note="W -> A (in Ref. 2; AA sequence and 4; AA sequence).
                     /evidence=ECO:0000305."
     Region          81
                     /region_name="Conflict"
                     /note="K -> KC (in Ref. 2; AA sequence).
                     /evidence=ECO:0000305."
ORIGIN      
        1 mkvailflsi lvlavasesi eesrddfave elgratcagq dqtckvtcdc cgergecvcg
       61 gpcicrqgnf liawyklasc kk
//

LOCUS       1EIT_A                    37 aa            linear   INV 28-FEB-2022
DEFINITION  Chain A, MU-AGATOXIN-I.
ACCESSION   1EIT_A
VERSION     1EIT_A
DBSOURCE    pdb: molecule 1EIT, chain A, release Feb 16, 2022;
            deposition: Dec 14, 1995;
            class: NEUROTOXIN;
            source: Mmdb_id: 73571, Pdb_id 1: 1EIT;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Agelenopsis aperta
  ORGANISM  Agelenopsis aperta
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Entelegynae; Agelenidae; Agelenopsis.
REFERENCE   1  (residues 1 to 37)
  AUTHORS   Skinner,W.S., Adams,M.E., Quistad,G.B., Kataoka,H., Cesarin,B.J.,
            Enderlin,F.E. and Schooley,D.A.
  TITLE     Purification and characterization of two classes of neurotoxins
            from the funnel web spider, Agelenopsis aperta
  JOURNAL   J Biol Chem 264 (4), 2150-2155 (1989)
   PUBMED   2914898
REFERENCE   2  (residues 1 to 37)
  AUTHORS   Adams,M.E., Mintz,I.M., Reily,M.D., Thanabal,V. and Bean,B.P.
  TITLE     Structure and properties of omega-agatoxin IVB, a new antagonist of
            P-type calcium channels
  JOURNAL   Mol Pharmacol 44 (4), 681-688 (1993)
   PUBMED   8232218
REFERENCE   3  (residues 1 to 37)
  AUTHORS   Reily,M.D., Holub,K.E., Gray,W.R., Norris,T.M. and Adams,M.E.
  TITLE     Structure-activity relationships for P-type calcium
            channel-selective omega-agatoxins
  JOURNAL   Nat Struct Biol 1 (12), 853-856 (1994)
   PUBMED   7773772
REFERENCE   4  (residues 1 to 37)
  AUTHORS   Reily,M.D., Thanabal,V. and Adams,M.E.
  TITLE     The solution structure of omega-Aga-IVB, a P-type calcium channel
            antagonist from venom of the funnel web spider, Agelenopsis aperta
  JOURNAL   J Biomol NMR 5 (2), 122-132 (1995)
   PUBMED   7703698
REFERENCE   5  (residues 1 to 37)
  AUTHORS   Omecinsky,D.O., Holub,K.E., Adams,M.E. and Reily,M.D.
  TITLE     Three-dimensional structure analysis of mu-agatoxins: further
            evidence for common motifs among neurotoxins with diverse ion
            channel specificities
  JOURNAL   Biochemistry 35 (9), 2836-2844 (1996)
   PUBMED   8608119
REFERENCE   6  (residues 1 to 37)
  AUTHORS   Omecinsky,D.O. and Reily,M.D.
  TITLE     Direct Submission
  JOURNAL   Submitted (14-DEC-1995)
COMMENT     On Jul 10, 2009 this sequence version replaced gi:157830954.
            NMR STUDY OF MU-AGATOXIN.
FEATURES             Location/Qualifiers
     source          1..37
                     /organism="Agelenopsis aperta"
                     /db_xref="taxon:6908"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     Bond            bond(9,22)
                     /bond_type="disulfide"
     Bond            bond(16,32)
                     /bond_type="disulfide"
     SecStr          21..24
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(24,30)
                     /bond_type="disulfide"
     SecStr          30..33
                     /sec_str_type="sheet"
                     /note="strand 2"
     NonStdRes       37
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 ecvpenghcr dwydeccegf ycscrqppkc icrnnnx
//

LOCUS       MYC2_CRODU                65 aa            linear   VRT 22-FEB-2023
DEFINITION  RecName: Full=Crotamine; Short=Crt; AltName: Full=Myotoxin; Flags:
            Precursor.
ACCESSION   Q9PWF3
VERSION     Q9PWF3.1
DBSOURCE    UniProtKB: locus MYC2_CRODU, accession Q9PWF3;
            class: standard.
            extra accessions:P01475
            created: Sep 27, 2004.
            sequence updated: May 1, 2000.
            annotation updated: Feb 22, 2023.
            xrefs: AF053075.1, AAC06241.1, AF223946.1, AAF34910.1, AF223947.1,
            AAF34911.1, CXRSMT, 1H5O_A, 1Z99_A
            xrefs (non-sequence databases): PDBsum:1H5O, PDBsum:1Z99,
            AlphaFoldDB:Q9PWF3, BMRB:Q9PWF3, SMR:Q9PWF3, GO:0005576,
            GO:0015459, GO:0090729, GO:0042742, GO:0050832, GO:0044564,
            GO:0031640, Gene3D:2.20.20.10, InterPro:IPR023355,
            InterPro:IPR000881, Pfam:PF00819, PRINTS:PR00283, SUPFAM:SSF57392,
            PROSITE:PS00459, PROSITE:PS51345
KEYWORDS    3D-structure; Antibiotic; Antimicrobial; Direct protein sequencing;
            Disulfide bond; Fungicide; Ion channel impairing toxin; Myotoxin;
            Neurotoxin; Pharmaceutical; Potassium channel impairing toxin;
            Secreted; Signal; Toxin; Voltage-gated potassium channel impairing
            toxin.
SOURCE      Crotalus durissus terrificus (tropical rattlesnake)
  ORGANISM  Crotalus durissus terrificus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
            Toxicofera; Serpentes; Colubroidea; Viperidae; Crotalinae;
            Crotalus.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Radis-Baptista,G., Oguiura,N., Hayashi,M.A., Camargo,M.E.,
            Grego,K.F., Oliveira,E.B. and Yamane,T.
  TITLE     Nucleotide sequence of crotamine isoform precursors from a single
            South American rattlesnake (Crotalus durissus terrificus)
  JOURNAL   Toxicon 37 (7), 973-984 (1999)
   PUBMED   10484745
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=Martinopolis; TISSUE=Venom gland
REFERENCE   2  (residues 1 to 65)
  AUTHORS   Radis-Baptista,G., Kubo,T., Oguiura,N., Svartman,M., Almeida,T.M.,
            Batistic,R.F., Oliveira,E.B., Vianna-Morgante,A.M. and Yamane,T.
  TITLE     Structure and chromosomal localization of the gene for crotamine, a
            toxin from the South American rattlesnake, Crotalus durissus
            terrificus
  JOURNAL   Toxicon 42 (7), 747-752 (2003)
   PUBMED   14757205
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].;
            TISSUE=Liver
REFERENCE   3  (residues 1 to 65)
  AUTHORS   Laure,C.J.
  TITLE     The primary structure of crotamine
  JOURNAL   Hoppe-Seyler's Z. Physiol. Chem. 356, 213-215 (1975)
   PUBMED   1176086
  REMARK    PROTEIN SEQUENCE OF 23-64, FUNCTION, TOXIC DOSE, AND SUBCELLULAR
            LOCATION.
REFERENCE   4  (residues 1 to 65)
  AUTHORS   Peigneur,S., Orts,D.J., Prieto da Silva,A.R., Oguiura,N.,
            Boni-Mitake,M., de Oliveira,E.B., Zaharenko,A.J., de Freitas,J.C.
            and Tytgat,J.
  TITLE     Crotamine pharmacology revisited: novel insights based on the
            inhibition of KV channels
  JOURNAL   Mol Pharmacol 82 (1), 90-96 (2012)
   PUBMED   22498659
  REMARK    PROTEIN SEQUENCE OF 23-42, MASS SPECTROMETRY, FUNCTION AS POTASSIUM
            CHANNEL INHIBITOR, AND PROBABLE SITES AT TYR-23; LYS-24; ARG-55 AND
            TRP-56.
REFERENCE   5  (residues 1 to 65)
  AUTHORS   Chang,C.C. and Tseng,K.H.
  TITLE     Effect of crotamine, a toxin of South American rattlesnake venom,
            on the sodium channel of murine skeletal muscle
  JOURNAL   Br J Pharmacol 63 (3), 551-559 (1978)
   PUBMED   667499
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   6  (residues 1 to 65)
  AUTHORS   Mancin,A.C., Soares,A.M., Andriao-Escarso,S.H., Faca,V.M.,
            Greene,L.J., Zuccolotto,S., Pela,I.R. and Giglio,J.R.
  TITLE     The analgesic activity of crotamine, a neurotoxin from Crotalus
            durissus terrificus (South American rattlesnake) venom: a
            biochemical and pharmacological study
  JOURNAL   Toxicon 36 (12), 1927-1937 (1998)
   PUBMED   9839677
  REMARK    FUNCTION, AND TOXIC DOSE.
REFERENCE   7  (residues 1 to 65)
  AUTHORS   Kerkis,A., Kerkis,I., Radis-Baptista,G., Oliveira,E.B.,
            Vianna-Morgante,A.M., Pereira,L.V. and Yamane,T.
  TITLE     Crotamine is a novel cell-penetrating protein from the venom of
            rattlesnake Crotalus durissus terrificus
  JOURNAL   FASEB J 18 (12), 1407-1409 (2004)
   PUBMED   15231729
  REMARK    FUNCTION AS CELL PENETRATING PEPTIDE.
REFERENCE   8  (residues 1 to 65)
  AUTHORS   Nascimento,F.D., Hayashi,M.A., Kerkis,A., Oliveira,V.,
            Oliveira,E.B., Radis-Baptista,G., Nader,H.B., Yamane,T.,
            Tersariol,I.L. and Kerkis,I.
  TITLE     Crotamine mediates gene delivery into cells through the binding to
            heparan sulfate proteoglycans
  JOURNAL   J Biol Chem 282 (29), 21349-21360 (2007)
   PUBMED   17491023
  REMARK    FUNCTION AS CELL PENETRATING PEPTIDE.
REFERENCE   9  (residues 1 to 65)
  AUTHORS   Rizzi,C.T., Carvalho-de-Souza,J.L., Schiavon,E., Cassola,A.C.,
            Wanke,E. and Troncone,L.R.
  TITLE     Crotamine inhibits preferentially fast-twitching muscles but is
            inactive on sodium channels
  JOURNAL   Toxicon 50 (4), 553-562 (2007)
   PUBMED   17588630
  REMARK    FUNCTION.
REFERENCE   10 (residues 1 to 65)
  AUTHORS   Hayashi,M.A.F., Nascimento,F.D., Kerkis,A., Oliveira,V.,
            Oliveira,E.B., Pereira,A., Radis-Baptista,G., Nader,H.B.,
            Yamane,T., Kerkis,I. and Tersariol,I.L.
  TITLE     Cytotoxic effects of crotamine are mediated through lysosomal
            membrane permeabilization
  JOURNAL   Toxicon 52 (3), 508-517 (2008)
   PUBMED   18662711
  REMARK    FUNCTION.
REFERENCE   11 (residues 1 to 65)
  AUTHORS   Yount,N.Y., Kupferwasser,D., Spisni,A., Dutz,S.M., Ramjan,Z.H.,
            Sharma,S., Waring,A.J. and Yeaman,M.R.
  TITLE     Selective reciprocity in antimicrobial activity versus cytotoxicity
            of hBD-2 and crotamine
  JOURNAL   Proc Natl Acad Sci U S A 106 (35), 14972-14977 (2009)
   PUBMED   19706485
  REMARK    FUNCTION AS ANTIMICROBIAL PEPTIDE, AND DOCKING STUDIES WITH
            POTASSIUM CHANNELS.
REFERENCE   12 (residues 1 to 65)
  AUTHORS   Pereira,A., Kerkis,A., Hayashi,M.A.F., Pereira,A.S., Silva,F.S.,
            Oliveira,E.B., Prieto da Silva,A.R., Yamane,T., Radis-Baptista,G.
            and Kerkis,I.
  TITLE     Crotamine toxicity and efficacy in mouse models of melanoma
  JOURNAL   Expert Opin. Invest. Drugs 20, 1189-1200 (2011)
   PUBMED   21834748
  REMARK    BIOASSAY IN MOUSE MODELS OF MELANOMA.
REFERENCE   13 (residues 1 to 65)
  AUTHORS   Oguiura,N., Boni-Mitake,M., Affonso,R. and Zhang,G.
  TITLE     In vitro antibacterial and hemolytic activities of crotamine, a
            small basic myotoxin from rattlesnake Crotalus durissus
  JOURNAL   J. Antibiot. 64, 327-331 (2011)
   PUBMED   21386851
  REMARK    FUNCTION AS ANTIBACTERIAL PEPTIDE.
REFERENCE   14 (residues 1 to 65)
  AUTHORS   Nascimento,F.D., Sancey,L., Pereira,A., Rome,C., Oliveira,V.,
            Oliveira,E.B., Nader,H.B., Yamane,T., Kerkis,I., Tersariol,I.L.,
            Coll,J.L. and Hayashi,M.A.
  TITLE     The natural cell-penetrating peptide crotamine targets tumor tissue
            in vivo and triggers a lethal calcium-dependent pathway in cultured
            cells
  JOURNAL   Mol Pharm 9 (2), 211-221 (2012)
   PUBMED   22142367
  REMARK    FUNCTION.
REFERENCE   15 (residues 1 to 65)
  AUTHORS   Yamane,E.S., Bizerra,F.C., Oliveira,E.B., Moreira,J.T., Rajabi,M.,
            Nunes,G.L., de Souza,A.O., da Silva,I.D., Yamane,T., Karpel,R.L.,
            Silva,P.I. Jr. and Hayashi,M.A.
  TITLE     Unraveling the antifungal activity of a South American rattlesnake
            toxin crotamine
  JOURNAL   Biochimie 95 (2), 231-240 (2013)
   PUBMED   23022146
  REMARK    FUNCTION AS ANTIMICROBIAL PEPTIDE, SYNTHESIS OF 23-65, AND CIRCULAR
            DICHROISM ANALYSIS.;
            TISSUE=Venom
REFERENCE   16 (residues 1 to 65)
  AUTHORS   Kerkis,I., Silva,F.S., Pereira,A., Kerkis,A. and Radis-Baptista,G.
  TITLE     Biological versatility of crotamine--a cationic peptide from the
            venom of a South American rattlesnake
  JOURNAL   Expert Opin. Invest. Drugs 19, 1515-1525 (2010)
   PUBMED   21062230
  REMARK    REVIEW.
REFERENCE   17 (residues 1 to 65)
  AUTHORS   Nicastro,G., Franzoni,L., de Chiara,C., Mancin,A.C., Giglio,J.R.
            and Spisni,A.
  TITLE     Solution structure of crotamine, a Na+ channel affecting toxin from
            Crotalus durissus terrificus venom
  JOURNAL   Eur J Biochem 270 (9), 1969-1979 (2003)
   PUBMED   12709056
  REMARK    STRUCTURE BY NMR OF 23-64, AND DISULFIDE BONDS.
REFERENCE   18 (residues 1 to 65)
  AUTHORS   Fadel,V., Bettendorff,P., Herrmann,T., de Azevedo,W.F. Jr.,
            Oliveira,E.B., Yamane,T. and Wuthrich,K.
  TITLE     Automated NMR structure determination and disulfide bond
            identification of the myotoxin crotamine from Crotalus durissus
            terrificus
  JOURNAL   Toxicon 46 (7), 759-767 (2005)
   PUBMED   16185738
  REMARK    STRUCTURE BY NMR OF 23-64, AND DISULFIDE BONDS.
COMMENT     On Nov 15, 2013 this sequence version replaced P01475.1.
            [FUNCTION] Cationic peptide that possesses multiple functions. It
            acts as a cell-penetrating peptide (CPP), and as a potent
            voltage-gated potassium channel inhibitor. It exhibits
            antimicrobial activities, hind limb paralysis, and severe muscle
            necrosis by a non-enzymatic mechanism. As a cell-penetrating
            peptide, crotamine has high specificity for actively proliferating
            cells, and interacts inside the cell with subcellular and
            subnuclear structures, like vesicular compartments, chromosomes and
            centrioles. It penetrates into the cells as fast as five minutes
            after its addition to cell culture medium (PubMed:18662711). In
            vivo, after intraperitoneal administration, it is found in cells of
            peritoneal fluid and bone marrow, demonstrating preferential
            nuclear and perinuclear localization. To enter the cell, it
            interacts with the chains of heparan sulfate membrane proteoglycan
            (HSPG), and is endocytosed (in complex with HSPG) in vesicles which
            are transported into the cell with the help of clathrin. Inside the
            cell, crotamine accumulates in lysosomal vesicles. As soon as the
            peptide accumulates in endosomes/lysosomes vesicles, these
            compartments are disrupted and their contents released into the
            cytosol. This loss of lysosomal content induces cell death at high
            concentrations, or promotes the distribution of crotamine in
            cytoplasmic compartments, which is a step before crotamine nuclear
            uptake (PubMed:15231729, PubMed:17491023). As a potassium channel
            inhibitor, this toxin selectively inhibits Kv1.1/KCNA1, Kv1.2/KCNA2
            and Kv1.3/KCNA3 channels with an IC(50) of 369, 386 and 287 nM,
            respectively (PubMed:22498659). The inhibition of Kv1.3/KCNA
            channels induced by this toxin occurs rapidly and is
            voltage-independent. The channel inhibition is reversible after
            washing, suggesting a pure and classical channel blockage effect,
            without effects in potassium channel kinetics (PubMed:22498659). As
            an antimicrobial peptide, crotamine shows antibacterial activity
            against E.coli and B.subtilis, and antifungal activity against
            Candida spp., Trichosporon spp. and C.neoformans. It kills bacteria
            through membrane permeabilization. {ECO:0000269|PubMed:1176086,
            ECO:0000269|PubMed:15231729, ECO:0000269|PubMed:17491023,
            ECO:0000269|PubMed:17588630, ECO:0000269|PubMed:18662711,
            ECO:0000269|PubMed:19706485, ECO:0000269|PubMed:21386851,
            ECO:0000269|PubMed:22142367, ECO:0000269|PubMed:22498659,
            ECO:0000269|PubMed:23022146, ECO:0000269|PubMed:667499,
            ECO:0000269|PubMed:9839677}.
            [SUBUNIT] Monomer. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:1176086}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:1176086}.
            [MASS SPECTROMETRY] Mass=4885.6; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:22498659}.
            [TOXIC DOSE] LD(50) is 1.5 mg/kg by intravenous injection.
            {ECO:0000269|PubMed:1176086}.
            [TOXIC DOSE] LD(50) is 32.8 mg/kg by intraperitoneal injection into
            mice. {ECO:0000269|PubMed:9839677}.
            [PHARMACEUTICAL] Has high potential for use as an anticancer agent.
            In vivo treatment with this protein significantly delays tumor
            implantation, inhibits tumor growth and prolongs the lifespan of
            the mice with melanoma tumors. It has also potent and specific
            toxicity against tumor cell lines of aggressive mouse and human
            tumors, but low cytotoxicity against non-tumoral cell lines. In
            addition, this protein can act as a carrier capable of delivering
            DNA into replicating cells with low cytotoxicity against normal
            proliferative cells (PubMed:21062230, PubMed:22142367,
            PubMed:21834748).
            [MISCELLANEOUS] Negative results: has no hemolytic activity
            (PubMed:21386851, PubMed:23022146). Has low harmful effects on
            normal mammal cells. Does not show activity against the filamentous
            fungi A.fumigatus and T.rubrum at concentrations up to 125 ug/mL
            (PubMed:23022146). Does not directly affect voltage-gated sodium
            channels Nav1.1/SCN1A, Nav1.2/SCN2A, Nav1.3/SCN3A, Nav1.4/SCN4A,
            Nav1.5/SCN5A and Nav1.6/SCN8A (PubMed:17588630).
            {ECO:0000305|PubMed:17588630, ECO:0000305|PubMed:21386851,
            ECO:0000305|PubMed:23022146}.
            [SIMILARITY] Belongs to the crotamine-myotoxin family.
            {ECO:0000305}.
            [CAUTION] The analgesic activity produced by crotamine in Mancin et
            al., 1998 may be a misinterpretation (PubMed:9839677). This
            activity is probably due to the co-elution with the 14 amino acids
            crotalphine peptide (AC P08878). In that article crotamine was
            purified uniquely by gel filtration G-75. This single
            chromatographic step without going through a RP-HPLC is not
            sufficient to separate crotamine from other low molecular weight
            peptides such as the potent analgesic crotalphine peptide.
            {ECO:0000305}.
            [CAUTION] Studies have shown that crotamine is present in the venom
            of certain specimens of C.durissus terrificus, and absent in
            others. This is due to geographical variations (PubMed:10484745).
            {ECO:0000305|PubMed:10484745}.
            [WEB RESOURCE] Name=Wikipedia;
            URL='https://en.wikipedia.org/wiki/Crotamine'.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Crotalus durissus terrificus"
                     /sub_species="terrificus"
                     /db_xref="taxon:8732"
     gene            1..65
                     /gene="CRO2"
                     /gene_synonym="CRT-P1"
     Protein         1..65
                     /product="Crotamine"
                     /note="Crt; Myotoxin"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000269|PubMed:1176086."
     Region          23..64
                     /region_name="Mature chain"
                     /note="Crotamine. /evidence=ECO:0000269|PubMed:1176086.
                     /id=PRO_0000035184."
     Region          23..64
                     /region_name="Myotoxins"
                     /note="Myotoxin, crotamine; pfam00819"
                     /db_xref="CDD:109859"
     Site            23
                     /site_type="other"
                     /note="Involved in the interaction surface toward Kv.
                     /evidence=ECO:0000305."
     Region          24..40
                     /region_name="Short sequence motif of biological interest"
                     /note="Nuclear localization signal."
     Region          24..29
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1H5O."
     Site            24
                     /site_type="other"
                     /note="Involved in the interaction surface toward Kv.
                     /evidence=ECO:0000305."
     Bond            bond(26,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12709056,
                     ECO:0000269|PubMed:16185738, ECO:0000312|PDB:1H5O,
                     ECO:0000312|PDB:1Z99."
     Region          31..35
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1H5O."
     Bond            bond(33,52)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12709056,
                     ECO:0000269|PubMed:16185738, ECO:0000312|PDB:1H5O,
                     ECO:0000312|PDB:1Z99."
     Region          36..38
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1Z99."
     Bond            bond(40,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12709056,
                     ECO:0000269|PubMed:16185738, ECO:0000312|PDB:1H5O,
                     ECO:0000312|PDB:1Z99."
     Region          41..44
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1H5O."
     Region          49..61
                     /region_name="Short sequence motif of biological interest"
                     /note="Nuclear localization signal."
     Region          49..52
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1H5O."
     Site            55
                     /site_type="other"
                     /note="Involved in the interaction surface toward Kv.
                     /evidence=ECO:0000305."
     Region          56..60
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1H5O."
     Site            56
                     /site_type="other"
                     /note="Involved in the interaction surface toward Kv.
                     /evidence=ECO:0000305."
ORIGIN      
        1 mkilyllfaf lflaflsepg naykqchkkg ghcfpkekic lppssdfgkm dcrwrwkcck
       61 kgsgk
//

LOCUS       TO1A_HADVE                37 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Hv1a; Short=Omega-HXTX-Hv1a; AltName:
            Full=Omega-atracotoxin-Hv1a; Short=Omega-ACTX-Hv1;
            Short=Omega-AcTx-Hv1a; Short=Omega-atracotoxin-Hv1; AltName:
            Full=Omega/kappa-atracotoxin-Hv1a; Short=Omega/kappa-HXTX-Hv1a.
ACCESSION   P56207
VERSION     P56207.1
DBSOURCE    UniProtKB: locus TO1A_HADVE, accession P56207;
            class: standard.
            created: Nov 1, 1997.
            sequence updated: Nov 1, 1997.
            annotation updated: Feb 22, 2023.
            xrefs: 1AXH_A, 1HVW_A
            xrefs (non-sequence databases): PDBsum:1AXH, PDBsum:1HVW,
            AlphaFoldDB:P56207, BMRB:P56207, SMR:P56207,
            ArachnoServer:AS000193, EvolutionaryTrace:P56207, GO:0005576,
            GO:0019855, GO:0090729, GO:0006952, InterPro:IPR009415,
            InterPro:IPR018071, Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    3D-structure; Calcium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Toxin; Voltage-gated calcium channel
            impairing toxin.
SOURCE      Hadronyche versuta
  ORGANISM  Hadronyche versuta
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Hadronyche.
REFERENCE   1  (residues 1 to 37)
  AUTHORS   Fletcher,J.I., Smith,R., O'Donoghue,S.I., Nilges,M., Connor,M.,
            Howden,M.E., Christie,M.J. and King,G.F.
  TITLE     The structure of a novel insecticidal neurotoxin,
            omega-atracotoxin-HV1, from the venom of an Australian funnel web
            spider
  JOURNAL   Nat Struct Biol 4 (7), 559-566 (1997)
   PUBMED   9228949
  REMARK    PROTEIN SEQUENCE, SYNTHESIS, TOXIC DOSE, STRUCTURE BY NMR, AND
            SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 37)
  AUTHORS   Wang,X., Smith,R., Fletcher,J.I., Wilson,H., Wood,C.J., Howden,M.E.
            and King,G.F.
  TITLE     Structure-function studies of omega-atracotoxin, a potent
            antagonist of insect voltage-gated calcium channels
  JOURNAL   Eur J Biochem 264 (2), 488-494 (1999)
   PUBMED   10491095
  REMARK    TOXIC DOSE.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 37)
  AUTHORS   Bloomquist,J.R.
  TITLE     Mode of action of atracotoxin at central and peripheral synapses of
            insects
  JOURNAL   Invertebr. Neurosci. 5, 45-50 (2003)
   PUBMED   14608494
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 37)
  AUTHORS   Tedford,H.W., Gilles,N., Menez,A., Doering,C.J., Zamponi,G.W. and
            King,G.F.
  TITLE     Scanning mutagenesis of omega-atracotoxin-Hv1a reveals a spatially
            restricted epitope that confers selective activity against insect
            calcium channels
  JOURNAL   J Biol Chem 279 (42), 44133-44140 (2004)
   PUBMED   15308644
  REMARK    FUNCTION, TOXIC DOSE, AND MUTAGENESIS OF GLN-9; PRO-10; ASN-27 AND
            ARG-35.
REFERENCE   5  (residues 1 to 37)
  AUTHORS   Mukherjee,A.K., Sollod,B.L., Wikel,S.K. and King,G.F.
  TITLE     Orally active acaricidal peptide toxins from spider venom
  JOURNAL   Toxicon 47 (2), 182-187 (2006)
   PUBMED   16330063
  REMARK    FUNCTION, AND TOXIC DOSE.
REFERENCE   6  (residues 1 to 37)
  AUTHORS   Khan,S.A., Zafar,Y., Briddon,R.W., Malik,K.A. and Mukhtar,Z.
  TITLE     Spider venom toxin protects plants from insect attack
  JOURNAL   Transgenic Res 15 (3), 349-357 (2006)
   PUBMED   16779650
  REMARK    TRANSGENIC PROTECTION OF PLANTS.
REFERENCE   7  (residues 1 to 37)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    FUNCTION.;
            STRAIN=XenFW194; TISSUE=Venom, and Venom gland
REFERENCE   8  (residues 1 to 37)
  AUTHORS   Tedford,H.W., Maggio,F., Reenan,R.A. and King,G.
  TITLE     A model genetic system for testing the in vivo function of peptide
            toxins
  JOURNAL   Peptides 28 (1), 51-56 (2007)
   PUBMED   17141372
  REMARK    FUNCTION.
REFERENCE   9  (residues 1 to 37)
  AUTHORS   Fitches,E.C., Pyati,P., King,G.F. and Gatehouse,J.A.
  TITLE     Fusion to snowdrop lectin magnifies the oral activity of
            insecticidal omega-Hexatoxin-Hv1a peptide by enabling its delivery
            to the central nervous system
  JOURNAL   PLoS One 7 (6), e39389 (2012)
   PUBMED   22761779
  REMARK    BIOTECHNOLOGY, AND RECOMBINANT EXPRESSION AS A CHIMERIC VARIANT.
REFERENCE   10 (residues 1 to 37)
  AUTHORS   Bonning,B.C., Pal,N., Liu,S., Wang,Z., Sivakumar,S., Dixon,P.M.,
            King,G.F. and Miller,W.A.
  TITLE     Toxin delivery by the coat protein of an aphid-vectored plant virus
            provides plant resistance to aphids
  JOURNAL   Nat Biotechnol 32 (1), 102-105 (2014)
   PUBMED   24316580
  REMARK    BIOTECHNOLOGY, AND RECOMBINANT EXPRESSION AS A CHIMERIC VARIANT.
REFERENCE   11 (residues 1 to 37)
  AUTHORS   Nakasu,E.Y., Williamson,S.M., Edwards,M.G., Fitches,E.C.,
            Gatehouse,J.A., Wright,G.A. and Gatehouse,A.M.
  TITLE     Novel biopesticide based on a spider venom peptide shows no adverse
            effects on honeybees
  JOURNAL   Proc Biol Sci 281 (1787) (2014)
   PUBMED   24898372
  REMARK    BIOTECHNOLOGY, AND RECOMBINANT EXPRESSION AS A CHIMERIC VARIANT.
REFERENCE   12 (residues 1 to 37)
  AUTHORS   Herzig,V., Ikonomopoulou,M., Smith,J.J., Dziemborowicz,S.,
            Gilchrist,J., Kuhn-Nentwig,L., Rezende,F.O., Moreira,L.A.,
            Nicholson,G.M., Bosmans,F. and King,G.F.
  TITLE     Molecular basis of the remarkable species selectivity of an
            insecticidal sodium channel toxin from the African spider
            Augacephalus ezendami
  JOURNAL   Sci Rep 6, 29538 (2016)
   PUBMED   27383378
  REMARK    TOXIC DOSE.
            Publication Status: Online-Only
REFERENCE   13 (residues 1 to 37)
  AUTHORS   Fanning,P.D., VanWoerkom,A., Wise,J.C. and Isaacs,R.
  TITLE     Assessment of a commercial spider venom peptide against
            spotted-wing Drosophila and interaction with adjuvants
  JOURNAL   J. Pest Sci. 4, 1279-1290 (2018)
  REMARK    BIOTECHNOLOGY.
            DOI: 10.1007/s10340-018-1016-7
REFERENCE   14 (residues 1 to 37)
  AUTHORS   Powell,M.E., Bradish,H.M., Cao,M., Makinson,R., Brown,A.P.,
            Gatehouse,J.A. and Fitches,E.C.
  TITLE     Demonstrating the potential of a novel spider venom-based
            biopesticide for target-specific control of the small hive beetle,
            a serious pest of the European honeybee
  JOURNAL   J. Pest Sci. 93, 391-402 (2020)
   PUBMED   31997983
  REMARK    BIOTECHNOLOGY.
REFERENCE   15 (residues 1 to 37)
  AUTHORS   Tedford,H.W., Fletcher,J.I. and King,G.F.
  TITLE     Functional significance of the beta hairpin in the insecticidal
            neurotoxin omega-atracotoxin-Hv1a
  JOURNAL   J Biol Chem 276 (28), 26568-26576 (2001)
   PUBMED   11313356
  REMARK    STRUCTURE BY NMR OF 4-23, TOXIC DOSE, AND MUTAGENESIS OF ASN-27 AND
            ARG-35.
COMMENT     [FUNCTION] Reversibly and voltage-independently blocks both
            mid-low- (M-LVA) and high-voltage-activated (HVA) calcium channels
            in cockroach DUM neurons (PubMed:17610847). Is lethal to many
            insect species but not toxic to mammals (PubMed:9228949,
            PubMed:16779650). May target the insect high-voltage-activated
            calcium channel Dmca1D. Also inhibits acarines calcium channels. An
            extremely high toxin concentration partially inhibits
            Cav1.2/CACNA1C, Cav2.1/CACNA1A and Cav2.2/CACNA1B calcium channel
            of rats. As for omega-AcTx-Hv2a, the phenotypic effect of injection
            of this toxin into lone star ticks (Amblyomma americanum) is
            curling of all eight legs into closed loops.
            {ECO:0000269|PubMed:14608494, ECO:0000269|PubMed:15308644,
            ECO:0000269|PubMed:16330063, ECO:0000269|PubMed:17141372,
            ECO:0000269|PubMed:17610847, ECO:0000269|PubMed:9228949}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:9228949}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:9228949}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:11313356, ECO:0000269|PubMed:9228949}.
            [TOXIC DOSE] PD(50) is 3 umol/kg in tobacco budworms (Heliothis
            armigera). {ECO:0000305|PubMed:9228949}.
            [TOXIC DOSE] PD(50) is 0.25 umol/kg in tobacco budworms (Heliothis
            virescens). {ECO:0000305|PubMed:9228949}.
            [TOXIC DOSE] LD(50) is 89-91 pmol/g (0.38 mg/kg) to house crickets
            (Acheta domesticus). {ECO:0000269|PubMed:10491095}.
            [TOXIC DOSE] LD(50) is 86.5 pmol/g in house flies (Musca
            domestica). {ECO:0000269|PubMed:10491095}.
            [TOXIC DOSE] LD(50) is 716 +-23 pmol/g (3.00 +-0.10 ug/g) when
            orally administered into lone star ticks (Amblyomma americanum).
            [TOXIC DOSE] LD(50) is 447 +-3 pmol/g (1877 +-0.013 ug/g) when
            injected into lone star ticks (Amblyomma americanum).
            [TOXIC DOSE] LD(50) is 147 nmol/g in triatomine bug (Rhodinius
            prolixus). {ECO:0000269|PubMed:27383378}.
            [TOXIC DOSE] PD(50) is 0.32 umol/kg in Periplaneta americana.
            {ECO:0000269|PubMed:9228949}.
            [BIOTECHNOLOGY] Spear and Spear T (Vesparon) are biological
            insecticides containing 20% of the active ingredient
            GS-omega/kappa-Hxtx-Hv1a. They are effective against thrips,
            whiteflies, and spider mites in greenhouse settings. They have a
            large molecular weight, are hydrophilic, and have many hydrogen
            donors. They kill some insects on contact. The peptides block two
            ion channels in the insect nervous system (a voltage-gated calcium
            channel (Cav) and a calcium-activated potassium channel (KCa)).
            {ECO:0000269|Ref.13}.
            [BIOTECHNOLOGY] Could be considered as a biological insecticide
            candidate, when fused to Galanthus nivalis agglutinin (GNA), a
            protein with the potential to cross the insect gut
            (PubMed:22761779). This chimeric Hv1a/GNA variant shows a gain in
            toxicity on insects when administered orally (tested on Mamestra
            brassicae), while maintaining similar effects as the wild-type
            toxin when injected (PubMed:22761779). Transport of fusion protein
            from gut contents to the hemolymph of insect larvae, and binding to
            the nerve chord indicate that the fusion with GNA permits to
            deliver the toxin to sites of action within the insect central
            nervous system (PubMed:22761779). The Hv1a/GNA variant does not
            show adverse effects on honeybees (PubMed:22761779,
            PubMed:24898372). {ECO:0000269|PubMed:22761779,
            ECO:0000269|PubMed:24898372}.
            [BIOTECHNOLOGY] Potential biopesticide that could protect honeybees
            from the parasitic small hive beetle pest Aethina tumida, but is
            harmless to honeybees. Is orally toxic to A.tumida, when fused to
            Galanthus nivalis agglutinin (GNA), a protein with the potential to
            cross the insect gut. {ECO:0000269|PubMed:22761779}.
            [BIOTECHNOLOGY] Could be considered as a biological insecticide
            candidate, when fused to a luteovirus coat protein, which is able
            for delivery of fused proteins into the hemocoel of pea aphids.
            This luteovirus coat protein is used as a carrier to greatly
            enhance the oral toxicity of Hv1a to a range of aphid pest species
            (Acyrthosiphon pisum, Rhopalosiphum padi, Aphis glycines and Myzus
            persicae). {ECO:0000269|PubMed:24316580}.
            [MISCELLANEOUS] When expressed in tobacco plants, the toxin induces
            a 100% mortality of insect larvae H.armigera and S.littoralis after
            ingestion. {ECO:0000269|PubMed:16779650}.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
            [WEB RESOURCE] Name=Chemical and engineering news;
            URL='https://cen.acs.org/articles/95/i11/Spider-venom-insecticide-
            whose-time.html'.
FEATURES             Location/Qualifiers
     source          1..37
                     /organism="Hadronyche versuta"
                     /db_xref="taxon:6904"
     Protein         1..37
                     /product="Omega-hexatoxin-Hv1a"
                     /note="Omega-HXTX-Hv1a; Omega-atracotoxin-Hv1a;
                     Omega/kappa-atracotoxin-Hv1a; Omega-ACTX-Hv1;
                     Omega-AcTx-Hv1a; Omega/kappa-HXTX-Hv1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..37
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          1..37
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Hv1a.
                     /evidence=ECO:0000269|PubMed:9228949. /id=PRO_0000044988."
     Bond            bond(4,18)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:9228949, ECO:0000312|PDB:1AXH,
                     ECO:0000312|PDB:1HVW."
     Site            9
                     /site_type="mutagenized"
                     /note="Q->A: 4-fold decrease in toxicity to crickets, and
                     insignificant decrease to flies. 16-fold decrease in
                     binding affinity to cockroach membranes.
                     /evidence=ECO:0000269|PubMed:15308644."
     Site            10
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000305|PubMed:15308644."
     Site            10
                     /site_type="mutagenized"
                     /note="P->A: 6-fold decrease in toxicity to crickets and
                     15-fold to flies. 190-fold decrease in binding affinity to
                     cockroach membranes.
                     /evidence=ECO:0000269|PubMed:15308644."
     Bond            bond(11,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:9228949, ECO:0000312|PDB:1AXH,
                     ECO:0000312|PDB:1HVW."
     Site            13
                     /site_type="mutagenized"
                     /note="Y->A: 16-fold decrease in binding affinity to
                     cockroach membranes."
     Region          14..16
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1AXH."
     Bond            bond(17,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:9228949, ECO:0000312|PDB:1AXH,
                     ECO:0000312|PDB:1HVW."
     Region          17..20
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AXH."
     Region          22..26
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AXH."
     Site            27
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000305|PubMed:15308644."
     Site            27
                     /site_type="mutagenized"
                     /note="N->A: 14-fold decrease in toxicity to crickets and
                     30-fold to flies. Abolishes toxicity to crickets and
                     flies; when associated with A-35. 195-fold decrease in
                     binding affinity to cockroach membranes.
                     /evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:15308644."
     Site            27
                     /site_type="mutagenized"
                     /note="N->D: 12-fold decrease in toxicity to crickets.
                     /evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:15308644."
     Region          28..30
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AXH."
     Region          32..36
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AXH."
     Site            35
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000305|PubMed:15308644."
     Site            35
                     /site_type="mutagenized"
                     /note="R->A: 4.4-fold decrease in toxicity to crickets,
                     and 15 to flies. Abolishes toxicity to crickets and flies;
                     when associated with A-27. 280-fold decrease in binding
                     affinity to cockroach membranes.
                     /evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:15308644."
     Site            35
                     /site_type="mutagenized"
                     /note="R->E: 7.8-fold decrease in toxicity to crickets.
                     /evidence=ECO:0000269|PubMed:11313356,
                     ECO:0000269|PubMed:15308644."
ORIGIN      
        1 sptcipsgqp cpynenccsq sctfkeneng ntvkrcd
//

LOCUS       6CHC_A                    30 aa            linear       01-DEC-2020
DEFINITION  Chain A, Beta/kappa-theraphotoxin-Cg2a.
ACCESSION   6CHC_A
VERSION     6CHC_A
DBSOURCE    pdb: molecule 6CHC, chain A, release May 16, 2018;
            deposition: Feb 22, 2018;
            class: TOXIN;
            source: Mmdb_id: 999999, Pdb_id 1: 6CHC;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Unknown.
  ORGANISM  Unknown.
            Unclassified.
REFERENCE   1  (residues 1 to 30)
  AUTHORS   Moyer,B.D., Murray,J.K., Ligutti,J., Andrews,K., Favreau,P.,
            Jordan,J.B., Lee,J.H., Liu,D., Long,J., Sham,K., Shi,L.,
            Stocklin,R., Wu,B., Yin,R., Yu,V., Zou,A., Biswas,K. and
            Miranda,L.P.
  TITLE     Pharmacological characterization of potent and selective NaV1.7
            inhibitors engineered from Chilobrachys jingzhao tarantula venom
            peptide JzTx-V
  JOURNAL   PLoS ONE 13 (5), e0196791 (2018)
   PUBMED   29723257
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 30)
  AUTHORS   Jordan,J.B.
  TITLE     Direct Submission
  JOURNAL   Submitted (22-FEB-2018)
COMMENT     JzTx-V toxin peptide, wild-type.
FEATURES             Location/Qualifiers
     source          1..30
                     /organism="unknown"
     Bond            bond(3,17)
                     /bond_type="disulfide"
     NonStdRes       7
                     /non_std_residue="NLE"
     Bond            bond(10,22)
                     /bond_type="disulfide"
     Bond            bond(16,26)
                     /bond_type="disulfide"
ORIGIN      
        1 rycqkwxwtc dskraccegl rcklwcrkii
//

LOCUS       6CGW_A                    29 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Beta/kappa-theraphotoxin-Cg2a.
ACCESSION   6CGW_A
VERSION     6CGW_A
DBSOURCE    pdb: molecule 6CGW, chain A, release May 16, 2018;
            deposition: Feb 21, 2018;
            class: TOXIN;
            source: Mmdb_id: 161517, Pdb_id 1: 6CGW;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Chilobrachys guangxiensis
  ORGANISM  Chilobrachys guangxiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Chilobrachys.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Moyer,B.D., Murray,J.K., Ligutti,J., Andrews,K., Favreau,P.,
            Jordan,J.B., Lee,J.H., Liu,D., Long,J., Sham,K., Shi,L.,
            Stocklin,R., Wu,B., Yin,R., Yu,V., Zou,A., Biswas,K. and
            Miranda,L.P.
  TITLE     Pharmacological characterization of potent and selective NaV1.7
            inhibitors engineered from Chilobrachys jingzhao tarantula venom
            peptide JzTx-V
  JOURNAL   PLoS ONE 13 (5), e0196791 (2018)
   PUBMED   29723257
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 29)
  AUTHORS   Jordan,J.B. and Andrews,K.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-FEB-2018)
COMMENT     Solution NMR structure of JzTx-V, a Nav 1.7 inhibitory peptide.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Chilobrachys guangxiensis"
                     /db_xref="taxon:278060"
     Bond            bond(2,16)
                     /bond_type="disulfide"
     NonStdRes       6
                     /non_std_residue="NLE"
     Bond            bond(9,21)
                     /bond_type="disulfide"
     Bond            bond(15,25)
                     /bond_type="disulfide"
ORIGIN      
        1 ycqkwxwtcd skracceglr cklwcrkei
//

LOCUS       CM3A_CONGE                75 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin GIIIA; AltName: Full=G3.9; AltName:
            Full=Geographutoxin I; Short=GTx-I; AltName: Full=Myotoxin I;
            Flags: Precursor.
ACCESSION   P01523
VERSION     P01523.3
DBSOURCE    UniProtKB: locus CM3A_CONGE, accession P01523;
            class: standard.
            extra accessions:X5IG12
            created: Jul 21, 1986.
            sequence updated: Dec 11, 2019.
            annotation updated: Feb 22, 2023.
            xrefs: AB910835.1, BAO65603.1, MXKN1, 1TCG_A, 1TCH_A, 1TCJ_A,
            1TCK_A
            xrefs (non-sequence databases): PDBsum:1TCG, PDBsum:1TCH,
            PDBsum:1TCJ, PDBsum:1TCK, AlphaFoldDB:P01523, SMR:P01523,
            TCDB:8.B.28.1.3, ConoServer:1570, ConoServer:1464,
            EvolutionaryTrace:P01523, GO:0005576, GO:0019871, GO:0090729,
            InterPro:IPR004214, InterPro:IPR008036, Pfam:PF02950,
            PROSITE:PS60013
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues; Direct
            protein sequencing; Disulfide bond; Hydroxylation; Ion channel
            impairing toxin; Neurotoxin; Secreted; Signal; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Conus geographus (geography cone)
  ORGANISM  Conus geographus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Gastridium.
REFERENCE   1  (residues 1 to 75)
  AUTHORS   Dutertre,S., Jin,A.H., Vetter,I., Hamilton,B., Sunagar,K.,
            Lavergne,V., Dutertre,V., Fry,B.G., Antunes,A., Venter,D.J.,
            Alewood,P.F. and Lewis,R.J.
  TITLE     Evolution of separate predation- and defence-evoked venoms in
            carnivorous cone snails
  JOURNAL   Nat Commun 5, 3521 (2014)
   PUBMED   24662800
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], AND IDENTIFICATION BY MASS
            SPECTROMETRY.;
            TISSUE=Venom, and Venom duct
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 75)
  AUTHORS   Corpuz,G.P., Jacobsen,R.B., Jimenez,E.C., Watkins,M., Walker,C.,
            Colledge,C., Garrett,J.E., McDougal,O., Li,W., Gray,W.R.,
            Hillyard,D.R., Rivier,J., McIntosh,J.M., Cruz,L.J. and Olivera,B.M.
  TITLE     Definition of the M-conotoxin superfamily: characterization of
            novel peptides from molluscivorous Conus venoms
  JOURNAL   Biochemistry 44 (22), 8176-8186 (2005)
   PUBMED   15924437
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 2-75.;
            TISSUE=Venom duct
REFERENCE   3  (residues 1 to 75)
  AUTHORS   Cruz,L.J., Gray,W.R., Olivera,B.M., Zeikus,R.D., Kerr,L.,
            Yoshikami,D. and Moczydlowski,E.
  TITLE     Conus geographus toxins that discriminate between neuronal and
            muscle sodium channels
  JOURNAL   J Biol Chem 260 (16), 9280-9288 (1985)
   PUBMED   2410412
  REMARK    PROTEIN SEQUENCE OF 52-73, FUNCTION, AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 75)
  AUTHORS   Sato,S., Nakamura,H., Ohizumi,Y., Kobayashi,J. and Hirata,Y.
  TITLE     The amino acid sequences of homologous hydroxyproline-containing
            myotoxins from the marine snail Conus geographus venom
  JOURNAL   FEBS Lett 155 (2), 277-280 (1983)
   PUBMED   6852238
  REMARK    PROTEIN SEQUENCE OF 52-73, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   5  (residues 1 to 75)
  AUTHORS   Hidaka,Y., Sato,K., Nakamura,H., Kobayashi,J., Ohizumi,Y. and
            Shimonishi,Y.
  TITLE     Disulfide pairings in geographutoxin I, a peptide neurotoxin from
            Conus geographus
  JOURNAL   FEBS Lett 264 (1), 29-32 (1990)
   PUBMED   2338142
  REMARK    DISULFIDE BONDS.
REFERENCE   6  (residues 1 to 75)
  AUTHORS   Sato,K., Ishida,Y., Wakamatsu,K., Kato,R., Honda,H., Ohizumi,Y.,
            Nakamura,H., Ohya,M., Lancelin,J.M., Kohda,D. et al.
  TITLE     Active site of mu-conotoxin GIIIA, a peptide blocker of muscle
            sodium channels
  JOURNAL   J Biol Chem 266 (26), 16989-16991 (1991)
   PUBMED   1654319
  REMARK    FUNCTION, AND MUTAGENESIS OF ARG-52; ASP-53; ASP-63; ARG-64 AND
            ARG-70.
REFERENCE   7  (residues 1 to 75)
  AUTHORS   Becker,S., Prusak-Sochaczewski,E., Zamponi,G., Beck-Sickinger,A.G.,
            Gordon,R.D. and French,R.J.
  TITLE     Action of derivatives of mu-conotoxin GIIIA on sodium channels.
            Single amino acid substitutions in the toxin separately affect
            association and dissociation rates
  JOURNAL   Biochemistry 31 (35), 8229-8238 (1992)
   PUBMED   1326324
  REMARK    FUNCTION, AND MUTAGENESIS OF ASP-53; LYS-59; ARG-64 AND GLN-69.
REFERENCE   8  (residues 1 to 75)
  AUTHORS   Safo,P., Rosenbaum,T., Shcherbatko,A., Choi,D.Y., Han,E.,
            Toledo-Aral,J.J., Olivera,B.M., Brehm,P. and Mandel,G.
  TITLE     Distinction among neuronal subtypes of voltage-activated sodium
            channels by mu-conotoxin PIIIA
  JOURNAL   J Neurosci 20 (1), 76-80 (2000)
   PUBMED   10627583
  REMARK    FUNCTION.
REFERENCE   9  (residues 1 to 75)
  AUTHORS   Lopez-Vera,E., Walewska,A., Skalicky,J.J., Olivera,B.M. and
            Bulaj,G.
  TITLE     Role of hydroxyprolines in the in vitro oxidative folding and
            biological activity of conotoxins
  JOURNAL   Biochemistry 47 (6), 1741-1751 (2008)
   PUBMED   18189422
  REMARK    SYNTHESIS OF 52-73, AND ROLE OF HYDROXYLATION.
REFERENCE   10 (residues 1 to 75)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    FUNCTION.
REFERENCE   11 (residues 1 to 75)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION, AND SYNTHESIS OF 52-73.
REFERENCE   12 (residues 1 to 75)
  AUTHORS   Harvey,P.J., Kurniawan,N.D., Finol-Urdaneta,R.K., McArthur,J.R.,
            Van Lysebetten,D., Dash,T.S., Hill,J.M., Adams,D.J., Durek,T. and
            Craik,D.J.
  TITLE     NMR Structure of mu-Conotoxin GIIIC: Leucine 18 Induces Local
            Repacking of the N-Terminus Resulting in Reduced NaV Channel
            Potency
  JOURNAL   Molecules 23 (10), E2715 (2018)
   PUBMED   30360356
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   13 (residues 1 to 75)
  AUTHORS   Ott,K.H., Becker,S., Gordon,R.D. and Ruterjans,H.
  TITLE     Solution structure of mu-conotoxin GIIIA analysed by 2D-NMR and
            distance geometry calculations
  JOURNAL   FEBS Lett 278 (2), 160-166 (1991)
   PUBMED   1991506
  REMARK    STRUCTURE BY NMR OF 52-73, HYDROXYLATION AT PRO-57; PRO-58 AND
            PRO-68, AMIDATION AT ALA-73, AND DISULFIDE BONDS.
REFERENCE   14 (residues 1 to 75)
  AUTHORS   Lancelin,J.M., Kohda,D., Tate,S., Yanagawa,Y., Abe,T., Satake,M.
            and Inagaki,F.
  TITLE     Tertiary structure of conotoxin GIIIA in aqueous solution
  JOURNAL   Biochemistry 30 (28), 6908-6916 (1991)
   PUBMED   2069951
  REMARK    STRUCTURE BY NMR OF 52-73, HYDROXYLATION AT PRO-57; PRO-58 AND
            PRO-68, AMIDATION AT ALA-73, AND DISULFIDE BONDS.
REFERENCE   15 (residues 1 to 75)
  AUTHORS   Wakamatsu,K., Kohda,D., Hatanaka,H., Lancelin,J.M., Ishida,Y.,
            Oya,M., Nakamura,H., Inagaki,F. and Sato,K.
  TITLE     Structure-activity relationships of mu-conotoxin GIIIA: structure
            determination of active and inactive sodium channel blocker
            peptides by NMR and simulated annealing calculations
  JOURNAL   Biochemistry 31 (50), 12577-12584 (1992)
   PUBMED   1335283
  REMARK    STRUCTURE BY NMR OF 52-73 (WILD-TYPE AND MUTANT ARG-64), SYNTHESIS
            OF 52-73, DISULFIDE BONDS, AND MUTAGENESIS OF ARG-64.
COMMENT     On Dec 20, 2019 this sequence version replaced P01523.2.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin potently blocks rat Nav1.4/SCN4A (IC(50)= 19-110 nM)
            (PubMed:1654319, PubMed:1326324, PubMed:10627583, PubMed:21652775,
            PubMed:30360356). It also moderately blocks rNav1.1/SCN1A (Kd=260
            nM), rNav1.2/SCN2A (IC(50)=2.7-17.8 uM), and mNav1.6/SCN8A
            (IC(50)=680 nM) (PubMed:10627583, PubMed:21652775). The inhibition
            is reversible. In vivo, induces paralysis to an isolated skeletal
            muscle preparation from frog (cutaneous pectoralis) within a few
            minutes (PubMed:2410412). {ECO:0000269|PubMed:10627583,
            ECO:0000269|PubMed:18950653, ECO:0000269|PubMed:21652775,
            ECO:0000269|PubMed:2410412, ECO:0000269|PubMed:30360356}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:6852238}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:6852238}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-4 branch, since 4 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [PTM] Hydroxylated; hydroxylations improve the ability to block
            Nav1.4/SCN4A sodium channels but does not affect folding.
            {ECO:0000269|PubMed:1991506, ECO:0000269|PubMed:2069951}.
            [MISCELLANEOUS] Negative results: does not or only weakly blocks
            rNav1.3/SCN3A, rNav1.5/SCN5A, rNav1.7/SCN9A (IC(50)=6.0 uM and >100
            uM), and rNav1.8/SCN10A (PubMed:10627583, PubMed:21652775).
            {ECO:0000269|PubMed:10627583, ECO:0000269|PubMed:21652775}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..75
                     /organism="Conus geographus"
                     /db_xref="taxon:6491"
     Protein         1..75
                     /product="Mu-conotoxin GIIIA"
                     /note="G3.9; Geographutoxin I; Myotoxin I; GTx-I"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..20
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          3..75
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          21..51
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:2410412,
                     ECO:0000269|PubMed:6852238. /id=PRO_0000246004."
     Region          52..73
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin GIIIA.
                     /evidence=ECO:0000269|PubMed:2410412,
                     ECO:0000269|PubMed:6852238. /id=PRO_0000044493."
     Site            52
                     /site_type="mutagenized"
                     /note="R->A: 5-fold decrease in activity on Nav channels
                     (probably Nav1.4/SCN4A) from rat diaphragm.
                     /evidence=ECO:0000269|PubMed:1654319."
     Site            53
                     /site_type="mutagenized"
                     /note="D->A: 2-fold decrease in activity on Nav channels
                     (probably Nav1.4/SCN4A) from rat diaphragm.
                     /evidence=ECO:0000269|PubMed:1654319."
     Site            53
                     /site_type="mutagenized"
                     /note="D->N: Increase in activity on Nav channel from eel
                     electric membranes, and decrease in binding to rat
                     Nav1.4/SCN4A by increasing the rate of dissociation from
                     rat Nav1.4/SCN4A channel and decreasing the rate of
                     association. /evidence=ECO:0000269|PubMed:1326324."
     Bond            bond(54,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:1335283,
                     ECO:0000269|PubMed:1991506, ECO:0000269|PubMed:2069951,
                     ECO:0000269|PubMed:2338142, ECO:0000312|PDB:1TCG,
                     ECO:0000312|PDB:1TCH, ECO:0000312|PDB:1TCJ,
                     ECO:0000312|PDB:1TCK."
     Region          54..58
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1TCG."
     Bond            bond(55,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:1335283,
                     ECO:0000269|PubMed:1991506, ECO:0000269|PubMed:2069951,
                     ECO:0000269|PubMed:2338142, ECO:0000312|PDB:1TCG,
                     ECO:0000312|PDB:1TCH, ECO:0000312|PDB:1TCJ,
                     ECO:0000312|PDB:1TCK."
     Site            57
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline; partial.
                     /evidence=ECO:0000269|PubMed:1991506,
                     ECO:0000269|PubMed:2069951, ECO:0000269|PubMed:2410412."
     Site            58
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline; partial.
                     /evidence=ECO:0000269|PubMed:1991506,
                     ECO:0000269|PubMed:2069951, ECO:0000269|PubMed:2410412."
     Site            59
                     /site_type="mutagenized"
                     /note="K->Q: Important decrease in activity on Nav channel
                     from eel electric membranes, and decrease in binding to
                     rat Nav1.4/SCN4A by increasing the rate of dissociation
                     from rat Nav1.4/SCN4A channel and potently decreasing the
                     rate of association.
                     /evidence=ECO:0000269|PubMed:1326324."
     Bond            bond(61,72)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:1335283,
                     ECO:0000269|PubMed:1991506, ECO:0000269|PubMed:2069951,
                     ECO:0000269|PubMed:2338142, ECO:0000312|PDB:1TCG,
                     ECO:0000312|PDB:1TCH, ECO:0000312|PDB:1TCJ,
                     ECO:0000312|PDB:1TCK."
     Site            63
                     /site_type="mutagenized"
                     /note="D->A: 3.5-fold decrease in activity on Nav channels
                     (probably Nav1.4/SCN4A) from rat diaphragm.
                     /evidence=ECO:0000269|PubMed:1654319."
     Region          64..66
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1TCG."
     Site            64
                     /site_type="other"
                     /note="Important for binding sodium channel."
     Site            64
                     /site_type="mutagenized"
                     /note="R->A: 200-fold decrease in activity on Nav channels
                     (probably Nav1.4/SCN4A) from rat diaphragm.
                     /evidence=ECO:0000269|PubMed:1654319."
     Site            64
                     /site_type="mutagenized"
                     /note="R->Q: Loss of activity on Nav channel from eel
                     electric membranes, and important decrease in binding to
                     rat Nav1.4/SCN4A by increasing the rate of dissociation
                     from rat Nav1.4/SCN4A channel without modifying the rate
                     of association. /evidence=ECO:0000269|PubMed:1326324."
     Site            68
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:1991506,
                     ECO:0000269|PubMed:2069951, ECO:0000269|PubMed:2410412."
     Site            69
                     /site_type="mutagenized"
                     /note="Q->K: Increase in activity on Nav channel from eel
                     electric membranes, and important increase in binding to
                     rat Nav1.4/SCN4A (seemingly irreversible) by potently
                     decreasing the rates of both dissociation and association
                     to rat Nav1.4/SCN4A channel.
                     /evidence=ECO:0000269|PubMed:1326324."
     Region          70..72
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1TCG."
     Site            70
                     /site_type="mutagenized"
                     /note="R->A: 25-fold decrease in activity on Nav channels
                     (probably Nav1.4/SCN4A) from rat diaphragm.
                     /evidence=ECO:0000269|PubMed:1654319."
     Site            73
                     /site_type="amidation"
                     /note="Alanine amide.
                     /evidence=ECO:0000269|PubMed:1991506,
                     ECO:0000269|PubMed:2069951, ECO:0000269|PubMed:2410412."
ORIGIN      
        1 mmsklgvllt iclllfplta lpmdgdepan rpvermqdni sseqyplfek rrdcctppkk
       61 ckdrqckpqr ccagr
//

LOCUS       JZT1A_CHIGU               62 aa            linear   INV 12-OCT-2022
DEFINITION  RecName: Full=Delta-theraphotoxin-Cg1a 1; Short=Delta-TRTX-Cg1a;
            AltName: Full=Jingzhaotoxin-1; AltName: Full=Jingzhaotoxin-I;
            Short=JZTX-I; AltName: Full=Peptide F5-24.92; Flags: Precursor.
ACCESSION   P83974
VERSION     P83974.2
DBSOURCE    UniProtKB: locus JZT1A_CHIGU, accession P83974;
            class: standard.
            extra accessions:Q5W1E3
            created: Jul 5, 2004.
            sequence updated: Jan 4, 2005.
            annotation updated: Oct 12, 2022.
            xrefs: AJ854060.1, CAH69598.1
            xrefs (non-sequence databases): AlphaFoldDB:P83974, SMR:P83974,
            ArachnoServer:AS000045, GO:0005576, GO:0035792, GO:0044231,
            GO:0008200, GO:0015459, GO:0017080, GO:0090729, InterPro:IPR011696,
            Pfam:PF07740
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Postsynaptic neurotoxin; Potassium
            channel impairing toxin; Presynaptic neurotoxin; Secreted; Signal;
            Toxin; Voltage-gated potassium channel impairing toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Chilobrachys guangxiensis
  ORGANISM  Chilobrachys guangxiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Chilobrachys.
REFERENCE   1  (residues 1 to 62)
  AUTHORS   Xiao,Y., Tang,J., Hu,W., Xie,J., Maertens,C., Tytgat,J. and
            Liang,S.
  TITLE     Jingzhaotoxin-I, a novel spider neurotoxin preferentially
            inhibiting cardiac sodium channel inactivation
  JOURNAL   J Biol Chem 280 (13), 12069-12076 (2005)
   PUBMED   15548530
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 30-62, FUNCTION,
            AND SUBCELLULAR LOCATION.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 62)
  AUTHORS   Liao,Z., Cao,J., Li,S., Yan,X., Hu,W., He,Q., Chen,J., Tang,J.,
            Xie,J. and Liang,S.
  TITLE     Proteomic and peptidomic analysis of the venom from Chinese
            tarantula Chilobrachys jingzhao
  JOURNAL   Proteomics 7 (11), 1892-1907 (2007)
   PUBMED   17476710
  REMARK    PROTEIN SEQUENCE OF 30-62, AND IDENTIFICATION BY MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 62)
  AUTHORS   Yuan,C., Yang,S., Liao,Z. and Liang,S.
  TITLE     Effects and mechanism of Chinese tarantula toxins on the Kv2.1
            potassium channels
  JOURNAL   Biochem Biophys Res Commun 352 (3), 799-804 (2007)
   PUBMED   17150181
  REMARK    FUNCTION, AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 62)
  AUTHORS   Xiao,Y., Li,J., Deng,M., Dai,C. and Liang,S.
  TITLE     Characterization of the excitatory mechanism induced by
            Jingzhaotoxin-I inhibiting sodium channel inactivation
  JOURNAL   Toxicon 50 (4), 507-517 (2007)
   PUBMED   17618665
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   5  (residues 1 to 62)
  AUTHORS   Tao,H., Wu,Y., Deng,M., He,J., Wang,M., Xiao,Y. and Liang,S.
  TITLE     Molecular determinants for the tarantula toxin jingzhaotoxin-I
            interacting with potassium channel Kv2.1
  JOURNAL   Toxicon 63, 129-136 (2013)
   PUBMED   23246579
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   6  (residues 1 to 62)
  AUTHORS   Tao,H., Chen,X., Lu,M., Wu,Y., Deng,M., Zeng,X., Liu,Z. and
            Liang,S.
  TITLE     Molecular determinant for the tarantula toxin Jingzhaotoxin-I
            slowing the fast inactivation of voltage-gated sodium channels
  JOURNAL   Toxicon 111, 13-21 (2016)
   PUBMED   26721415
  REMARK    FUNCTION.
REFERENCE   7  (residues 1 to 62)
  AUTHORS   Zeng,X.Z., Zhu,Q. and Liang,S.P.
  TITLE     Sequence-specific assignment of 1H-NMR resonance and determination
            of the secondary structure of Jingzhaotoxin-I
  JOURNAL   Acta Biochim Biophys Sin (Shanghai) 37 (8), 567-572 (2005)
   PUBMED   16077905
  REMARK    STRUCTURE BY NMR OF 30-62, AND DISULFIDE BONDS.;
            TISSUE=Venom
COMMENT     [FUNCTION] Inhibits voltage-gated sodium channels, preferentially
            subtype Nav1.5/SCN5A (in cardiac myocytes), but also Nav1.6/SCN8A
            and Nav1.7/SCN9A (TTX-sensitive Nav in rat DRG neurons) and
            invertebrate Nav (in insect neurons) as well as voltage-gated
            potassium channels of the subtype Kv2.1/KCNB1. Is suggested to bind
            to site 3 of the sodium channels and inhibit the inactivation of
            the activated channels, thereby blocking neuronal transmission. On
            potassium channels, inhibits activation of channels with an IC(50)
            of 8.05 uM through a voltage sensor-trapping mechanism
            (PubMed:23246579). Increases muscle contraction in several assays
            (mouse phrenic nerve-diaphragm, toad heart, rat vas deferens) and
            is suggested to act both presynaptically and postsynaptically.
            {ECO:0000269|PubMed:15548530, ECO:0000269|PubMed:17150181,
            ECO:0000269|PubMed:17618665, ECO:0000269|PubMed:23246579}.
            [FUNCTION] Moderately inhibits voltage-gated sodium channels and
            weakly inhibits voltage-gated potassium channel (PubMed:17150181,
            PubMed:17618665, PubMed:23246579, PubMed:26721415). Inhibits the
            inactivation of rat Nav1.2/SCN2A (IC(50)=870 nM), rat Nav1.3/SCN3A
            (IC(50)=845 nM), rat Nav1.4/SCN4A (IC(50)=339 nM), human
            Nav1.5/SCN5A (IC(50)=335 nM) and human Nav1.7/SCN9A sodium channels
            (IC(50)=348 nM) (PubMed:26721415). The toxin delays the
            inactivation of sodium channels without affecting the activation
            and steady-state inactivation kinetics in the physiological range
            of voltages (PubMed:26721415). Site-directed mutagenesis of the
            sodium channel indicates that the toxin interacts with site 3
            located at the extracellular S3-S4 linker of domain IV
            (PubMed:26721415). On potassium channels, it inhibits activation of
            channels with an IC(50) of 8.05 uM through a voltage
            sensor-trapping mechanism (PubMed:23246579). It increases muscle
            contraction in several assays (mouse phrenic nerve-diaphragm, toad
            heart, rat vas deferens) and is suggested to act both
            presynaptically and postsynaptically (PubMed:17618665).
            {ECO:0000269|PubMed:15548530, ECO:0000269|PubMed:17150181,
            ECO:0000269|PubMed:17618665, ECO:0000269|PubMed:23246579,
            ECO:0000269|PubMed:26721415}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:15548530}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:15548530}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:16077905}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 33
            (Jztx-1) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..62
                     /organism="Chilobrachys guangxiensis"
                     /db_xref="taxon:278060"
     Protein         1..62
                     /product="Delta-theraphotoxin-Cg1a 1"
                     /note="Delta-TRTX-Cg1a; Jingzhaotoxin-1; Jingzhaotoxin-I;
                     Peptide F5-24.92; JZTX-I"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..29
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:15548530,
                     ECO:0000269|PubMed:17476710. /id=PRO_0000398385."
     Region          30..62
                     /region_name="Mature chain"
                     /note="Delta-theraphotoxin-Cg1a 1.
                     /evidence=ECO:0000269|PubMed:15548530,
                     ECO:0000269|PubMed:17476710. /id=PRO_0000035594."
     Region          30..60
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(31,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:16077905."
     Bond            bond(38,51)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:16077905."
     Bond            bond(45,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:16077905."
ORIGIN      
        1 mktsilfvif slallfalsa ateieetdra cgqfwwkcge gkppccanfa ckiglylciw
       61 sp
//

LOCUS       TX15_GRARO                82 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin GTx1-15; AltName:
            Full=Beta/omega-theraphotoxin-Gr2a; Short=Beta/omega-TRTX-Gr2a;
            AltName: Full=GpTx-1; AltName: Full=GpTx-I; Flags: Precursor.
ACCESSION   P0DJA9
VERSION     P0DJA9.1
DBSOURCE    UniProtKB: locus TX15_GRARO, accession P0DJA9;
            class: standard.
            extra accessions:M5AYC6
            created: Dec 14, 2011.
            sequence updated: Dec 14, 2011.
            annotation updated: Feb 22, 2023.
            xrefs: AB201016.1, BAN13512.1
            xrefs (non-sequence databases): AlphaFoldDB:P0DJA9, SMR:P0DJA9,
            ArachnoServer:AS001910, GO:0005576, GO:0005246, GO:0008200,
            GO:0017080, GO:0090729, InterPro:IPR011696, InterPro:IPR013140,
            Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Amidation; Calcium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Grammostola rosea (Chilean rose tarantula)
  ORGANISM  Grammostola rosea
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Grammostola.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   Ono,S., Kimura,T. and Kubo,T.
  TITLE     Characterization of voltage-dependent calcium channel blocking
            peptides from the venom of the tarantula Grammostola rosea
  JOURNAL   Toxicon 58 (3), 265-276 (2011)
   PUBMED   21740921
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 47-80, FUNCTION,
            MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    FUNCTION, AND SYNTHESIS.
COMMENT     [FUNCTION] Potent voltage-gated sodium channel blocker (By
            similarity). Potently inhibits the voltage-gated sodium channels
            Nav1.7/SCN9A (IC(50)=0.58-10 nM) (By similarity). Shows a moderate
            activity on Nav1.1/SCN1A (IC(50)=6 nM), Nav1.2/SCN2A (IC(50)=5-128
            nM), Nav1.3/SCN3A (IC(50)=20.3-170 nM), and Nav1.6/SCN8A
            (IC(50)=17-20.1 nM) (PubMed:29703751) (By similarity). Shows an
            unclear inhibition of Nav1.4/SCN4A (IC(50)=200 nM to >10 uM),
            Nav1.5/SCN5A (IC(50)=140 nM to >10 uM) and Nav1.8/SCN10A
            (IC(50)=68-12200 nM) (PubMed:29703751) (By similarity). Weakly
            blocks the low voltage-gated calcium channels Cav3.1/CACNA1G (30%
            inhibition of the peak current by 9.8 nM of the toxin)
            (PubMed:21740921). It shows moderate affinity for lipid bilayers
            (PubMed:29703751). {ECO:0000250|UniProtKB:P0DL72,
            ECO:0000250|UniProtKB:P0DL73, ECO:0000269|PubMed:21740921,
            ECO:0000269|PubMed:29703751}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21740921}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:21740921}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P0DL72}.
            [DOMAIN] This toxin is amphipathic in nature with a hydrophobic
            face on one side of the molecule (composed of residues
            51-Phe-Met-52 and 73-His--Phe-80) and a hydrophilic (mostly
            cationic) face on the opposite side (composed of residues
            56-Ile--Lys-61 and 64-Arg--Pro-65). {ECO:0000250|UniProtKB:P0DL72}.
            [MASS SPECTROMETRY] Mass=4071.21; Method=MALDI; Note=Monoisotopic
            mass (after thiol reduction).;
            Evidence={ECO:0000269|PubMed:21740921}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of GpTx-1 from Grammostola porteri (AC P0DL72)
            and Gtx1-15 from Paraphysa scrofa (AC P0DL73). {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 08
            (Gtx1-15) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Grammostola rosea"
                     /db_xref="taxon:432528"
     Protein         1..82
                     /product="Toxin GTx1-15"
                     /note="Beta/omega-theraphotoxin-Gr2a; GpTx-1; GpTx-I;
                     Beta/omega-TRTX-Gr2a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..46
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:21740921.
                     /id=PRO_0000414299."
     Region          47..80
                     /region_name="Processed active peptide"
                     /note="Toxin GTx1-15.
                     /evidence=ECO:0000269|PubMed:21740921.
                     /id=PRO_0000414300."
     Region          47..78
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(48,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83471."
     Bond            bond(55,69)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83471."
     Bond            bond(62,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83471."
     Site            80
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000250|UniProtKB:P0DL72,
                     ECO:0000250|UniProtKB:P0DL73."
ORIGIN      
        1 mktsvvfvia glallsvacy aselkeqssi nevlstifhf eqpeerdclg fmrkcipdnd
       61 kccrpnlvcs rthkwckyvf gk
//

LOCUS       JZT34_CHIGU               87 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Cg1a; Short=Mu-TRTX-Cg1a; AltName:
            Full=Jingzhaotoxin-34; Short=JZTX-34; AltName: Full=Peptide
            F6-25.51; Flags: Precursor.
ACCESSION   B1P1F7
VERSION     B1P1F7.1
DBSOURCE    UniProtKB: locus JZT34_CHIGU, accession B1P1F7;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: Apr 29, 2008.
            annotation updated: Feb 22, 2023.
            xrefs: EU233888.1, ABY71707.1
            xrefs (non-sequence databases): AlphaFoldDB:B1P1F7, SMR:B1P1F7,
            ArachnoServer:AS000836, GO:0005576, GO:0008200, GO:0015459,
            GO:0017080, GO:0090729, InterPro:IPR011696, Pfam:PF07740,
            SUPFAM:SSF57059
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Pharmaceutical; Potassium channel impairing toxin;
            Secreted; Signal; Toxin; Voltage-gated potassium channel impairing
            toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Chilobrachys guangxiensis
  ORGANISM  Chilobrachys guangxiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Chilobrachys.
REFERENCE   1  (residues 1 to 87)
  AUTHORS   Chen,J., Deng,M., He,Q., Meng,E., Jiang,L., Liao,Z., Rong,M. and
            Liang,S.
  TITLE     Molecular diversity and evolution of cystine knot toxins of the
            tarantula Chilobrachys jingzhao
  JOURNAL   Cell Mol Life Sci 65 (15), 2431-2444 (2008)
   PUBMED   18581053
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND FUNCTION.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 87)
  AUTHORS   Liao,Z., Cao,J., Li,S., Yan,X., Hu,W., He,Q., Chen,J., Tang,J.,
            Xie,J. and Liang,S.
  TITLE     Proteomic and peptidomic analysis of the venom from Chinese
            tarantula Chilobrachys jingzhao
  JOURNAL   Proteomics 7 (11), 1892-1907 (2007)
   PUBMED   17476710
  REMARK    PROTEIN SEQUENCE OF 51-62, MASS SPECTROMETRY, AND SUBCELLULAR
            LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 87)
  AUTHORS   Chen,J., Zhang,Y., Rong,M., Zhao,L., Jiang,L., Zhang,D., Wang,M.,
            Xiao,Y. and Liang,S.
  TITLE     Expression and characterization of jingzhaotoxin-34, a novel
            neurotoxin from the venom of the tarantula Chilobrachys jingzhao
  JOURNAL   Peptides 30 (6), 1042-1048 (2009)
   PUBMED   19463735
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 87)
  AUTHORS   Zeng,X., Li,P., Chen,B., Huang,J., Lai,R., Liu,J. and Rong,M.
  TITLE     Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic
            Effects against Pain
  JOURNAL   Toxins (Basel) 10 (2), E64 (2018)
   PUBMED   29393892
  REMARK    SYNTHESIS OF 51-85, AND FUNCTION.
            Publication Status: Online-Only
COMMENT     [FUNCTION] Potent and selective inhibitor of hNav1.7/SCN9A
            (IC(50)=610 nM) (PubMed:29393892). Also shows a weak activity
            towards Nav1.3/SCN3A (IC(50)=7950 nM) (PubMed:29393892). In
            addition, inhibits voltage-gated potassium channels (Kv) in rat DRG
            neurons (PubMed:18581053). It does not alter the voltage dependence
            of activation, but it causes a small hyperpolarizing shift in the
            steady-state inactivations of Nav1.7/SNC9A (PubMed:29393892).
            Chimera experiments show that the toxin binds to the DIIS3-S4
            linker (site 4) of Nav1.7/SCN9A, whereas Nav1.7/SCN9A Asp-827
            residue is shown by substitution experiments to be critical for its
            sensitivity (PubMed:19463735, PubMed:29393892). The toxin traps the
            domain II voltage sensor in the closed configuration, and not in an
            outward position (PubMed:29393892). In vivo, shows analgesic
            activity in three rodent pain models (formalin-induced,
            acid-induced, and thermal) (PubMed:29393892).
            {ECO:0000269|PubMed:18581053, ECO:0000269|PubMed:29393892,
            ECO:0000305|PubMed:19463735}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:17476710}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:17476710}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:B1P1E3}.
            [MASS SPECTROMETRY] Mass=4153.5; Method=MALDI; Note=Monoisotopic
            mass.; Evidence={ECO:0000269|PubMed:17476710}.
            [PHARMACEUTICAL] Is a promising lead molecule for the development
            of novel therapeutics in the treatment of pain.
            {ECO:0000305|PubMed:29393892}.
            [MISCELLANEOUS] Negative results: does not inhibit TTX-resistant
            sodium currents on rat dorsal root ganglion (DRG) neurons
            (PubMed:18581053, PubMed:19463735, PubMed:29393892). Has no
            activity on voltage-gated potassium channel Kv2.1/KCNB1 expressed
            in frog oocytes (PubMed:19463735). Does not show activity towards
            Nav1.1/SCN1A, Nav1.2/SCN2A, Nav1.4/SCN4A, Nav1.5/SCN5A,
            Nav1.6/SCN8A, Nav1.8/SCN10A sodium channel (PubMed:29393892).
            {ECO:0000269|PubMed:18581053, ECO:0000269|PubMed:19463735,
            ECO:0000269|PubMed:29393892}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 39
            (Jztx-34) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..87
                     /organism="Chilobrachys guangxiensis"
                     /db_xref="taxon:278060"
     Protein         1..87
                     /product="Mu-theraphotoxin-Cg1a"
                     /note="Mu-TRTX-Cg1a; Jingzhaotoxin-34; Peptide F6-25.51;
                     JZTX-34"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..50
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:17476710.
                     /id=PRO_0000379918."
     Region          51..85
                     /region_name="Processed active peptide"
                     /note="Mu-theraphotoxin-Cg1a.
                     /evidence=ECO:0000305|PubMed:17476710.
                     /id=PRO_0000379919."
     Region          51..81
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(52,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
     Bond            bond(59,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
     Bond            bond(65,79)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
ORIGIN      
        1 mkvlvlitla vlgamfvwts aaeleergsd qrdspawvks merifqseer acrewlggcs
       61 kdadccahle crkkwpyhcv wdwtvrk
//

LOCUS       CM3B_CONBU                78 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin BuIIIB; AltName: Full=Conotoxin Bu16;
            Flags: Precursor.
ACCESSION   C1J5M6
VERSION     C1J5M6.1
DBSOURCE    UniProtKB: locus CM3B_CONBU, accession C1J5M6;
            class: standard.
            created: Sep 22, 2009.
            sequence updated: May 26, 2009.
            annotation updated: Feb 22, 2023.
            xrefs: FJ240166.1, ACO50771.1, 2LO9_A, 2LOC_A
            xrefs (non-sequence databases): PDBsum:2LO9, PDBsum:2LOC,
            AlphaFoldDB:C1J5M6, BMRB:C1J5M6, SMR:C1J5M6, ConoServer:3715,
            GO:0005576, GO:0008200, GO:0017080, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues;
            Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Conus bullatus
  ORGANISM  Conus bullatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Textilia.
REFERENCE   1  (residues 1 to 78)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], SYNTHESIS OF 51-75, FUNCTION ON SCN4A,
            AND AMIDATION AT CYS-75.;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 78)
  AUTHORS   Hu,H., Bandyopadhyay,P.K., Olivera,B.M. and Yandell,M.
  TITLE     Characterization of the Conus bullatus genome and its venom-duct
            transcriptome
  JOURNAL   BMC Genomics 12, 60 (2011)
   PUBMED   21266071
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 26-78.;
            TISSUE=Venom duct
            Publication Status: Online-Only
REFERENCE   3  (residues 1 to 78)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION, AND SYNTHESIS OF 52-75.
REFERENCE   4  (residues 1 to 78)
  AUTHORS   Wilson,M.J., Zhang,M.M., Gajewiak,J., Azam,L., Rivier,J.E.,
            Olivera,B.M. and Yoshikami,D.
  TITLE     Alpha- and beta-subunit composition of voltage-gated sodium
            channels investigated with mu-conotoxins and the recently
            discovered muO section sign-conotoxin GVIIJ
  JOURNAL   J Neurophysiol 113 (7), 2289-2301 (2015)
   PUBMED   25632083
  REMARK    FUNCTION, AND SYNTHESIS OF 52-75.
REFERENCE   5  (residues 1 to 78)
  AUTHORS   Kuang,Z., Zhang,M.-M., Gupta,K., Gajewiak,J., Gulyas,J.,
            Balaram,P., Rivier,J.E., Olivera,B.M., Yoshikami,D., Bulaj,G. and
            Norton,R.S.
  TITLE     Mammalian neuronal sodium channel blocker mu-conotoxin BuIIIB has a
            structured N-terminus that influences potency
  JOURNAL   ACS Chem Biol 8 (6), 1344-1351 (2013)
   PUBMED   23557677
  REMARK    STRUCTURE BY NMR OF 52-75, SYNTHESIS OF 52-75, MUTAGENESIS OF
            VAL-52; GLY-53; GLU-54; ARG-55 AND 52-VAL--ARG-55, FUNCTION ON
            SCN3A, AND DISULFIDE BONDS.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This synthetic toxin potently blocks rNav1.4/SCN4A (Kd=0.34-3.6
            nM), rNav1.2/SCN2A (Kd=13 nM), rNav1.3/SCN3A (Kd=200 nM),
            rNav1.1/SCN1A (Kd=360 nM), mNav1.6/SCN8A (IC(50)=1.8 uM),
            rNav1.5/SCN5A (IC(50)=9 uM), rNav1.6/SCN8A (IC(50)>30 uM)
            (PubMed:18950653, PubMed:21652775, PubMed:25632083,
            PubMed:23557677). It is noteworthy that the toxin is 50-fold more
            potent on mouse Nav1.6 than on rat Nav1.6 (PubMed:25632083). The
            block of SCN4A is very slowly reversible (PubMed:18950653).
            {ECO:0000269|PubMed:18950653, ECO:0000269|PubMed:21652775,
            ECO:0000269|PubMed:23557677, ECO:0000269|PubMed:25632083}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:18950653}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:18950653}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MISCELLANEOUS] Negative results: does not or very weakly inhibits
            rNav1.7 and rNav1.8. {ECO:0000269|PubMed:21652775,
            ECO:0000269|PubMed:23557677}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..78
                     /organism="Conus bullatus"
                     /db_xref="taxon:89438"
     Protein         1..78
                     /product="Mu-conotoxin BuIIIB"
                     /note="Conotoxin Bu16"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          <23..76
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          23..51
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000384433."
     Region          26..46
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          28..46
                     /region_name="Compositionally biased region"
                     /note="Basic and acidic residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          52..75
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin BuIIIB.
                     /evidence=ECO:0000305|PubMed:18950653.
                     /id=PRO_0000384434."
     Site            52..55
                     /site_type="mutagenized"
                     /note="Missing: 4-fold increase in blocking SCN3A (K(d) is
                     53 nM). /evidence=ECO:0000269|PubMed:23557677."
     Site            52
                     /site_type="mutagenized"
                     /note="V->A: 3.5-decrease in blocking SCN3A (K(d) is 710
                     nM). /evidence=ECO:0000269|PubMed:23557677."
     Site            53
                     /site_type="mutagenized"
                     /note="G->A: 5-fold increase in blocking SCN3A (K(d) is 36
                     nM). /evidence=ECO:0000269|PubMed:23557677."
     Site            53
                     /site_type="mutagenized"
                     /note="G->A: Mutated into D-Ala. 40-fold increase in
                     blocking SCN3A (K(d) is 4.8 nM).
                     /evidence=ECO:0000269|PubMed:23557677."
     Region          54..57
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2LO9."
     Site            54
                     /site_type="mutagenized"
                     /note="E->A: 13-fold increase in blocking SCN3A (K(d) is
                     15 nM). /evidence=ECO:0000269|PubMed:23557677."
     Site            55
                     /site_type="mutagenized"
                     /note="R->A: No change in blocking SCN3A (K(d) is 118 nM).
                     /evidence=ECO:0000269|PubMed:23557677."
     Bond            bond(56,68)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:23557677,
                     ECO:0000312|PDB:2LO9, ECO:0000312|PDB:2LOC."
     Bond            bond(57,74)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:23557677,
                     ECO:0000312|PDB:2LO9, ECO:0000312|PDB:2LOC."
     Region          60..62
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2LO9."
     Region          63..65
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2LO9."
     Bond            bond(64,75)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:23557677,
                     ECO:0000312|PDB:2LO9, ECO:0000312|PDB:2LOC."
     Region          66..71
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2LO9."
     Site            75
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:18950653."
ORIGIN      
        1 mmsklgvllt iclllfplfa lpqdgdqpad rpaermqddi sseqnpllek rvgercckng
       61 krgcgrwcrd hsrccgrr
//

LOCUS       2M50_A                    35 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-theraphotoxin-Hh2a.
ACCESSION   2M50_A
VERSION     2M50_A
DBSOURCE    pdb: molecule 2M50, chain A, release Aug 28, 2013;
            deposition: Feb 12, 2013;
            class: TOXIN;
            source: Mmdb_id: 110961, Pdb_id 1: 2M50;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Cyriopagopus schmidti (Selenocosmia huwena)
  ORGANISM  Cyriopagopus schmidti
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Cyriopagopus.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Minassian,N.A., Gibbs,A., Shih,A.Y., Liu,Y., Neff,R.A.,
            Sutton,S.W., Mirzadegan,T., Connor,J., Fellows,R., Husovsky,M.,
            Nelson,S., Hunter,M.J., Flinspach,M. and Wickenden,A.D.
  TITLE     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin huwentoxin-IV
            (mu-TRTX-Hh2a)
  JOURNAL   J. Biol. Chem. 288 (31), 22707-22720 (2013)
   PUBMED   23760503
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Gibbs,A., Minassian,N., Flinspach,M. and Wickenden,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (12-FEB-2013)
COMMENT     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin, Huwentoxin-IV
            (-TRTX-Hh2a).
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Cyriopagopus schmidti"
                     /db_xref="taxon:29017"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     Bond            bond(9,24)
                     /bond_type="disulfide"
     Bond            bond(16,31)
                     /bond_type="disulfide"
     SecStr          21..24
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          31..34
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 ecleifkacn psndqcckss klvcsrktrw cayqi
//

LOCUS       2M4Z_A                    35 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-theraphotoxin-Hh2a.
ACCESSION   2M4Z_A
VERSION     2M4Z_A
DBSOURCE    pdb: molecule 2M4Z, chain A, release Aug 28, 2013;
            deposition: Feb 12, 2013;
            class: TOXIN;
            source: Mmdb_id: 110960, Pdb_id 1: 2M4Z;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Cyriopagopus schmidti (Selenocosmia huwena)
  ORGANISM  Cyriopagopus schmidti
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Cyriopagopus.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Minassian,N.A., Gibbs,A., Shih,A.Y., Liu,Y., Neff,R.A.,
            Sutton,S.W., Mirzadegan,T., Connor,J., Fellows,R., Husovsky,M.,
            Nelson,S., Hunter,M.J., Flinspach,M. and Wickenden,A.D.
  TITLE     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin huwentoxin-IV
            (mu-TRTX-Hh2a)
  JOURNAL   J. Biol. Chem. 288 (31), 22707-22720 (2013)
   PUBMED   23760503
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Gibbs,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (12-FEB-2013)
COMMENT     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin, Huwentoxin-IV
            (-TRTX-Hh2a).
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Cyriopagopus schmidti"
                     /db_xref="taxon:29017"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     SecStr          5..8
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(9,24)
                     /bond_type="disulfide"
     Bond            bond(16,31)
                     /bond_type="disulfide"
     SecStr          21..24
                     /sec_str_type="sheet"
                     /note="strand 2"
     SecStr          29..34
                     /sec_str_type="sheet"
                     /note="strand 3"
ORIGIN      
        1 ecleifkacn psndqcckss klvcsrktra ckyqi
//

LOCUS       2M4X_A                    35 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-theraphotoxin-Hh2a.
ACCESSION   2M4X_A
VERSION     2M4X_A
DBSOURCE    pdb: molecule 2M4X, chain A, release Aug 28, 2013;
            deposition: Feb 11, 2013;
            class: TOXIN;
            source: Mmdb_id: 110959, Pdb_id 1: 2M4X;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Cyriopagopus schmidti (Selenocosmia huwena)
  ORGANISM  Cyriopagopus schmidti
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Cyriopagopus.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Minassian,N.A., Gibbs,A., Shih,A.Y., Liu,Y., Neff,R.A.,
            Sutton,S.W., Mirzadegan,T., Connor,J., Fellows,R., Husovsky,M.,
            Nelson,S., Hunter,M.J., Flinspach,M. and Wickenden,A.D.
  TITLE     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin huwentoxin-IV
            (mu-TRTX-Hh2a)
  JOURNAL   J. Biol. Chem. 288 (31), 22707-22720 (2013)
   PUBMED   23760503
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Gibbs,A. and Flinspach,M.
  TITLE     Direct Submission
  JOURNAL   Submitted (11-FEB-2013)
COMMENT     Analysis of the structural and molecular basis of voltage-sensitive
            sodium channel inhibition by the spider toxin, Huwentoxin-IV
            (-TRTX-Hh2a).
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Cyriopagopus schmidti"
                     /db_xref="taxon:29017"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     Bond            bond(9,24)
                     /bond_type="disulfide"
     Bond            bond(16,31)
                     /bond_type="disulfide"
ORIGIN      
        1 ecleifkacn psndqcckss klvcsrktrw ckyqi
//

LOCUS       2MI5_A                    57 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-diguetoxin-Dc1a.
ACCESSION   2MI5_A
VERSION     2MI5_A
DBSOURCE    pdb: molecule 2MI5, chain A, release Jul 23, 2014;
            deposition: Dec 8, 2013;
            class: TOXIN;
            source: Mmdb_id: 121623, Pdb_id 1: 2MI5;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Diguetia canities
  ORGANISM  Diguetia canities
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Haplogynae; Pholcoidea; Diguetidae;
            Diguetia.
REFERENCE   1  (residues 1 to 57)
  AUTHORS   Krapcho,K.J., Kral RM,Jr., Vanwagenen,B.C., Eppler,K.G. and
            Morgan,T.K.
  TITLE     Characterization and cloning of insecticidal peptides from the
            primitive weaving spider Diguetia canities
  JOURNAL   Insect Biochem. Mol. Biol. 25 (9), 991-1000 (1995)
   PUBMED   8541888
REFERENCE   2  (residues 1 to 57)
  AUTHORS   Bloomquist,J.R., Kinne,L.P., Deutsch,V. and Simpson,S.F.
  TITLE     Mode of action of an insecticidal peptide toxin from the venom of a
            weaving spider (Diguetia canities)
  JOURNAL   Toxicon 34 (9), 1072-1075 (1996)
   PUBMED   8896202
REFERENCE   3  (residues 1 to 57)
  AUTHORS   Bende,N.S., Dziemborowicz,S., Mobli,M., Herzig,V., Gilchrist,J.,
            Wagner,J., Nicholson,G.M., King,G.F. and Bosmans,F.
  TITLE     A distinct sodium channel voltage-sensor locus determines insect
            selectivity of the spider toxin Dc1a
  JOURNAL   Nat Commun 5, 4350 (2014)
   PUBMED   25014760
  REMARK    Publication Status: Online-Only
REFERENCE   4  (residues 1 to 57)
  AUTHORS   Bende,N.S., Mobli,M. and King,G.F.
  TITLE     Direct Submission
  JOURNAL   Submitted (08-DEC-2013)
COMMENT     Structure of insect-specific sodium channel toxin mu-Dc1a.
FEATURES             Location/Qualifiers
     source          1..57
                     /organism="Diguetia canities"
                     /db_xref="taxon:38407"
     Region          2..56
                     /region_name="m_DGTX_Dc1a_b_c"
                     /note="Spider Toxins mu-diguetoxin-1 a, b and c;
                     pfam17491"
                     /db_xref="CDD:340206"
     SecStr          6..9
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(13,26)
                     /bond_type="disulfide"
     SecStr          16..19
                     /sec_str_type="sheet"
                     /note="strand 2"
     Bond            bond(20,40)
                     /bond_type="disulfide"
     Bond            bond(25,54)
                     /bond_type="disulfide"
     SecStr          27..32
                     /sec_str_type="sheet"
                     /note="strand 3"
     SecStr          33..37
                     /sec_str_type="sheet"
                     /note="strand 4"
     SecStr          38..44
                     /sec_str_type="sheet"
                     /note="strand 5"
     Bond            bond(42,52)
                     /bond_type="disulfide"
     SecStr          50..56
                     /sec_str_type="sheet"
                     /note="strand 6"
ORIGIN      
        1 sakdgdvegp agckkydvec dsgeccqkqy lwykwrpldc rclksgffss kcvcrdv
//

LOCUS       JZTX5_CHIGU               83 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta/kappa-theraphotoxin-Cg2a;
            Short=Beta/kappa-TRTX-Cg2a; AltName: Full=Beta-theraphotoxin-Cj2a;
            AltName: Full=Jingzhaotoxin-5; AltName: Full=Jingzhaotoxin-V;
            Short=JZTX-V; AltName: Full=Peptide F8-15.73; Flags: Precursor.
ACCESSION   Q2PAY4
VERSION     Q2PAY4.1
DBSOURCE    UniProtKB: locus JZTX5_CHIGU, accession Q2PAY4;
            class: standard.
            extra accessions:P84629
            created: Nov 28, 2006.
            sequence updated: Feb 7, 2006.
            annotation updated: Feb 22, 2023.
            xrefs: AM072411.1, CAJ21615.1, 6CGW_A, 6CHC_A, 6CNU_B
            xrefs (non-sequence databases): PDBsum:6CGW, PDBsum:6CHC,
            PDBsum:6CNU, AlphaFoldDB:Q2PAY4, SMR:Q2PAY4,
            ArachnoServer:AS000047, GO:0005576, GO:0015459, GO:0017080,
            GO:0090729, SUPFAM:SSF57059
KEYWORDS    3D-structure; Amidation; Direct protein sequencing; Disulfide bond;
            Ion channel impairing toxin; Knottin; Neurotoxin; Potassium channel
            impairing toxin; Secreted; Signal; Toxin; Voltage-gated potassium
            channel impairing toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Chilobrachys guangxiensis
  ORGANISM  Chilobrachys guangxiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Chilobrachys.
REFERENCE   1  (residues 1 to 83)
  AUTHORS   Zeng,X., Deng,M., Lin,Y., Yuan,C., Pi,J. and Liang,S.
  TITLE     Isolation and characterization of Jingzhaotoxin-V, a novel
            neurotoxin from the venom of the spider Chilobrachys jingzhao
  JOURNAL   Toxicon 49 (3), 388-399 (2007)
   PUBMED   17157888
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 54-82, FUNCTION,
            SUBCELLULAR LOCATION, MASS SPECTROMETRY, AND AMIDATION AT ILE-82.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 83)
  AUTHORS   Liao,Z., Cao,J., Li,S., Yan,X., Hu,W., He,Q., Chen,J., Tang,J.,
            Xie,J. and Liang,S.
  TITLE     Proteomic and peptidomic analysis of the venom from Chinese
            tarantula Chilobrachys jingzhao
  JOURNAL   Proteomics 7 (11), 1892-1907 (2007)
   PUBMED   17476710
  REMARK    PROTEIN SEQUENCE OF 54-82, AND IDENTIFICATION BY MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 83)
  AUTHORS   Cai,L.J., Xu,D.H., Luo,J., Chen,R.Z., Chi,Y.P., Zeng,X.Z.,
            Wang,X.C. and Liang,S.P.
  TITLE     [Inhibition of Jingzhaotoxin-V on Kv4.3 channel]
  JOURNAL   Sheng Li Xue Bao 62 (3), 255-260 (2010)
   PUBMED   20571743
  REMARK    SYNTHESIS OF 54-82, AND FUNCTION.
REFERENCE   4  (residues 1 to 83)
  AUTHORS   Yuan,C., Yang,S., Liao,Z. and Liang,S.
  TITLE     Effects and mechanism of Chinese tarantula toxins on the Kv2.1
            potassium channels
  JOURNAL   Biochem Biophys Res Commun 352 (3), 799-804 (2007)
   PUBMED   17150181
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 83)
  AUTHORS   Chen,J., Deng,M., He,Q., Meng,E., Jiang,L., Liao,Z., Rong,M. and
            Liang,S.
  TITLE     Molecular diversity and evolution of cystine knot toxins of the
            tarantula Chilobrachys jingzhao
  JOURNAL   Cell Mol Life Sci 65 (15), 2431-2444 (2008)
   PUBMED   18581053
  REMARK    FUNCTION.;
            TISSUE=Venom gland
REFERENCE   6  (residues 1 to 83)
  AUTHORS   Luo,J., Zhang,Y., Gong,M., Lu,S., Ma,Y., Zeng,X. and Liang,S.
  TITLE     Molecular surface of JZTX-V (beta-Theraphotoxin-Cj2a) interacting
            with voltage-gated sodium channel subtype NaV1.4
  JOURNAL   Toxins (Basel) 6 (7), 2177-2193 (2014)
   PUBMED   25055801
  REMARK    FUNCTION, AND MUTAGENESIS OF TRP-58; MET-59; TRP-60; ARG-73 AND
            LYS-75.
            Publication Status: Online-Only
REFERENCE   7  (residues 1 to 83)
  AUTHORS   Moyer,B.D., Murray,J.K., Ligutti,J., Andrews,K., Favreau,P.,
            Jordan,J.B., Lee,J.H., Liu,D., Long,J., Sham,K., Shi,L.,
            Stocklin,R., Wu,B., Yin,R., Yu,V., Zou,A., Biswas,K. and
            Miranda,L.P.
  TITLE     Pharmacological characterization of potent and selective NaV1.7
            inhibitors engineered from Chilobrachys jingzhao tarantula venom
            peptide JzTx-V
  JOURNAL   PLoS One 13 (5), e0196791 (2018)
   PUBMED   29723257
  REMARK    STRUCTURE BY NMR OF 54-82 OF MUTANTS PRA-[NLE6]JZTX-V(1-29) AND
            AM-8145, DISULFIDE BOND, FUNCTION, FUNCTION OF ANALOGS AM-8145;
            AM-0422 AND AM-8394, AND SYNTHESIS OF 54-82.;
            TISSUE=Venom
            Publication Status: Online-Only
COMMENT     [FUNCTION] This gating-modifier toxin shows an important inhibitory
            activity on sodium channels (PubMed:29723257). It is very active on
            Nav1.7/SCN9A (IC(50)
            0.6 nM), and also shows activity on Nav1.3/SCN3A (IC(50)=292 nM),
            Nav1.4/SCN4A (IC(50)=2.2-159 nM), and Nav1.5/SCN5A (IC(50)=2.3-2.9
            uM) (PubMed:25055801, PubMed:29723257). It has also been shown to
            inhibit tetrodotoxin (TTX)-resistant (IC(50)=27.6 nM) and
            TTX-sensitive (IC(50)=30.2 nM) sodium channels in rat dorsal root
            ganglion neurons (PubMed:17157888). Lower inhibitory activity has
            also been shown on potassium channels: Kv4.2/KCND2 (IC(50)=604.2
            nM), Kv4.3/KCND3 (IC(50)=425.1 nM), and Kv2.1/KCNB1 (IC(50)=14.3
            uM) (PubMed:17157888, PubMed:20571743, PubMed:17150181). It binds
            to phospholipid membranes. Like its analog AM-8145, it may act by
            interacting only with the second voltage-sensor domain of
            Nav1.7/SCN9A (Probable). {ECO:0000269|PubMed:17150181,
            ECO:0000269|PubMed:17157888, ECO:0000269|PubMed:18581053,
            ECO:0000269|PubMed:20571743, ECO:0000269|PubMed:29723257}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:17157888}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:17157888}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:29723257}.
            [MASS SPECTROMETRY] Mass=3605.73; Mass_error=0.3; Method=MALDI;
            Evidence={ECO:0000269|PubMed:17157888}.
            [MISCELLANEOUS] Negative results: does not inhibit Kv1.2/KCNA2,
            Kv1.3/KCNA3, and Kv1.4/KCNA4 channels (PubMed:17157888). Shows an
            extremely weak inhibition on Kv4.1/KCND1 (PubMed:17150181).
            {ECO:0000269|PubMed:17150181, ECO:0000269|PubMed:17157888}.
            [MISCELLANEOUS] The analog AM-8145 has a propargylglycine (Pra)
            N-terminally inserted, a norleucine (Nle) that replaces Met-59
            (Met-6), and a Glu instead of Ile-81 (Ile-28). This analog potently
            blocks Nav1.7/SCN9A (IC(50)=0.5 nM) by interacting only with its
            second voltage-sensor domain (PubMed:29723257). It is 30- to
            120-fold less active on TTX-sensitive sodium channels, and shows no
            or very low activity on TTX-resistant sodium channels
            (PubMed:29723257). {ECO:0000269|PubMed:29723257}.
            [MISCELLANEOUS] The analog AM-0422 has a beta-cyanoalanine (CyA)
            N-terminally inserted, a norleucine (Nle) that replaces Met-59
            (Met-6), a propargylglycine (Pra) instead of Glu-70 (Glu-17), and a
            Glu instead of Ile-81 (Ile-28). This analog potently blocks
            Nav1.7/SCN9A (IC(50)=0.8 nM) (PubMed:29723257). It also potently
            blocks TTX-sensitive sodium channels in mouse and rat DRG neurons
            (IC(50)=9-27 nM) (PubMed:29723257). It also specifically blocks
            capsaicin-induced rat DRG neuron action potential firing
            (PubMed:29723257). In addition, it specifically blocks
            mechanically-induced C-fiber action potential firing from afferent
            nerve terminals (PubMed:29723257). {ECO:0000269|PubMed:29723257}.
            [MISCELLANEOUS] The analog AM-8394 has a propargylglycine (Pra)
            N-terminally inserted, a norleucine (Nle) that replaces Met-59
            (Met-6), and Glu residues instead of Leu-72 (Leu-19) and Ile-81
            (Ile-28) (PubMed:29723257). This analog show a weak inhibitory
            activity on Nav1.7/SCN9A (IC(50)>1 uM) (PubMed:29723257). It does
            not show activity on TTX-sensitive sodium channels in mouse and rat
            DRG neurons (PubMed:29723257). As a consequence, it can be used as
            a negative control peptide. {ECO:0000269|PubMed:29723257}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..83
                     /organism="Chilobrachys guangxiensis"
                     /db_xref="taxon:278060"
     Protein         1..83
                     /product="Beta/kappa-theraphotoxin-Cg2a"
                     /note="Beta/kappa-TRTX-Cg2a; Beta-theraphotoxin-Cj2a;
                     Jingzhaotoxin-5; Jingzhaotoxin-V; Peptide F8-15.73;
                     JZTX-V"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..53
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:17157888,
                     ECO:0000305|PubMed:17476710. /id=PRO_0000262454."
     Region          54..82
                     /region_name="Processed active peptide"
                     /note="Beta/kappa-theraphotoxin-Cg2a.
                     /evidence=ECO:0000269|PubMed:17157888,
                     ECO:0000269|PubMed:17476710. /id=PRO_0000262455."
     Bond            bond(55,69)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29723257,
                     ECO:0000312|PDB:6CGW, ECO:0000312|PDB:6CHC."
     Region          57..60
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6CGW."
     Site            58
                     /site_type="mutagenized"
                     /note="W->A: 61-fold decrease of binding affinity to
                     Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25055801."
     Site            59
                     /site_type="mutagenized"
                     /note="M->A: 49-fold decrease of binding affinity to
                     Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25055801."
     Site            60
                     /site_type="mutagenized"
                     /note="W->A: 375-fold decrease of binding affinity to
                     Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25055801."
     Bond            bond(62,74)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29723257,
                     ECO:0000312|PDB:6CGW, ECO:0000312|PDB:6CHC."
     Region          63..65
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6CHC."
     Bond            bond(68,78)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29723257,
                     ECO:0000312|PDB:6CGW, ECO:0000312|PDB:6CHC."
     Region          72..80
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6CNU."
     Site            73
                     /site_type="mutagenized"
                     /note="R->A: 410-fold decrease of binding affinity to
                     Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25055801."
     Site            75
                     /site_type="mutagenized"
                     /note="K->A: 128-fold decrease of binding affinity to
                     Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25055801."
     Site            82
                     /site_type="amidation"
                     /note="Isoleucine amide.
                     /evidence=ECO:0000269|PubMed:17157888."
ORIGIN      
        1 mkasvfavil glvvlcacsf aedeqdqfvs pnellksmfv esrheftpev egrycqkwmw
       61 tcdskracce glrcklwcrk iig
//

LOCUS       2MF3_A                    47 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, U2-segestritoxin-Sf1a.
ACCESSION   2MF3_A
VERSION     2MF3_A
DBSOURCE    pdb: molecule 2MF3, chain A, release Mar 18, 2015;
            deposition: Oct 4, 2013;
            class: TOXIN;
            source: Mmdb_id: 123741, Pdb_id 1: 2MF3;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Segestria florentina
  ORGANISM  Segestria florentina
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Haplogynae; Dysderoidea; Segestriidae;
            Segestria.
REFERENCE   1  (residues 1 to 47)
  AUTHORS   Bende,N.S., Dziemborowicz,S., Herzig,V., Ramanujam,V., Brown,G.W.,
            Bosmans,F., Nicholson,G.M., King,G.F. and Mobli,M.
  TITLE     The insecticidal spider toxin SFI1 is a knottin peptide that blocks
            the pore of insect voltage-gated sodium channels via a large
            beta-hairpin loop
  JOURNAL   FEBS J. 282 (5), 904-920 (2015)
   PUBMED   25559770
REFERENCE   2  (residues 1 to 47)
  AUTHORS   Mobli,M., Bende,N.S. and King,G.F.
  TITLE     Direct Submission
  JOURNAL   Submitted (04-OCT-2013)
COMMENT     SGTX-Sf1a.
FEATURES             Location/Qualifiers
     source          1..47
                     /organism="Segestria florentina"
                     /db_xref="taxon:31925"
     Region          2..36
                     /region_name="Toxin_28"
                     /note="SFI toxin family; pfam08115"
                     /db_xref="CDD:285352"
     Bond            bond(4,20)
                     /bond_type="disulfide"
     Bond            bond(11,23)
                     /bond_type="disulfide"
     Bond            bond(19,43)
                     /bond_type="disulfide"
     SecStr          21..25
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(25,41)
                     /bond_type="disulfide"
     SecStr          41..45
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 skecmtdgtv cyihnhndcc gsclcsngpi arpwemmvgn cmcgpka
//

LOCUS       CALM1_HUMAN              149 aa            linear   PRI 08-NOV-2023
DEFINITION  RecName: Full=Calmodulin-1.
ACCESSION   P0DP23
VERSION     P0DP23.1
DBSOURCE    UniProtKB: locus CALM1_HUMAN, accession P0DP23;
            class: standard.
            extra
            accessions:P02593,P62158,P70667,P99014,Q13942,Q53S29,Q61379,Q61380,
            Q96HK3
            created: May 10, 2017.
            sequence updated: May 10, 2017.
            annotation updated: Nov 8, 2023.
            xrefs: M27319.1, AAA35635.1, U12022.1, AAB60644.1, U11886.1,
            BT006818.1, AAP35464.1, AC006536.2, AAD45181.1, AL512791.3,
            BC000454.2, AAH00454.1, BC008597.1, AAH08597.1, BC011834.2,
            AAH11834.1, BC047523.1, MCHU, NP_001316851.1, NP_001734.1,
            NP_005175.2, NP_008819.1, 1CDL_A, 1CDL_B, 1CDL_C, 1CDL_D, 1CLL_A,
            1CTR_A, 1IWQ_A, 1J7O_A, 1J7P_A, 1K90_D, 1K90_E, 1K90_F, 1K93_D,
            1K93_E, 1K93_F, 1L7Z_A, 1LVC_D, 1LVC_E, 1LVC_F, 1NKF_A, 1PK0_D,
            1PK0_E, 1PK0_F, 1S26_D, 1S26_E, 1S26_F, 1SK6_D, 1SK6_E, 1SK6_F,
            1SW8_A, 1UP5_A, 1UP5_B, 1WRZ_A, 1XFU_O, 1XFU_P, 1XFU_Q, 1XFU_R,
            1XFU_S, 1XFU_T, 1XFV_O, 1XFV_P, 1XFV_Q, 1XFV_R, 1XFV_S, 1XFV_T,
            1XFW_O, 1XFW_P, 1XFW_Q, 1XFW_R, 1XFW_S, 1XFW_T, 1XFX_O, 1XFX_P,
            1XFX_Q, 1XFX_R, 1XFX_S, 1XFX_T, 1XFY_O, 1XFY_P, 1XFY_Q, 1XFY_R,
            1XFY_S, 1XFY_T, 1XFZ_O, 1XFZ_P, 1XFZ_Q, 1XFZ_R, 1XFZ_S, 1XFZ_T,
            1Y6W_A, 1YR5_A, 1YRT_B, 1YRU_B, 1ZOT_B, 1ZUZ_A, 2BE6_A, 2BE6_B,
            2BE6_C, 2F3Y_A, 2F3Z_A, 2HF5_A, 2I08_A, 2JZI_A, 2K0E_A, 2K0F_A,
            2K0J_A, 2K61_A, 2KNE_A, 2KUG_A, 2KUH_A, 2L53_A, 2L7L_A, 2LGF_A,
            2LL6_A, 2LL7_A, 2LQC_A, 2LQP_A, 2LV6_A, 2M0J_A, 2M0K_A, 2M55_A,
            2MG5_A, 2N27_A, 2N6A_A, 2N77_A, 2N8J_A, 2R28_A, 2R28_B, 2V01_A,
            2V02_A, 2VAY_A, 2W73_A, 2W73_B, 2W73_E, 2W73_F, 2WEL_D, 2X0G_B,
            2Y4V_A, 3BYA_A, 3DVE_A, 3DVJ_A, 3DVK_A, 3DVM_A, 3EVV_A, 3EWT_A,
            3EWV_A, 3G43_A, 3G43_B, 3G43_C, 3G43_D, 3HR4_B, 3HR4_D, 3HR4_F,
            3HR4_H, 3J41_E, 3J41_F, 3O77_A, 3O78_A, 3O78_B, 3OXQ_A, 3OXQ_B,
            3OXQ_C, 3OXQ_D, 3SUI_A, 3UCT_A, 3UCT_B, 3UCW_A, 3UCW_B, 3UCW_C,
            3UCW_D, 3UCY_A, 4BW7_A, 4BW7_C, 4BW8_A, 4BW8_B, 4BYF_B, 4BYF_D,
            4DCK_B, 4DJC_A, 4GOW_D, 4JPZ_C, 4JPZ_I, 4JQ0_C, 4L79_B, 4LZX_A,
            4M1L_A, 4OVN_A, 4OVN_B, 4OVN_C, 4OVN_D, 4OVN_E, 4Q57_A, 4Q5U_A,
            4UMO_C, 4UMO_D, 4UPU_A, 4V0C_C, 4V0C_D, 5COC_A, 5DBR_A, 5DOW_A,
            5DOW_C, 5DOW_E, 5DOW_G, 5DSU_A, 5GGM_A, 5I0I_C, 5I0I_E, 5I0I_G,
            5I0I_I, 5J03_B, 5J8H_A, 5JQA_A, 5JTH_A, 5K7L_B, 5K8Q_A, 5OEO_A,
            5TP5_A, 5TP6_A, 5V02_R, 5V03_R, 5V7X_B, 5WBX_R, 5WC5_R, 6B8L_B,
            6B8L_D, 6B8L_F, 6B8L_H, 6B8M_B, 6B8M_D, 6B8M_F, 6B8M_H, 6B8N_B,
            6B8N_D, 6B8N_F, 6B8N_H, 6B8P_B, 6B8P_D, 6B8P_F, 6B8P_H, 6B8Q_B,
            6B8Q_D, 6B8Q_F, 6B8Q_H, 6BUT_A, 6C1D_R, 6C1G_R, 6C1H_R, 6CNM_E,
            6CNM_F, 6CNM_G, 6CNM_H, 6CNN_E, 6CNN_F, 6CNN_G, 6CNN_H, 6CNO_E,
            6CNO_F, 6CNO_G, 6CNO_H, 6DAD_A, 6DAD_B, 6DAE_A, 6DAE_B, 6DAF_A,
            6DAF_B, 6DAH_A, 6DAH_B, 6DAH_C, 6DAH_D, 6E2F_E, 6E2G_E, 6EEB_A,
            6FEG_B, 6FEH_B, 6GDK_A, 6GDL_A, 6HCS_A, 6HCS_C, 6HCS_E, 6HCS_G,
            6HR1_A, 6HR1_B, 6JI8_C, 6JI8_F, 6JI8_I, 6JI8_L, 6JII_C, 6JII_F,
            6JII_I, 6JII_L, 6JIU_C, 6JIU_F, 6JIU_I, 6JIU_L, 6JIY_C, 6JIY_F,
            6JIY_I, 6JIY_L, 6JRS_C, 6JRS_F, 6JRS_I, 6JRS_L, 6JV2_B, 6JV2_D,
            6JV2_F, 6JV2_H, 6K4K_C, 6K4K_D, 6K4L_C, 6K4L_D, 6K4R_C, 6K4R_D,
            6M2W_C, 6M2W_F, 6M2W_I, 6M2W_L, 6M7H_A, 6MUD_A, 6MUE_A, 6N5W_C,
            6O5G_A, 6OS4_A, 6PAW_C, 6PAW_D, 6PAW_G, 6PAW_H, 6PBX_B, 6PBX_D,
            6PBX_F, 6PBX_H, 6PBY_B, 6PBY_D, 6PBY_F, 6PBY_H, 6TV7_A, 6U39_A,
            6U39_C, 6U39_E, 6U39_G, 6U39_I, 6U39_K, 6U39_M, 6U39_O, 6U39_Q,
            6U39_S, 6U3A_A, 6U3A_B, 6U3B_A, 6U3D_A, 6U3D_B, 6UZZ_B, 6UZZ_D,
            6UZZ_F, 6UZZ_H, 6V00_B, 6V00_E, 6V00_H, 6V00_K, 6V01_B, 6V01_E,
            6V01_H, 6V01_K, 6X32_C, 6X32_F, 6X32_I, 6X32_L, 6X33_C, 6X33_F,
            6X33_I, 6X33_L, 6X35_C, 6X35_F, 6X35_I, 6X35_L, 6X36_C, 6X36_F,
            6X36_I, 6X36_L, 6XXX, 6XY3, 6XYR_A, 6Y4P_A, 6Y94_A, 6Y95_A, 6YA9_A,
            6YNS_A, 6YNS_B, 6YNS_C, 6YNS_D, 6YNS_E, 6YNS_F, 6YNS_G, 6YNS_H,
            6YNS_I, 6YNS_J, 6YNS_K, 6YNS_L, 6YNU_A, 6YNU_C, 6ZBI_A, 7AUG_A,
            7BF1, 7BF2, 7KL5_A, 7L8V_A, 7PSZ_A, 7PU9_A, 7SHQ_B, 7SX3_C, 7SX4_C,
            7T2Q_A, 7TCI_B, 7TCI_D, 7TCI_F, 7TCI_H, 7TCP_B, 7TCP_D, 7TCP_F,
            7TCP_H, 7TZC_C, 7TZC_D, 7TZC_E, 7TZC_K, 7U9T_I, 7U9T_J, 7U9T_K,
            7U9T_L, 7UA3_I, 7UA3_J, 7UA3_K, 7UA3_L, 7UA4_I, 7UA4_J, 7UA4_K,
            7UA4_L, 7VMB_C, 7VUO_C, 7VUR_A, 7VUR_B, 7VUS_A, 7VUS_B, 7VUS_C,
            7VUS_D, 7VUT_A, 7VUT_B, 7VUU_A, 7VUU_B, 7VUU_C, 7VUU_D, 7VVD_C,
            7VVD_E, 7VVH_C, 7WJI_E, 7WR3_C, 7WR3_D, 7WR4_B, 7WR5_B, 7WZS_C,
            7XN4_D, 7XN5_D, 7XN6_D, 7ZRP_A, 7ZRP_C, 7ZRQ_A, 8AHS_A, 8DGH_A,
            8DGK_A, 8DUJ_C, 8DUJ_F, 8DUJ_I, 8DUJ_L, 8DVE_C, 8DVE_F, 8DVE_I,
            8DVE_L, 8EOW_E, 8EOW_F, 8EOW_G, 8EOW_H, 8EP0_E, 8EP0_F, 8EP0_G,
            8EP0_H, 8EP1_E, 8EP1_F, 8EP1_G, 8EP1_H, 8FNY_B, 8FNY_D, 8FO6_B,
            8GM4_B, 8GM5_B, 8SIK_B, 8SIK_D, 8SIK_F, 8SIK_H, 8SIM_B, 8SIM_D,
            8SIM_F, 8SIM_H, 8SIN_B, 8SIN_D, 8SIN_F, 8SIN_H
            xrefs (non-sequence databases): CCDS:CCDS9892.1, PDBsum:1CDL,
            PDBsum:1CLL, PDBsum:1CTR, PDBsum:1IWQ, PDBsum:1J7O, PDBsum:1J7P,
            PDBsum:1K90, PDBsum:1K93, PDBsum:1L7Z, PDBsum:1LVC, PDBsum:1NKF,
            PDBsum:1PK0, PDBsum:1S26, PDBsum:1SK6, PDBsum:1SW8, PDBsum:1UP5,
            PDBsum:1WRZ, PDBsum:1XFU, PDBsum:1XFV, PDBsum:1XFW, PDBsum:1XFX,
            PDBsum:1XFY, PDBsum:1XFZ, PDBsum:1Y6W, PDBsum:1YR5, PDBsum:1YRT,
            PDBsum:1YRU, PDBsum:1ZOT, PDBsum:1ZUZ, PDBsum:2BE6, PDBsum:2F3Y,
            PDBsum:2F3Z, PDBsum:2HF5, PDBsum:2I08, PDBsum:2JZI, PDBsum:2K0E,
            PDBsum:2K0F, PDBsum:2K0J, PDBsum:2K61, PDBsum:2KNE, PDBsum:2KUG,
            PDBsum:2KUH, PDBsum:2L53, PDBsum:2L7L, PDBsum:2LGF, PDBsum:2LL6,
            PDBsum:2LL7, PDBsum:2LQC, PDBsum:2LQP, PDBsum:2LV6, PDBsum:2M0J,
            PDBsum:2M0K, PDBsum:2M55, PDBsum:2MG5, PDBsum:2N27, PDBsum:2N6A,
            PDBsum:2N77, PDBsum:2N8J, PDBsum:2R28, PDBsum:2V01, PDBsum:2V02,
            PDBsum:2VAY, PDBsum:2W73, PDBsum:2WEL, PDBsum:2X0G, PDBsum:2Y4V,
            PDBsum:3BYA, PDBsum:3DVE, PDBsum:3DVJ, PDBsum:3DVK, PDBsum:3DVM,
            PDBsum:3EVV, PDBsum:3EWT, PDBsum:3EWV, PDBsum:3G43, PDBsum:3HR4,
            PDBsum:3J41, PDBsum:3O77, PDBsum:3O78, PDBsum:3OXQ, PDBsum:3SUI,
            PDBsum:3UCT, PDBsum:3UCW, PDBsum:3UCY, PDBsum:4BW7, PDBsum:4BW8,
            PDBsum:4BYF, PDBsum:4DCK, PDBsum:4DJC, PDBsum:4GOW, PDBsum:4JPZ,
            PDBsum:4JQ0, PDBsum:4L79, PDBsum:4LZX, PDBsum:4M1L, PDBsum:4OVN,
            PDBsum:4Q57, PDBsum:4Q5U, PDBsum:4UMO, PDBsum:4UPU, PDBsum:4V0C,
            PDBsum:5COC, PDBsum:5DBR, PDBsum:5DOW, PDBsum:5DSU, PDBsum:5GGM,
            PDBsum:5I0I, PDBsum:5J03, PDBsum:5J8H, PDBsum:5JQA, PDBsum:5JTH,
            PDBsum:5K7L, PDBsum:5K8Q, PDBsum:5OEO, PDBsum:5TP5, PDBsum:5TP6,
            PDBsum:5V02, PDBsum:5V03, PDBsum:5V7X, PDBsum:5WBX, PDBsum:5WC5,
            PDBsum:6B8L, PDBsum:6B8M, PDBsum:6B8N, PDBsum:6B8P, PDBsum:6B8Q,
            PDBsum:6BUT, PDBsum:6C1D, PDBsum:6C1G, PDBsum:6C1H, PDBsum:6CNM,
            PDBsum:6CNN, PDBsum:6CNO, PDBsum:6DAD, PDBsum:6DAE, PDBsum:6DAF,
            PDBsum:6DAH, PDBsum:6E2F, PDBsum:6E2G, PDBsum:6EEB, PDBsum:6FEG,
            PDBsum:6FEH, PDBsum:6GDK, PDBsum:6GDL, PDBsum:6HCS, PDBsum:6HR1,
            PDBsum:6JI8, PDBsum:6JII, PDBsum:6JIU, PDBsum:6JIY, PDBsum:6JRS,
            PDBsum:6JV2, PDBsum:6K4K, PDBsum:6K4L, PDBsum:6K4R, PDBsum:6M2W,
            PDBsum:6M7H, PDBsum:6MUD, PDBsum:6MUE, PDBsum:6N5W, PDBsum:6O5G,
            PDBsum:6OS4, PDBsum:6PAW, PDBsum:6PBX, PDBsum:6PBY, PDBsum:6TV7,
            PDBsum:6U39, PDBsum:6U3A, PDBsum:6U3B, PDBsum:6U3D, PDBsum:6UZZ,
            PDBsum:6V00, PDBsum:6V01, PDBsum:6X32, PDBsum:6X33, PDBsum:6X35,
            PDBsum:6X36, PDBsum:6XXX, PDBsum:6XY3, PDBsum:6XYR, PDBsum:6Y4P,
            PDBsum:6Y94, PDBsum:6Y95, PDBsum:6YA9, PDBsum:6YNS, PDBsum:6YNU,
            PDBsum:6ZBI, PDBsum:7AUG, PDBsum:7BF1, PDBsum:7BF2, PDBsum:7KL5,
            PDBsum:7L8V, PDBsum:7PSZ, PDBsum:7PU9, PDBsum:7SHQ, PDBsum:7SX3,
            PDBsum:7SX4, PDBsum:7T2Q, PDBsum:7TCI, PDBsum:7TCP, PDBsum:7TZC,
            PDBsum:7U9T, PDBsum:7UA3, PDBsum:7UA4, PDBsum:7VMB, PDBsum:7VUO,
            PDBsum:7VUR, PDBsum:7VUS, PDBsum:7VUT, PDBsum:7VUU, PDBsum:7VVD,
            PDBsum:7VVH, PDBsum:7WJI, PDBsum:7WR3, PDBsum:7WR4, PDBsum:7WR5,
            PDBsum:7WZS, PDBsum:7XN4, PDBsum:7XN5, PDBsum:7XN6, PDBsum:7ZRP,
            PDBsum:7ZRQ, PDBsum:8AHS, PDBsum:8DGH, PDBsum:8DGK, PDBsum:8DUJ,
            PDBsum:8DVE, PDBsum:8EOW, PDBsum:8EP0, PDBsum:8EP1, PDBsum:8FNY,
            PDBsum:8FO6, PDBsum:8GM4, PDBsum:8GM5, PDBsum:8SIK, PDBsum:8SIM,
            PDBsum:8SIN, AlphaFoldDB:P0DP23, SASBDB:P0DP23, SMR:P0DP23,
            IntAct:P0DP23, STRING:9606.ENSP00000272298, ChEMBL:CHEMBL6093,
            DrugBank:DB08039, DrugBank:DB01429, DrugBank:DB01244,
            DrugBank:DB01373, DrugBank:DB11093, DrugBank:DB13800,
            DrugBank:DB11348, DrugBank:DB14481, DrugBank:DB00477,
            DrugBank:DB00527, DrugBank:DB02868, DrugBank:DB04209,
            DrugBank:DB01023, DrugBank:DB04841, DrugBank:DB00623,
            DrugBank:DB00753, DrugBank:DB00836, DrugBank:DB01065,
            DrugBank:DB08231, DrugBank:DB04513, DrugBank:DB00622,
            DrugBank:DB01115, DrugBank:DB00850, DrugBank:DB00925,
            DrugBank:DB01100, DrugBank:DB04825, DrugBank:DB01069,
            DrugBank:DB03900, DrugBank:DB00831, DrugBank:DB03977,
            DrugCentral:P0DP23, MoonDB:P0DP23, GlyGen:P0DP23, iPTMnet:P0DP23,
            MetOSite:P0DP23, PhosphoSitePlus:P0DP23, BioMuta:CALM1,
            jPOST:P0DP23, MassIVE:P0DP23, PaxDb:9606-ENSP00000272298,
            PeptideAtlas:P0DP23, Pumba:P0DP23, Antibodypedia:4344, DNASU:801,
            Ensembl:ENST00000356978.9, Ensembl:ENSP00000349467.4,
            Ensembl:ENSG00000198668.14, GeneID:801, GeneID:805, GeneID:808,
            KEGG:hsa:801, KEGG:hsa:805, KEGG:hsa:808,
            MANE-Select:ENST00000356978.9, AGR:HGNC:1442, AGR:HGNC:1445,
            AGR:HGNC:1449, CTD:801, CTD:805, CTD:808, DisGeNET:801,
            DisGeNET:805, DisGeNET:808, GeneCards:CALM1, GeneReviews:CALM1,
            HGNC:1442, HPA:ENSG00000198668, MalaCards:CALM1, MIM:114180,
            MIM:614916, MIM:616247, neXtProt:NX_P0DP23,
            OpenTargets:ENSG00000143933, OpenTargets:ENSG00000160014,
            OpenTargets:ENSG00000198668, Orphanet:3286, Orphanet:101016,
            VEuPathDB:HostDB:ENSG00000198668, eggNOG:KOG0027,
            InParanoid:P0DP23, OMA:SCDRHPP, OrthoDB:22601at2759,
            PathwayCommons:P0DP23, Reactome:R-HSA-111932,
            Reactome:R-HSA-111933, Reactome:R-HSA-111957,
            Reactome:R-HSA-111997, Reactome:R-HSA-114608,
            Reactome:R-HSA-1445148, Reactome:R-HSA-1474151,
            Reactome:R-HSA-163615, Reactome:R-HSA-180024,
            Reactome:R-HSA-1855204, Reactome:R-HSA-2025928,
            Reactome:R-HSA-203615, Reactome:R-HSA-2151201,
            Reactome:R-HSA-2514859, Reactome:R-HSA-2672351,
            Reactome:R-HSA-2871809, Reactome:R-HSA-4086398,
            Reactome:R-HSA-418359, Reactome:R-HSA-425561,
            Reactome:R-HSA-438066, Reactome:R-HSA-442720,
            Reactome:R-HSA-442729, Reactome:R-HSA-442982,
            Reactome:R-HSA-445355, Reactome:R-HSA-451308,
            Reactome:R-HSA-5210891, Reactome:R-HSA-5218920,
            Reactome:R-HSA-5218921, Reactome:R-HSA-5576892,
            Reactome:R-HSA-5578775, Reactome:R-HSA-5607763,
            Reactome:R-HSA-5626467, Reactome:R-HSA-5627123,
            Reactome:R-HSA-5673000, Reactome:R-HSA-5673001,
            Reactome:R-HSA-6802946, Reactome:R-HSA-6802952,
            Reactome:R-HSA-6802955, Reactome:R-HSA-70221,
            Reactome:R-HSA-8876725, Reactome:R-HSA-9009391,
            Reactome:R-HSA-9022535, Reactome:R-HSA-9022692,
            Reactome:R-HSA-936837, Reactome:R-HSA-9617324,
            Reactome:R-HSA-9619229, Reactome:R-HSA-9619483,
            Reactome:R-HSA-9620244, Reactome:R-HSA-9648002,
            Reactome:R-HSA-9649948, Reactome:R-HSA-9656223,
            Reactome:R-HSA-9664323, Reactome:R-HSA-983695, SignaLink:P0DP23,
            SIGNOR:P0DP23, BioGRID-ORCS:801, BioGRID-ORCS:805,
            BioGRID-ORCS:808, ChiTaRS:CALM1, Pharos:P0DP23, PRO:PR:P0DP23,
            Proteomes:UP000005640, RNAct:P0DP23, Bgee:ENSG00000198668,
            ExpressionAtlas:P0DP23, GO:0034704, GO:1902494, GO:0005813,
            GO:0005737, GO:0005829, GO:0005576, GO:0043209, GO:0005654,
            GO:0005634, GO:0005886, GO:0032991, GO:0030017, GO:0097225,
            GO:0005876, GO:0000922, GO:0031982, GO:0008076, GO:0010856,
            GO:0019855, GO:0005509, GO:0048306, GO:0019901, GO:0072542,
            GO:0043539, GO:0031432, GO:0044325, GO:0016240, GO:0035458,
            GO:0071346, GO:0005513, GO:0007186, GO:0000086, GO:1990456,
            GO:1905913, GO:1901842, GO:0010801, GO:0060315, GO:0140056,
            GO:0051343, GO:0010800, GO:0032516, GO:0031954, GO:0035307,
            GO:0071902, GO:0046427, GO:0060316, GO:0050848, GO:0098901,
            GO:0055117, GO:0010881, GO:1901844, GO:0032465, GO:0002027,
            GO:0010880, GO:0060314, GO:0051592, GO:0021762, CDD:cd00051,
            Gene3D:1.10.238.10, InterPro:IPR011992, InterPro:IPR018247,
            InterPro:IPR002048, PANTHER:PTHR23050, PANTHER:PTHR23050:SF510,
            Pfam:PF13499, PRINTS:PR00450, SMART:SM00054, SUPFAM:SSF47473,
            PROSITE:PS00018, PROSITE:PS50222
KEYWORDS    3D-structure; Acetylation; Calcium; Cell projection; Cilium;
            Cytoplasm; Cytoskeleton; Direct protein sequencing; Disease
            variant; Flagellum; Host-virus interaction; Isopeptide bond; Long
            QT syndrome; Metal-binding; Methylation; Phosphoprotein; Reference
            proteome; Repeat; Ubl conjugation.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 149)
  AUTHORS   Wawrzynczak,E.J. and Perham,R.N.
  TITLE     Isolation and nucleotide sequence of a cDNA encoding human
            calmodulin
  JOURNAL   Biochem Int 9 (2), 177-185 (1984)
   PUBMED   6385987
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
REFERENCE   2  (residues 1 to 149)
  AUTHORS   Rhyner,J.A., Ottiger,M., Wicki,R., Greenwood,T.M. and Strehler,E.E.
  TITLE     Structure of the human CALM1 calmodulin gene and identification of
            two CALM1-related pseudogenes CALM1P1 and CALM1P2
  JOURNAL   Eur J Biochem 225 (1), 71-82 (1994)
   PUBMED   7925473
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].;
            TISSUE=Blood
REFERENCE   3  (residues 1 to 149)
  AUTHORS   Kalnine,N., Chen,X., Rolfs,A., Halleck,A., Hines,L., Eisenstein,S.,
            Koundinya,M., Raphael,J., Moreira,D., Kelley,T., LaBaer,J., Lin,Y.,
            Phelan,M. and Farmer,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-MAY-2003) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
REFERENCE   4  (residues 1 to 149)
  AUTHORS   Heilig,R., Eckenberg,R., Petit,J.L., Fonknechten,N., Da Silva,C.,
            Cattolico,L., Levy,M., Barbe,V., de Berardinis,V., Ureta-Vidal,A.,
            Pelletier,E., Vico,V., Anthouard,V., Rowen,L., Madan,A., Qin,S.,
            Sun,H., Du,H., Pepin,K., Artiguenave,F., Robert,C., Cruaud,C.,
            Bruls,T., Jaillon,O., Friedlander,L., Samson,G., Brottier,P.,
            Cure,S., Segurens,B., Aniere,F., Samain,S., Crespeau,H., Abbasi,N.,
            Aiach,N., Boscus,D., Dickhoff,R., Dors,M., Dubois,I., Friedman,C.,
            Gouyvenoux,M., James,R., Madan,A., Mairey-Estrada,B., Mangenot,S.,
            Martins,N., Menard,M., Oztas,S., Ratcliffe,A., Shaffer,T.,
            Trask,B., Vacherie,B., Bellemere,C., Belser,C., Besnard-Gonnet,M.,
            Bartol-Mavel,D., Boutard,M., Briez-Silla,S., Combette,S.,
            Dufosse-Laurent,V., Ferron,C., Lechaplais,C., Louesse,C.,
            Muselet,D., Magdelenat,G., Pateau,E., Petit,E.,
            Sirvain-Trukniewicz,P., Trybou,A., Vega-Czarny,N., Bataille,E.,
            Bluet,E., Bordelais,I., Dubois,M., Dumont,C., Guerin,T.,
            Haffray,S., Hammadi,R., Muanga,J., Pellouin,V., Robert,D.,
            Wunderle,E., Gauguet,G., Roy,A., Sainte-Marthe,L., Verdier,J.,
            Verdier-Discala,C., Hillier,L., Fulton,L., McPherson,J.,
            Matsuda,F., Wilson,R., Scarpelli,C., Gyapay,G., Wincker,P.,
            Saurin,W., Quetier,F., Waterston,R., Hood,L. and Weissenbach,J.
  TITLE     The DNA sequence and analysis of human chromosome 14
  JOURNAL   Nature 421 (6923), 601-607 (2003)
   PUBMED   12508121
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
            Erratum:[Nature. 2023 Jul 25;:. PMID: 37491470]
REFERENCE   5  (residues 1 to 149)
  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,
            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,
            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,
            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,
            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,
            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,
            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,
            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,
            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,
            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,
            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,
            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,
            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,
            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,
            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,
            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,
            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,
            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,
            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,
            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,
            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,
            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,
            Makowski,K.A., Bosak,S. and Malek,J.
  CONSRTM   MGC Project Team
  TITLE     The status, quality, and expansion of the NIH full-length cDNA
            project: the Mammalian Gene Collection (MGC)
  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)
   PUBMED   15489334
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].;
            TISSUE=Brain, Lung, Lymph, Placenta, and Urinary bladder
            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to
            Morin, Ryan]]
REFERENCE   6  (residues 1 to 149)
  AUTHORS   Sasagawa,T., Ericsson,L.H., Walsh,K.A., Schreiber,W.E.,
            Fischer,E.H. and Titani,K.
  TITLE     Complete amino acid sequence of human brain calmodulin
  JOURNAL   Biochemistry 21 (10), 2565-2569 (1982)
   PUBMED   7093203
  REMARK    PROTEIN SEQUENCE OF 2-149, ACETYLATION AT ALA-2, AND METHYLATION AT
            LYS-116.;
            TISSUE=Brain
REFERENCE   7  (residues 1 to 149)
  AUTHORS   Bienvenut,W.V., Bensaad,K. and Vousden,K.H.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-FEB-2008) to UniProtKB
  REMARK    PROTEIN SEQUENCE OF 2-31 AND 92-107, CLEAVAGE OF INITIATOR
            METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
            SPECTROMETRY.;
            TISSUE=Osteosarcoma
REFERENCE   8  (residues 1 to 149)
  AUTHORS   Lubec,G., Afjehi-Sadat,L., Chen,W.-Q. and Sun,Y.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-DEC-2008) to UniProtKB
  REMARK    PROTEIN SEQUENCE OF 15-31; 77-107 AND 128-149, AND IDENTIFICATION
            BY MASS SPECTROMETRY.;
            TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex
REFERENCE   9  (residues 1 to 149)
  AUTHORS   Mayans,O., van der Ven,P.F., Wilm,M., Mues,A., Young,P.,
            Furst,D.O., Wilmanns,M. and Gautel,M.
  TITLE     Structural basis for activation of the titin kinase domain during
            myofibrillogenesis
  JOURNAL   Nature 395 (6705), 863-869 (1998)
   PUBMED   9804419
  REMARK    INTERACTION WITH TTN.
            Erratum:[Nature 1999 Feb 25;397(6712):719]
REFERENCE   10 (residues 1 to 149)
  AUTHORS   Andersen,J.S., Wilkinson,C.J., Mayor,T., Mortensen,P., Nigg,E.A.
            and Mann,M.
  TITLE     Proteomic characterization of the human centrosome by protein
            correlation profiling
  JOURNAL   Nature 426 (6966), 570-574 (2003)
   PUBMED   14654843
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION
            [LARGE SCALE ANALYSIS].;
            TISSUE=Lymphoblast
REFERENCE   11 (residues 1 to 149)
  AUTHORS   Kelly,S., Yotis,J., Macris,M. and Harley,V.
  TITLE     Recombinant expression, purification and characterisation of the
            HMG domain of human SRY
  JOURNAL   Protein Pept Lett 10 (3), 281-286 (2003)
   PUBMED   12871148
  REMARK    INTERACTION WITH SRY.
REFERENCE   12 (residues 1 to 149)
  AUTHORS   Shen,C., Ye,Y., Robertson,S.E., Lau,A.W., Mak,D.O. and Chou,M.M.
  TITLE     Calcium/calmodulin regulates ubiquitination of the
            ubiquitin-specific protease TRE17/USP6
  JOURNAL   J Biol Chem 280 (43), 35967-35973 (2005)
   PUBMED   16127172
  REMARK    INTERACTION WITH USP6.
REFERENCE   13 (residues 1 to 149)
  AUTHORS   Sim,H., Rimmer,K., Kelly,S., Ludbrook,L.M., Clayton,A.H. and
            Harley,V.R.
  TITLE     Defective calmodulin-mediated nuclear transport of the
            sex-determining region of the Y chromosome (SRY) in XY sex reversal
  JOURNAL   Mol Endocrinol 19 (7), 1884-1892 (2005)
   PUBMED   15746192
  REMARK    INTERACTION WITH SRY.
REFERENCE   14 (residues 1 to 149)
  AUTHORS   Rush,J., Moritz,A., Lee,K.A., Guo,A., Goss,V.L., Spek,E.J.,
            Zhang,H., Zha,X.M., Polakiewicz,R.D. and Comb,M.J.
  TITLE     Immunoaffinity profiling of tyrosine phosphorylation in cancer
            cells
  JOURNAL   Nat Biotechnol 23 (1), 94-101 (2005)
   PUBMED   15592455
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   15 (residues 1 to 149)
  AUTHORS   Tsang,W.Y., Spektor,A., Luciano,D.J., Indjeian,V.B., Chen,Z.,
            Salisbury,J.L., Sanchez,I. and Dynlacht,B.D.
  TITLE     CP110 cooperates with two calcium-binding proteins to regulate
            cytokinesis and genome stability
  JOURNAL   Mol Biol Cell 17 (8), 3423-3434 (2006)
   PUBMED   16760425
  REMARK    FUNCTION, INTERACTION WITH CCP110, AND SUBCELLULAR LOCATION.
REFERENCE   16 (residues 1 to 149)
  AUTHORS   Spektor,A., Tsang,W.Y., Khoo,D. and Dynlacht,B.D.
  TITLE     Cep97 and CP110 suppress a cilia assembly program
  JOURNAL   Cell 130 (4), 678-690 (2007)
   PUBMED   17719545
  REMARK    INTERACTION WITH CEP97 AND CCP110.
REFERENCE   17 (residues 1 to 149)
  AUTHORS   Wiener,R., Haitin,Y., Shamgar,L., Fernandez-Alonso,M.C., Martos,A.,
            Chomsky-Hecht,O., Rivas,G., Attali,B. and Hirsch,J.A.
  TITLE     The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit
            assembly and protein interaction
  JOURNAL   J Biol Chem 283 (9), 5815-5830 (2008)
   PUBMED   18165683
  REMARK    INTERACTION WITH KCNQ1.
REFERENCE   18 (residues 1 to 149)
  AUTHORS   Wright,N.T., Prosser,B.L., Varney,K.M., Zimmer,D.B., Schneider,M.F.
            and Weber,D.J.
  TITLE     S100A1 and calmodulin compete for the same binding site on
            ryanodine receptor
  JOURNAL   J Biol Chem 283 (39), 26676-26683 (2008)
   PUBMED   18650434
  REMARK    INTERACTION WITH RYR1 AND RYR2.
REFERENCE   19 (residues 1 to 149)
  AUTHORS   Dephoure,N., Zhou,C., Villen,J., Beausoleil,S.A., Bakalarski,C.E.,
            Elledge,S.J. and Gygi,S.P.
  TITLE     A quantitative atlas of mitotic phosphorylation
  JOURNAL   Proc Natl Acad Sci U S A 105 (31), 10762-10767 (2008)
   PUBMED   18669648
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Cervix carcinoma
REFERENCE   20 (residues 1 to 149)
  AUTHORS   Gauci,S., Helbig,A.O., Slijper,M., Krijgsveld,J., Heck,A.J. and
            Mohammed,S.
  TITLE     Lys-N and trypsin cover complementary parts of the phosphoproteome
            in a refined SCX-based approach
  JOURNAL   Anal Chem 81 (11), 4493-4501 (2009)
   PUBMED   19413330
  REMARK    ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
            METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
            SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   21 (residues 1 to 149)
  AUTHORS   Mayya,V., Lundgren,D.H., Hwang,S.I., Rezaul,K., Wu,L., Eng,J.K.,
            Rodionov,V. and Han,D.K.
  TITLE     Quantitative phosphoproteomic analysis of T cell receptor signaling
            reveals system-wide modulation of protein-protein interactions
  JOURNAL   Sci Signal 2 (84), ra46 (2009)
   PUBMED   19690332
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100 AND TYR-139, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Leukemic T-cell
            Publication Status: Online-Only
REFERENCE   22 (residues 1 to 149)
  AUTHORS   Choudhary,C., Kumar,C., Gnad,F., Nielsen,M.L., Rehman,M.,
            Walther,T.C., Olsen,J.V. and Mann,M.
  TITLE     Lysine acetylation targets protein complexes and co-regulates major
            cellular functions
  JOURNAL   Science 325 (5942), 834-840 (2009)
   PUBMED   19608861
  REMARK    ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-22 AND LYS-95, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   23 (residues 1 to 149)
  AUTHORS   Wang,Z., Wu,T., Shi,L., Zhang,L., Zheng,W., Qu,J.Y., Niu,R. and
            Qi,R.Z.
  TITLE     Conserved motif of CDK5RAP2 mediates its localization to
            centrosomes and the Golgi complex
  JOURNAL   J Biol Chem 285 (29), 22658-22665 (2010)
   PUBMED   20466722
  REMARK    INTERACTION WITH CDK5RAP2.
REFERENCE   24 (residues 1 to 149)
  AUTHORS   Zhou,Y., Tzeng,W.P., Wong,H.C., Ye,Y., Jiang,J., Chen,Y., Huang,Y.,
            Suppiah,S., Frey,T.K. and Yang,J.J.
  TITLE     Calcium-dependent association of calmodulin with the rubella virus
            nonstructural protease domain
  JOURNAL   J Biol Chem 285 (12), 8855-8868 (2010)
   PUBMED   20086014
  REMARK    INTERACTION WITH RUBELLA VIRUS PROTEASE/METHYLTRANSFERASE P150.
REFERENCE   25 (residues 1 to 149)
  AUTHORS   Burkard,T.R., Planyavsky,M., Kaupe,I., Breitwieser,F.P.,
            Burckstummer,T., Bennett,K.L., Superti-Furga,G. and Colinge,J.
  TITLE     Initial characterization of the human central proteome
  JOURNAL   BMC Syst Biol 5, 17 (2011)
   PUBMED   21269460
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
            Publication Status: Online-Only
REFERENCE   26 (residues 1 to 149)
  AUTHORS   Rigbolt,K.T., Prokhorova,T.A., Akimov,V., Henningsen,J.,
            Johansen,P.T., Kratchmarova,I., Kassem,M., Mann,M., Olsen,J.V. and
            Blagoev,B.
  TITLE     System-wide temporal characterization of the proteome and
            phosphoproteome of human embryonic stem cell differentiation
  JOURNAL   Sci Signal 4 (164), rs3 (2011)
   PUBMED   21406692
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
            Publication Status: Online-Only
REFERENCE   27 (residues 1 to 149)
  AUTHORS   Liu,Y., Zheng,X., Mueller,G.A., Sobhany,M., DeRose,E.F., Zhang,Y.,
            London,R.E. and Birnbaumer,L.
  TITLE     Crystal structure of calmodulin binding domain of orai1 in complex
            with Ca2+ calmodulin displays a unique binding mode
  JOURNAL   J Biol Chem 287 (51), 43030-43041 (2012)
   PUBMED   23109337
  REMARK    INTERACTION WITH ORAI1.
REFERENCE   28 (residues 1 to 149)
  AUTHORS   Bienvenut,W.V., Sumpton,D., Martinez,A., Lilla,S., Espagne,C.,
            Meinnel,T. and Giglione,C.
  TITLE     Comparative large scale characterization of plant versus mammal
            proteins reveals similar and idiosyncratic N-alpha-acetylation
            features
  JOURNAL   Mol Cell Proteomics 11 (6), M111.015131 (2012)
   PUBMED   22223895
  REMARK    ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
            METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
            SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   29 (residues 1 to 149)
  AUTHORS   Umasankar,P.K., Sanker,S., Thieman,J.R., Chakraborty,S.,
            Wendland,B., Tsang,M. and Traub,L.M.
  TITLE     Distinct and separable activities of the endocytic clathrin-coat
            components Fcho1/2 and AP-2 in developmental patterning
  JOURNAL   Nat Cell Biol 14 (5), 488-501 (2012)
   PUBMED   22484487
  REMARK    INTERACTION WITH FCHO1.
            Publication Status: Online-Only
REFERENCE   30 (residues 1 to 149)
  AUTHORS   Van Damme,P., Lasa,M., Polevoda,B., Gazquez,C., Elosegui-Artola,A.,
            Kim,D.S., De Juan-Pardo,E., Demeyer,K., Hole,K., Larrea,E.,
            Timmerman,E., Prieto,J., Arnesen,T., Sherman,F., Gevaert,K. and
            Aldabe,R.
  TITLE     N-terminal acetylome analyses and functional insights of the
            N-terminal acetyltransferase NatB
  JOURNAL   Proc Natl Acad Sci U S A 109 (31), 12449-12454 (2012)
   PUBMED   22814378
  REMARK    ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
            METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
            SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   31 (residues 1 to 149)
  AUTHORS   Zhou,H., Di Palma,S., Preisinger,C., Peng,M., Polat,A.N., Heck,A.J.
            and Mohammed,S.
  TITLE     Toward a comprehensive characterization of a human cancer cell
            phosphoproteome
  JOURNAL   J Proteome Res 12 (1), 260-271 (2013)
   PUBMED   23186163
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-102, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Cervix carcinoma, and Erythroleukemia
REFERENCE   32 (residues 1 to 149)
  AUTHORS   Bian,Y., Song,C., Cheng,K., Dong,M., Wang,F., Huang,J., Sun,D.,
            Wang,L., Ye,M. and Zou,H.
  TITLE     An enzyme assisted RP-RPLC approach for in-depth analysis of human
            liver phosphoproteome
  JOURNAL   J Proteomics 96, 253-262 (2014)
   PUBMED   24275569
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 AND THR-111, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Liver
REFERENCE   33 (residues 1 to 149)
  AUTHORS   Guo,A., Gu,H., Zhou,J., Mulhern,D., Wang,Y., Lee,K.A., Yang,V.,
            Aguiar,M., Kornhauser,J., Jia,X., Ren,J., Beausoleil,S.A.,
            Silva,J.C., Vemulapalli,V., Bedford,M.T. and Comb,M.J.
  TITLE     Immunoaffinity enrichment and mass spectrometry analysis of protein
            methylation
  JOURNAL   Mol Cell Proteomics 13 (1), 372-387 (2014)
   PUBMED   24129315
  REMARK    METHYLATION [LARGE SCALE ANALYSIS] AT LYS-116, AND IDENTIFICATION
            BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Colon carcinoma
REFERENCE   34 (residues 1 to 149)
  AUTHORS   Vaca Jacome,A.S., Rabilloud,T., Schaeffer-Reiss,C., Rompais,M.,
            Ayoub,D., Lane,L., Bairoch,A., Van Dorsselaer,A. and Carapito,C.
  TITLE     N-terminome analysis of the human mitochondrial proteome
  JOURNAL   Proteomics 15 (14), 2519-2524 (2015)
   PUBMED   25944712
  REMARK    ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
            METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
            SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   35 (residues 1 to 149)
  AUTHORS   Zhao,Y.G., Chen,Y., Miao,G., Zhao,H., Qu,W., Li,D., Wang,Z.,
            Liu,N., Li,L., Chen,S., Liu,P., Feng,D. and Zhang,H.
  TITLE     The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA
            Activity to Control ER-Isolation Membrane Contacts for
            Autophagosome Formation
  JOURNAL   Mol Cell 67 (6), 974-989 (2017)
   PUBMED   28890335
  REMARK    FUNCTION, AND INTERACTION WITH PIK3C3.
REFERENCE   36 (residues 1 to 149)
  AUTHORS   Hendriks,I.A., Lyon,D., Young,C., Jensen,L.J., Vertegaal,A.C. and
            Nielsen,M.L.
  TITLE     Site-specific mapping of the human SUMO proteome reveals
            co-modification with phosphorylation
  JOURNAL   Nat Struct Mol Biol 24 (3), 325-336 (2017)
   PUBMED   28112733
  REMARK    SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-22, AND IDENTIFICATION BY
            MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   37 (residues 1 to 149)
  AUTHORS   Stucchi,R., Plucinska,G., Hummel,J.J.A., Zahavi,E.E., Guerra San
            Juan,I., Klykov,O., Scheltema,R.A., Altelaar,A.F.M. and
            Hoogenraad,C.C.
  TITLE     Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca(2+)/CaM
            Controls DCV Binding and Liprin-alpha/TANC2 Recruits DCVs to
            Postsynaptic Sites
  JOURNAL   Cell Rep 24 (3), 685-700 (2018)
   PUBMED   30021165
  REMARK    INTERACTION WITH KIF1A.
REFERENCE   38 (residues 1 to 149)
  AUTHORS   Fuchs,S., Hansen,S.C., Markones,M., Mymrikov,E.V., Heerklotz,H. and
            Hunte,C.
  TITLE     Calcineurin B homologous protein 3 binds with high affinity to the
            CHP binding domain of the human sodium/proton exchanger NHE1
  JOURNAL   Sci Rep 8 (1), 14837 (2018)
   PUBMED   30287853
  REMARK    INTERACTION WITH SLC9A1.
            Publication Status: Online-Only
REFERENCE   39 (residues 1 to 149)
  AUTHORS   Bauer,C.K., Schneeberger,P.E., Kortuem,F., Altmueller,J.,
            Santos-Simarro,F., Baker,L., Keller-Ramey,J., White,S.M.,
            Campeau,P.M., Gripp,K.W. and Kutsche,K.
  TITLE     Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance
            Ca(2+)-Activated K(+) Channel SK3 Cause Zimmermann-Laband Syndrome
  JOURNAL   Am J Hum Genet 104 (6), 1139-1157 (2019)
   PUBMED   31155282
  REMARK    INTERACTION WITH KCNN3.
REFERENCE   40 (residues 1 to 149)
  AUTHORS   Bhogaraju,S., Bonn,F., Mukherjee,R., Adams,M., Pfleiderer,M.M.,
            Galej,W.P., Matkovic,V., Lopez-Mosqueda,J., Kalayil,S., Shin,D. and
            Dikic,I.
  TITLE     Inhibition of bacterial ubiquitin ligases by SidJ-calmodulin
            catalysed glutamylation
  JOURNAL   Nature 572 (7769), 382-386 (2019)
   PUBMED   31330532
  REMARK    INTERACTION WITH LEGIONELLA PNEUMOPHILA SIDJ (MICROBIAL INFECTION),
            AND FUNCTION (MICROBIAL INFECTION).
REFERENCE   41 (residues 1 to 149)
  AUTHORS   Costanzi,E., Coletti,A., Zambelli,B., Macchiarulo,A., Bellanda,M.
            and Battistutta,R.
  TITLE     Calmodulin binds to the STAS domain of SLC26A5 prestin with a
            calcium-dependent, one-lobe, binding mode
  JOURNAL   J Struct Biol 213 (2), 107714 (2021)
   PUBMED   33667636
  REMARK    INTERACTION WITH SLC26A5.
REFERENCE   42 (residues 1 to 149)
  AUTHORS   Peng,T., Tao,X., Xia,Z., Hu,S., Xue,J., Zhu,Q., Pan,X., Zhang,Q.
            and Li,S.
  TITLE     Pathogen hijacks programmed cell death signaling by arginine
            ADPR-deacylization of caspases
  JOURNAL   Mol Cell 82 (10), 1806-1820 (2022)
   PUBMED   35338844
  REMARK    INTERACTION WITH C.VIOLACEUM COPC TOXIN (MICROBIAL INFECTION), AND
            FUNCTION (MICROBIAL INFECTION).
REFERENCE   43 (residues 1 to 149)
  AUTHORS   Liu,Y., Zeng,H., Hou,Y., Li,Z., Li,L., Song,X., Ding,J., Shao,F.
            and Xu,Y.
  TITLE     Calmodulin Binding Activates Chromobacterium CopC Effector to
            ADP-Riboxanate Host Apoptotic Caspases
  JOURNAL   mBio 13 (3), e0069022 (2022)
   PUBMED   35446120
  REMARK    INTERACTION WITH C.VIOLACEUM COPC TOXIN (MICROBIAL INFECTION), AND
            FUNCTION (MICROBIAL INFECTION).
REFERENCE   44 (residues 1 to 149)
  AUTHORS   Alphonse,N., Wanford,J.J., Voak,A.A., Gay,J., Venkhaya,S.,
            Burroughs,O., Mathew,S., Lee,T., Evans,S.L., Zhao,W., Frowde,K.,
            Alrehaili,A., Dickenson,R.E., Munk,M., Panina,S., Mahmood,I.F.,
            Llorian,M., Stanifer,M.L., Boulant,S., Berchtold,M.W.,
            Bergeron,J.R.C., Wack,A., Lesser,C.F. and Odendall,C.
  TITLE     A family of conserved bacterial virulence factors dampens
            interferon responses by blocking calcium signaling
  JOURNAL   Cell 185 (13), 2354-2369 (2022)
   PUBMED   35568036
  REMARK    FUNCTION, ACTIVITY REGULATION (MICROBIAL INFECTION), AND
            INTERACTION WITH S.FLEXNERI OSPC1 AND OSPC3 (MICROBIAL INFECTION).
REFERENCE   45 (residues 1 to 149)
  AUTHORS   Siedlecka,M., Goch,G., Ejchart,A., Sticht,H. and Bierzynski,A.
  TITLE     Alpha-helix nucleation by a calcium-binding peptide loop
  JOURNAL   Proc Natl Acad Sci U S A 96 (3), 903-908 (1999)
   PUBMED   9927666
  REMARK    STRUCTURE BY NMR OF 95-104.
REFERENCE   46 (residues 1 to 149)
  AUTHORS   Chou,J.J., Li,S., Klee,C.B. and Bax,A.
  TITLE     Solution structure of Ca(2+)-calmodulin reveals flexible hand-like
            properties of its domains
  JOURNAL   Nat Struct Biol 8 (11), 990-997 (2001)
   PUBMED   11685248
  REMARK    STRUCTURE BY NMR OF 1-77 AND 83-149.
REFERENCE   47 (residues 1 to 149)
  AUTHORS   Chattopadhyaya,R., Meador,W.E., Means,A.R. and Quiocho,F.A.
  TITLE     Calmodulin structure refined at 1.7 A resolution
  JOURNAL   J Mol Biol 228 (4), 1177-1192 (1992)
   PUBMED   1474585
  REMARK    X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH CALCIUM, AND
            CALCIUM-BINDING SITES.
REFERENCE   48 (residues 1 to 149)
  AUTHORS   Cook,W.J., Walter,L.J. and Walter,M.R.
  TITLE     Drug binding by calmodulin: crystal structure of a
            calmodulin-trifluoperazine complex
  JOURNAL   Biochemistry 33 (51), 15259-15265 (1994)
   PUBMED   7803388
  REMARK    X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS).
REFERENCE   49 (residues 1 to 149)
  AUTHORS   Drum,C.L., Yan,S.Z., Bard,J., Shen,Y.Q., Lu,D., Soelaiman,S.,
            Grabarek,Z., Bohm,A. and Tang,W.J.
  TITLE     Structural basis for the activation of anthrax adenylyl cyclase
            exotoxin by calmodulin
  JOURNAL   Nature 415 (6870), 396-402 (2002)
   PUBMED   11807546
  REMARK    X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 6-149.
REFERENCE   50 (residues 1 to 149)
  AUTHORS   Shen,Y., Lee,Y.S., Soelaiman,S., Bergson,P., Lu,D., Chen,A.,
            Beckingham,K., Grabarek,Z., Mrksich,M. and Tang,W.J.
  TITLE     Physiological calcium concentrations regulate calmodulin binding
            and catalysis of adenylyl cyclase exotoxins
  JOURNAL   EMBO J 21 (24), 6721-6732 (2002)
   PUBMED   12485993
  REMARK    X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 1-149 IN COMPLEX WITH
            ANTHRAX EDEMA FACTOR CYA.
REFERENCE   51 (residues 1 to 149)
  AUTHORS   Yamauchi,E., Nakatsu,T., Matsubara,M., Kato,H. and Taniguchi,H.
  TITLE     Crystal structure of a MARCKS peptide containing the
            calmodulin-binding domain in complex with Ca2+-calmodulin
  JOURNAL   Nat Struct Biol 10 (3), 226-231 (2003)
   PUBMED   12577052
  REMARK    X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH MARCKS.
REFERENCE   52 (residues 1 to 149)
  AUTHORS   Van Petegem,F., Chatelain,F.C. and Minor,D.L. Jr.
  TITLE     Insights into voltage-gated calcium channel regulation from the
            structure of the CaV1.2 IQ domain-Ca2+/calmodulin complex
  JOURNAL   Nat Struct Mol Biol 12 (12), 1108-1115 (2005)
   PUBMED   16299511
  REMARK    X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-150 IN COMPLEX WITH
            CACNA1C.
REFERENCE   53 (residues 1 to 149)
  AUTHORS   Shen,Y., Zhukovskaya,N.L., Guo,Q., Florian,J. and Tang,W.J.
  TITLE     Calcium-independent calmodulin binding and two-metal-ion catalytic
            mechanism of anthrax edema factor
  JOURNAL   EMBO J 24 (5), 929-941 (2005)
   PUBMED   15719022
  REMARK    X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) IN COMPLEX WITH ANTHRAX EDEMA
            FACTOR CYA.
REFERENCE   54 (residues 1 to 149)
  AUTHORS   Chagot,B. and Chazin,W.J.
  TITLE     Solution NMR structure of Apo-calmodulin in complex with the IQ
            motif of human cardiac sodium channel NaV1.5
  JOURNAL   J Mol Biol 406 (1), 106-119 (2011)
   PUBMED   21167176
  REMARK    STRUCTURE BY NMR IN COMPLEX WITH SCN5A.
REFERENCE   55 (residues 1 to 149)
  AUTHORS   Reichow,S.L., Clemens,D.M., Freites,J.A., Nemeth-Cahalan,K.L.,
            Heyden,M., Tobias,D.J., Hall,J.E. and Gonen,T.
  TITLE     Allosteric mechanism of water-channel gating by Ca2+-calmodulin
  JOURNAL   Nat Struct Mol Biol 20 (9), 1085-1092 (2013)
   PUBMED   23893133
  REMARK    STRUCTURE BY ELECTRON MICROSCOPY (25 ANGSTROMS) IN COMPLEX WITH
            MIP, FUNCTION, AND INTERACTION WITH MIP.
REFERENCE   56 (residues 1 to 149)
  AUTHORS   Sachyani,D., Dvir,M., Strulovich,R., Tria,G., Tobelaim,W.,
            Peretz,A., Pongs,O., Svergun,D., Attali,B. and Hirsch,J.A.
  TITLE     Structural basis of a Kv7.1 potassium channel gating module:
            studies of the intracellular c-terminal domain in complex with
            calmodulin
  JOURNAL   Structure 22 (11), 1582-1594 (2014)
   PUBMED   25441029
  REMARK    X-RAY CRYSTALLOGRAPHY (2.86 ANGSTROMS) IN COMPLEX WITH KCNQ1 AND
            CALCIUM, FUNCTION, INTERACTION WITH KCNQ1, AND DOMAIN.
REFERENCE   57 (residues 1 to 149)
  AUTHORS   Strulovich,R., Tobelaim,W.S., Attali,B. and Hirsch,J.A.
  TITLE     Structural Insights into the M-Channel Proximal
            C-Terminus/Calmodulin Complex
  JOURNAL   Biochemistry 55 (38), 5353-5365 (2016)
   PUBMED   27564677
  REMARK    X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH CALCIUM;
            KCNQ2 AND KCNQ3, INTERACTION WITH KCNQ2 AND KCNQ3, AND
            CALCIUM-BINDING SITES.
REFERENCE   58 (residues 1 to 149)
  AUTHORS   Wang,X. and Putkey,J.A.
  TITLE     PEP-19 modulates calcium binding to calmodulin by electrostatic
            steering
  JOURNAL   Nat Commun 7, 13583 (2016)
   PUBMED   27876793
  REMARK    STRUCTURE BY NMR OF 77-149 IN COMPLEX WITH PCP4, INTERACTION WITH
            PCP4, AND REGION.
            Publication Status: Online-Only
REFERENCE   59 (residues 1 to 149)
  AUTHORS   Gruschus,J.M., Yap,T.L., Pistolesi,S., Maltsev,A.S. and Lee,J.C.
  TITLE     NMR structure of calmodulin complexed to an N-terminally acetylated
            alpha-synuclein peptide
  JOURNAL   Biochemistry 52 (20), 3436-3445 (2013)
   PUBMED   23607618
  REMARK    STRUCTURE BY NMR, AND INTERACTION WITH ALPHA-SYNUCLEIN/SNCA.
REFERENCE   60 (residues 1 to 149)
  AUTHORS   Zhang,K., Peng,T., Tao,X., Tian,M., Li,Y., Wang,Z., Ma,S., Hu,S.,
            Pan,X., Xue,J., Luo,J., Wu,Q., Fu,Y. and Li,S.
  TITLE     Structural insights into caspase ADPR deacylization catalyzed by a
            bacterial effector and host calmodulin
  JOURNAL   Mol Cell 82 (24), 4712-4726 (2022)
   PUBMED   36423631
  REMARK    STRUCTURE BY ELECTRON MICROSCOPY (3.18 ANGSTROMS) IN COMPLEX WITH
            C.VIOLACEUM COPC AND CASP3, INTERACTION WITH C.VIOLACEUM COPC TOXIN
            (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL INFECTION).
REFERENCE   61 (residues 1 to 149)
  AUTHORS   Nyegaard,M., Overgaard,M.T., Sondergaard,M.T., Vranas,M.,
            Behr,E.R., Hildebrandt,L.L., Lund,J., Hedley,P.L., Camm,A.J.,
            Wettrell,G., Fosdal,I., Christiansen,M. and Borglum,A.D.
  TITLE     Mutations in calmodulin cause ventricular tachycardia and sudden
            cardiac death
  JOURNAL   Am J Hum Genet 91 (4), 703-712 (2012)
   PUBMED   23040497
  REMARK    INVOLVEMENT IN CPVT4, VARIANTS CPVT4 ILE-54 AND SER-98, AND
            CHARACTERIZATION OF VARIANTS CPVT4 ILE-54 AND SER-98.
REFERENCE   62 (residues 1 to 149)
  AUTHORS   Crotti,L., Johnson,C.N., Graf,E., De Ferrari,G.M., Cuneo,B.F.,
            Ovadia,M., Papagiannis,J., Feldkamp,M.D., Rathi,S.G., Kunic,J.D.,
            Pedrazzini,M., Wieland,T., Lichtner,P., Beckmann,B.M., Clark,T.,
            Shaffer,C., Benson,D.W., Kaab,S., Meitinger,T., Strom,T.M.,
            Chazin,W.J., Schwartz,P.J. and George,A.L. Jr.
  TITLE     Calmodulin mutations associated with recurrent cardiac arrest in
            infants
  JOURNAL   Circulation 127 (9), 1009-1017 (2013)
   PUBMED   23388215
  REMARK    INVOLVEMENT IN LQT14, VARIANTS LQT14 GLY-130 AND LEU-142, AND
            CHARACTERIZATION OF VARIANTS LQT14 GLY-130 AND LEU-142.
REFERENCE   63 (residues 1 to 149)
  AUTHORS   Nomikos,M., Thanassoulas,A., Beck,K., Vassilakopoulou,V., Hu,H.,
            Calver,B.L., Theodoridou,M., Kashir,J., Blayney,L., Livaniou,E.,
            Rizkallah,P., Nounesis,G. and Lai,F.A.
  TITLE     Altered RyR2 regulation by the calmodulin F90L mutation associated
            with idiopathic ventricular fibrillation and early sudden cardiac
            death
  JOURNAL   FEBS Lett 588 (17), 2898-2902 (2014)
   PUBMED   25036739
  REMARK    CHARACTERIZATION OF VARIANT LQT14 LEU-90.
REFERENCE   64 (residues 1 to 149)
  AUTHORS   Marsman,R.F., Barc,J., Beekman,L., Alders,M., Dooijes,D., van den
            Wijngaard,A., Ratbi,I., Sefiani,A., Bhuiyan,Z.A., Wilde,A.A. and
            Bezzina,C.R.
  TITLE     A mutation in CALM1 encoding calmodulin in familial idiopathic
            ventricular fibrillation in childhood and adolescence
  JOURNAL   J Am Coll Cardiol 63 (3), 259-266 (2014)
   PUBMED   24076290
  REMARK    INVOLVEMENT IN LQT14, AND VARIANT LQT14 LEU-90.
REFERENCE   65 (residues 1 to 149)
  AUTHORS   Vassilakopoulou,V., Calver,B.L., Thanassoulas,A., Beck,K., Hu,H.,
            Buntwal,L., Smith,A., Theodoridou,M., Kashir,J., Blayney,L.,
            Livaniou,E., Nounesis,G., Lai,F.A. and Nomikos,M.
  TITLE     Distinctive malfunctions of calmodulin mutations associated with
            heart RyR2-mediated arrhythmic disease
  JOURNAL   Biochim Biophys Acta 1850 (11), 2168-2176 (2015)
   PUBMED   26164367
  REMARK    VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS
            CPVT4 ILE-54 AND SER-98, VARIANTS LQT14 GLY-130 AND LEU-142,
            CHARACTERIZATION OF VARIANTS LQT14 GLY-130 AND LEU-142, AND
            INTERACTION WITH RYR2.
REFERENCE   66 (residues 1 to 149)
  AUTHORS   Gomez-Hurtado,N., Boczek,N.J., Kryshtal,D.O., Johnson,C.N., Sun,J.,
            Nitu,F.R., Cornea,R.L., Chazin,W.J., Calvert,M.L., Tester,D.J.,
            Ackerman,M.J. and Knollmann,B.C.
  TITLE     Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V)
            Activates Arrhythmogenic Ca Waves and Sparks
  JOURNAL   Circ Arrhythm Electrophysiol 9 (8) (2016) In press
   PUBMED   27516456
  REMARK    VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS
            CPVT4 ILE-54; SER-98, AND INTERACTION WITH RYR2.
REFERENCE   67 (residues 1 to 149)
  AUTHORS   Boczek,N.J., Gomez-Hurtado,N., Ye,D., Calvert,M.L., Tester,D.J.,
            Kryshtal,D., Hwang,H.S., Johnson,C.N., Chazin,W.J., Loporcaro,C.G.,
            Shah,M., Papez,A.L., Lau,Y.R., Kanter,R., Knollmann,B.C. and
            Ackerman,M.J.
  TITLE     Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded
            Calmodulin Variants in Long QT Syndrome and Functional
            Characterization of a Novel Long QT Syndrome-Associated Calmodulin
            Missense Variant, E141G
  JOURNAL   Circ Cardiovasc Genet 9 (2), 136-146 (2016)
   PUBMED   26969752
  REMARK    VARIANTS LQT14 GLY-141 AND LEU-142, CHARACTERIZATION OF VARIANT
            LQT14 GLY-141, AND FUNCTION.
REFERENCE   68 (residues 1 to 149)
  AUTHORS   Yu,C.C., Ko,J.S., Ai,T., Tsai,W.C., Chen,Z., Rubart,M., Vatta,M.,
            Everett,T.H. IV, George,A.L. Jr. and Chen,P.S.
  TITLE     Arrhythmogenic calmodulin mutations impede activation of
            small-conductance calcium-activated potassium current
  JOURNAL   Heart Rhythm 13 (8), 1716-1723 (2016)
   PUBMED   27165696
  REMARK    VARIANTS CPVT4 ILE-54 AND SER-98, CHARACTERIZATION OF VARIANTS
            CPVT4 ILE-54 AND SER-98, VARIANTS LQT14 LEU-90 AND GLY-130,
            CHARACTERIZATION OF VARIANTS LQT14 LEU-90 AND GLY-130, AND
            FUNCTION.
REFERENCE   69 (residues 1 to 149)
  AUTHORS   Rocchetti,M., Sala,L., Dreizehnter,L., Crotti,L., Sinnecker,D.,
            Mura,M., Pane,L.S., Altomare,C., Torre,E., Mostacciuolo,G.,
            Severi,S., Porta,A., De Ferrari,G.M., George,A.L. Jr.,
            Schwartz,P.J., Gnecchi,M., Moretti,A. and Zaza,A.
  TITLE     Elucidating arrhythmogenic mechanisms of long-QT syndrome
            CALM1-F142L mutation in patient-specific induced pluripotent stem
            cell-derived cardiomyocytes
  JOURNAL   Cardiovasc Res 113 (5), 531-541 (2017)
   PUBMED   28158429
  REMARK    CHARACTERIZATION OF VARIANT LQT14 LEU-142.
REFERENCE   70 (residues 1 to 149)
  AUTHORS   Wren,L.M., Jimenez-Jaimez,J., Al-Ghamdi,S., Al-Aama,J.Y., Bdeir,A.,
            Al-Hassnan,Z.N., Kuan,J.L., Foo,R.Y., Potet,F., Johnson,C.N.,
            Aziz,M.C., Carvill,G.L., Kaski,J.P., Crotti,L., Perin,F.,
            Monserrat,L., Burridge,P.W., Schwartz,P.J., Chazin,W.J.,
            Bhuiyan,Z.A. and George,A.L. Jr.
  TITLE     Genetic Mosaicism in Calmodulinopathy
  JOURNAL   Circ Genom Precis Med 12 (9), 375-385 (2019)
   PUBMED   31454269
  REMARK    VARIANT LQT14 VAL-141, CHARACTERIZATION OF VARIANT LQT14 VAL-141,
            AND FUNCTION.
COMMENT     On May 12, 2017 this sequence version replaced P62158.2.
            [FUNCTION] Calmodulin acts as part of a calcium signal transduction
            pathway by mediating the control of a large number of enzymes, ion
            channels, aquaporins and other proteins through calcium-binding
            (PubMed:16760425, PubMed:23893133, PubMed:26969752,
            PubMed:27165696, PubMed:28890335, PubMed:31454269,
            PubMed:35568036). Calcium-binding is required for the activation of
            calmodulin (PubMed:16760425, PubMed:23893133, PubMed:26969752,
            PubMed:27165696, PubMed:28890335, PubMed:31454269,
            PubMed:35568036). Among the enzymes to be stimulated by the
            calmodulin-calcium complex are a number of protein kinases, such as
            myosin light-chain kinases and calmodulin-dependent protein kinase
            type II (CaMK2), and phosphatases (PubMed:16760425,
            PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335,
            PubMed:31454269, PubMed:35568036). Together with CCP110 and
            centrin, is involved in a genetic pathway that regulates the
            centrosome cycle and progression through cytokinesis
            (PubMed:16760425). Is a regulator of voltage-dependent L-type
            calcium channels (PubMed:31454269). Mediates calcium-dependent
            inactivation of CACNA1C (PubMed:26969752). Positively regulates
            calcium-activated potassium channel activity of KCNN2
            (PubMed:27165696). Forms a potassium channel complex with KCNQ1 and
            regulates electrophysiological activity of the channel via
            calcium-binding (PubMed:25441029). Acts as a sensor to modulate the
            endoplasmic reticulum contacts with other organelles mediated by
            VMP1:ATP2A2 (PubMed:28890335). {ECO:0000269|PubMed:16760425,
            ECO:0000269|PubMed:23893133, ECO:0000269|PubMed:25441029,
            ECO:0000269|PubMed:26969752, ECO:0000269|PubMed:27165696,
            ECO:0000269|PubMed:28890335, ECO:0000269|PubMed:31454269,
            ECO:0000269|PubMed:35568036}.
            [FUNCTION] (Microbial infection) Required for Legionella
            pneumophila SidJ glutamylase activity.
            {ECO:0000269|PubMed:31330532}.
            [FUNCTION] (Microbial infection) Required for C.violaceum CopC
            arginine ADP-riboxanase activity. {ECO:0000269|PubMed:35338844,
            ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36423631}.
            ACTIVITY REGULATION: (Microbial infection) Inactivated by
            S.flexneri OspC1 and OspC3 proteins, which specifically bind the
            apo-form of calmodulin, thereby preventing calcium-binding and
            activity. {ECO:0000269|PubMed:35568036}.
            [SUBUNIT] Interacts with MYO1C, MYO5A and RRAD. Interacts with
            MYO10 (By similarity). Interacts with CEP97, CCP110, TTN/titin and
            SRY (PubMed:9804419, PubMed:12871148, PubMed:15746192,
            PubMed:16760425, PubMed:17719545). Interacts with USP6; the
            interaction is calcium dependent (PubMed:16127172). Interacts with
            CDK5RAP2 (PubMed:20466722). Interacts with SCN5A (PubMed:21167176).
            Interacts with RYR1 (PubMed:18650434). Interacts with FCHO1
            (PubMed:22484487). Interacts with MIP in a 1:2 stoichiometry; the
            interaction with the cytoplasmic domains from two MIP subunits
            promotes MIP water channel closure (PubMed:23893133). Interacts
            with ORAI1; this may play a role in the regulation of
            ORAI1-mediated calcium transport (By similarity). Interacts with
            IQCF1 (By similarity). Interacts with SYT7 (By similarity).
            Interacts with CEACAM1 (via cytoplasmic domain); this interaction
            is in a calcium dependent manner and reduces homophilic cell
            adhesion through dissociation of dimer (By similarity). Interacts
            with RYR2; regulates RYR2 calcium-release channel activity
            (PubMed:27516456, PubMed:18650434, PubMed:26164367). Interacts with
            PCP4; regulates calmodulin calcium-binding (PubMed:27876793).
            Interacts with the heterotetrameric KCNQ2 and KCNQ3 channel; the
            interaction is calcium-independent, constitutive and participates
            in the proper assembly of a functional heterotetrameric M channel
            (PubMed:27564677). Interacts with alpha-synuclein/SNCA
            (PubMed:23607618). Interacts with SLC9A1 in a calcium-dependent
            manner (PubMed:30287853). In the absence of Ca(+2), interacts with
            GIMAP4 (via IQ domain) (By similarity). Interacts with SCN8A; the
            interaction modulates the inactivation rate of SCN8A (By
            similarity). Interaction with KIF1A; the interaction is increased
            in presence of calcium and increases neuronal dense core vesicles
            motility (PubMed:30021165). Interacts with KCNN3 (PubMed:31155282).
            Interacts with KCNQ1 (via C-terminus); forms a heterooctameric
            structure (with 4:4 KCNQ1:CALM stoichiometry) in a
            calcium-independent manner (PubMed:18165683, PubMed:25441029).
            Interacts with PIK3C3; the interaction modulates PIK3C3 kinase
            activity (PubMed:28890335). Interacts with HINT1; interaction
            increases in the presence of calcium ions (By similarity).
            Interacts with HINT3 (By similarity). Interacts with GARIN2; in
            mature sperm flagella (By similarity). Interacts with IQUB (By
            similarity). Interacts with SLC26A5 (via STAS domain); this
            interaction is calcium-dependent and the STAS domain interacts with
            only one lobe of CALM which is an elongated conformation
            (PubMed:33667636). {ECO:0000250|UniProtKB:P0DP26,
            ECO:0000250|UniProtKB:P62157, ECO:0000250|UniProtKB:P62161,
            ECO:0000250|UniProtKB:P62204, ECO:0000269|PubMed:12485993,
            ECO:0000269|PubMed:12577052, ECO:0000269|PubMed:12871148,
            ECO:0000269|PubMed:15719022, ECO:0000269|PubMed:15746192,
            ECO:0000269|PubMed:16127172, ECO:0000269|PubMed:16299511,
            ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17719545,
            ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:18650434,
            ECO:0000269|PubMed:20466722, ECO:0000269|PubMed:21167176,
            ECO:0000269|PubMed:22484487, ECO:0000269|PubMed:23109337,
            ECO:0000269|PubMed:23607618, ECO:0000269|PubMed:23893133,
            ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:26164367,
            ECO:0000269|PubMed:27516456, ECO:0000269|PubMed:27564677,
            ECO:0000269|PubMed:27876793, ECO:0000269|PubMed:28890335,
            ECO:0000269|PubMed:30021165, ECO:0000269|PubMed:30287853,
            ECO:0000269|PubMed:31155282, ECO:0000269|PubMed:33667636,
            ECO:0000269|PubMed:9804419}.
            [SUBUNIT] (Microbial infection) Interacts with Rubella virus
            protease/methyltransferase p150. {ECO:0000269|PubMed:20086014}.
            [SUBUNIT] (Microbial infection) Interacts with Legionella
            pneumophila glutamylase SidJ. {ECO:0000269|PubMed:31330532}.
            [SUBUNIT] (Microbial infection) Interacts with C.violaceum CopC
            (PubMed:35446120, PubMed:35338844, PubMed:36423631). C.violaceum
            CopC interacts specifically with the apo form of calmodulin
            (PubMed:35446120, PubMed:36423631). {ECO:0000269|PubMed:35338844,
            ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36423631}.
            [SUBUNIT] (Microbial infection) Interacts with S.flexneri OspC1 and
            OspC3 (PubMed:35568036). S.flexneri OspC1 and OspC3 interact
            specifically with the apo form of calmodulin and prevents
            calcium-binding (PubMed:35568036). {ECO:0000269|PubMed:35568036}.
            [INTERACTION] P0DP23; O75874: IDH1; NbExp=7; IntAct=EBI-25817233,
            EBI-715695.
            [SUBCELLULAR LOCATION] Cytoplasm, cytoskeleton, spindle
            {ECO:0000269|PubMed:16760425}. Cytoplasm, cytoskeleton, spindle
            pole {ECO:0000269|PubMed:16760425}. Cytoplasm, cytoskeleton,
            microtubule organizing center, centrosome
            {ECO:0000269|PubMed:14654843}. Cell projection, cilium, flagellum
            {ECO:0000250|UniProtKB:P0DP26}. Note=Distributed throughout the
            cell during interphase, but during mitosis becomes dramatically
            localized to the spindle poles and the spindle microtubules.
            [DOMAIN] The N-terminal and C-terminal lobes of CALM bind to the
            C-terminus of KCNQ1 in a clamp-like conformation. Binding of CALM
            C-terminus to KCNQ1 is calcium-independent but is essential for
            assembly of the structure. Binding of CALM N-terminus to KCNQ1 is
            calcium-dependent and regulates electrophysiological activity of
            the channel. {ECO:0000269|PubMed:25441029}.
            [PTM] Ubiquitination results in a strongly decreased activity.
            {ECO:0000250}.
            [PTM] Phosphorylation results in a decreased activity.
            {ECO:0000250}.
            [DISEASE] Ventricular tachycardia, catecholaminergic polymorphic, 4
            (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by
            stress-induced, bidirectional ventricular tachycardia that may
            degenerate into cardiac arrest and cause sudden death. Patients
            present with recurrent syncope, seizures, or sudden death after
            physical activity or emotional stress. CPVT4 inheritance is
            autosomal dominant. {ECO:0000269|PubMed:23040497,
            ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696,
            ECO:0000269|PubMed:27516456}. Note=The disease is caused by
            variants affecting the gene represented in this entry. Mutations in
            CALM1 are the cause of CPVT4.
            [DISEASE] Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long
            QT syndrome, a heart disorder characterized by a prolonged QT
            interval on the ECG and polymorphic ventricular arrhythmias. They
            cause syncope and sudden death in response to exercise or emotional
            stress, and can present with a sentinel event of sudden cardiac
            death in infancy. {ECO:0000269|PubMed:23388215,
            ECO:0000269|PubMed:24076290, ECO:0000269|PubMed:25036739,
            ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752,
            ECO:0000269|PubMed:27165696, ECO:0000269|PubMed:28158429,
            ECO:0000269|PubMed:31454269}. Note=The disease is caused by
            variants affecting the gene represented in this entry.
            [MISCELLANEOUS] This protein has four functional calcium-binding
            sites. {ECO:0000269|PubMed:1474585, ECO:0000269|PubMed:27564677}.
            [SIMILARITY] Belongs to the calmodulin family. {ECO:0000305}.
            [WEB RESOURCE] Name=Protein Spotlight; Note=A question of length -
            Issue 105 of May 2009;
            URL='https://web.expasy.org/spotlight/back_issues/105'.
FEATURES             Location/Qualifiers
     source          1..149
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     gene            1..149
                     /gene="CALM1"
                     /gene_synonym="CALM"
                     /gene_synonym="CAM"
                     /gene_synonym="CAM1"
     Protein         1..149
                     /product="Calmodulin-1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..149
                     /region_name="PTZ00184"
                     /note="calmodulin; Provisional"
                     /db_xref="CDD:185504"
     Region          2..149
                     /region_name="Mature chain"
                     /note="Calmodulin-1. /id=PRO_0000439932."
     Region          2..4
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Site            2
                     /site_type="acetylation"
                     /note="N-acetylalanine.
                     /evidence=ECO:0000269|PubMed:7093203, ECO:0000269|Ref.7,
                     ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
                     ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712."
     Region          7..20
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          8..43
                     /region_name="Domain"
                     /note="EF-hand 1.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00448."
     Region          21..23
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2M0J."
     Bond            bond(22)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO2); alternate.
                     /evidence=ECO:0007744|PubMed:28112733."
     Bond            bond(22)
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in ubiquitin); alternate.
                     /evidence=ECO:0000250|UniProtKB:P62157."
     Site            22
                     /site_type="acetylation"
                     /note="N6-acetyllysine; alternate.
                     /evidence=ECO:0007744|PubMed:19608861."
     Region          25..28
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          30..39
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          44..79
                     /region_name="Domain"
                     /note="EF-hand 2.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00448."
     Site            45
                     /site_type="phosphorylation"
                     /note="Phosphothreonine; by CaMK4.
                     /evidence=ECO:0000250|UniProtKB:P0DP29."
     Region          46..56
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          54
                     /region_name="Variant"
                     /note="N -> I (in CPVT4; increased RYR2 calcium-release
                     channel activity; not changed calcium-dependent
                     inactivation of L-type calcium channel; not changed
                     protein abundance; not changed structure; not changed
                     thermal stability both in the absence and presence of
                     calcium; no effect on the calcium binding affinity;
                     significantly increased binding of RYR2; increased
                     ryanodine-sensitive calcium-release channel activity;
                     decreased of KCNN2 calcium-activated potassium channel
                     activity; not changed KCNN2 expression; not changed KCNN2
                     location at membrane; dbSNP:rs267607276).
                     /evidence=ECO:0000269|PubMed:23040497,
                     ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696,
                     ECO:0000269|PubMed:27516456. /id=VAR_069222."
     Region          57..59
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4LZX."
     Region          61..65
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          66..93
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          77..149
                     /region_name="Region of interest in the sequence"
                     /note="Necessary and sufficient for interaction with PCP4.
                     /evidence=ECO:0000269|PubMed:27876793."
     Region          81..116
                     /region_name="Domain"
                     /note="EF-hand 3.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00448."
     Site            82
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163."
     Region          90
                     /region_name="Variant"
                     /note="F -> L (in LQT14; significantly decreased of KCNN2
                     calcium-activated potassium channel activity; not changed
                     KCNN2 expression; not changed KCNN2 location at membrane;
                     decreased thermal stability in presence of calcium ions;
                     decreased interaction with RYR2; dbSNP:rs730882253).
                     /evidence=ECO:0000269|PubMed:24076290,
                     ECO:0000269|PubMed:25036739, ECO:0000269|PubMed:27165696.
                     /id=VAR_073275."
     Region          94..96
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1WRZ."
     Site            95
                     /site_type="acetylation"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0007744|PubMed:19608861."
     Region          97..101
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          98
                     /region_name="Variant"
                     /note="N -> S (in CPVT4; the mutant has significantly
                     reduced calcium affinity compared to wild-type;
                     calmodulin-RYR2 interaction is defective at low
                     intracellular Ca(2+) concentrations and restored at
                     moderate to high Ca(2+) concentrations; increased RYR2
                     calcium-release channel activity; decreased KCNN2
                     calcium-activated potassium channel activity; not changed
                     KCNN2 expression; not changed KCNN2 location at membrane;
                     dbSNP:rs267607277). /evidence=ECO:0000269|PubMed:23040497,
                     ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696,
                     ECO:0000269|PubMed:27516456. /id=VAR_078541."
     Site            100
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine.
                     /evidence=ECO:0007744|PubMed:18669648,
                     ECO:0007744|PubMed:19690332."
     Site            102
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:21406692,
                     ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569."
     Region          103..112
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Site            111
                     /site_type="phosphorylation"
                     /note="Phosphothreonine.
                     /evidence=ECO:0007744|PubMed:24275569."
     Region          113..115
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4LZX."
     Site            116
                     /site_type="methylation"
                     /note="N6,N6,N6-trimethyllysine; alternate.
                     /evidence=ECO:0000269|PubMed:7093203,
                     ECO:0007744|PubMed:24129315."
     Site            116
                     /site_type="methylation"
                     /note="N6-methyllysine; alternate.
                     /evidence=ECO:0007744|PubMed:24129315."
     Region          117..149
                     /region_name="Domain"
                     /note="EF-hand 4.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00448."
     Region          119..129
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          130..132
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:4DCK."
     Region          130
                     /region_name="Variant"
                     /note="D -> G (in LQT14; reduction in calcium affinity;
                     not changed protein abundance; not changed structure;
                     significantly decreased thermal stability in presence of
                     calcium; significantly decreased RYR2 interaction;
                     increased ryanodine-sensitive calcium-release channel
                     activity; decreased of KCNN2 calcium-activated potassium
                     channel activity; not changed KCNN2 expression; not
                     changed KCNN2 location at membrane; dbSNP:rs730882252).
                     /evidence=ECO:0000269|PubMed:23388215,
                     ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:27165696.
                     /id=VAR_078542."
     Region          133..138
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Region          139..146
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:4DJC."
     Site            139
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine.
                     /evidence=ECO:0007744|PubMed:19690332."
     Region          141
                     /region_name="Variant"
                     /note="E -> G (in LQT14; decreased calcium affinity; loss
                     of CACNA1C calcium-dependent-inactivation; no effect on
                     intracellular RYR2-mediated calcium release).
                     /evidence=ECO:0000269|PubMed:26969752. /id=VAR_078263."
     Region          141
                     /region_name="Variant"
                     /note="E -> V (in LQT14; loss-of-function variant causing
                     impaired negative regulation of high voltage-gated calcium
                     channel activity; impaired regulation of cardiac muscle
                     cell action potential; decreased calcium ion binding).
                     /evidence=ECO:0000269|PubMed:31454269. /id=VAR_083814."
     Region          142
                     /region_name="Variant"
                     /note="F -> L (in LQT14; reduction in calcium affinity;
                     not changed protein abundance; not changed structure;
                     significantly decreased thermal stability in presence of
                     calcium; no effect on RYR2 interaction; significantly
                     reduced ryanodine-sensitive calcium-release channel
                     activity; impaired negative regulation of high
                     voltage-gated calcium channel activity; impaired
                     regulation of cardiac muscle cell action potential;
                     dbSNP:rs1085307479 and dbSNP:rs199744595).
                     /evidence=ECO:0000269|PubMed:23388215,
                     ECO:0000269|PubMed:26164367, ECO:0000269|PubMed:26969752,
                     ECO:0000269|PubMed:28158429. /id=VAR_073282."
ORIGIN      
        1 madqlteeqi aefkeafslf dkdgdgtitt kelgtvmrsl gqnpteaelq dminevdadg
       61 ngtidfpefl tmmarkmkdt dseeeireaf rvfdkdgngy isaaelrhvm tnlgekltde
      121 evdemiread idgdgqvnye efvqmmtak
//

LOCUS       CT5A_CONSP                59 aa            linear   INV 28-JUN-2023
DEFINITION  RecName: Full=Mu-conotoxin SrVA; AltName: Full=Conotoxin sr5a;
            AltName: Full=Sr5.1; AltName: Full=Sr5.2; AltName: Full=Sr5.3;
            Flags: Precursor.
ACCESSION   P84845
VERSION     P84845.2
DBSOURCE    UniProtKB: locus CT5A_CONSP, accession P84845;
            class: standard.
            extra accessions:C0KYC0,C0KYC1,C0KYC2
            created: May 16, 2006.
            sequence updated: Mar 23, 2010.
            annotation updated: Jun 28, 2023.
            xrefs: FJ646602.1, ACN22840.1, FJ646603.1, ACN22841.1, FJ646604.1,
            ACN22842.1
            xrefs (non-sequence databases): AlphaFoldDB:P84845,
            ConoServer:1618, ConoServer:3699, ConoServer:3700, ConoServer:3782,
            GO:0005576, GO:0017080, GO:0090729, GO:0035821, InterPro:IPR031565,
            Pfam:PF16981
KEYWORDS    Alternative splicing; Cleavage on pair of basic residues; Direct
            protein sequencing; Disulfide bond; Ion channel impairing toxin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Conus spurius
  ORGANISM  Conus spurius
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Lindaconus.
REFERENCE   1  (residues 1 to 59)
  AUTHORS   Zamora-Bustillos,R., Aguilar,M.B., Falcon,A. and Heimer de la
            Cotera,E.P.
  TITLE     Identification, by RT-PCR, of four novel T-1-superfamily conotoxins
            from the vermivorous snail Conus spurius from the Gulf of Mexico
  JOURNAL   Peptides 30 (8), 1396-1404 (2009)
   PUBMED   19447151
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SR5A AND SR5.2).;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 59)
  AUTHORS   Aguilar,M.B., Lezama-Monfil,L., Maillo,M., Pedraza-Lara,H.,
            Lopez-Vera,E. and Heimer de la Cotera,E.P.
  TITLE     A biologically active hydrophobic T-1-conotoxin from the venom of
            Conus spurius
  JOURNAL   Peptides 27 (3), 500-505 (2006)
   PUBMED   16297502
  REMARK    PROTEIN SEQUENCE OF 47-59, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND DISULFIDE BONDS.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 59)
  AUTHORS   Ruelas-Callejas,A., Aguilar,M.B., Arteaga-Tlecuitl,R., Gomora,J.C.
            and Lopez-Vera,E.
  TITLE     The T-1 conotoxin mu-SrVA from the worm hunting marine snail Conus
            spurius preferentially blocks the human NaV1.5 channel
  JOURNAL   Peptides 156, 170859 (2022)
   PUBMED   35940316
  REMARK    FUNCTION, AND SYNTHESIS OF 47-59.
COMMENT     On Mar 30, 2010 this sequence version replaced P84845.1.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels
            (PubMed:35940316). This peptide inhibits the cardiac sodium channel
            hNav1.5/SCN5A (33% inhibition at 200 nM, 50% at 400 nM, and 55% at
            600 nM) (PubMed:35940316). Does not interfere with the
            voltage-dependence of activation, but affects the
            voltage-dependence of inactivation of hNav1.5 (PubMed:35940316). In
            vivo, intracranial injection into 9-day-old mice causes transient
            symptoms, including extension of the body and clockwise and
            counter-clockwise turns, that last 3 to 4 minutes
            (PubMed:16297502). Intracranial injection into 16-day-old mice,
            causes transient symptoms, including agitated breathing and
            occasional turning followed by scratching and grooming behavior,
            that last for 15-19 minutes (PubMed:16297502).
            {ECO:0000269|PubMed:16297502, ECO:0000269|PubMed:35940316}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:16297502}.
            [ALTERNATIVE PRODUCTS] Event=Alternative splicing; Named
            isoforms=2; Name=sr5a; Synonyms=Sr5.1; IsoId=P84845-1;
            Sequence=Displayed; Name=Sr5.2; IsoId=P84845-2;
            Sequence=VSP_038848.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:16297502}.
            [DOMAIN] The cysteine framework is V (CC-CC). {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=1616.6; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:16297502}.
            [MASS SPECTROMETRY] Mass=1616.42; Method=MALDI;
            Evidence={ECO:0000269|PubMed:16297502}.
            [MISCELLANEOUS] Negative results: shows very weak inhibition of
            neuronal sodium channels rNav1.6/SCN8A (14% inhibition at 200 nM),
            and rNav1.7/SCN9A (7%). {ECO:0000269|PubMed:35940316}.
            [SIMILARITY] Belongs to the conotoxin T superfamily.
            {ECO:0000269|PubMed:16297502}.
FEATURES             Location/Qualifiers
     source          1..59
                     /organism="Conus spurius"
                     /db_xref="taxon:192919"
     Protein         1..59
                     /product="Mu-conotoxin SrVA"
                     /note="Conotoxin sr5a; Sr5.1; Sr5.2; Sr5.3"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..59
                     /region_name="Chi-conotoxin"
                     /note="chi-Conotoxin or t superfamily; pfam16981"
                     /db_xref="CDD:293586"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          7
                     /region_name="Variant"
                     /note="F -> L (in Sr5.3)."
     Region          22..36
                     /region_name="Splicing variant"
                     /note="Missing (in isoform Sr5.2).
                     /evidence=ECO:0000303|PubMed:19447151. /id=VSP_038848."
     Region          23..44
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305. /id=PRO_0000392714."
     Region          47..59
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin SrVA.
                     /evidence=ECO:0000269|PubMed:16297502.
                     /id=PRO_0000235846."
     Bond            bond(51,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:16297502."
     Bond            bond(52,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:16297502."
ORIGIN      
        1 mrclpvfvil llliasapsv daqlktkddv plasfhdnak gtqhkriinw cclifyqcc
//

LOCUS       BDS1_ANESU                43 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Delta/kappa-actitoxin-Avd4a;
            Short=Delta/kappa-AITX-Avd4a; AltName: Full=Antihypertensive
            protein BDS-1; AltName: Full=Blood depressing substance I;
            Short=BDS-I.
ACCESSION   P11494
VERSION     P11494.1
DBSOURCE    UniProtKB: locus BDS1_ANESU, accession P11494;
            class: standard.
            created: Oct 1, 1989.
            sequence updated: Oct 1, 1989.
            annotation updated: Feb 22, 2023.
            xrefs: A33041, 1BDS_A, 2BDS_A
            xrefs (non-sequence databases): PDBsum:1BDS, PDBsum:2BDS,
            AlphaFoldDB:P11494, BMRB:P11494, SMR:P11494, TCDB:8.B.11.1.3,
            EvolutionaryTrace:P11494, GO:0005576, GO:0042151, GO:0008200,
            GO:0015459, GO:0017080, GO:0090729, GO:0008217, Gene3D:2.20.20.10,
            InterPro:IPR012414, InterPro:IPR023355, Pfam:PF07936,
            SUPFAM:SSF57392
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond;
            Hypotensive agent; Ion channel impairing toxin; Nematocyst;
            Neurotoxin; Potassium channel impairing toxin; Secreted; Toxin;
            Voltage-gated potassium channel impairing toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Anemonia sulcata (snake-locks sea anemone)
  ORGANISM  Anemonia sulcata
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Anemonia.
REFERENCE   1  (residues 1 to 43)
  AUTHORS   Beress,L., Doppelfeld,I.-S., Etschenberg,E., Graf,E.,
            Henschen-Edman,A. and Zwick,J.
  TITLE     Polypeptides, process for their preparation, and their use as
            hypotensive active compounds
  JOURNAL   Patent: DE DE3324689 17-JAN-1985;
  REMARK    PROTEIN SEQUENCE, AND FUNCTION.
REFERENCE   2  (residues 1 to 43)
  AUTHORS   Diochot,S., Schweitz,H., Beress,L. and Lazdunski,M.
  TITLE     Sea anemone peptides with a specific blocking activity against the
            fast inactivating potassium channel Kv3.4
  JOURNAL   J Biol Chem 273 (12), 6744-6749 (1998)
   PUBMED   9506974
  REMARK    PROTEIN SEQUENCE, AND FUNCTION.
REFERENCE   3  (residues 1 to 43)
  AUTHORS   Yeung,S.Y., Thompson,D., Wang,Z., Fedida,D. and Robertson,B.
  TITLE     Modulation of Kv3 subfamily potassium currents by the sea anemone
            toxin BDS: significance for CNS and biophysical studies
  JOURNAL   J Neurosci 25 (38), 8735-8745 (2005)
   PUBMED   16177043
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 43)
  AUTHORS   Liu,P., Jo,S. and Bean,B.P.
  TITLE     Modulation of neuronal sodium channels by the sea anemone peptide
            BDS-I
  JOURNAL   J Neurophysiol 107 (11), 3155-3167 (2012)
   PUBMED   22442564
  REMARK    FUNCTION ON NAV1.7/SCN9A.
REFERENCE   5  (residues 1 to 43)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
REFERENCE   6  (residues 1 to 43)
  AUTHORS   Driscoll,P.C., Clore,G.M., Beress,L. and Gronenborn,A.M.
  TITLE     A proton nuclear magnetic resonance study of the antihypertensive
            and antiviral protein BDS-I from the sea anemone Anemonia sulcata:
            sequential and stereospecific resonance assignment and secondary
            structure
  JOURNAL   Biochemistry 28 (5), 2178-2187 (1989)
   PUBMED   2566325
  REMARK    STRUCTURE BY NMR, AND DISULFIDE BONDS.
REFERENCE   7  (residues 1 to 43)
  AUTHORS   Driscoll,P.C., Gronenborn,A.M., Beress,L. and Clore,G.M.
  TITLE     Determination of the three-dimensional solution structure of the
            antihypertensive and antiviral protein BDS-I from the sea anemone
            Anemonia sulcata: a study using nuclear magnetic resonance and
            hybrid distance geometry-dynamical simulated annealing
  JOURNAL   Biochemistry 28 (5), 2188-2198 (1989)
   PUBMED   2566326
  REMARK    STRUCTURE BY NMR, AND DISULFIDE BONDS.
COMMENT     On Jul 26, 2005 this sequence version replaced gi:419939.
            [FUNCTION] Acts as a gating modifier on both Kv and Nav ion
            channels, and also acts on blood pressure. Voltage-dependently
            inhibits voltage-gated potassium channels Kv3 (Kv3.1/KCNC1,
            Kv3.2/KCNC2 and Kv3.4/KCNC4) and slows inactivation of the
            voltage-gated sodium channel Nav1.7/SCN9A (PubMed:16177043,
            PubMed:22442564, PubMed:9506974). Inhibits all Kv3.1, Kv3.2 and
            Kv3.4 by about 50% when tested at a voltage of +40 mV (45%, 48% and
            56%, respectively). May act by binding residues in voltage-sensing
            domains S3b and S4 of Kv3 (PubMed:16177043). On sodium channel,
            tests have been done on human Nav1.7/SCN9A (expressed in HEK293
            cells) (EC(50)=3 nM) and rat SCG neurons that mostly carry Nav1.7
            channels (EC(50)=300 nM) (PubMed:22442564). This toxin also reduces
            blood pressure (Ref.1). {ECO:0000269|PubMed:16177043,
            ECO:0000269|PubMed:22442564, ECO:0000269|PubMed:9506974,
            ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [MISCELLANEOUS] Negative results: does not affect on Nav1.1/SCN1A
            and Nav1.6/SCN8A sodium channels (PubMed:22442564). It has little
            or no functional effect on cardiac muscle, as well as on skeletal
            muscle myotubes, suggesting lack of functional interaction with
            Nav1.4/SCN4A or Nav1.5/SCN5A (PubMed:9506974).
            {ECO:0000269|PubMed:22442564, ECO:0000269|PubMed:9506974}.
            [MISCELLANEOUS] This protein sequence is identical to BDS-1 from
            A.viridis (AC P0DMX6). {ECO:0000305}.
            [SIMILARITY] Belongs to the sea anemone type 3 (BDS) potassium
            channel toxin family. {ECO:0000305}.
            [CAUTION] Opinions are divided on whether Anemonia viridis
            (Forsskal, 1775) and Anemonia sulcata (Pennant, 1777) are separate
            species. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..43
                     /organism="Anemonia sulcata"
                     /db_xref="taxon:6108"
     Protein         1..43
                     /product="Delta/kappa-actitoxin-Avd4a"
                     /note="Delta/kappa-AITX-Avd4a; Antihypertensive protein
                     BDS-1; Blood depressing substance I; BDS-I"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..43
                     /region_name="Mature chain"
                     /note="Delta/kappa-actitoxin-Avd4a.
                     /evidence=ECO:0000269|PubMed:9506974, ECO:0000269|Ref.1.
                     /id=PRO_0000221541."
     Region          2..37
                     /region_name="Defensin_4"
                     /note="Potassium-channel blocking toxin; pfam07936"
                     /db_xref="CDD:254527"
     Bond            bond(4,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:2566326."
     Region          4..6
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2BDS."
     Bond            bond(6,32)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:2566326."
     Region          14..16
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1BDS."
     Region          18
                     /region_name="Variant"
                     /note="L -> F."
     Bond            bond(22,40)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:2566326."
     Region          31..34
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1BDS."
     Region          37..40
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1BDS."
ORIGIN      
        1 aapcfcsgkp grgdlwilrg tcpggygyts ncykwpnicc yph
//

LOCUS       SCAT_MESMA                85 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-toxin BmKAs1; Short=BmK AS-1; AltName: Full=BmK
            activator of skeletal-muscle ryanodine receptor; AltName:
            Full=Toxin BmP09; Flags: Precursor.
ACCESSION   Q9UAC8
VERSION     Q9UAC8.1
DBSOURCE    UniProtKB: locus SCAT_MESMA, accession Q9UAC8;
            class: standard.
            created: Dec 19, 2001.
            sequence updated: May 1, 2000.
            annotation updated: Feb 22, 2023.
            xrefs: AF079061.1, AAD47375.1
            xrefs (non-sequence databases): AlphaFoldDB:Q9UAC8, SMR:Q9UAC8,
            GO:0005576, GO:0015459, GO:0019871, GO:0090729, GO:0006952,
            CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Potassium channel impairing toxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 85)
  AUTHORS   Lan,Z.D., Dai,L., Zhuo,X.L., Feng,J.C., Xu,K. and Chi,C.W.
  TITLE     Gene cloning and sequencing of BmK AS and BmK AS-1, two novel
            neurotoxins from the scorpion Buthus martensi Karsch
  JOURNAL   Toxicon 37 (5), 815-823 (1999)
   PUBMED   10219991
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 85)
  AUTHORS   Ji,Y.H., Li,Y.J., Zhang,J.W., Song,B.L., Yamaki,T., Mochizuki,T.,
            Hoshino,M. and Yanaihara,N.
  TITLE     Covalent structures of BmK AS and BmK AS-1, two novel bioactive
            polypeptides purified from Chinese scorpion Buthus martensi Karsch
  JOURNAL   Toxicon 37 (3), 519-536 (1999)
   PUBMED   10080355
  REMARK    PROTEIN SEQUENCE OF 20-85, AND DISULFIDE BONDS.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 85)
  AUTHORS   Yao,J., Chen,X., Li,H., Zhou,Y., Yao,L., Wu,G., Chen,X., Zhang,N.,
            Zhou,Z., Xu,T., Wu,H. and Ding,J.
  TITLE     BmP09, a 'long chain' scorpion peptide blocker of BK channels
  JOURNAL   J Biol Chem 280 (15), 14819-14828 (2005)
   PUBMED   15695820
  REMARK    PROTEIN SEQUENCE OF 20-85, CHARACTERIZATION, MASS SPECTROMETRY, AND
            3D-STRUCTURE MODELING.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 85)
  AUTHORS   Jia,L.Y., Zhang,J.W. and Ji,Y.H.
  TITLE     Biosensor binding assay of BmK AS-1, a novel Na+ channel-blocking
            scorpion ligand on rat brain synaptosomes
  JOURNAL   Neuroreport 10 (16), 3359-3362 (1999)
   PUBMED   10599845
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 85)
  AUTHORS   Li,Y.J., Liu,Y. and Ji,Y.H.
  TITLE     BmK AS: new scorpion neurotoxin binds to distinct receptor sites of
            mammal and insect voltage-gated sodium channels
  JOURNAL   J Neurosci Res 61 (5), 541-548 (2000)
   PUBMED   10956424
  REMARK    FUNCTION.
REFERENCE   6  (residues 1 to 85)
  AUTHORS   Xiao,H., Mao,X., Tan,Z., Shi,Y., Zhao,Z. and Ji,Y.
  TITLE     Modulation of BmKAS-1 and BmK1-3-2 to sodium channel in rat dorsal
            root ganglion neurons
  JOURNAL   Chin Med J (Engl) 114 (3), 253-256 (2001)
   PUBMED   11780308
  REMARK    FUNCTION.
REFERENCE   7  (residues 1 to 85)
  AUTHORS   Wu,Y., Ji,Y.H. and Shi,Y.L.
  TITLE     Sodium current in NG108-15 cell inhibited by scorpion toxin BmKAS-1
            and restored by its specific monoclonal antibodies
  JOURNAL   J Nat Toxins 10 (3), 193-198 (2001)
   PUBMED   11491459
  REMARK    FUNCTION.
REFERENCE   8  (residues 1 to 85)
  AUTHORS   Tan,Z.Y., Mao,X., Xiao,H., Zhao,Z.Q. and Ji,Y.H.
  TITLE     Buthus martensi Karsch agonist of skeletal-muscle RyR-1, a scorpion
            active polypeptide: antinociceptive effect on rat peripheral
            nervous system and spinal cord, and inhibition of voltage-gated
            Na(+) currents in dorsal root ganglion neurons
  JOURNAL   Neurosci Lett 297 (2), 65-68 (2001)
   PUBMED   11121871
  REMARK    FUNCTION.
COMMENT     [FUNCTION] Beta toxins bind voltage-independently at site-4 of
            sodium channels (Nav) and shift the voltage of activation toward
            more negative potentials thereby affecting sodium channel
            activation and promoting spontaneous and repetitive firing. BmKAs1
            also significantly stimulates the binding of [3H]-ryanodine to
            ryanodine receptors on the sarcoplasmic reticulum of the skeletal
            muscle. It also displays antinociceptive effect in rat models.
            [FUNCTION] Toxin BmP09 (which may be post-translationally modified)
            specifically and reversibly blocks large conductance
            calcium-dependent and voltage-dependent potassium channels (BK) but
            has no effect on sodium channels.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [PTM] A possible sulfoxide Met-85 on BmP09 could explain the
            difference of function between BmK AS-1 and BmP09.
            [MASS SPECTROMETRY] Mass=7721; Method=Electrospray; Note=Toxin
            BmP09.; Evidence={ECO:0000269|PubMed:15695820}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..85
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..85
                     /product="Beta-toxin BmKAs1"
                     /note="BmK AS-1; BmK activator of skeletal-muscle
                     ryanodine receptor; Toxin BmP09"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000269|PubMed:10080355,
                     ECO:0000269|PubMed:15695820."
     Region          20..85
                     /region_name="Mature chain"
                     /note="Beta-toxin BmKAs1. /id=PRO_0000035263."
     Region          20..82
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          27..69
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(31,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:10080355."
     Bond            bond(35,56)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:10080355."
     Bond            bond(42,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:10080355."
     Bond            bond(46,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:10080355."
ORIGIN      
        1 mkiiiflivc sfvligvkad ngyllnkytg ckiwcvinne scnsecklrr gnygycyfwk
       61 lacycegapk selwayetnk cngkm
//

LOCUS       O16B_CONMR                82 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin MrVIB; AltName: Full=CGX-1002; Flags:
            Precursor.
ACCESSION   Q26443
VERSION     Q26443.1
DBSOURCE    UniProtKB: locus O16B_CONMR, accession Q26443;
            class: standard.
            created: May 30, 2000.
            sequence updated: Nov 1, 1996.
            annotation updated: Feb 22, 2023.
            xrefs: S78990.1, AAB34916.1, B58586, 1RMK_A
            xrefs (non-sequence databases): PDBsum:1RMK, AlphaFoldDB:Q26443,
            SMR:Q26443, ConoServer:597, EvolutionaryTrace:Q26443, GO:0005576,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950, SUPFAM:SSF57059
KEYWORDS    3D-structure; Cleavage on pair of basic residues; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Conus marmoreus
  ORGANISM  Conus marmoreus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Conus.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   McIntosh,J.M., Hasson,A., Spira,M.E., Gray,W.R., Li,W., Marsh,M.,
            Hillyard,D.R. and Olivera,B.M.
  TITLE     A new family of conotoxins that blocks voltage-gated sodium
            channels
  JOURNAL   J Biol Chem 270 (28), 16796-16802 (1995)
   PUBMED   7622492
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 52-82, MASS
            SPECTROMETRY, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Fainzilber,M., van der Schors,R., Lodder,J.C., Li,K.W.,
            Geraerts,W.P. and Kits,K.S.
  TITLE     New sodium channel-blocking conotoxins also affect calcium currents
            in Lymnaea neurons
  JOURNAL   Biochemistry 34 (16), 5364-5371 (1995)
   PUBMED   7727394
  REMARK    PROTEIN SEQUENCE OF 52-82, FUNCTION, MASS SPECTROMETRY, AND
            SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 82)
  AUTHORS   Daly,N.L., Ekberg,J.A., Thomas,L., Adams,D.J., Lewis,R.J. and
            Craik,D.J.
  TITLE     Structures of muO-conotoxins from Conus marmoreus. I nhibitors of
            tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in
            mammalian sensory neurons
  JOURNAL   J Biol Chem 279 (24), 25774-25782 (2004)
   PUBMED   15044438
  REMARK    STRUCTURE BY NMR OF 52-82, AND DISULFIDE BONDS.
REFERENCE   4  (residues 1 to 82)
  AUTHORS   Bulaj,G., Zhang,M.M., Green,B.R., Fiedler,B., Layer,R.T., Wei,S.,
            Nielsen,J.S., Low,S.J., Klein,B.D., Wagstaff,J.D., Chicoine,L.,
            Harty,T.P., Terlau,H., Yoshikami,D. and Olivera,B.M.
  TITLE     Synthetic muO-conotoxin MrVIB blocks TTX-resistant sodium channel
            NaV1.8 and has a long-lasting analgesic activity
  JOURNAL   Biochemistry 45 (23), 7404-7414 (2006)
   PUBMED   16752929
  REMARK    SYNTHESIS OF 52-82, AND FUNCTION.
REFERENCE   5  (residues 1 to 82)
  AUTHORS   Zorn,S., Leipold,E., Hansel,A., Bulaj,G., Olivera,B.M., Terlau,H.
            and Heinemann,S.H.
  TITLE     The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by
            associating with domain-3
  JOURNAL   FEBS Lett 580 (5), 1360-1364 (2006)
   PUBMED   16458302
  REMARK    SYNTHESIS OF 52-82, AND FUNCTION.
COMMENT     On Apr 26, 2005 this sequence version replaced gi:7438644.
            [FUNCTION] MuO-conotoxins are gating-modifier toxins that inhibit
            sodium current by trapping the domain II voltage sensor in the
            closed position to prevent opening of the sodium channel. This
            toxin has a preference for Nav1.4/SCN4A over Nav1.2/SCN2A sodium
            channels. It blocks Nav channels by interacting mainly with the
            C-terminal part of the pore loop of domain-3. It also blocks
            fast-inactivating calcium current. Blocks Nav1.8/SCN10A sodium
            channels and has potent and long-lasting local anesthetic effects.
            It can also block propagation of action potentials in A- and
            C-fibers in sciatic nerve as well as skeletal muscle in isolated
            preparations. {ECO:0000269|PubMed:16458302,
            ECO:0000269|PubMed:16752929}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:7622492,
            ECO:0000269|PubMed:7727394}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:7622492, ECO:0000305|PubMed:7727394}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:15044438}.
            [DOMAIN] The cysteine framework is VI/VII (C-C-CC-C-C).
            [MASS SPECTROMETRY] Mass=3404.8; Method=LSI;
            Evidence={ECO:0000269|PubMed:7622492}.
            [MASS SPECTROMETRY] Mass=3404.9; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:7727394}.
            [MISCELLANEOUS] This peptide was under preclinical trial by
            Cognetix Inc under the name CGX-1002 as a local anesthetic agent.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Conus marmoreus"
                     /db_xref="taxon:42752"
     Protein         1..82
                     /product="Mu-conotoxin MrVIB"
                     /note="CGX-1002"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..82
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:7622492,
                     ECO:0000269|PubMed:7727394. /id=PRO_0000034902."
     Region          52..82
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin MrVIB.
                     /evidence=ECO:0000269|PubMed:7622492,
                     ECO:0000269|PubMed:7727394. /id=PRO_0000034903."
     Bond            bond(53,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15044438,
                     ECO:0000312|PDB:1RMK."
     Bond            bond(60,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15044438,
                     ECO:0000312|PDB:1RMK."
     Region          69..71
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1RMK."
     Bond            bond(70,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15044438,
                     ECO:0000312|PDB:1RMK."
     Region          78..82
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1RMK."
ORIGIN      
        1 mkltcmmiva vlfltawtlv maddsnngla nhflksrdem edpeasklek racskkweyc
       61 ivpilgfvyc cpglicgpfv cv
//

LOCUS       1EYO_A                    30 aa            linear   SYN 28-FEB-2022
DEFINITION  Chain A, CONOTOXIN TVIIA.
ACCESSION   1EYO_A
VERSION     1EYO_A
DBSOURCE    pdb: molecule 1EYO, chain A, release Feb 16, 2022;
            deposition: May 7, 2000;
            class: TOXIN;
            source: Mmdb_id: 13977, Pdb_id 1: 1EYO;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      synthetic construct
  ORGANISM  synthetic construct
            other sequences; artificial sequences.
REFERENCE   1  (residues 1 to 30)
  AUTHORS   Hill,J.M., Alewood,P.F. and Craik,D.J.
  TITLE     Solution structure of the sodium channel antagonist conotoxin GS: a
            new molecular caliper for probing sodium channel geometry
  JOURNAL   Structure 5 (4), 571-583 (1997)
   PUBMED   9115446
REFERENCE   2  (residues 1 to 30)
  AUTHORS   Hill,J.M., Atkins,A.R., Loughnan,M.L., Jones,A., Adams,D.A.,
            Martin,R.C., Lewis,R.J., Craik,D.J. and Alewood,P.F.
  TITLE     Conotoxin TVIIA, a novel peptide from the venom of Conus tulipa 1.
            Isolation, characterization and chemical synthesis
  JOURNAL   Eur J Biochem 267 (15), 4642-4648 (2000)
   PUBMED   10903496
REFERENCE   3  (residues 1 to 30)
  AUTHORS   Hill,J.M., Alewood,P.F. and Craik,D.J.
  TITLE     Conotoxin TVIIA, a novel peptide from the venom of Conus tulipa 2.
            Three-dimensional solution structure
  JOURNAL   Eur J Biochem 267 (15), 4649-4657 (2000)
   PUBMED   10903497
REFERENCE   4  (residues 1 to 30)
  AUTHORS   Hill,J.M., Alewood,P.F. and Craik,D.J.
  TITLE     Direct Submission
  JOURNAL   Submitted (07-MAY-2000)
COMMENT     SOLUTION STRUCTURE OF CONOTOXIN TVIIA FROM CONUS TULIPA.
FEATURES             Location/Qualifiers
     source          1..30
                     /organism="synthetic construct"
                     /db_xref="taxon:32630"
     Bond            bond(2,14)
                     /bond_type="disulfide"
     SecStr          5..8
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(9,19)
                     /bond_type="disulfide"
     NonStdRes       10
                     /non_std_residue="HYP"
     NonStdRes       11
                     /non_std_residue="HYP"
     Bond            bond(13,24)
                     /bond_type="disulfide"
     SecStr          16..19
                     /sec_str_type="sheet"
                     /note="strand 2"
     SecStr          22..26
                     /sec_str_type="sheet"
                     /note="strand 3"
ORIGIN      
        1 scsgrdsrcx xvccmglmcs rgkcvsiyge
//

LOCUS       TX15_GRAPO                34 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Toxin GTx1-15; AltName:
            Full=Beta/omega-theraphotoxin-Gr2a; Short=Beta/omega-TRTX-Gr2a;
            AltName: Full=Toxin GpTx-1.
ACCESSION   P0DL72
VERSION     P0DL72.1
DBSOURCE    UniProtKB: locus TX15_GRAPO, accession P0DL72;
            class: standard.
            created: Oct 25, 2017.
            sequence updated: Oct 25, 2017.
            annotation updated: May 3, 2023.
            xrefs: 6MK5_A
            xrefs (non-sequence databases): PDBsum:6MK5, AlphaFoldDB:P0DL72,
            BMRB:P0DL72, SMR:P0DL72, GO:0005576, GO:0005246, GO:0008200,
            GO:0017080, GO:0090729, InterPro:IPR011696, InterPro:IPR013140,
            Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    3D-structure; Amidation; Calcium channel impairing toxin; Direct
            protein sequencing; Disulfide bond; Ion channel impairing toxin;
            Knottin; Secreted; Toxin; Voltage-gated calcium channel impairing
            toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Grammostola porteri
  ORGANISM  Grammostola porteri
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Grammostola.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Murray,J.K., Ligutti,J., Liu,D., Zou,A., Poppe,L., Li,H.,
            Andrews,K.L., Moyer,B.D., McDonough,S.I., Favreau,P., Stocklin,R.
            and Miranda,L.P.
  TITLE     Engineering potent and selective analogues of GpTx-1, a tarantula
            venom peptide antagonist of the Na(V)1.7 sodium channel
  JOURNAL   J Med Chem 58 (5), 2299-2314 (2015)
   PUBMED   25658507
  REMARK    PROTEIN SEQUENCE, FUNCTION, SYNTHESIS, STRUCTURE BY NMR,
            MUTAGENESIS OF ASP-1; LEU-3; GLY-4; PHE-5; MET-6; ARG-7; LYS-8;
            ILE-10; PRO-11; ASP-12; ASN-13; LYS-15; ARG-18; PRO-19; ASN-20;
            LEU-21; VAL-22; SER-24; ARG-25; THR-26; HIS-27; LYS-28; TRP-29;
            LYS-31; TYR-32; VAL-33 AND PHE-34, AMIDATION AT PHE-34, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 34)
  AUTHORS   Deuis,J.R., Wingerd,J.S., Winter,Z., Durek,T., Dekan,Z.,
            Sousa,S.R., Zimmermann,K., Hoffmann,T., Weidner,C., Nassar,M.A.,
            Alewood,P.F., Lewis,R.J. and Vetter,I.
  TITLE     Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse
            Model of NaV1.7-Mediated Pain
  JOURNAL   Toxins (Basel) 8 (3), E78 (2016)
   PUBMED   26999206
  REMARK    FUNCTION.
            Publication Status: Online-Only
COMMENT     [FUNCTION] Potent voltage-gated sodium channel blocker
            (PubMed:25658507). Potently inhibits the voltage-gated sodium
            channels Nav1.7/SCN9A (IC(50)=0.58-10 nM) (PubMed:25658507,
            PubMed:26999206). Also shows a moderate activity on Nav1.1/SCN1A
            (IC(50)=6 nM), Nav1.2/SCN2A (IC(50)=5-128 nM), Nav1.3/SCN3A
            (IC(50)=20.3-170 nM), and Nav1.6/SCN8A (IC(50)=17-20.1 nM)
            (PubMed:25658507, PubMed:26999206). Shows an unclear inhibition of
            Nav1.4/SCN4A (IC(50)=200 nM to >10 uM), Nav1.5/SCN5A (IC(50)=140 nM
            to >10 uM) and Nav1.8/SCN10A (IC(50)=68-12200 nM) (PubMed:25658507,
            PubMed:26999206). Weakly blocks the low voltage-gated calcium
            channels Cav3.1/CACNA1G (30% inhibition of the peak current at 9.8
            nM) (By similarity). shows moderate affinity for lipid bilayers (By
            similarity). In vivo, when tested on the OD1-induced mouse model of
            Nav1.7/SCN9A-mediated pain, the toxin is effective when
            co-administered with OD1, but lacks efficacy when delivered
            systemically (PubMed:26999206). {ECO:0000250|UniProtKB:P0DJA9,
            ECO:0000250|UniProtKB:P0DL73, ECO:0000269|PubMed:25658507,
            ECO:0000269|PubMed:26999206}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:25658507}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:25658507}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:25658507}.
            [DOMAIN] This toxin is amphipathic in nature with a hydrophobic
            face on one side of the molecule (composed of residues 5-Phe-Met-6
            and 27-His--Phe-34) and a hydrophilic (mostly cationic) face on the
            opposite side (composed of residues 10-Ile--Lys-15 and
            18-Arg--Pro-19). {ECO:0000269|PubMed:25658507}.
            [MASS SPECTROMETRY] Mass=4073.9; Method=MALDI; Note=Average mass.;
            Evidence={ECO:0000269|PubMed:25658507}.
            [MISCELLANEOUS] The mutant [Phe5Ala]GpTx1 may be used as a tool for
            probing Nav1.7/SCN9A inhibition in vivo.
            {ECO:0000269|PubMed:25658507}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of Gtx1-15 from Grammostola rosea (AC P0DJA9) and
            Gtx1-15 from Paraphysa scrofa (AC P0DL73). {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 08
            (Gtx1-15) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Grammostola porteri"
                     /db_xref="taxon:1749325"
     Protein         1..34
                     /product="Toxin GTx1-15"
                     /note="Beta/omega-theraphotoxin-Gr2a; Toxin GpTx-1;
                     Beta/omega-TRTX-Gr2a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Mature chain"
                     /note="Toxin GTx1-15.
                     /evidence=ECO:0000269|PubMed:25658507.
                     /id=PRO_0000441929."
     Region          1..32
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Site            1
                     /site_type="mutagenized"
                     /note="D->A: Decrease in selectivity for hNav1.7/SCN9A
                     over hNav1.4/SCN4A. No change in activity on hNav1.7/SCN9A
                     and hNav1.5/SCN5A and 1.5-fold increase in activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Site            1
                     /site_type="mutagenized"
                     /note="D->AD: 4-fold decrease in activity on
                     hNav1.7/SCN9A, no change on hNav1.5/SCN5A and loss of
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:25658507."
     Site            3
                     /site_type="mutagenized"
                     /note="L->A: 5-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Site            4
                     /site_type="mutagenized"
                     /note="G->A: 3-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.2-fold decrease in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            5..6
                     /site_type="mutagenized"
                     /note="FM->AF: 1200-fold increase in selectivity for
                     hNav1.7/SCN9A over hNav1.4/SCN4A; compound 71.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            5
                     /site_type="mutagenized"
                     /note="F->A: 2.5-fold increase in selectivity for
                     hNav1.7/SCN9A over hNav1.4/SCN4A.
                     5-fold decrease in activity on hNav1.7/SCN9A, more than
                     5-fold decrease in activity on hNav1.5/SCN5A and
                     25-fold decrease in activity on hNav1.4/SCN4A (depending
                     on the method used). 3.6-fold decrease in activity on
                     TTX-S sodium channels from mouse DRG neurons.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            5
                     /site_type="other"
                     /note="Important for activity and sodium channel
                     selectivity. /evidence=ECO:0000305|PubMed:25658507."
     Site            6
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            6
                     /site_type="mutagenized"
                     /note="M->A: 5-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.4-fold decrease in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            7
                     /site_type="mutagenized"
                     /note="R->A: 10-fold decrease in activity on
                     hNav1.7/SCN9A, no change on hNav1.5/SCN5A and loss of
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            8
                     /site_type="mutagenized"
                     /note="K->A: 5-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Bond            bond(9,23)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:25658507."
     Site            10
                     /site_type="mutagenized"
                     /note="I->A: 2-fold decrease in activity on hNav1.7/SCN9A,
                     and no change on hNav1.5/SCN5A and hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Region          11..13
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6MK5."
     Site            11
                     /site_type="mutagenized"
                     /note="P->A: No significant change on hNav1.7/SCN9A,
                     hNav1.5/SCN5A and hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            12
                     /site_type="mutagenized"
                     /note="D->A: No change in activity on hNav1.7/SCN9A and
                     hNav1.5/SCN5A and 3-fold increase in activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Site            13
                     /site_type="mutagenized"
                     /note="N->A: 2-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            15
                     /site_type="mutagenized"
                     /note="K->A: 3-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.7-fold decrease in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Bond            bond(16,30)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:25658507."
     Region          18..20
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6MK5."
     Site            18
                     /site_type="mutagenized"
                     /note="R->A: No change in activity on hNav1.7/SCN9A and
                     hNav1.4/SCN4A, and decrease in activity on hNav1.5/SCN5A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            19
                     /site_type="mutagenized"
                     /note="P->A: No change in activity on hNav1.7/SCN9A,
                     decrease in activity on hNav1.5/SCN5A, and 1.8-fold
                     increase in activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            20
                     /site_type="mutagenized"
                     /note="N->A: 8-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Region          21..24
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6MK5."
     Site            21
                     /site_type="mutagenized"
                     /note="L->A: Decrease in activity on hNav1.7/SCN9A,
                     hNav1.4/SCN4A, and hNav1.5/SCN5A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            22
                     /site_type="mutagenized"
                     /note="V->A: 4-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.4-fold decrease in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            24
                     /site_type="mutagenized"
                     /note="S->A: 5-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.4-fold increase in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Region          25..28
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:6MK5."
     Site            25
                     /site_type="mutagenized"
                     /note="R->A: 4-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Site            26
                     /site_type="other"
                     /note="Important for activity and sodium channel
                     selectivity. /evidence=ECO:0000305|PubMed:25658507."
     Site            26
                     /site_type="mutagenized"
                     /note="T->A: 3-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.2-fold decrease in
                     activity on hNav1.4/SCN4A. 1200-fold increase in
                     selectivity for hNav1.7/SCN9A over hNav1.4/SCN4A; compound
                     71. /evidence=ECO:0000269|PubMed:25658507."
     Site            27
                     /site_type="mutagenized"
                     /note="H->A: 11-fold decrease in activity on
                     hNav1.7/SCN9A, no change on hNav1.5/SCN5A and 1.5-fold
                     decrease in activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            27
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            28
                     /site_type="other"
                     /note="Important for activity and sodium channel
                     selectivity. /evidence=ECO:0000305|PubMed:25658507."
     Site            28
                     /site_type="mutagenized"
                     /note="K->A: 5-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. 1200-fold increase in selectivity for
                     hNav1.7/SCN9A over hNav1.4/SCN4A; compound 71.
                     /evidence=ECO:0000269|PubMed:25658507."
     Region          29..32
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6MK5."
     Site            29
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            29
                     /site_type="mutagenized"
                     /note="W->A: Loss of activity on hNav1.7/SCN9A and
                     hNav1.4/SCN4A, and no change on hNav1.5/SCN5A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            31
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            31
                     /site_type="mutagenized"
                     /note="K->A: Loss of activity on hNav1.7/SCN9A and
                     hNav1.4/SCN4A, and no change on hNav1.5/SCN5A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            32
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            32
                     /site_type="mutagenized"
                     /note="Y->A: 9-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and loss of activity on
                     hNav1.4/SCN4A. /evidence=ECO:0000269|PubMed:25658507."
     Site            33
                     /site_type="mutagenized"
                     /note="V->A: 2-fold decrease in activity on hNav1.7/SCN9A,
                     no change on hNav1.5/SCN5A and 1.7-fold decrease in
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            34
                     /site_type="mutagenized"
                     /note="F->A: 13-fold decrease in activity on
                     hNav1.7/SCN9A, no change on hNav1.5/SCN5A and loss of
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            34
                     /site_type="mutagenized"
                     /note="F->FA: 5-fold decrease in activity on
                     hNav1.7/SCN9A, no change on hNav1.5/SCN5A and loss of
                     activity on hNav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:25658507."
     Site            34
                     /site_type="other"
                     /note="Important for activity.
                     /evidence=ECO:0000305|PubMed:25658507."
     Site            34
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000269|PubMed:25658507."
ORIGIN      
        1 dclgfmrkci pdndkccrpn lvcsrthkwc kyvf
//

LOCUS       O16A_CONMR                82 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin MrVIA; AltName: Full=Conotoxin Mr6.5;
            Flags: Precursor.
ACCESSION   P56708
VERSION     P56708.2
DBSOURCE    UniProtKB: locus O16A_CONMR, accession P56708;
            class: standard.
            extra accessions:F6LPM9
            created: May 30, 2000.
            sequence updated: Mar 19, 2014.
            annotation updated: Feb 22, 2023.
            xrefs: JF322917.1, ADZ74146.1, A58586
            xrefs (non-sequence databases): AlphaFoldDB:P56708, SMR:P56708,
            ConoServer:1554, GO:0005576, GO:0005246, GO:0008200, GO:0017080,
            GO:0090729, InterPro:IPR004214, Pfam:PF02950, SUPFAM:SSF57059
KEYWORDS    Calcium channel impairing toxin; Direct protein sequencing;
            Disulfide bond; Ion channel impairing toxin; Knottin; Neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Conus marmoreus
  ORGANISM  Conus marmoreus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Conus.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   Liu,Z., Li,H., Liu,N., Wu,C., Jiang,J., Yue,J., Jing,Y. and Dai,Q.
  TITLE     Diversity and evolution of conotoxins in Conus virgo, Conus
            eburneus, Conus imperialis and Conus marmoreus from the South China
            Sea
  JOURNAL   Toxicon 60 (6), 982-989 (2012)
   PUBMED   22781954
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Fainzilber,M., van der Schors,R., Lodder,J.C., Li,K.W.,
            Geraerts,W.P. and Kits,K.S.
  TITLE     New sodium channel-blocking conotoxins also affect calcium currents
            in Lymnaea neurons
  JOURNAL   Biochemistry 34 (16), 5364-5371 (1995)
   PUBMED   7727394
  REMARK    PROTEIN SEQUENCE OF 52-82, FUNCTION, MASS SPECTROMETRY, AND
            SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 82)
  AUTHORS   McIntosh,J.M., Hasson,A., Spira,M.E., Gray,W.R., Li,W., Marsh,M.,
            Hillyard,D.R. and Olivera,B.M.
  TITLE     A new family of conotoxins that blocks voltage-gated sodium
            channels
  JOURNAL   J Biol Chem 270 (28), 16796-16802 (1995)
   PUBMED   7622492
  REMARK    PROTEIN SEQUENCE OF 52-82, SYNTHESIS OF 52-82, MASS SPECTROMETRY,
            AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 82)
  AUTHORS   Terlau,H., Stocker,M., Shon,K.J., McIntosh,J.M. and Olivera,B.M.
  TITLE     MicroO-conotoxin MrVIA inhibits mammalian sodium channels, but not
            through site I
  JOURNAL   J Neurophysiol 76 (3), 1423-1429 (1996)
   PUBMED   8890263
  REMARK    FUNCTION, AND SYNTHESIS OF 52-82.
REFERENCE   5  (residues 1 to 82)
  AUTHORS   Safo,P., Rosenbaum,T., Shcherbatko,A., Choi,D.Y., Han,E.,
            Toledo-Aral,J.J., Olivera,B.M., Brehm,P. and Mandel,G.
  TITLE     Distinction among neuronal subtypes of voltage-activated sodium
            channels by mu-conotoxin PIIIA
  JOURNAL   J Neurosci 20 (1), 76-80 (2000)
   PUBMED   10627583
  REMARK    FUNCTION.
REFERENCE   6  (residues 1 to 82)
  AUTHORS   Zorn,S., Leipold,E., Hansel,A., Bulaj,G., Olivera,B.M., Terlau,H.
            and Heinemann,S.H.
  TITLE     The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by
            associating with domain-3
  JOURNAL   FEBS Lett 580 (5), 1360-1364 (2006)
   PUBMED   16458302
  REMARK    FUNCTION, AND SYNTHESIS OF 52-82.
COMMENT     On Mar 21, 2014 this sequence version replaced P56708.1.
            [FUNCTION] MuO-conotoxins are gating-modifier toxins that inhibit
            sodium current by trapping the domain II voltage sensor in the
            closed position to prevent opening of the sodium channel. This
            toxin inhibits rNav1.2/SCN2A (IC(50)=532 nM), rNav1.4/SCN4A
            (IC(50)=438 nM) and rNav1.7/SCN9A (IC(50)=345 nM)
            (PubMed:10627583). It blocks Nav channels by interacting mainly
            with the C-terminal part of the pore loop of domain-3
            (PubMed:16458302). It does not bind on site 1 (PubMed:8890263). At
            small concentration, this toxin also acts as a calcium current
            agonist, whereas at higher doses it blocks fast-inactivating
            calcium current (PubMed:7727394). {ECO:0000269|PubMed:10627583,
            ECO:0000269|PubMed:16458302, ECO:0000269|PubMed:7727394,
            ECO:0000269|PubMed:8890263}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:7622492,
            ECO:0000269|PubMed:7727394}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:7622492, ECO:0000305|PubMed:7727394}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:Q26443}.
            [DOMAIN] The cysteine framework is VI/VII (C-C-CC-C-C).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=3487.8; Method=LSI;
            Evidence={ECO:0000269|PubMed:7622492}.
            [MASS SPECTROMETRY] Mass=3488.1; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:7727394}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Conus marmoreus"
                     /db_xref="taxon:42752"
     Protein         1..82
                     /product="Mu-conotoxin MrVIA"
                     /note="Conotoxin Mr6.5"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..82
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:7622492,
                     ECO:0000269|PubMed:7727394. /id=PRO_0000425737."
     Region          52..82
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin MrVIA.
                     /evidence=ECO:0000269|PubMed:7622492,
                     ECO:0000269|PubMed:7727394. /id=PRO_0000044875."
     Bond            bond(53,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:Q26443."
     Bond            bond(60,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:Q26443."
     Bond            bond(70,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:Q26443."
ORIGIN      
        1 mkltcmmiva vlfltawtlv maddsnngla nhfsksrdem edpeasklek racrkkweyc
       61 ivpiigfiyc cpglicgpfv cv
//

LOCUS       5T3M_A                    35 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-theraphotoxin-Hs2a.
ACCESSION   5T3M_A
VERSION     5T3M_A
DBSOURCE    pdb: molecule 5T3M, chain A, release Jan 8, 2020;
            deposition: Aug 25, 2016;
            class: TOXIN;
            source: Mmdb_id: 154263, Pdb_id 1: 5T3M;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Cyriopagopus schmidti (Selenocosmia huwena)
  ORGANISM  Cyriopagopus schmidti
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Cyriopagopus.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Rahnama,S., Deuis,J.R., Cardoso,F.C., Ramanujam,V., Lewis,R.J.,
            Rash,L.D., King,G.F., Vetter,I. and Mobli,M.
  TITLE     The structure, dynamics and selectivity profile of a NaV1.7
            potency-optimised huwentoxin-IV variant
  JOURNAL   PLoS ONE 12 (3), e0173551 (2017)
   PUBMED   28301520
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Rahnama,S., Sharma,G. and Mobli,M.
  TITLE     Direct Submission
  JOURNAL   Submitted (25-AUG-2016)
COMMENT     On Jan 17, 2020 this sequence version replaced gi:1243913455.
            Solution structure of a triple mutant of HwTx-IV - a potent blocker
            of Nav1.7.
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Cyriopagopus schmidti"
                     /db_xref="taxon:29017"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     Bond            bond(9,24)
                     /bond_type="disulfide"
     Bond            bond(16,31)
                     /bond_type="disulfide"
     SecStr          23..26
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          28..32
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 gclgifkacn psndqcckss klvcsrktrw ckwqi
//

LOCUS       3SOF1_NAJAT               62 aa            linear   VRT 03-MAY-2023
DEFINITION  RecName: Full=Mu-elapitoxin-Na1a; Short=Mu-EPTX-Na1a.
ACCESSION   P0DUK7
VERSION     P0DUK7.1
DBSOURCE    UniProtKB: locus 3SOF1_NAJAT, accession P0DUK7;
            class: standard.
            created: Jun 2, 2021.
            sequence updated: Jun 2, 2021.
            annotation updated: May 3, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DUK7, SMR:P0DUK7,
            GO:0005576, GO:0017080, GO:0090729, CDD:cd00206, Gene3D:2.10.60.10,
            InterPro:IPR003572, InterPro:IPR003571, InterPro:IPR045860,
            InterPro:IPR018354, InterPro:IPR035076, Pfam:PF00087,
            PRINTS:PR00282, SUPFAM:SSF57302, PROSITE:PS00272
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Secreted; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Naja atra (Chinese cobra)
  ORGANISM  Naja atra
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
            Toxicofera; Serpentes; Colubroidea; Elapidae; Elapinae; Naja.
REFERENCE   1  (residues 1 to 62)
  AUTHORS   Zhang,F., Zhang,C., Xu,X., Zhang,Y., Gong,X., Yang,Z., Zhang,H.,
            Tang,D., Liang,S. and Liu,Z.
  TITLE     Naja atra venom peptide reduces pain by selectively blocking the
            voltage-gated sodium channel Nav1.8
  JOURNAL   J Biol Chem 294 (18), 7324-7334 (2019)
   PUBMED   30804211
  REMARK    PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, AND 3D-STRUCTURE
            MODELING.;
            TISSUE=Venom
COMMENT     [FUNCTION] Potent inhibitor of hNav1.8/SCN10A (IC(50)=141-380 nM)
            (PubMed:30804211). Is highly selective for this channel and acts in
            a reversible manner (PubMed:30804211). Shows a depolarizing shift
            of activation and hyperpolarizing shift of inactivation
            (PubMed:30804211). In contrast to the very similar cytotoxin A5 (AC
            P62375), does not seem to bind integrin alpha-V/beta-3, since it
            does not promote or inhibit the proliferation of HUVECs and C-PAE
            cells (PubMed:30804211). In vivo, in rodent models of inflammatory
            and neuropathic pain, it alleviates nociceptive behaviors more
            potently than does morphine (PubMed:30804211). It displays no
            evident cytotoxic, hemolytic and cardiotoxic activities and
            produces no obvious adverse responses in mice even at a dose
            30-fold higher than that producing a significant analgesic effect
            (PubMed:30804211). {ECO:0000269|PubMed:30804211}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:30804211}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:30804211}.
            [MASS SPECTROMETRY] Mass=7053.48; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:30804211}.
            [MISCELLANEOUS] Is classified as a P-type cytotoxin, since a
            proline residue stands at position 52 (Pro-31 in standard
            classification). {ECO:0000250|UniProtKB:P62375}.
            [MISCELLANEOUS] Negative results: Shows no or very weak inhibition
            of rNav1.1/SCN1A, hNav1.2/SCN2A, hNav1.3/SCN3A, hNav1.4/SCN4A
            (IC(50)>10 uM), hNav1.5/SCN5A (IC(50)=8.51 uM), hNav1.6/SCN8A,
            hNav1.7/SCN9A, and Nav1.9/SCN11A (PubMed:30804211). Has no effect
            on transient receptor potential cation channels TRPV1, TRPV2,
            TRPV3, TRPV4, TRPA1, TRPM8, TRPC3, TRPC4, TRPC5, and TRPC6
            (PubMed:30804211). {ECO:0000269|PubMed:30804211}.
            [SIMILARITY] Belongs to the snake three-finger toxin family.
            Short-chain subfamily. Orphan group XV sub-subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..62
                     /organism="Naja atra"
                     /db_xref="taxon:8656"
     Protein         1..62
                     /product="Mu-elapitoxin-Na1a"
                     /note="Mu-EPTX-Na1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..62
                     /region_name="Mature chain"
                     /note="Mu-elapitoxin-Na1a.
                     /evidence=ECO:0000250|UniProtKB:P62375.
                     /id=PRO_0000452710."
     Region          1..62
                     /region_name="snake_toxin"
                     /note="Snake toxin domain, present in short and long
                     neurotoxins, cytotoxins and short toxins, and in other
                     miscellaneous venom peptides. The toxin acts by binding to
                     the nicotinic acetylcholine receptors in the postsynaptic
                     membrane of skeletal muscles and...; cd00206"
                     /db_xref="CDD:119411"
     Bond            bond(3,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P62375."
     Site            order(6,11,26..27,32..37)
                     /site_type="active"
                     /note="receptor binding site [active]"
                     /db_xref="CDD:119411"
     Bond            bond(15,40)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P62375."
     Bond            bond(44,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P62375."
     Bond            bond(56,61)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P62375."
ORIGIN      
        1 lkchntqlpf iyktcpegkn lcfkatlkkf plkfpfkrgc adncpknsal lkyvccstdk
       61 cn
//

LOCUS       NA12_BUNGR                48 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Delta-actitoxin-Bgr2a; Short=Delta-AITX-Bgr2a;
            AltName: Full=Bg II; Short=BgII; AltName: Full=Neurotoxin Bg-2.
ACCESSION   P0C1F4
VERSION     P0C1F4.1
DBSOURCE    UniProtKB: locus NA12_BUNGR, accession P0C1F4;
            class: standard.
            created: May 16, 2006.
            sequence updated: May 16, 2006.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0C1F4, SMR:P0C1F4,
            GO:0005576, GO:0042151, GO:0017080, GO:0090729, GO:0009966,
            Gene3D:2.20.20.10, InterPro:IPR000693, InterPro:IPR023355,
            Pfam:PF00706, PIRSF:PIRSF001905, SUPFAM:SSF57392
KEYWORDS    Cardiotoxin; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Nematocyst; Neurotoxin; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Bunodosoma granuliferum
  ORGANISM  Bunodosoma granuliferum
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Bunodosoma.
REFERENCE   1  (residues 1 to 48)
  AUTHORS   Loret,E.P., del Valle,R.M., Mansuelle,P., Sampieri,F. and Rochat,H.
  TITLE     Positively charged amino acid residues located similarly in sea
            anemone and scorpion toxins
  JOURNAL   J Biol Chem 269 (24), 16785-16788 (1994)
   PUBMED   7911468
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND TOXIC DOSE.
REFERENCE   2  (residues 1 to 48)
  AUTHORS   Goudet,C., Ferrer,T., Galan,L., Artiles,A., Batista,C.F.,
            Possani,L.D., Alvarez,J., Aneiros,A. and Tytgat,J.
  TITLE     Characterization of two Bunodosoma granulifera toxins active on
            cardiac sodium channels
  JOURNAL   Br J Pharmacol 134 (6), 1195-1206 (2001)
   PUBMED   11704639
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND MASS SPECTROMETRY.
REFERENCE   3  (residues 1 to 48)
  AUTHORS   Bosmans,F., Aneiros,A. and Tytgat,J.
  TITLE     The sea anemone Bunodosoma granulifera contains surprisingly
            efficacious and potent insect-selective toxins
  JOURNAL   FEBS Lett 532 (1-2), 131-134 (2002)
   PUBMED   12459477
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 48)
  AUTHORS   Rodriguez,A.A., Cassoli,J.S., Sa,F., Dong,Z.Q., de Freitas,J.C.,
            Pimenta,A.M., de Lima,M.E., Konno,K., Lee,S.M., Garateix,A. and
            Zaharenko,A.J.
  TITLE     Peptide fingerprinting of the neurotoxic fractions isolated from
            the secretions of sea anemones Stichodactyla helianthus and
            Bunodosoma granulifera. New members of the APETx-like family
            identified by a 454 pyrosequencing approach
  JOURNAL   Peptides 34 (1), 26-38 (2012)
   PUBMED   22015268
  REMARK    FUNCTION, AND MASS SPECTROMETRY.
REFERENCE   5  (residues 1 to 48)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Binds voltage-dependently at site 3 of sodium channels
            (Nav) and inhibits the inactivation of the activated channels,
            thereby blocking neuronal transmission. Possesses the highest
            efficacy for the insect sodium channel para/tipE (EC(50)=5.5 nM)
            (PubMed:12459477), and has effect on Nav1.2/SCN2A (in complex with
            SCN1B), Nav1.4/SCN4A (in complex with SCN1B) and Nav1.5/SCN5A (in
            complex with SCN1B) (PubMed:12459477). Also interacts with sodium
            channels in cardiac cells (PubMed:11704639). Shows lethality to
            crabs (PubMed:22015268). {ECO:0000269|PubMed:11704639,
            ECO:0000269|PubMed:12459477, ECO:0000269|PubMed:22015268,
            ECO:0000269|PubMed:7911468}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=5072.7; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:11704639}.
            [MASS SPECTROMETRY] Mass=5069.9; Method=MALDI;
            Evidence={ECO:0000269|PubMed:22015268}.
            [TOXIC DOSE] LD(50) is 0.4 ug/kg by intracerebroventricular
            injection into mice. {ECO:0000269|PubMed:7911468}.
            [MISCELLANEOUS] Negative results: has no effect on voltage-gated
            sodium channel Nav1.8/SCN10A (in complex with SCN1B).
            [SIMILARITY] Belongs to the sea anemone sodium channel inhibitory
            toxin family. Type I subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..48
                     /organism="Bunodosoma granuliferum"
                     /db_xref="taxon:31164"
     Protein         1..48
                     /product="Delta-actitoxin-Bgr2a"
                     /note="Delta-AITX-Bgr2a; Bg II; Neurotoxin Bg-2; BgII"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..48
                     /region_name="Mature chain"
                     /note="Delta-actitoxin-Bgr2a.
                     /evidence=ECO:0000269|PubMed:11704639,
                     ECO:0000269|PubMed:7911468. /id=PRO_0000236030."
     Region          3..46
                     /region_name="Toxin_4"
                     /note="Anenome neurotoxin; pfam00706"
                     /db_xref="CDD:109750"
     Bond            bond(4,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(6,35)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            16
                     /site_type="other"
                     /note="Important for toxicity."
     Bond            bond(28,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
ORIGIN      
        1 gascrcdsdg ptsrgntltg tlwligrcps gwhncrgsgp figycckq
//

LOCUS       TX1_CERMR                 33 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-theraphotoxin-Cm1a; Short=Beta-TRTX-Cm1a;
            AltName: Full=CcoTx-I; AltName: Full=Ceratotoxin-1; Short=CcoTx1.
ACCESSION   P84507
VERSION     P84507.1
DBSOURCE    UniProtKB: locus TX1_CERMR, accession P84507;
            class: standard.
            created: Oct 25, 2005.
            sequence updated: Oct 25, 2005.
            annotation updated: Feb 22, 2023.
            xrefs: 5EPM_C, 5EPM_D, 6BR0_A
            xrefs (non-sequence databases): PDBsum:5EPM, PDBsum:6BR0,
            AlphaFoldDB:P84507, BMRB:P84507, SMR:P84507, ABCD:P84507,
            ArachnoServer:AS000221, GO:0005615, GO:0005246, GO:0019871,
            GO:0090729, GO:0044489, InterPro:IPR011696, InterPro:IPR013140,
            Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    3D-structure; Amidation; Calcium channel impairing toxin; Direct
            protein sequencing; Disulfide bond; Ion channel impairing toxin;
            Knottin; Neurotoxin; Pharmaceutical; Secreted; Toxin; Voltage-gated
            calcium channel impairing toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Ceratogyrus marshalli
  ORGANISM  Ceratogyrus marshalli
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Ceratogyrus.
REFERENCE   1  (residues 1 to 33)
  AUTHORS   Bosmans,F., Rash,L., Zhu,S., Diochot,S., Lazdunski,M., Escoubas,P.
            and Tytgat,J.
  TITLE     Four novel tarantula toxins as selective modulators of
            voltage-gated sodium channel subtypes
  JOURNAL   Mol Pharmacol 69 (2), 419-429 (2006)
   PUBMED   16267209
  REMARK    PROTEIN SEQUENCE, FUNCTION, BIOASSAY, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND AMIDATION AT LEU-33.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 33)
  AUTHORS   Shcherbatko,A., Rossi,A., Foletti,D., Zhu,G., Bogin,O., Galindo
            Casas,M., Rickert,M., Hasa-Moreno,A., Bartsevich,V., Crameri,A.,
            Steiner,A.R., Henningsen,R., Gill,A., Pons,J., Shelton,D.L.,
            Rajpal,A. and Strop,P.
  TITLE     Engineering Highly Potent and Selective Microproteins against
            Nav1.7 Sodium Channel for Treatment of Pain
  JOURNAL   J Biol Chem 291 (27), 13974-13986 (2016)
   PUBMED   27129258
  REMARK    FUNCTION, MUTAGENESIS OF TRP-5; LYS-12; LYS-18; 19-ASN--THR-21;
            ARG-24; 25-ARG-ASP-26 AND 31-TYR-ASP-32, X-RAY CRYSTALLOGRAPHY
            (1.75 ANGSTROMS) OF MUTANT 2670 IN COMPLEX WITH AN ANTIBODY
            FRAGMENT, AND PHARMACEUTICAL.
REFERENCE   3  (residues 1 to 33)
  AUTHORS   Sousa,S.R., Wingerd,J.S., Brust,A., Bladen,C., Ragnarsson,L.,
            Herzig,V., Deuis,J.R., Dutertre,S., Vetter,I., Zamponi,G.W.,
            King,G.F., Alewood,P.F. and Lewis,R.J.
  TITLE     Discovery and mode of action of a novel analgesic beta-toxin from
            the African spider Ceratogyrus darlingi
  JOURNAL   PLoS One 12 (9), e0182848 (2017)
   PUBMED   28880874
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   4  (residues 1 to 33)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    FUNCTION, AND SYNTHESIS.
COMMENT     [FUNCTION] Inhibits many voltage-gated sodium channels and one
            voltage-gated calcium channel (Cav2.2/CACNA1B (IC(50)=400 nM),
            Nav1.2/SCN2A (IC(50)=3-70 nM), Nav1.1/SCN1A (IC(50)=523-1060 nM),
            Nav1.7/SCN9A (IC(50)=129.1-5120 nM), Nav1.4/SCN4A (IC(50)=263-888
            nM or >10 uM) and Nav1.5/SCN5A (IC(50)=188-323 nM or >10 uM))
            (PubMed:16267209, PubMed:27129258, PubMed:28880874,
            PubMed:29703751). It acts by shifting the voltage dependence of
            channel activation to more depolarized potentials and by blocking
            the inward component of the sodium current (PubMed:16267209). It
            shows moderate affinity for lipid bilayers (PubMed:29703751). On
            Nav1.7/SCN9A, it has been shown to interact with the S3-S4 loop of
            domain DII (site 4) (PubMed:27129258). Is significantly more potent
            against Nav1.2/SCN2A than the other Nav channel subtypes
            (PubMed:16267209). In vivo, this toxin causes general ataxia, lack
            of response to stimuli, and semiparalysis (PubMed:16267209). After
            a few minutes, the mice are unable to stand, and breathing is
            reduced in rhythm and intensity (PubMed:16267209). Symptoms
            gradually increase with progressive slowing of breathing and
            flaccid paralysis, death occurred within 10 to 20 minutes post
            injection (PubMed:16267209). Animals remain totally flaccid, and no
            symptoms of excitatory neurotoxicity are observed
            (PubMed:16267209). {ECO:0000269|PubMed:16267209,
            ECO:0000269|PubMed:27129258, ECO:0000269|PubMed:28880874,
            ECO:0000269|PubMed:29703751}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:16267209}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:16267209}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000305|PubMed:27129258}.
            [MASS SPECTROMETRY] Mass=4041.79; Method=MALDI;
            Evidence={ECO:0000269|PubMed:16267209}.
            [PHARMACEUTICAL] Derivatives such as D1Z/M5I/K18Y/R24Ka or
            D1Z/M5I/R27Na are under preclinical trial by Pfizer to treat pain.
            {ECO:0000305|PubMed:27129258}.
            [MISCELLANEOUS] Synthetic variant D1Z/M5I/K18Y/R24Ka has a
            N-terminal pyroglutamate and a C-terminal amidation. It shows an
            IC(50)=2.7 nM on Nav1.7/SCN9A and IC(50)>3 uM on Nav1.4/SCN4A and
            Nav1.5/SCN5A. {ECO:0000269|PubMed:27129258}.
            [MISCELLANEOUS] Synthetic variant D1Z/M5I/R27Na has a N-terminal
            pyroglutamate and a C-terminal amidation. It shows an IC(50)=2.8 nM
            on Nav1.7/SCN9A and IC(50)>3 uM on Nav1.4/SCN4A and Nav1.5/SCN5A.
            {ECO:0000269|PubMed:27129258}.
            [MISCELLANEOUS] Negative results: does not inhibit Cav1.3/CACNA1D
            and Cav3.1/CACNA1G (PubMed:28880874). Does not inhibit
            Nav1.3/SCN3A, Nav1.6/SCN8A, Nav1.8/SCN10A (PubMed:16267209,
            PubMed:28880874). {ECO:0000269|PubMed:16267209,
            ECO:0000269|PubMed:28880874}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 04
            (CcoTx1) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..33
                     /organism="Ceratogyrus marshalli"
                     /db_xref="taxon:316287"
     Protein         1..33
                     /product="Beta-theraphotoxin-Cm1a"
                     /note="Beta-TRTX-Cm1a; CcoTx-I; Ceratotoxin-1; CcoTx1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..33
                     /region_name="Processed active peptide"
                     /note="Beta-theraphotoxin-Cm1a.
                     /evidence=ECO:0000269|PubMed:16267209.
                     /id=PRO_0000045000."
     Region          1..31
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305|PubMed:27129258."
     Site            5
                     /site_type="mutagenized"
                     /note="W->I: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka and
                     synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305|PubMed:27129258."
     Region          11..13
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:5EPM."
     Site            12
                     /site_type="mutagenized"
                     /note="K->E: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka and
                     synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Bond            bond(16,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305|PubMed:27129258."
     Site            18
                     /site_type="mutagenized"
                     /note="K->Y: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka.
                     /evidence=ECO:0000269|PubMed:27129258."
     Site            19..21
                     /site_type="mutagenized"
                     /note="NYT->RLV: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka and
                     synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Region          20..22
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5EPM."
     Region          24..26
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:5EPM."
     Site            24
                     /site_type="mutagenized"
                     /note="R->K: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka.
                     /evidence=ECO:0000269|PubMed:27129258."
     Site            25..26
                     /site_type="mutagenized"
                     /note="RD->SH: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka and
                     synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Site            27
                     /site_type="mutagenized"
                     /note="R->N: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Region          28..31
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5EPM."
     Site            31..32
                     /site_type="mutagenized"
                     /note="YD->WK: Important increase in potency toward
                     Nav1.7/SCN9A, and low potency on Nav1.4/SCN4A and
                     Nav1.5/SCN5A; synthetic variant D1Z/M5I/K18Y/R24Ka and
                     synthetic variant D1Z/M5I/R27Na.
                     /evidence=ECO:0000269|PubMed:27129258."
     Site            33
                     /site_type="amidation"
                     /note="Leucine amide.
                     /evidence=ECO:0000269|PubMed:16267209."
ORIGIN      
        1 dclgwfkscd pkndkcckny tcsrrdrwck ydl
//

LOCUS       BDS2_ANESU                43 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=DeltaKappa-actitoxin-Avd4b;
            Short=DeltaKappa-AITX-Avd4b; AltName: Full=Antihypertensive protein
            BDS-2; AltName: Full=Blood depressing substance II; Short=BDS-II.
ACCESSION   P59084
VERSION     P59084.1
DBSOURCE    UniProtKB: locus BDS2_ANESU, accession P59084;
            class: standard.
            created: Nov 8, 2002.
            sequence updated: Nov 8, 2002.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P59084, SMR:P59084,
            GO:0005576, GO:0042151, GO:0008200, GO:0015459, GO:0090729,
            Gene3D:2.20.20.10, InterPro:IPR012414, InterPro:IPR023355,
            Pfam:PF07936, SUPFAM:SSF57392
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Nematocyst; Neurotoxin; Potassium channel impairing toxin;
            Secreted; Toxin; Voltage-gated potassium channel impairing toxin.
SOURCE      Anemonia sulcata (snake-locks sea anemone)
  ORGANISM  Anemonia sulcata
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Anemonia.
REFERENCE   1  (residues 1 to 43)
  AUTHORS   Beress,L., Doppelfeld,I.-S., Etschenberg,E., Graf,E.,
            Henschen-Edman,A. and Zwick,J.
  TITLE     Polypeptides, process for their preparation, and their use as
            hypotensive active compounds
  JOURNAL   Patent: DE DE3324689 17-JAN-1985;
  REMARK    PROTEIN SEQUENCE, AND FUNCTION.
REFERENCE   2  (residues 1 to 43)
  AUTHORS   Diochot,S., Schweitz,H., Beress,L. and Lazdunski,M.
  TITLE     Sea anemone peptides with a specific blocking activity against the
            fast inactivating potassium channel Kv3.4
  JOURNAL   J Biol Chem 273 (12), 6744-6749 (1998)
   PUBMED   9506974
  REMARK    PROTEIN SEQUENCE, AND FUNCTION.
REFERENCE   3  (residues 1 to 43)
  AUTHORS   Yeung,S.Y., Thompson,D., Wang,Z., Fedida,D. and Robertson,B.
  TITLE     Modulation of Kv3 subfamily potassium currents by the sea anemone
            toxin BDS: significance for CNS and biophysical studies
  JOURNAL   J Neurosci 25 (38), 8735-8745 (2005)
   PUBMED   16177043
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 43)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Acts as a gating modifier on both Kv and Nav ion
            channels. Voltage-dependently inhibits voltage-gated potassium
            channels Kv3 (Kv3.1/KCNC1, Kv3.2/KCNC2 and Kv3.4/KCNC4)
            (PubMed:9506974, PubMed:16177043). Slows inactivation of the
            voltage-gated sodium channel Nav1.7/SCN9A (By similarity). Inhibits
            all Kv3.1, Kv3.2 and Kv3.4 by about 50% when tested at a voltage of
            +40 mV (PubMed:16177043). May act by binding residues in
            voltage-sensing domains S3b and S4 of Kv3 (PubMed:16177043). Tests
            have been done on human Nav1.7/SCN9A and rat SCG neurons that
            mostly carry Nav1.7 channels (EC(50)=300 nM) (By similarity). This
            toxin also reduces blood pressure (Ref.1).
            {ECO:0000250|UniProtKB:P11494, ECO:0000269|PubMed:16177043,
            ECO:0000269|PubMed:9506974, ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [SIMILARITY] Belongs to the sea anemone type 3 (BDS) potassium
            channel toxin family. {ECO:0000305}.
            [CAUTION] Opinions are divided on whether Anemonia viridis
            (Forsskal, 1775) and Anemonia sulcata (Pennant, 1777) are separate
            species. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..43
                     /organism="Anemonia sulcata"
                     /db_xref="taxon:6108"
     Protein         1..43
                     /product="DeltaKappa-actitoxin-Avd4b"
                     /note="DeltaKappa-AITX-Avd4b; Antihypertensive protein
                     BDS-2; Blood depressing substance II; BDS-II"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..43
                     /region_name="Mature chain"
                     /note="DeltaKappa-actitoxin-Avd4b.
                     /evidence=ECO:0000269|PubMed:9506974, ECO:0000269|Ref.1.
                     /id=PRO_0000221542."
     Region          2..37
                     /region_name="Defensin_4"
                     /note="Potassium-channel blocking toxin; pfam07936"
                     /db_xref="CDD:254527"
     Bond            bond(4,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
     Bond            bond(6,32)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
     Bond            bond(22,40)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
ORIGIN      
        1 aapcfcpgkp drgdlwilrg tcpggygyts ncykwpnicc yph
//

LOCUS       CM3A_CONSE                31 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin SmIIIA; Flags: Precursor.
ACCESSION   P60207
VERSION     P60207.1
DBSOURCE    UniProtKB: locus CM3A_CONSE, accession P60207;
            class: standard.
            created: Jan 16, 2004.
            sequence updated: Jan 16, 2004.
            annotation updated: Feb 22, 2023.
            xrefs: 1Q2J_A
            xrefs (non-sequence databases): PDBsum:1Q2J, AlphaFoldDB:P60207,
            SMR:P60207, ConoServer:1629, GO:0005576, GO:0019871, GO:0090729,
            InterPro:IPR008036, PROSITE:PS60013
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues;
            Disulfide bond; Ion channel impairing toxin; Neurotoxin;
            Pyrrolidone carboxylic acid; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Conus stercusmuscarum
  ORGANISM  Conus stercusmuscarum
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Pionoconus.
REFERENCE   1  (residues 1 to 31)
  AUTHORS   West,P.J., Bulaj,G., Garrett,J.E., Olivera,B.M. and Yoshikami,D.
  TITLE     Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant
            sodium channels in amphibian sympathetic and sensory neurons
  JOURNAL   Biochemistry 41 (51), 15388-15393 (2002)
   PUBMED   12484778
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], FUNCTION ON TTX-RESISTANT SODIUM
            CHANNELS, SYNTHESIS OF 7-28, AND SYNTHESIS OF 8-28.;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 31)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION ON SODIUM CHANNELS, AND SYNTHESIS OF 7-28.
REFERENCE   3  (residues 1 to 31)
  AUTHORS   Favreau,P., Benoit,E., Hocking,H.G., Carlier,L., D' hoedt,D.,
            Leipold,E., Markgraf,R., Schlumberger,S., Cordova,M.A.,
            Gaertner,H., Paolini-Bertrand,M., Hartley,O., Tytgat,J.,
            Heinemann,S.H., Bertrand,D., Boelens,R., Stocklin,R. and Molgo,J.
  TITLE     A novel micro-conopeptide, CnIIIC, exerts potent and preferential
            inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic
            acetylcholine receptors
  JOURNAL   Br J Pharmacol 166 (5), 1654-1668 (2012)
   PUBMED   22229737
  REMARK    FUNCTION, AND SYNTHESIS OF 7-28.
REFERENCE   4  (residues 1 to 31)
  AUTHORS   Zhang,M.M., Wilson,M.J., Azam,L., Gajewiak,J., Rivier,J.E.,
            Bulaj,G., Olivera,B.M. and Yoshikami,D.
  TITLE     Co-expression of Na(V)beta subunits alters the kinetics of
            inhibition of voltage-gated sodium channels by pore-blocking
            mu-conotoxins
  JOURNAL   Br J Pharmacol 168 (7), 1597-1610 (2013)
   PUBMED   23146020
  REMARK    FUNCTION ON SODIUM CHANNELS, AND SYNTHESIS OF 7-28.
REFERENCE   5  (residues 1 to 31)
  AUTHORS   Keizer,D.W., West,P.J., Lee,E.F., Yoshikami,D., Olivera,B.M.,
            Bulaj,G. and Norton,R.S.
  TITLE     Structural basis for tetrodotoxin-resistant sodium channel binding
            by mu-conotoxin SmIIIA
  JOURNAL   J Biol Chem 278 (47), 46805-46813 (2003)
   PUBMED   12970353
  REMARK    STRUCTURE BY NMR OF 7-28, PYROGLUTAMATE FORMATION AT GLN-7,
            AMIDATION AT CYS-28, SYNTHESIS OF 7-28, AND DISULFIDE BONDS.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin blocks rNav1.5/SCN5A (IC(50) is 1.3 uM), rNav1.6/SCN8A
            (IC(50) is 160 nM), rNav1.7/SCN9A (IC(50) is 1.3 uM), rNav1.1/SCN1A
            (K(d) is 3.8 nM), rNav1.2/SCN2A (K(d) is 1.3 nM), rNav1.4/SCN4A
            (K(d) is 0.22 nM), rNav1.6/SCN8A (K(d) is 69 nM), and rNav1.7/SCN9A
            (K(d) is 260 nM). This toxin is very potent but weakly
            discriminating among sodium channels. The block of these channels
            is modified when beta-subunits are coexpressed with alpha subunits.
            Hence, blocks of channels containing beta-1 and beta-3 subunits are
            more potent (compared to channels without beta subunits), whereas
            blocks of channels containing beta-2 and beta-4 subunits are less
            potent (compared to channels without beta subunits).
            {ECO:0000269|PubMed:12484778, ECO:0000269|PubMed:21652775,
            ECO:0000269|PubMed:22229737, ECO:0000269|PubMed:23146020}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues.
            [PTM] SmIIIA' is a putative isoform where the N-terminal AA is
            missing.
            [MISCELLANEOUS] All peptide bonds in this toxin adopt the trans
            conformation. {ECO:0000305|PubMed:12970353}.
            [MISCELLANEOUS] Negative results: does not show activity on
            rNav1.8/SCN10A (IC(50) is >10 uM). {ECO:0000305|PubMed:21652775}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
            [WEB RESOURCE] Name=Biological Magnetic Resonance Data Bank;
            Note=Mu-conotoxin SmIIIA entry;
            URL='http://www.bmrb.wisc.edu/data_library/summary/index.php?bmrbId
            =5881'.
FEATURES             Location/Qualifiers
     source          1..31
                     /organism="Conus stercusmuscarum"
                     /db_xref="taxon:89452"
     Protein         <1..31
                     /product="Mu-conotoxin SmIIIA"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          <1..6
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305. /id=PRO_0000035055."
     Region          7..28
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin SmIIIA.
                     /evidence=ECO:0000305|PubMed:12970353.
                     /id=PRO_0000035056."
     Site            7
                     /site_type="pyrrolidone-carboxylic-acid"
                     /note="Pyrrolidone carboxylic acid.
                     /evidence=ECO:0000305|PubMed:12970353."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12970353."
     Bond            bond(10,27)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12970353."
     Region          11..14
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1Q2J."
     Bond            bond(16,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:12970353."
     Region          18..26
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1Q2J."
     Site            28
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:12970353."
ORIGIN      
        1 plfdkrqrcc ngrrgcssrw crdhsrccgr r
//

LOCUS       TX2_CERMR                 33 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-theraphotoxin-Cm1b; Short=Beta-TRTX-Cm1b;
            AltName: Full=CcoTx-II; AltName: Full=Ceratotoxin-2; Short=CcoTx2.
ACCESSION   P84508
VERSION     P84508.1
DBSOURCE    UniProtKB: locus TX2_CERMR, accession P84508;
            class: standard.
            created: Oct 25, 2005.
            sequence updated: Oct 25, 2005.
            annotation updated: Feb 22, 2023.
            xrefs: 6BTV_A
            xrefs (non-sequence databases): PDBsum:6BTV, AlphaFoldDB:P84508,
            BMRB:P84508, SMR:P84508, ArachnoServer:AS000248, GO:0005615,
            GO:0005246, GO:0019871, GO:0090729, GO:0044489, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    3D-structure; Amidation; Calcium channel impairing toxin; Direct
            protein sequencing; Disulfide bond; Ion channel impairing toxin;
            Knottin; Neurotoxin; Secreted; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Ceratogyrus marshalli
  ORGANISM  Ceratogyrus marshalli
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Ceratogyrus.
REFERENCE   1  (residues 1 to 33)
  AUTHORS   Bosmans,F., Rash,L., Zhu,S., Diochot,S., Lazdunski,M., Escoubas,P.
            and Tytgat,J.
  TITLE     Four novel tarantula toxins as selective modulators of
            voltage-gated sodium channel subtypes
  JOURNAL   Mol Pharmacol 69 (2), 419-429 (2006)
   PUBMED   16267209
  REMARK    PROTEIN SEQUENCE, FUNCTION, BIOASSAY, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND AMIDATION AT LEU-33.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 33)
  AUTHORS   Sousa,S.R., Wingerd,J.S., Brust,A., Bladen,C., Ragnarsson,L.,
            Herzig,V., Deuis,J.R., Dutertre,S., Vetter,I., Zamponi,G.W.,
            King,G.F., Alewood,P.F. and Lewis,R.J.
  TITLE     Discovery and mode of action of a novel analgesic beta-toxin from
            the African spider Ceratogyrus darlingi
  JOURNAL   PLoS One 12 (9), e0182848 (2017)
   PUBMED   28880874
  REMARK    FUNCTION.
            Publication Status: Online-Only
REFERENCE   3  (residues 1 to 33)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    STRUCTURE BY NMR, FUNCTION, SYNTHESIS, AND DISULFIDE BOND.
COMMENT     [FUNCTION] Inhibits several voltage-gated sodium channels and only
            one voltage-gated calcium channel (Cav2.2/CACNA1B (IC(50)=1.1 uM)
            and Nav1.2/SCN2A (IC(50)=3.7-80 nM), Nav1.3/SCN3A (IC(50)=88-5570
            nM), Nav1.1/SCN1A (IC(50)=170-407 nM), Nav1.7/SCN9A
            (IC(50)=95.5-230 nM), Nav1.6/SCN6A (IC(50)=49.9-3990 nM),
            Nav1.4/SCN4A (IC(50)=113-400 nM or >10 uM), Nav1.5/SCN5A
            (IC(50)=1524-1634 nM or >10 uM)) (PubMed:16267209, PubMed:28880874,
            PubMed:29703751). The toxin acts by shifting the voltage dependence
            of channel activation to more depolarized potentials and by
            blocking the inward component of the sodium current
            (PubMed:16267209). It shows moderate affinity for lipid bilayers
            without cholesterol and high affinity for lipid bilayers containing
            cholesterol (PubMed:29703751). In vivo, this toxin causes general
            ataxia, lack of response to stimuli, and semiparalysis
            (PubMed:16267209). After a few minutes, the mice are unable to
            stand, and breathing is reduced in rhythm and intensity
            (PubMed:16267209). Symptoms gradually increase with progressive
            slowing of breathing and flaccid paralysis; death occurred within
            10 to 20 minutes post injection (PubMed:16267209). Animals remain
            totally flaccid, and no symptoms of excitatory neurotoxicity are
            observed (PubMed:16267209). {ECO:0000269|PubMed:16267209,
            ECO:0000269|PubMed:28880874, ECO:0000269|PubMed:29703751}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:16267209}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:16267209}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P84507}.
            [MASS SPECTROMETRY] Mass=4089.61; Method=MALDI;
            Evidence={ECO:0000269|PubMed:16267209}.
            [MISCELLANEOUS] Negative results: does not inhibit Cav1.3 and
            Cav3.1 (PubMed:28880874). Does not or only weakly inhibits
            Nav1.8/SCN10A (PubMed:16267209, PubMed:28880874).
            {ECO:0000269|PubMed:28880874}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 04
            (CcoTx1) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..33
                     /organism="Ceratogyrus marshalli"
                     /db_xref="taxon:316287"
     Protein         1..33
                     /product="Beta-theraphotoxin-Cm1b"
                     /note="Beta-TRTX-Cm1b; CcoTx-II; Ceratotoxin-2; CcoTx2"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..33
                     /region_name="Processed active peptide"
                     /note="Beta-theraphotoxin-Cm1b.
                     /evidence=ECO:0000269|PubMed:16267209.
                     /id=PRO_0000045001."
     Region          1..31
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29703751,
                     ECO:0000312|PDB:6BTV."
     Region          5..8
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6BTV."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29703751,
                     ECO:0000312|PDB:6BTV."
     Region          11..13
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:6BTV."
     Bond            bond(16,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:29703751,
                     ECO:0000312|PDB:6BTV."
     Region          20..22
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6BTV."
     Region          24..26
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6BTV."
     Region          28..31
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:6BTV."
     Site            33
                     /site_type="amidation"
                     /note="Leucine amide.
                     /evidence=ECO:0000269|PubMed:16267209."
ORIGIN      
        1 dclgwfkscd pkndkcckny tcsrrdrwck yyl
//

LOCUS       TX1A_HETMC                35 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Delta-theraphotoxin-Hm1a; Short=Delta-TRTX-Hm1a;
            AltName: Full=Heteroscodratoxin-1; Short=HmTx1; AltName:
            Full=Kappa-theraphotoxin-Hm1a; Short=Kappa-TRTX-Hm1a.
ACCESSION   P60992
VERSION     P60992.1
DBSOURCE    UniProtKB: locus TX1A_HETMC, accession P60992;
            class: standard.
            created: Apr 26, 2004.
            sequence updated: Apr 26, 2004.
            annotation updated: Feb 22, 2023.
            xrefs: 2N6O_A
            xrefs (non-sequence databases): PDBsum:2N6O, AlphaFoldDB:P60992,
            BMRB:P60992, SMR:P60992, TCDB:8.B.5.3.3, ArachnoServer:AS000224,
            GO:0005576, GO:0008200, GO:0015459, GO:0017080, GO:0090729,
            GO:0044488, InterPro:IPR011696, Pfam:PF07740, SUPFAM:SSF57059
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Knottin; Neurotoxin; Pharmaceutical;
            Potassium channel impairing toxin; Secreted; Toxin; Voltage-gated
            potassium channel impairing toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Heteroscodra maculata
  ORGANISM  Heteroscodra maculata
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Heteroscodra.
REFERENCE   1  (residues 1 to 35)
  AUTHORS   Escoubas,P., Diochot,S., Celerier,M.L., Nakajima,T. and
            Lazdunski,M.
  TITLE     Novel tarantula toxins for subtypes of voltage-dependent potassium
            channels in the Kv2 and Kv4 subfamilies
  JOURNAL   Mol Pharmacol 62 (1), 48-57 (2002)
   PUBMED   12065754
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, BIOASSAY, AND 3D-STRUCTURE MODELING.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 35)
  AUTHORS   Osteen,J.D., Herzig,V., Gilchrist,J., Emrick,J.J., Zhang,C.,
            Wang,X., Castro,J., Garcia-Caraballo,S., Grundy,L., Rychkov,G.Y.,
            Weyer,A.D., Dekan,Z., Undheim,E.A., Alewood,P., Stucky,C.L.,
            Brierley,S.M., Basbaum,A.I., Bosmans,F., King,G.F. and Julius,D.
  TITLE     Selective spider toxins reveal a role for the Nav1.1 channel in
            mechanical pain
  JOURNAL   Nature 534 (7608), 494-499 (2016)
   PUBMED   27281198
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 35)
  AUTHORS   Chow,C.Y., Chin,Y.K.Y., Ma,L., Undheim,E.A.B., Herzig,V. and
            King,G.F.
  TITLE     A selective NaV1.1 activator with potential for treatment of Dravet
            syndrome epilepsy
  JOURNAL   Biochem Pharmacol 181, 113991 (2020)
   PUBMED   32335140
  REMARK    MASS SPECTROMETRY, AND STABILITY IN CEREBROSPINAL FLUID AND SERUM.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 35)
  AUTHORS   Richards,K.L., Milligan,C.J., Richardson,R.J., Jancovski,N.,
            Grunnet,M., Jacobson,L.H., Undheim,E.A.B., Mobli,M., Chow,C.Y.,
            Herzig,V., Csoti,A., Panyi,G., Reid,C.A., King,G.F. and Petrou,S.
  TITLE     Selective NaV1.1 activation rescues Dravet syndrome mice from
            seizures and premature death
  JOURNAL   Proc Natl Acad Sci U S A 115 (34), E8077-E8085 (2018)
   PUBMED   30076230
  REMARK    STRUCTURE BY NMR, FUNCTION, DISULFIDE BOND, PHARMACEUTICAL,
            BIOASSAY ON DRAVET SYNDROME MICE MODEL, STABILITY IN CEREBROSPINAL
            FLUID, AND RECOMBINANT EXPRESSION.
COMMENT     [FUNCTION] Gating-modifier toxin that potently inhibits
            inactivation of the mammalian Nav1.1/SCN1A sodium channel
            (EC(50)=38 nM) (PubMed:27281198, PubMed:30076230). Also moderately
            inhibits inactivation of Nav1.2/SCN2A (EC(50)=236 nM) and
            Nav1.3/SCN3A (EC(50)=220 nM) when the channels are expressed in
            oocytes without the beta-1 auxiliary subunit (PubMed:27281198).
            Does not inhibit inactivation of Nav1.2/SCN2A when the channel is
            coexpressed with the beta-1 auxiliary subunit (PubMed:30076230).
            When tested on Nav1.1/SCN1A channel, it enhances peak current
            amplitude and potently delays channel inactivation in a
            dose-dependent manner, leading to a large sustained current
            (PubMed:30076230). It has no effect on the voltage-dependence of
            steady-state activation, and induces a depolarizing shift in the
            voltage dependence of inactivation (PubMed:30076230). In addition,
            it does not modify the recovery from fast inactivation in
            Nav1.1/SCN1A (PubMed:30076230). The binding affinity and subtype
            selectivity of the toxin towards Nav1.1/SCN1A channel is determined
            by residues within both the S1-S2 and S3-S4 loops of the domain IV
            voltage sensor of the channel (PubMed:27281198). This toxin also
            weakly inhibits several subtypes of voltage-gated potassium
            channels (PubMed:27281198). It moderately blocks Kv2.1/KCNB1 (23%
            inhibition at 100 nM), Kv2.2/KCNB2 (19.7% at 100 nM and 51% at 300
            nM), Kv4.1/KCND1 (IC(50)=280 nM), Kv4.2/KCND2 (39% at 300 nM) and
            Kv4.3/KCND3 (43% at 300 nM) (PubMed:12065754). In vivo,
            intracerebroventricular injection into mice elicits convulsions,
            spasms, tremors and rapid death (PubMed:12065754). When injected
            into mouse hindpaw, the toxin elicits an immediate and robust
            response to pain (PubMed:27281198). However, intraplantar injection
            of toxin does not cause neurogenic inflammation or alter
            sensitivity to heat, indicative of a modality-specific effect on
            mechanosensitive neurons (PubMed:27281198). In Dravet syndrome mice
            model, intracerebroventricular infusion of this peptide rescues
            mice from seizures and premature death (PubMed:30076230).
            {ECO:0000269|PubMed:12065754, ECO:0000269|PubMed:27281198,
            ECO:0000269|PubMed:30076230}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12065754,
            ECO:0000269|PubMed:27281198}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:12065754, ECO:0000305|PubMed:27281198}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:30076230}.
            [MASS SPECTROMETRY] Mass=3994.59; Method=MALDI;
            Evidence={ECO:0000269|PubMed:12065754}.
            [MASS SPECTROMETRY] Mass=3995.55; Method=MALDI;
            Evidence={ECO:0000269|PubMed:27281198}.
            [MASS SPECTROMETRY] Mass=3995.51; Method=MALDI; Note=Monoisotopic
            mass.; Evidence={ECO:0000269|PubMed:32335140}.
            [PHARMACEUTICAL] May be used to develop new agents to treat
            Nav1.1/SCN1A-associated epilepsies, such as the Dravet syndrome. In
            Dravet syndrome mice model, by a selective activation of
            Nav1.1/SCN1A channels, this peptide restores the function of
            inhibitory interneurons without affecting the firing of excitatory
            neurons. {ECO:0000305|PubMed:30076230}.
            [MISCELLANEOUS] Shows poor stability in cerebrospinal fluid and
            moderate stability in human serum (PubMed:32335140,
            PubMed:30076230). Half-life of the toxin is about 1.7 hour in
            cerebrospinal fluid (PubMed:30076230). Half-life of the native
            toxin is about 10 hours in human serum (PubMed:32335140).
            {ECO:0000269|PubMed:30076230, ECO:0000269|PubMed:32335140}.
            [MISCELLANEOUS] Negative results: does not inhibit Nav1.4/SCN4A,
            Nav1.5/SCN5A, Nav1.6/SCN8A, Nav1.7/SCN9A, and Nav1.8/SCN10A at
            concentrations up to 50 nM or 1 uM (PubMed:27281198,
            PubMed:30076230). Does not inhibit Nav1.2/SCN2A at concentrations
            up to 50 nM (PubMed:30076230). Has no or very weak effect on
            Kv1.1/KCNA1, Kv1.2/KCNA2, Kv1.3/KCNA3, Kv1.4/KCNA4, Kv1.5/KCNA5,
            Kv1.6/KCNA6 and Kv3.4/KCNC4 (PubMed:12065754). Does not show
            significant effects on Kv1.7/KCNQ1, Kv10.1/KCNH1/EAG1,
            Kv11.1/KCNH2/ERG1, KCa1.1/KCNMA1, KCa2.1/KCNN1 and KCa2.3/KCNN3
            (PubMed:12065754). {ECO:0000269|PubMed:12065754,
            ECO:0000269|PubMed:27281198, ECO:0000269|PubMed:30076230}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 09
            (HaTx) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..35
                     /organism="Heteroscodra maculata"
                     /db_xref="taxon:268413"
     Protein         1..35
                     /product="Delta-theraphotoxin-Hm1a"
                     /note="Delta-TRTX-Hm1a; Heteroscodratoxin-1;
                     Kappa-theraphotoxin-Hm1a; HmTx1; Kappa-TRTX-Hm1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..35
                     /region_name="Processed active peptide"
                     /note="Delta-theraphotoxin-Hm1a.
                     /evidence=ECO:0000269|PubMed:12065754,
                     ECO:0000269|PubMed:27281198. /id=PRO_0000045017."
     Region          1..30
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:30076230,
                     ECO:0007744|PDB:2N6O."
     Region          5..7
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2N6O."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:30076230,
                     ECO:0007744|PDB:2N6O."
     Region          12..14
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2N6O."
     Bond            bond(15,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:30076230,
                     ECO:0007744|PDB:2N6O."
     Region          23..26
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2N6O."
ORIGIN      
        1 ecrylfggcs stsdcckhls crsdwkycaw dgtfs
//

LOCUS       O17J_CONGE                82 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin GVIIJ; AltName: Full=Conotoxin
            muO-GVIIJ; AltName: Full=MuO'section sign'-GVIIJ; Flags: Precursor.
ACCESSION   X5IWS1
VERSION     X5IWS1.2
DBSOURCE    UniProtKB: locus O17J_CONGE, accession X5IWS1;
            class: standard.
            created: Feb 15, 2017.
            sequence updated: Feb 15, 2017.
            annotation updated: Feb 22, 2023.
            xrefs: AB910851.1, BAO65619.1, 2N8H_A
            xrefs (non-sequence databases): PDBsum:2N8H, AlphaFoldDB:X5IWS1,
            BMRB:X5IWS1, SMR:X5IWS1, TCDB:8.B.4.1.9, GO:0005576, GO:0008200,
            GO:0017080, GO:0090729, InterPro:IPR004214, Pfam:PF02950
KEYWORDS    3D-structure; Bromination; Direct protein sequencing; Disulfide
            bond; Hydroxylation; Ion channel impairing toxin; Knottin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Conus geographus (geography cone)
  ORGANISM  Conus geographus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Gastridium.
REFERENCE   1  (residues 1 to 82)
  AUTHORS   Dutertre,S., Jin,A.H., Vetter,I., Hamilton,B., Sunagar,K.,
            Lavergne,V., Dutertre,V., Fry,B.G., Antunes,A., Venter,D.J.,
            Alewood,P.F. and Lewis,R.J.
  TITLE     Evolution of separate predation- and defence-evoked venoms in
            carnivorous cone snails
  JOURNAL   Nat Commun 5, 3521 (2014)
   PUBMED   24662800
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 1-75, PROTEIN SEQUENCE OF 48-59 AND
            65-74, MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom, and Venom duct
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 82)
  AUTHORS   Gajewiak,J., Azam,L., Imperial,J., Walewska,A., Green,B.R.,
            Bandyopadhyay,P.K., Raghuraman,S., Ueberheide,B., Bern,M.,
            Zhou,H.M., Minassian,N.A., Hagan,R.H., Flinspach,M., Liu,Y.,
            Bulaj,G., Wickenden,A.D., Olivera,B.M., Yoshikami,D. and Zhang,M.M.
  TITLE     A disulfide tether stabilizes the block of sodium channels by the
            conotoxin muO section sign-GVIIJ
  JOURNAL   Proc Natl Acad Sci U S A 111 (7), 2758-2763 (2014)
   PUBMED   24497506
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 48-82, FUNCTION,
            SYNTHESIS OF 48-82, DISULFIDE BOND, BROMINATION AT TRP-49,
            HYDROXYLATION AT PRO-53, S-CYSTEINYLATION AT CYS-71, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom, and Venom duct
REFERENCE   3  (residues 1 to 82)
  AUTHORS   Zhang,M.M., Gajewiak,J., Azam,L., Bulaj,G., Olivera,B.M. and
            Yoshikami,D.
  TITLE     Probing the Redox States of Sodium Channel Cysteines at the Binding
            Site of muO section sign-Conotoxin GVIIJ
  JOURNAL   Biochemistry 54 (25), 3911-3920 (2015)
   PUBMED   26039939
  REMARK    SYNTHESIS OF 48-82 (WITHOUT BROMINATION).
REFERENCE   4  (residues 1 to 82)
  AUTHORS   Wilson,M.J., Zhang,M.M., Gajewiak,J., Azam,L., Rivier,J.E.,
            Olivera,B.M. and Yoshikami,D.
  TITLE     Alpha- and beta-subunit composition of voltage-gated sodium
            channels investigated with mu-conotoxins and the recently
            discovered muO section sign-conotoxin GVIIJ
  JOURNAL   J Neurophysiol 113 (7), 2289-2301 (2015)
   PUBMED   25632083
  REMARK    FUNCTION, AND SYNTHESIS OF 48-82.
REFERENCE   5  (residues 1 to 82)
  AUTHORS   Green,B.R., Gajewiak,J., Chhabra,S., Skalicky,J.J., Zhang,M.M.,
            Rivier,J.E., Bulaj,G., Olivera,B.M., Yoshikami,D. and Norton,R.S.
  TITLE     Structural Basis for the Inhibition of Voltage-gated Sodium
            Channels by Conotoxin muO section sign-GVIIJ
  JOURNAL   J Biol Chem 291 (13), 7205-7220 (2016)
   PUBMED   26817840
  REMARK    STRUCTURE BY NMR OF 48-82 OF MUTANT CYS-71, SYNTHESIS OF 48-82
            (WITHOUT BROMINATION), FUNCTION, DISULFIDE BONDS, AND MUTAGENESIS
            OF TRP-49; TRP-49; ASP-52; PRO-53; THR-56; LYS-59; LEU-60; ARG-61;
            LEU-62; TYR-63; SER-66; PHE-68; ASP-70; TYR-72; THR-73; LYS-74;
            THR-75; LYS-77; ASP-78 AND LYS-79.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin (GVIIJ(SSG)) blocks Nav1.1/SCN1A (Kd=11 nM),
            Nav1.2/SCN2A (Kd=11 nM), Nav1.3/SCN3A (Kd=15 nM), Nav1.4/SCN4A
            (Kd=4.7 nM), Nav1.6/SCN8A (Kd=360 nM) and Nav1.7/SCN9A (Kd=41 nM)
            (PubMed:24497506, PubMed:26039939). It binds the channel at the
            newly described site 8, which is composed by two surfaces whose one
            contains a non-disulfide-bonded cysteine (which is free to
            covalently bind the toxin Cys-71) (PubMed:24497506). It is
            noteworthy that coexpression of subunits beta-2 or beta-4 (but not
            beta-1 or beta-3) protects rNav1.1-1.7 against block by the toxin,
            since these subunits (thanks to their extracellular domain)
            covalently bind to the key cysteine of the channel, thus preventing
            the covalent binding of the toxin (PubMed:24497506,
            PubMed:25632083). {ECO:0000269|PubMed:24497506,
            ECO:0000269|PubMed:25632083, ECO:0000269|PubMed:26039939,
            ECO:0000269|PubMed:26817840}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:24662800}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:24662800}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:26817840}.
            [DOMAIN] The cysteine framework is VI/VII (C-C-CC-C-C).
            {ECO:0000305}.
            [PTM] Cys-71 is a key residue that tethers to the channel by
            covalent attachment, leading to nearly irreversible inhibition
            (k(off) very low) (PubMed:24497506, PubMed:26817840). In order to
            determine the solution structure without dimerization, this residue
            was mutated to Cys. {ECO:0000269|PubMed:24497506,
            ECO:0000269|PubMed:26817840}.
            [MASS SPECTROMETRY] Mass=3934.49; Method=MALDI;
            Evidence={ECO:0000269|PubMed:24497506}.
            [MISCELLANEOUS] Negative results: shows a very low affinity to
            Nav1.5/SCN5A (Kd=207 uM) and does not show activity on
            rNav1.8/SCN10A. {ECO:0000269|PubMed:24497506}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
            [SEQUENCE CAUTION] Sequence=BAO65619.1; Type=Erroneous termination;
            Note=Truncated C-terminus.; Evidence={ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..82
                     /organism="Conus geographus"
                     /db_xref="taxon:6491"
     Protein         1..82
                     /product="Mu-conotoxin GVIIJ"
                     /note="Conotoxin muO-GVIIJ; MuO'section sign'-GVIIJ"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..69
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..47
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:24497506.
                     /id=PRO_0000438880."
     Region          48..82
                     /region_name="Mature chain"
                     /note="Mu-conotoxin GVIIJ.
                     /evidence=ECO:0000269|PubMed:24497506.
                     /id=PRO_5004957961."
     Site            49
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:24497506."
     Site            49
                     /site_type="mutagenized"
                     /note="W->A: 10-fold decrease of affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Bond            bond(50,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24497506,
                     ECO:0000269|PubMed:26817840, ECO:0007744|PDB:2N8H."
     Site            52
                     /site_type="mutagenized"
                     /note="D->K: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            53
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:24497506."
     Site            53
                     /site_type="mutagenized"
                     /note="P->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            56
                     /site_type="mutagenized"
                     /note="T->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Bond            bond(57,69)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24497506,
                     ECO:0000269|PubMed:26817840, ECO:0007744|PDB:2N8H."
     Region          58..61
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2N8H."
     Site            59
                     /site_type="other"
                     /note="Functionally important residue, that binds to the
                     site 8 of the channel.
                     /evidence=ECO:0000305|PubMed:26817840."
     Site            59
                     /site_type="mutagenized"
                     /note="K->D: 280-fold decrease of affinity to
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:26817840."
     Site            60
                     /site_type="mutagenized"
                     /note="L->A: Small decrease in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            61
                     /site_type="other"
                     /note="Functionally important residue, that binds to the
                     site 8 of the channel.
                     /evidence=ECO:0000305|PubMed:26817840."
     Site            61
                     /site_type="mutagenized"
                     /note="R->D: 133-fold decrease of affinity to
                     Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:26817840."
     Site            62
                     /site_type="mutagenized"
                     /note="L->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            63
                     /site_type="other"
                     /note="Functionally important residue, that binds to the
                     site 8 of the channel.
                     /evidence=ECO:0000305|PubMed:26817840."
     Site            63
                     /site_type="mutagenized"
                     /note="Y->A: 53-fold decrease of affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Bond            bond(64,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:24497506,
                     ECO:0000269|PubMed:26817840, ECO:0007744|PDB:2N8H."
     Region          64..67
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2N8H."
     Site            66
                     /site_type="mutagenized"
                     /note="S->A: Small decrease in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            68
                     /site_type="mutagenized"
                     /note="F->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            70
                     /site_type="mutagenized"
                     /note="D->N: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Region          71..74
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2N8H."
     Site            71
                     /site_type="other"
                     /note="Functionally important residue, that binds to the
                     site 8 of the channel (distinct surface that K-59; R-61
                     and Y-63). /evidence=ECO:0000305|PubMed:26817840."
     Site            72
                     /site_type="mutagenized"
                     /note="Y->A,D,R: No change or small decrease in affinity
                     to Nav1.2/SCN2A. /evidence=ECO:0000269|PubMed:26817840."
     Site            73
                     /site_type="mutagenized"
                     /note="T->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            74
                     /site_type="mutagenized"
                     /note="K->D: 13-fold decrease of affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            74
                     /site_type="mutagenized"
                     /note="K->G,F: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            75
                     /site_type="mutagenized"
                     /note="T->A: Small decrease in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            77
                     /site_type="mutagenized"
                     /note="K->A: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            78
                     /site_type="mutagenized"
                     /note="D->K: No change in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
     Site            79
                     /site_type="mutagenized"
                     /note="K->D: Small decrease in affinity to Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:26817840."
ORIGIN      
        1 mkltcvviva allltacqli taldcggtqk hralrstikl sllrqhrgwc gdpgatcgkl
       61 rlyccsgfcd cytktckdks sa
//

LOCUS       TX15_PARSR                34 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Toxin GTx1-15; AltName:
            Full=Beta/omega-theraphotoxin-Gr2a; Short=Beta/omega-TRTX-Gr2a;
            AltName: Full=Toxin GpTx-1.
ACCESSION   P0DL73
VERSION     P0DL73.1
DBSOURCE    UniProtKB: locus TX15_PARSR, accession P0DL73;
            class: standard.
            created: Oct 25, 2017.
            sequence updated: Oct 25, 2017.
            annotation updated: May 3, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DL73, SMR:P0DL73,
            GO:0005576, GO:0005246, GO:0008200, GO:0017080, GO:0090729,
            InterPro:IPR011696, InterPro:IPR013140, Pfam:PF07740,
            SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Amidation; Calcium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin; Secreted;
            Toxin; Voltage-gated calcium channel impairing toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Paraphysa scrofa
  ORGANISM  Paraphysa scrofa
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Paraphysa.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Cherki,R.S., Kolb,E., Langut,Y., Tsveyer,L., Bajayo,N. and Meir,A.
  TITLE     Two tarantula venom peptides as potent and differential Na(V)
            channels blockers
  JOURNAL   Toxicon 77, 58-67 (2014)
   PUBMED   24211312
  REMARK    PROTEIN SEQUENCE, SUBCELLULAR LOCATION, SYNTHESIS, AMIDATION AT
            PHE-34, AND MASS SPECTROMETRY.;
            TISSUE=Venom
COMMENT     [FUNCTION] Potent voltage-gated sodium channel blocker
            (PubMed:24211312). Potently inhibits the voltage-gated sodium
            channels Nav1.7/SCN9A (IC(50)=0.58-10 nM) (PubMed:24211312) (By
            similarity). Shows a moderate activity on Nav1.1/SCN1A (IC(50)=6
            nM), Nav1.2/SCN2A (IC(50)=5-128 nM), Nav1.3/SCN3A (IC(50)=20.3-170
            nM), and Nav1.6/SCN8A (IC(50)=17-20.1 nM) (PubMed:24211312) (By
            similarity). Shows an unclear inhibition of Nav1.4/SCN4A
            (IC(50)=200 nM to >10 uM), Nav1.5/SCN5A (IC(50)=140 nM to >10 uM)
            and Nav1.8/SCN10A (IC(50)=68-12200 nM) (PubMed:24211312) (By
            similarity). Weakly blocks the low voltage-gated calcium channels
            Cav3.1/CACNA1G (30% inhibition of the peak current by 9.8 nM of the
            toxin) (By similarity). It shows moderate affinity for lipid
            bilayers (By similarity). {ECO:0000250|UniProtKB:P0DJA9,
            ECO:0000250|UniProtKB:P0DL72, ECO:0000269|PubMed:24211312}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:24211312}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:24211312}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P0DL72}.
            [DOMAIN] This toxin is amphipathic in nature with a hydrophobic
            face on one side of the molecule (composed of residues 5-Phe-Met-6
            and 27-His--Phe-34) and a hydrophilic (mostly cationic) face on the
            opposite side (composed of residues 10-Ile--Lys-15 and
            18-Arg--Pro-19). {ECO:0000250|UniProtKB:P0DL72}.
            [MASS SPECTROMETRY] Mass=4070.8; Method=Electrospray;
            Note=Monoisotopic mass.; Evidence={ECO:0000269|PubMed:24211312}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of Gtx1-15 from Grammostola rosea (AC P0DJA9) and
            GpTx-1 from Grammostola porteri (AC P0DL72). {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 08
            (Gtx1-15) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Paraphysa scrofa"
                     /db_xref="taxon:269635"
     Protein         1..34
                     /product="Toxin GTx1-15"
                     /note="Beta/omega-theraphotoxin-Gr2a; Toxin GpTx-1;
                     Beta/omega-TRTX-Gr2a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Mature chain"
                     /note="Toxin GTx1-15.
                     /evidence=ECO:0000269|PubMed:24211312.
                     /id=PRO_0000441930."
     Region          1..32
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(9,23)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(16,30)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Site            34
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000269|PubMed:24211312."
ORIGIN      
        1 dclgfmrkci pdndkccrpn lvcsrthkwc kyvf
//

LOCUS       BDS1_ANEVI                76 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Kappa-actitoxin-Avd4a; Short=Kappa-AITX-Avd4a;
            AltName: Full=Antihypertensive protein BDS-1; AltName: Full=Blood
            depressing substance 1; Short=BDS-1; Flags: Precursor.
ACCESSION   P0DMX6
VERSION     P0DMX6.1
DBSOURCE    UniProtKB: locus BDS1_ANEVI, accession P0DMX6;
            class: standard.
            created: Sep 16, 2015.
            sequence updated: Sep 16, 2015.
            annotation updated: Feb 22, 2023.
            xrefs: FK728690.1, FK727245.1, FK731753.1, FK734674.1, FK756071.1,
            FK756154.1, FK737141.1, FK733420.1, FK754388.1, FK721790.1,
            FK755366.1, FK745427.1, FK727043.1, FK752129.1
            xrefs (non-sequence databases): AlphaFoldDB:P0DMX6, SMR:P0DMX6,
            GO:0005576, GO:0042151, GO:0008200, GO:0015459, GO:0090729,
            GO:0008217, Gene3D:2.20.20.10, InterPro:IPR012414,
            InterPro:IPR023355, Pfam:PF07936, SUPFAM:SSF57392
KEYWORDS    Cleavage on pair of basic residues; Direct protein sequencing;
            Disulfide bond; Hypotensive agent; Ion channel impairing toxin;
            Nematocyst; Neurotoxin; Potassium channel impairing toxin;
            Secreted; Signal; Toxin; Voltage-gated potassium channel impairing
            toxin.
SOURCE      Anemonia viridis
  ORGANISM  Anemonia viridis
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Anemonia.
REFERENCE   1  (residues 1 to 76)
  AUTHORS   Sabourault,C., Ganot,P., Deleury,E., Allemand,D. and Furla,P.
  TITLE     Comprehensive EST analysis of the symbiotic sea anemone, Anemonia
            viridis
  JOURNAL   BMC Genomics 10, 333 (2009)
   PUBMED   19627569
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 76)
  AUTHORS   Loret,E.P., Luis,J., Nuccio,C., Villard,C., Mansuelle,P., Lebrun,R.
            and Villard,P.H.
  TITLE     A Low Molecular Weight Protein from the Sea Anemone Anemonia
            viridis with an Anti-Angiogenic Activity
  JOURNAL   Mar Drugs 16 (4), E134 (2018)
   PUBMED   29671760
  REMARK    PROTEIN SEQUENCE OF 34-76, AND MASS SPECTROMETRY.
            Publication Status: Online-Only
REFERENCE   3  (residues 1 to 76)
  AUTHORS   Kozlov,S. and Grishin,E.
  TITLE     The mining of toxin-like polypeptides from EST database by single
            residue distribution analysis
  JOURNAL   BMC Genomics 12, 88 (2011)
   PUBMED   21281459
  REMARK    NOMENCLATURE.
            Publication Status: Online-Only
REFERENCE   4  (residues 1 to 76)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
REFERENCE   5  (residues 1 to 76)
  AUTHORS   Nicosia,A., Maggio,T., Mazzola,S. and Cuttitta,A.
  TITLE     Evidence of accelerated evolution and ectodermal-specific
            expression of presumptive BDS toxin cDNAs from Anemonia viridis
  JOURNAL   Mar Drugs 11 (11), 4213-4231 (2013)
   PUBMED   24177670
  REMARK    3D-STRUCTURE MODELING, AND TISSUE SPECIFICITY.
            Publication Status: Online-Only
COMMENT     [FUNCTION] Acts as a gating modifier on both Kv and Nav ion
            channels, and also acts on blood pressure (By similarity).
            Voltage-dependently inhibits voltage-gated potassium channels Kv3
            (Kv3.1/KCNC1, Kv3.2/KCNC2 and Kv3.4/KCNC4) and slows inactivation
            of the voltage-gated sodium channel Nav1.7/SCN9A (By similarity).
            Inhibits all Kv3.1, Kv3.2 and Kv3.4 by about 50% when tested at a
            voltage of +40 mV (45%, 48% and 56%, respectively) (By similarity).
            May act by binding residues in voltage-sensing domains S3b and S4
            of Kv3 (By similarity). On sodium channels, tests have been done on
            human Nav1.7/SCN9A (expressed in HEK293 cells) (EC(50)=3 nM) and
            rat SCG neurons that mostly carry Nav1.7 channels (EC(50)=300 nM)
            (By similarity). This toxin also reduces blood pressure (By
            similarity). {ECO:0000250|UniProtKB:P11494}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [TISSUE SPECIFICITY] Highly expressed in the ectodermal tissue from
            the distal and proximal tentacles, body wall, and oral disk.
            {ECO:0000269|PubMed:24177670}.
            [MASS SPECTROMETRY] Mass=4708; Method=MALDI;
            Evidence={ECO:0000269|PubMed:29671760}.
            [MISCELLANEOUS] Is the most represented component of the BDS family
            in A.viridis. {ECO:0000305|PubMed:21281459}.
            [MISCELLANEOUS] This protein sequence is identical to BDS-1 from
            A.sulcata (AC P11494). {ECO:0000305}.
            [SIMILARITY] Belongs to the sea anemone type 3 (BDS) potassium
            channel toxin family. {ECO:0000305}.
            [CAUTION] Opinions are divided on whether Anemonia viridis
            (Forsskal, 1775) and Anemonia sulcata (Pennant, 1777) are separate
            species. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..76
                     /organism="Anemonia viridis"
                     /db_xref="taxon:51769"
     Protein         1..76
                     /product="Kappa-actitoxin-Avd4a"
                     /note="Kappa-AITX-Avd4a; Antihypertensive protein BDS-1;
                     Blood depressing substance 1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..31
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:29671760.
                     /id=PRO_0000433648."
     Region          34..76
                     /region_name="Mature chain"
                     /note="Kappa-actitoxin-Avd4a.
                     /evidence=ECO:0000269|PubMed:29671760.
                     /id=PRO_0000433649."
     Region          35..70
                     /region_name="Defensin_4"
                     /note="Potassium-channel blocking toxin; pfam07936"
                     /db_xref="CDD:254527"
     Bond            bond(37,72)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
     Bond            bond(39,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
     Bond            bond(55,73)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P11494."
ORIGIN      
        1 mnkalflclv vlcaavvfaa edlqkakhap fkraapcfcs gkpgrgdlwi lrgtcpggyg
       61 ytsncykwpn iccyph
//

LOCUS       H4A01_CYRHA               86 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Hhn1b 1; Short=Mu-TRTX-Hhn1b;
            AltName: Full=Hainantoxin-4; AltName: Full=Hainantoxin-IV;
            Short=HnTx-IV; AltName: Full=Peptide F8-18.88; Flags: Precursor.
ACCESSION   D2Y232
VERSION     D2Y232.1
DBSOURCE    UniProtKB: locus H4A01_CYRHA, accession D2Y232;
            class: standard.
            extra accessions:P83471
            created: Nov 2, 2010.
            sequence updated: Mar 2, 2010.
            annotation updated: Feb 22, 2023.
            xrefs: GU292909.1, ADB56725.1, 1NIY_A, 1RYG_A, 1RYV_A
            xrefs (non-sequence databases): PDBsum:1NIY, PDBsum:1RYG,
            PDBsum:1RYV, AlphaFoldDB:D2Y232, BMRB:D2Y232, SMR:D2Y232,
            ArachnoServer:AS000340, EvolutionaryTrace:D2Y232, GO:0005576,
            GO:0044231, GO:0008200, GO:0017080, GO:0090729, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    3D-structure; Amidation; Direct protein sequencing; Disulfide bond;
            Ion channel impairing toxin; Knottin; Neurotoxin; Presynaptic
            neurotoxin; Secreted; Signal; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Haplopelma hainanum
  ORGANISM  Haplopelma hainanum
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Haplopelma.
REFERENCE   1  (residues 1 to 86)
  AUTHORS   Tang,X., Zhang,Y., Hu,W., Xu,D., Tao,H., Yang,X., Li,Y., Jiang,L.
            and Liang,S.
  TITLE     Molecular diversification of peptide toxins from the tarantula
            Haplopelma hainanum (Ornithoctonus hainana) venom based on
            transcriptomic, peptidomic, and genomic analyses
  JOURNAL   J Proteome Res 9 (5), 2550-2564 (2010)
   PUBMED   20192277
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], PROTEIN SEQUENCE OF 50-84,
            AND IDENTIFICATION BY MASS SPECTROMETRY.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 86)
  AUTHORS   Liu,Z., Dai,J., Chen,Z., Hu,W., Xiao,Y. and Liang,S.
  TITLE     Isolation and characterization of hainantoxin-IV, a novel
            antagonist of tetrodotoxin-sensitive sodium channels from the
            Chinese bird spider Selenocosmia hainana
  JOURNAL   Cell Mol Life Sci 60 (5), 972-978 (2003)
   PUBMED   12827284
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, TOXIN TARGET, SUBCELLULAR
            LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY, TOXIC DOSE, AND
            DISULFIDE BONDS.
REFERENCE   3  (residues 1 to 86)
  AUTHORS   Xiao,Y. and Liang,S.
  TITLE     Inhibition of neuronal tetrodotoxin-sensitive Na+ channels by two
            spider toxins: hainantoxin-III and hainantoxin-IV
  JOURNAL   Eur J Pharmacol 477 (1), 1-7 (2003)
   PUBMED   14512091
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, TOXIN TARGET, SUBCELLULAR
            LOCATION, TISSUE SPECIFICITY, AND AMIDATION AT ILE-84.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 86)
  AUTHORS   Xiao,Y.C. and Liang,S.P.
  TITLE     Inhibition of sodium channels in rat dorsal root ganglion neurons
            by Hainantoxin-IV, a novel spider toxin
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35 (1), 82-85
            (2003)
   PUBMED   12518233
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 86)
  AUTHORS   Liu,Z.H., Chen,P. and Liang,S.P.
  TITLE     Synthesis and oxidative refolding of hainantoxin-IV
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34 (4),
            516-519 (2002)
   PUBMED   12098779
  REMARK    SYNTHESIS.
REFERENCE   6  (residues 1 to 86)
  AUTHORS   Xu,X., Xiong,X., Li,D.L., Xiao,Y.C., Wang,X.C. and Liang,S.P.
  TITLE     [Solid-phase synthesis and biological characterization of
            S12A-HNTX-IV and R29A-HNTX-IV: two mutants of hainantoxin-IV]
  JOURNAL   Sheng Wu Gong Cheng Xue Bao 21 (1), 92-96 (2005)
   PUBMED   15859335
  REMARK    SYNTHESIS, AND MUTAGENESIS OF SER-61 AND ARG-78.
REFERENCE   7  (residues 1 to 86)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    FUNCTION, AND SYNTHESIS.
REFERENCE   8  (residues 1 to 86)
  AUTHORS   Li,D., Xiao,Y., Xu,X., Xiong,X., Lu,S., Liu,Z., Zhu,Q., Wang,M.,
            Gu,X. and Liang,S.
  TITLE     Structure--activity relationships of hainantoxin-IV and structure
            determination of active and inactive sodium channel blockers
  JOURNAL   J Biol Chem 279 (36), 37734-37740 (2004)
   PUBMED   15201273
  REMARK    STRUCTURE BY NMR OF 50-84, DISULFIDE BONDS, AMIDATION AT ILE-84,
            AND MUTAGENESIS OF SER-61; ARG-75; LYS-76 AND ARG-78.
COMMENT     On Nov 3, 2010 this sequence version replaced P83471.1.
            [FUNCTION] Neurotoxin that selectively inhibits neuronal
            tetrodotoxin-sensitive voltage-gated sodium channels (Nav)
            (IC(50)=44.6 nM) (PubMed:14512091, PubMed:12518233). It is active
            on Nav1.2/SCN2A (IC(50)=22.4 nM), Nav1.6/SCN8A (IC(50)=50.1 nM) and
            Nav1.7/SCN9A (IC(50)=48.9 nM) (PubMed:29703751). It shows low
            affinity for lipid bilayers (PubMed:29703751).
            {ECO:0000269|PubMed:12518233, ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:29703751}.
            [SUBUNIT] Monomer.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:12827284, ECO:0000269|PubMed:14512091}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:15201273}.
            [MASS SPECTROMETRY] Mass=3988.58; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12827284}.
            [TOXIC DOSE] LD(50) is 0.2 +-0.07 mg/kg by intraperitoneal
            injection into mice. {ECO:0000269|PubMed:12827284}.
            [MISCELLANEOUS] Negative results: does not affect
            tetrodotoxin-resistant voltage-gated sodium channels or calcium
            channels. {ECO:0000269|PubMed:12518233,
            ECO:0000269|PubMed:14512091}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 22
            (Htx-4) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..86
                     /organism="Haplopelma hainanum"
                     /db_xref="taxon:209901"
     Protein         1..86
                     /product="Mu-theraphotoxin-Hhn1b 1"
                     /note="Mu-TRTX-Hhn1b; Hainantoxin-4; Hainantoxin-IV;
                     Peptide F8-18.88; HnTx-IV"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400566."
     Region          50..84
                     /region_name="Processed active peptide"
                     /note="Mu-theraphotoxin-Hhn1b 1.
                     /evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400567."
     Region          50..82
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(51,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000312|PDB:1NIY, ECO:0000312|PDB:1RYG,
                     ECO:0000312|PDB:1RYV."
     Bond            bond(58,73)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000312|PDB:1NIY, ECO:0000312|PDB:1RYG,
                     ECO:0000312|PDB:1RYV."
     Region          60..62
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1NIY."
     Region          61..64
                     /region_name="Conflict"
                     /note="SNDQ -> DQSN (in Ref. 3; AA sequence).
                     /evidence=ECO:0000305."
     Site            61
                     /site_type="mutagenized"
                     /note="S->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Bond            bond(65,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000312|PDB:1NIY, ECO:0000312|PDB:1RYG,
                     ECO:0000312|PDB:1RYV."
     Region          67..70
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1NIY."
     Region          71..73
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1NIY."
     Region          75..77
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1NIY."
     Site            75
                     /site_type="mutagenized"
                     /note="R->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            76
                     /site_type="other"
                     /note="Interacts with channel."
     Site            76
                     /site_type="mutagenized"
                     /note="K->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            78
                     /site_type="other"
                     /note="Interacts with channel."
     Site            78
                     /site_type="mutagenized"
                     /note="R->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Region          79..82
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1NIY."
     Site            84
                     /site_type="amidation"
                     /note="Isoleucine amide.
                     /evidence=ECO:0000269|PubMed:14512091,
                     ECO:0000269|PubMed:15201273."
ORIGIN      
        1 mkasmflala glallfvvcy aseseekefs nellssvlav ddnskgeere clgfgkgcnp
       61 sndqcckssn lvcsrkhrwc kyeigk
//

LOCUS       VSTX3_GRARO               34 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Voltage sensor toxin 3; Short=VSTX3; AltName:
            Full=Beta/kappa-theraphotoxin-Gr4a; Short=Beta/kappa-TRTX-Gr4a.
ACCESSION   P0C2P5
VERSION     P0C2P5.1
DBSOURCE    UniProtKB: locus VSTX3_GRARO, accession P0C2P5;
            class: standard.
            created: Apr 3, 2007.
            sequence updated: Apr 3, 2007.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0C2P5, SMR:P0C2P5,
            ArachnoServer:AS000425, GO:0005576, GO:0008200, GO:0015459,
            GO:0090729, InterPro:IPR011696, InterPro:IPR013140, Pfam:PF07740,
            SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Potassium channel impairing toxin;
            Secreted; Toxin.
SOURCE      Grammostola rosea (Chilean rose tarantula)
  ORGANISM  Grammostola rosea
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Grammostola.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Ruta,V. and MacKinnon,R.
  TITLE     Localization of the voltage-sensor toxin receptor on KvAP
  JOURNAL   Biochemistry 43 (31), 10071-10079 (2004)
   PUBMED   15287735
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
COMMENT     [FUNCTION] Potent voltage-gated sodium channel blocker (IC(50)=190
            nM and 210 nM on human and rat Nav1.3/SCN3A respectively, 430 nM on
            human Nav1.7/SCN9A, 770 nM and 290 nM on human and rat
            Nav1.8/SCN10A, respectively) (By similarity). Binds the
            voltage-sensor domain of the potassium channel KvAP (from Aeropyrum
            pernix) and weakly inhibits this channel (PubMed:15287735).
            {ECO:0000250|UniProtKB:P0DL74, ECO:0000269|PubMed:15287735}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:15287735}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:15287735}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] Shows only a very weak inhibition on human
            Nav1.5/SCN5A. {ECO:0000250|UniProtKB:P0DL74}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of VSTX3 from Paraphysa scrofa (AC P0DL74).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 61
            (VSTX3) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Grammostola rosea"
                     /db_xref="taxon:432528"
     Protein         1..34
                     /product="Voltage sensor toxin 3"
                     /note="VSTX3; Beta/kappa-theraphotoxin-Gr4a;
                     Beta/kappa-TRTX-Gr4a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Processed active peptide"
                     /note="Voltage sensor toxin 3.
                     /evidence=ECO:0000269|PubMed:15287735.
                     /id=PRO_0000283771."
     Region          1..31
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(16,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
ORIGIN      
        1 dclgwfkgcd pdndkccegy kcnrrdkwck yklw
//

LOCUS       VSTX3_PARSR               34 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Voltage sensor toxin 3; Short=VSTX3; AltName:
            Full=Beta/kappa-theraphotoxin-Gr4a; Short=Beta/kappa-TRTX-Gr4a.
ACCESSION   P0DL74
VERSION     P0DL74.1
DBSOURCE    UniProtKB: locus VSTX3_PARSR, accession P0DL74;
            class: standard.
            created: Oct 25, 2017.
            sequence updated: Oct 25, 2017.
            annotation updated: May 3, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DL74, SMR:P0DL74,
            GO:0005576, GO:0008200, GO:0015459, GO:0017080, GO:0090729,
            InterPro:IPR011696, InterPro:IPR013140, Pfam:PF07740,
            SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Potassium channel impairing toxin;
            Secreted; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Paraphysa scrofa
  ORGANISM  Paraphysa scrofa
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Paraphysa.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Cherki,R.S., Kolb,E., Langut,Y., Tsveyer,L., Bajayo,N. and Meir,A.
  TITLE     Two tarantula venom peptides as potent and differential Na(V)
            channels blockers
  JOURNAL   Toxicon 77, 58-67 (2014)
   PUBMED   24211312
  REMARK    PROTEIN SEQUENCE, SYNTHESIS, SUBCELLULAR LOCATION, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
COMMENT     [FUNCTION] Potent voltage-gated sodium channel blocker (IC(50)=190
            nM and 210 nM on human and rat Nav1.3/SCN3A respectively, 430 nM on
            human Nav1.7/SCN9A, 770 nM and 290 nM on human and rat
            Nav1.8/SCN10A respectively) (PubMed:24211312). Binds the
            voltage-sensor domain of the potassium channel KvAP (from Aeropyrum
            pernix) and weakly inhibits this channel (By similarity).
            {ECO:0000250|UniProtKB:P0C2P5, ECO:0000269|PubMed:24211312}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:24211312}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:24211312}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MASS SPECTROMETRY] Mass=4168.0; Method=Electrospray;
            Note=Monoisotopic mass.; Evidence={ECO:0000269|PubMed:24211312}.
            [MISCELLANEOUS] Shows only a very weak inhibition on human
            Nav1.5/SCN5A. {ECO:0000269|PubMed:24211312}.
            [MISCELLANEOUS] The primary structure of the mature peptide is
            identical to that of VSTX3 from Grammostola rosea (AC P0C2P5).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 61
            (VSTX3) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Paraphysa scrofa"
                     /db_xref="taxon:269635"
     Protein         1..34
                     /product="Voltage sensor toxin 3"
                     /note="VSTX3; Beta/kappa-theraphotoxin-Gr4a;
                     Beta/kappa-TRTX-Gr4a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Processed active peptide"
                     /note="Voltage sensor toxin 3.
                     /evidence=ECO:0000269|PubMed:24211312.
                     /id=PRO_0000442000."
     Region          1..31
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
     Bond            bond(16,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DL72."
ORIGIN      
        1 dclgwfkgcd pdndkccegy kcnrrdkwck yklw
//

LOCUS       NA13_BUNGR                48 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Delta-actitoxin-Bgr2b; Short=Delta-AITX-Bgr2b;
            AltName: Full=Bg III; Short=BgIII; AltName: Full=Neurotoxin Bg-3.
ACCESSION   P0C1F5
VERSION     P0C1F5.1
DBSOURCE    UniProtKB: locus NA13_BUNGR, accession P0C1F5;
            class: standard.
            created: May 16, 2006.
            sequence updated: May 16, 2006.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0C1F5, SMR:P0C1F5,
            GO:0005576, GO:0042151, GO:0017080, GO:0090729, GO:0009966,
            Gene3D:2.20.20.10, InterPro:IPR000693, InterPro:IPR023355,
            Pfam:PF00706, PIRSF:PIRSF001905, SUPFAM:SSF57392
KEYWORDS    Cardiotoxin; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Nematocyst; Neurotoxin; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Bunodosoma granuliferum
  ORGANISM  Bunodosoma granuliferum
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Bunodosoma.
REFERENCE   1  (residues 1 to 48)
  AUTHORS   Loret,E.P., del Valle,R.M., Mansuelle,P., Sampieri,F. and Rochat,H.
  TITLE     Positively charged amino acid residues located similarly in sea
            anemone and scorpion toxins
  JOURNAL   J Biol Chem 269 (24), 16785-16788 (1994)
   PUBMED   7911468
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND TOXIC DOSE.
REFERENCE   2  (residues 1 to 48)
  AUTHORS   Goudet,C., Ferrer,T., Galan,L., Artiles,A., Batista,C.F.,
            Possani,L.D., Alvarez,J., Aneiros,A. and Tytgat,J.
  TITLE     Characterization of two Bunodosoma granulifera toxins active on
            cardiac sodium channels
  JOURNAL   Br J Pharmacol 134 (6), 1195-1206 (2001)
   PUBMED   11704639
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND MASS SPECTROMETRY.
REFERENCE   3  (residues 1 to 48)
  AUTHORS   Bosmans,F., Aneiros,A. and Tytgat,J.
  TITLE     The sea anemone Bunodosoma granulifera contains surprisingly
            efficacious and potent insect-selective toxins
  JOURNAL   FEBS Lett 532 (1-2), 131-134 (2002)
   PUBMED   12459477
  REMARK    FUNCTION.
REFERENCE   4  (residues 1 to 48)
  AUTHORS   Rodriguez,A.A., Cassoli,J.S., Sa,F., Dong,Z.Q., de Freitas,J.C.,
            Pimenta,A.M., de Lima,M.E., Konno,K., Lee,S.M., Garateix,A. and
            Zaharenko,A.J.
  TITLE     Peptide fingerprinting of the neurotoxic fractions isolated from
            the secretions of sea anemones Stichodactyla helianthus and
            Bunodosoma granulifera. New members of the APETx-like family
            identified by a 454 pyrosequencing approach
  JOURNAL   Peptides 34 (1), 26-38 (2012)
   PUBMED   22015268
  REMARK    MASS SPECTROMETRY, AND FUNCTION.
REFERENCE   5  (residues 1 to 48)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Binds voltage-dependently at site 3 of sodium channels
            (Nav) and inhibits the inactivation of the activated channels,
            thereby blocking neuronal transmission. Has effect on SCN4A/SCN1B,
            and SCN5A/SCN1B, has no effect on SCN2A/SCN1B, and SCN10A/SCN1B.
            Possesses the highest efficacy for the insect sodium channel
            para/tipE. Also interacts with sodium channels in cardiac cells.
            Shows lethality to crabs (PubMed:22015268).
            {ECO:0000269|PubMed:11704639, ECO:0000269|PubMed:12459477,
            ECO:0000269|PubMed:7911468}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=5073.1; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:11704639}.
            [MASS SPECTROMETRY] Mass=5072.9; Method=MALDI;
            Evidence={ECO:0000269|PubMed:22015268}.
            [TOXIC DOSE] LD(50) is 21 ug/kg by intracerebroventricular
            injection into mice. {ECO:0000269|PubMed:7911468}.
            [SIMILARITY] Belongs to the sea anemone sodium channel inhibitory
            toxin family. Type I subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..48
                     /organism="Bunodosoma granuliferum"
                     /db_xref="taxon:31164"
     Protein         1..48
                     /product="Delta-actitoxin-Bgr2b"
                     /note="Delta-AITX-Bgr2b; Bg III; Neurotoxin Bg-3; BgIII"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..48
                     /region_name="Mature chain"
                     /note="Delta-actitoxin-Bgr2b.
                     /evidence=ECO:0000269|PubMed:11704639,
                     ECO:0000269|PubMed:7911468. /id=PRO_0000236031."
     Region          3..46
                     /region_name="Toxin_4"
                     /note="Anenome neurotoxin; pfam00706"
                     /db_xref="CDD:109750"
     Bond            bond(4,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01530."
     Bond            bond(6,35)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01530."
     Bond            bond(28,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01530."
ORIGIN      
        1 gascrcdsdg ptsrgdtltg tlwligrcps gwhncrgsgp figycckq
//

LOCUS       TX3_PARSR                 34 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-theraphotoxin-Ps1a; Short=Beta-TRTX-Ps1a;
            AltName: Full=PaurTx-III; AltName: Full=Phrixotoxin-3;
            Short=PaurTx3.
ACCESSION   P84510
VERSION     P84510.1
DBSOURCE    UniProtKB: locus TX3_PARSR, accession P84510;
            class: standard.
            created: Oct 25, 2005.
            sequence updated: Oct 25, 2005.
            annotation updated: Feb 22, 2023.
            xrefs: 5WE3_A
            xrefs (non-sequence databases): PDBsum:5WE3, AlphaFoldDB:P84510,
            BMRB:P84510, SMR:P84510, TCDB:8.B.3.1.4, ArachnoServer:AS000274,
            GO:0005615, GO:0019871, GO:0090729, GO:0044489, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Knottin; Neurotoxin; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Paraphysa scrofa
  ORGANISM  Paraphysa scrofa
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Paraphysa.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Bosmans,F., Rash,L., Zhu,S., Diochot,S., Lazdunski,M., Escoubas,P.
            and Tytgat,J.
  TITLE     Four novel tarantula toxins as selective modulators of
            voltage-gated sodium channel subtypes
  JOURNAL   Mol Pharmacol 69 (2), 419-429 (2006)
   PUBMED   16267209
  REMARK    PROTEIN SEQUENCE, FUNCTION, BIOASSAY, SUBCELLULAR LOCATION, AND
            MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 34)
  AUTHORS   Agwa,A.J., Peigneur,S., Chow,C.Y., Lawrence,N., Craik,D.J.,
            Tytgat,J., King,G.F., Henriques,S.T. and Schroeder,C.I.
  TITLE     Gating modifier toxins isolated from spider venom: Modulation of
            voltage-gated sodium channels and the role of lipid membranes
  JOURNAL   J Biol Chem 293 (23), 9041-9052 (2018)
   PUBMED   29703751
  REMARK    FUNCTION, AND SYNTHESIS.
REFERENCE   3  (residues 1 to 34)
  AUTHORS   Agwa,A.J., Huang,Y.H., Craik,D.J., Henriques,S.T. and
            Schroeder,C.I.
  TITLE     Lengths of the C-Terminus and Interconnecting Loops Impact
            Stability of Spider-Derived Gating Modifier Toxins
  JOURNAL   Toxins (Basel) 9 (8), E248 (2017)
   PUBMED   28805686
  REMARK    STRUCTURE BY NMR, DISULFIDE BOND, AND SYNTHESIS.
            Publication Status: Online-Only
COMMENT     [FUNCTION] Potent inhibitor of Nav1.2/SCN2A voltage-gated sodium
            channels (IC(50)=0.6-0.7 nM) (PubMed:16267209, PubMed:29703751).
            Also weakly inhibits Nav1.1/SCN1A, Nav1.4/SCN4A, Nav1.5/SCN5A,
            Nav1.7/SCN9A and Nav1.8/SCN10A (IC(50)=20-610 nM) (PubMed:16267209,
            PubMed:29703751). It acts by shifting the voltage dependence of
            channel activation to more depolarized potentials and by blocking
            the inward component of the sodium current (PubMed:16267209). It
            shows low affinity for lipid bilayers (PubMed:29703751). In vivo,
            this toxin causes general ataxia, lack of response to stimuli, and
            semiparalysis (PubMed:16267209). After a few minutes, the mice are
            unable to stand, and breathing is reduced in rhythm and intensity
            (PubMed:16267209). Symptoms gradually increase with progressive
            slowing of breathing and flaccid paralysis; death occurred within
            10 to 20 minutes post injection (PubMed:16267209). Animals remain
            totally flaccid, and no symptoms of excitatory neurotoxicity are
            observed (PubMed:16267209). {ECO:0000269|PubMed:16267209,
            ECO:0000269|PubMed:29703751}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:16267209}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:16267209}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:28805686}.
            [MASS SPECTROMETRY] Mass=4055.88; Method=MALDI;
            Evidence={ECO:0000269|PubMed:16267209}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 08
            (Gtx1-15) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Paraphysa scrofa"
                     /db_xref="taxon:269635"
     Protein         1..34
                     /product="Beta-theraphotoxin-Ps1a"
                     /note="Beta-TRTX-Ps1a; PaurTx-III; Phrixotoxin-3; PaurTx3"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Processed active peptide"
                     /note="Beta-theraphotoxin-Ps1a.
                     /evidence=ECO:0000269|PubMed:16267209.
                     /id=PRO_0000045003."
     Region          1..32
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:28805686,
                     ECO:0000312|PDB:5WE3."
     Bond            bond(9,23)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:28805686,
                     ECO:0000312|PDB:5WE3."
     Bond            bond(16,30)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:28805686,
                     ECO:0000312|PDB:5WE3."
     Region          18..20
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:5WE3."
     Region          21..23
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5WE3."
     Region          25..27
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:5WE3."
     Region          28..32
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5WE3."
ORIGIN      
        1 dclgflwkcn psndkccrpn lvcsrkdkwc kyqi
//

LOCUS       H4A03_CYRHA               86 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Hhn1b 3; Short=Mu-TRTX-Hhn1b;
            AltName: Full=Hainantoxin-4.3; AltName: Full=Hainantoxin-IV.3;
            Short=HnTx-IV.3; AltName: Full=Peptide F8-18.88; Flags: Precursor.
ACCESSION   D2Y2D7
VERSION     D2Y2D7.1
DBSOURCE    UniProtKB: locus H4A03_CYRHA, accession D2Y2D7;
            class: standard.
            extra accessions:P83471
            created: Nov 2, 2010.
            sequence updated: Mar 2, 2010.
            annotation updated: Feb 22, 2023.
            xrefs: GU293014.1, ADB56830.1
            xrefs (non-sequence databases): AlphaFoldDB:D2Y2D7, BMRB:D2Y2D7,
            SMR:D2Y2D7, ArachnoServer:AS000340, GO:0005576, GO:0044231,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Presynaptic neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Haplopelma hainanum
  ORGANISM  Haplopelma hainanum
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Haplopelma.
REFERENCE   1  (residues 1 to 86)
  AUTHORS   Tang,X., Zhang,Y., Hu,W., Xu,D., Tao,H., Yang,X., Li,Y., Jiang,L.
            and Liang,S.
  TITLE     Molecular diversification of peptide toxins from the tarantula
            Haplopelma hainanum (Ornithoctonus hainana) venom based on
            transcriptomic, peptidomic, and genomic analyses
  JOURNAL   J Proteome Res 9 (5), 2550-2564 (2010)
   PUBMED   20192277
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], PROTEIN SEQUENCE OF 50-84,
            AND IDENTIFICATION BY MASS SPECTROMETRY.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 86)
  AUTHORS   Liu,Z., Dai,J., Chen,Z., Hu,W., Xiao,Y. and Liang,S.
  TITLE     Isolation and characterization of hainantoxin-IV, a novel
            antagonist of tetrodotoxin-sensitive sodium channels from the
            Chinese bird spider Selenocosmia hainana
  JOURNAL   Cell Mol Life Sci 60 (5), 972-978 (2003)
   PUBMED   12827284
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, MASS SPECTROMETRY, TOXIC DOSE, AND DISULFIDE BONDS.
REFERENCE   3  (residues 1 to 86)
  AUTHORS   Xiao,Y. and Liang,S.
  TITLE     Inhibition of neuronal tetrodotoxin-sensitive Na+ channels by two
            spider toxins: hainantoxin-III and hainantoxin-IV
  JOURNAL   Eur J Pharmacol 477 (1), 1-7 (2003)
   PUBMED   14512091
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, AND AMIDATION AT ILE-84.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 86)
  AUTHORS   Xiao,Y.C. and Liang,S.P.
  TITLE     Inhibition of sodium channels in rat dorsal root ganglion neurons
            by Hainantoxin-IV, a novel spider toxin
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35 (1), 82-85
            (2003)
   PUBMED   12518233
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 86)
  AUTHORS   Liu,Z.H., Chen,P. and Liang,S.P.
  TITLE     Synthesis and oxidative refolding of hainantoxin-IV
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34 (4),
            516-519 (2002)
   PUBMED   12098779
  REMARK    SYNTHESIS.
REFERENCE   6  (residues 1 to 86)
  AUTHORS   Xu,X., Xiong,X., Li,D.L., Xiao,Y.C., Wang,X.C. and Liang,S.P.
  TITLE     [Solid-phase synthesis and biological characterization of
            S12A-HNTX-IV and R29A-HNTX-IV: two mutants of hainantoxin-IV]
  JOURNAL   Sheng Wu Gong Cheng Xue Bao 21 (1), 92-96 (2005)
   PUBMED   15859335
  REMARK    SYNTHESIS, AND MUTAGENESIS OF SER-61 AND ARG-78.
REFERENCE   7  (residues 1 to 86)
  AUTHORS   Li,D., Xiao,Y., Xu,X., Xiong,X., Lu,S., Liu,Z., Zhu,Q., Wang,M.,
            Gu,X. and Liang,S.
  TITLE     Structure--activity relationships of hainantoxin-IV and structure
            determination of active and inactive sodium channel blockers
  JOURNAL   J Biol Chem 279 (36), 37734-37740 (2004)
   PUBMED   15201273
  REMARK    STRUCTURE BY NMR OF 50-84, DISULFIDE BONDS, AMIDATION AT ILE-84,
            AND MUTAGENESIS OF SER-61; ARG-75; LYS-76 AND ARG-78.
COMMENT     [FUNCTION] Neurotoxin. Selectively blocks neuronal
            tetrodotoxin-sensitive voltage-gated sodium channels (Nav) with an
            IC(50) of 44.6 nM. Does not affect tetrodotoxin-resistant
            voltage-gated sodium channels or calcium channels.
            {ECO:0000269|PubMed:12518233, ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091}.
            [SUBUNIT] Monomer.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:12827284, ECO:0000269|PubMed:14512091}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            [MASS SPECTROMETRY] Mass=3988.58; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12827284}.
            [TOXIC DOSE] LD(50) is 0.2 +-0.07 mg/kg by intraperitoneal
            injection into mice. {ECO:0000269|PubMed:12827284}.
            [MISCELLANEOUS] Several genes are coding for Mu-theraphotoxin-Hhn1b
            for which the structure by NMR has been determined. The
            cross-references to PDB can be found in entry AC D2Y232.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 22
            (Htx-4) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..86
                     /organism="Haplopelma hainanum"
                     /db_xref="taxon:209901"
     Protein         1..86
                     /product="Mu-theraphotoxin-Hhn1b 3"
                     /note="Mu-TRTX-Hhn1b; Hainantoxin-4.3; Hainantoxin-IV.3;
                     Peptide F8-18.88; HnTx-IV.3"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400570."
     Region          50..84
                     /region_name="Processed active peptide"
                     /note="Mu-theraphotoxin-Hhn1b 3.
                     /evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400571."
     Region          50..82
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(51,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Bond            bond(58,73)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Region          61..64
                     /region_name="Conflict"
                     /note="SNDQ -> DQSN (in Ref. 3; AA sequence).
                     /evidence=ECO:0000305."
     Site            61
                     /site_type="mutagenized"
                     /note="S->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Bond            bond(65,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Site            75
                     /site_type="mutagenized"
                     /note="R->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            76
                     /site_type="other"
                     /note="Interacts with channel."
     Site            76
                     /site_type="mutagenized"
                     /note="K->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            78
                     /site_type="other"
                     /note="Interacts with channel."
     Site            78
                     /site_type="mutagenized"
                     /note="R->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Site            84
                     /site_type="amidation"
                     /note="Isoleucine amide.
                     /evidence=ECO:0000269|PubMed:14512091,
                     ECO:0000269|PubMed:15201273."
ORIGIN      
        1 mkasmflalt glallfvvcy aseseekefs nellssvlav ddnskgeere clgfgkgcnp
       61 sndqcckssn lvcsrkhrwc kyeigk
//

LOCUS       H4A02_CYRHA               86 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Hhn1b 2; Short=Mu-TRTX-Hhn1b;
            AltName: Full=Hainantoxin-4.2; AltName: Full=Hainantoxin-IV.2;
            Short=HnTx-IV.2; AltName: Full=Peptide F8-18.88; Flags: Precursor.
ACCESSION   D2Y233
VERSION     D2Y233.1
DBSOURCE    UniProtKB: locus H4A02_CYRHA, accession D2Y233;
            class: standard.
            extra accessions:P83471
            created: Nov 2, 2010.
            sequence updated: Mar 2, 2010.
            annotation updated: Feb 22, 2023.
            xrefs: GU292910.1, ADB56726.1
            xrefs (non-sequence databases): AlphaFoldDB:D2Y233, BMRB:D2Y233,
            SMR:D2Y233, ArachnoServer:AS000340, GO:0005576, GO:0044231,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Presynaptic neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Haplopelma hainanum
  ORGANISM  Haplopelma hainanum
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Haplopelma.
REFERENCE   1  (residues 1 to 86)
  AUTHORS   Tang,X., Zhang,Y., Hu,W., Xu,D., Tao,H., Yang,X., Li,Y., Jiang,L.
            and Liang,S.
  TITLE     Molecular diversification of peptide toxins from the tarantula
            Haplopelma hainanum (Ornithoctonus hainana) venom based on
            transcriptomic, peptidomic, and genomic analyses
  JOURNAL   J Proteome Res 9 (5), 2550-2564 (2010)
   PUBMED   20192277
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], PROTEIN SEQUENCE OF 50-84,
            AND IDENTIFICATION BY MASS SPECTROMETRY.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 86)
  AUTHORS   Liu,Z., Dai,J., Chen,Z., Hu,W., Xiao,Y. and Liang,S.
  TITLE     Isolation and characterization of hainantoxin-IV, a novel
            antagonist of tetrodotoxin-sensitive sodium channels from the
            Chinese bird spider Selenocosmia hainana
  JOURNAL   Cell Mol Life Sci 60 (5), 972-978 (2003)
   PUBMED   12827284
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, MASS SPECTROMETRY, TOXIC DOSE, AND DISULFIDE BONDS.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 86)
  AUTHORS   Xiao,Y. and Liang,S.
  TITLE     Inhibition of neuronal tetrodotoxin-sensitive Na+ channels by two
            spider toxins: hainantoxin-III and hainantoxin-IV
  JOURNAL   Eur J Pharmacol 477 (1), 1-7 (2003)
   PUBMED   14512091
  REMARK    PROTEIN SEQUENCE OF 50-84, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, AND AMIDATION AT ILE-84.;
            TISSUE=Venom
REFERENCE   4  (residues 1 to 86)
  AUTHORS   Xiao,Y.C. and Liang,S.P.
  TITLE     Inhibition of sodium channels in rat dorsal root ganglion neurons
            by Hainantoxin-IV, a novel spider toxin
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35 (1), 82-85
            (2003)
   PUBMED   12518233
  REMARK    FUNCTION.
REFERENCE   5  (residues 1 to 86)
  AUTHORS   Liu,Z.H., Chen,P. and Liang,S.P.
  TITLE     Synthesis and oxidative refolding of hainantoxin-IV
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34 (4),
            516-519 (2002)
   PUBMED   12098779
  REMARK    SYNTHESIS.
REFERENCE   6  (residues 1 to 86)
  AUTHORS   Xu,X., Xiong,X., Li,D.L., Xiao,Y.C., Wang,X.C. and Liang,S.P.
  TITLE     [Solid-phase synthesis and biological characterization of
            S12A-HNTX-IV and R29A-HNTX-IV: two mutants of hainantoxin-IV]
  JOURNAL   Sheng Wu Gong Cheng Xue Bao 21 (1), 92-96 (2005)
   PUBMED   15859335
  REMARK    SYNTHESIS, AND MUTAGENESIS OF SER-61 AND ARG-78.
REFERENCE   7  (residues 1 to 86)
  AUTHORS   Li,D., Xiao,Y., Xu,X., Xiong,X., Lu,S., Liu,Z., Zhu,Q., Wang,M.,
            Gu,X. and Liang,S.
  TITLE     Structure--activity relationships of hainantoxin-IV and structure
            determination of active and inactive sodium channel blockers
  JOURNAL   J Biol Chem 279 (36), 37734-37740 (2004)
   PUBMED   15201273
  REMARK    STRUCTURE BY NMR OF 50-84, DISULFIDE BONDS, AMIDATION AT ILE-84,
            AND MUTAGENESIS OF SER-61; ARG-75; LYS-76 AND ARG-78.
COMMENT     [FUNCTION] Neurotoxin. Selectively blocks neuronal
            tetrodotoxin-sensitive voltage-gated sodium channels (Nav) with an
            IC(50) of 44.6 nM. Does not affect tetrodotoxin-resistant
            voltage-gated sodium channels or calcium channels.
            {ECO:0000269|PubMed:12518233, ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091}.
            [SUBUNIT] Monomer.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12827284,
            ECO:0000269|PubMed:14512091}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:12827284, ECO:0000269|PubMed:14512091}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            [MASS SPECTROMETRY] Mass=3988.58; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12827284}.
            [TOXIC DOSE] LD(50) is 0.2 +-0.07 mg/kg by intraperitoneal
            injection into mice. {ECO:0000269|PubMed:12827284}.
            [MISCELLANEOUS] Several genes are coding for Mu-theraphotoxin-Hhn1b
            for which the structure by NMR has been determined. The
            cross-references to PDB can be found in entry AC D2Y232.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 22
            (Htx-4) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..86
                     /organism="Haplopelma hainanum"
                     /db_xref="taxon:209901"
     Protein         1..86
                     /product="Mu-theraphotoxin-Hhn1b 2"
                     /note="Mu-TRTX-Hhn1b; Hainantoxin-4.2; Hainantoxin-IV.2;
                     Peptide F8-18.88; HnTx-IV.2"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400568."
     Region          50..84
                     /region_name="Processed active peptide"
                     /note="Mu-theraphotoxin-Hhn1b 2.
                     /evidence=ECO:0000269|PubMed:12827284,
                     ECO:0000269|PubMed:14512091, ECO:0000269|PubMed:20192277.
                     /id=PRO_0000400569."
     Region          50..82
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(51,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Bond            bond(58,73)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Region          61..64
                     /region_name="Conflict"
                     /note="SNDQ -> DQSN (in Ref. 3; AA sequence).
                     /evidence=ECO:0000305."
     Site            61
                     /site_type="mutagenized"
                     /note="S->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Bond            bond(65,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15201273."
     Site            75
                     /site_type="mutagenized"
                     /note="R->A: No important change in activity.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            76
                     /site_type="other"
                     /note="Interacts with channel."
     Site            76
                     /site_type="mutagenized"
                     /note="K->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273."
     Site            78
                     /site_type="other"
                     /note="Interacts with channel."
     Site            78
                     /site_type="mutagenized"
                     /note="R->A: Important reduction in activity, without
                     change of toxin conformation.
                     /evidence=ECO:0000269|PubMed:15201273,
                     ECO:0000269|PubMed:15859335."
     Site            84
                     /site_type="amidation"
                     /note="Isoleucine amide.
                     /evidence=ECO:0000269|PubMed:14512091,
                     ECO:0000269|PubMed:15201273."
ORIGIN      
        1 mkasmflala gldllfvvcy aseseekefs nellssvlav ddnskgeere clgfgkgcnp
       61 sndqcckssn lvcsrkhrwc kyeigk
//

LOCUS       SCX3_BUTOC                72 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-mammal toxin Bot3; AltName: Full=Bot III;
            Short=BotIII; AltName: Full=Neurotoxin III; Flags: Precursor.
ACCESSION   P01485
VERSION     P01485.2
DBSOURCE    UniProtKB: locus SCX3_BUTOC, accession P01485;
            class: standard.
            created: Jul 21, 1986.
            sequence updated: Nov 13, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: NTSR3B
            xrefs (non-sequence databases): AlphaFoldDB:P01485, SMR:P01485,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Signal; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Buthus occitanus tunetanus (Tunisian scorpion)
  ORGANISM  Buthus occitanus tunetanus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Buthus.
REFERENCE   1  (residues 1 to 72)
  AUTHORS   Benkhadir,K., Kharrat,R., Cestele,S., Mosbah,A., Rochat,H., El
            Ayeb,M. and Karoui,H.
  TITLE     Molecular cloning and functional expression of the alpha-scorpion
            toxin BotIII: pivotal role of the C-terminal region for its
            interaction with voltage-dependent sodium channels
  JOURNAL   Peptides 25 (2), 151-161 (2004)
   PUBMED   15062995
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-66, AMIDATION AT ASN-72,
            FUNCTION, AND MUTAGENESIS OF ASN-72.;
            TISSUE=Muscle
REFERENCE   2  (residues 1 to 72)
  AUTHORS   Vargas,O., Gregoire,J., Martin,M.-F., Bechis,G. and Rochat,H.
  TITLE     Neurotoxins from the venoms of two scorpions: Buthus occitanus
            tunetanus and Buthus occitanus mardochei
  JOURNAL   Toxicon 20, 79-79 (1982)
  REMARK    PROTEIN SEQUENCE OF 9-72, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
COMMENT     On Nov 13, 2007 this sequence version replaced P01485.1.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. Is active against
            mammals and binds with high affinity to rat brain synaptosomes.
            {ECO:0000269|PubMed:15062995}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|Ref.2}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|Ref.2}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [PTM] When the toxin is not amidated, there are 75% loss of
            toxicity to mice, and total incapacity to bind rat brain
            synaptosomes. {ECO:0000269|PubMed:15062995}.
            [TOXIC DOSE] LD(50) is 1.25 ug/kg (25 ng/mouse) by
            intracerebroventricular injection into mice.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..72
                     /organism="Buthus occitanus tunetanus"
                     /sub_species="tunetanus"
                     /db_xref="taxon:6871"
     Protein         <1..72
                     /product="Alpha-mammal toxin Bot3"
                     /note="Bot III; Neurotoxin III; BotIII"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          <1..8
                     /region_name="Signal"
                     /note="/evidence=ECO:0000269|Ref.2."
     Region          9..72
                     /region_name="Mature chain"
                     /note="Alpha-mammal toxin Bot3.
                     /evidence=ECO:0000269|Ref.2. /id=PRO_0000066734."
     Region          10..72
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          10..63
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(20,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(24,44)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(30,54)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(34,56)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            72
                     /site_type="amidation"
                     /note="Asparagine amide.
                     /evidence=ECO:0000269|PubMed:15062995."
     Site            72
                     /site_type="mutagenized"
                     /note="N->H: No change in lethal activity to mice; when
                     N-72 is not amidated.
                     /evidence=ECO:0000269|PubMed:15062995."
     Site            72
                     /site_type="mutagenized"
                     /note="N->NGR: Total loss of lethal activity, and
                     incapacity to bind rat brain synaptosomes.
                     /evidence=ECO:0000269|PubMed:15062995."
ORIGIN      
        1 lvmagvesvk dgyivddrnc tyfcgrnayc neectklkge sgycqwaspy gnacycykvp
       61 dhvrtkgpgr cn
//

LOCUS       COCD_CONCL                84 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.2d; AltName: Full=Conotoxin
            CalTx 12.2.1D; AltName: Full=Conotoxin Cl12.1; Flags: Precursor.
ACCESSION   A7LI92
VERSION     A7LI92.2
DBSOURCE    UniProtKB: locus COCD_CONCL, accession A7LI92;
            class: standard.
            extra accessions:D6C4I1
            created: Mar 23, 2010.
            sequence updated: Jan 25, 2012.
            annotation updated: May 25, 2022.
            xrefs: FJ959123.1, ADB93093.1, EU022530.1, ABS59787.1
            xrefs (non-sequence databases): AlphaFoldDB:A7LI92,
            ConoServer:4009, GO:0005576, GO:0008200, GO:0090729,
            InterPro:IPR004214, Pfam:PF02950
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Signal; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Biggs,J.S., Watkins,M., Puillandre,N., Ownby,J.P., Lopez-Vera,E.,
            Christensen,S., Moreno,K.J., Bernaldez,J., Licea-Navarro,A.,
            Corneli,P.S. and Olivera,B.M.
  TITLE     Evolution of Conus peptide toxins: analysis of Conus californicus
            Reeve, 1844
  JOURNAL   Mol Phylogenet Evol 56 (1), 1-12 (2010)
   PUBMED   20363338
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 42-84.;
            TISSUE=Venom duct
COMMENT     On Jan 27, 2012 this sequence version replaced A7LI92.1.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [PTM] Contains 4 disulfide bonds. {ECO:0000305}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..84
                     /product="Mu-conotoxin-like Cal 12.2d"
                     /note="Conotoxin CalTx 12.2.1D; Conotoxin Cl12.1"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305. /id=PRO_0000392285."
     Region          43..84
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.2d. /id=PRO_0000392286."
     Site            72
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            77
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            81
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 mkltcvlvvl llvlpfgdli ttsntednkr gatpwqnslk argvcstpeg scvhngcicq
       61 napcchasgc nwanvcpgfl wdkn
//

LOCUS       COC3A_CONCL               86 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.3a; AltName:
            Full=Conotoxin CalTx 12.1.4C; AltName: Full=Conotoxin Cl12.2;
            Flags: Precursor.
ACCESSION   A6YR40
VERSION     A6YR40.2
DBSOURCE    UniProtKB: locus COC3A_CONCL, accession A6YR40;
            class: standard.
            extra accessions:D6C4I2
            created: Mar 23, 2010.
            sequence updated: Jan 25, 2012.
            annotation updated: May 25, 2022.
            xrefs: FJ959124.1, ADB93094.1, EF644194.1, ABR92964.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR40, ConoServer:813,
            GO:0005576, GO:0008200, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Signal; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 86)
  AUTHORS   Biggs,J.S., Watkins,M., Puillandre,N., Ownby,J.P., Lopez-Vera,E.,
            Christensen,S., Moreno,K.J., Bernaldez,J., Licea-Navarro,A.,
            Corneli,P.S. and Olivera,B.M.
  TITLE     Evolution of Conus peptide toxins: analysis of Conus californicus
            Reeve, 1844
  JOURNAL   Mol Phylogenet Evol 56 (1), 1-12 (2010)
   PUBMED   20363338
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].
REFERENCE   2  (residues 1 to 86)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 43-86.;
            TISSUE=Venom duct
COMMENT     On Jan 27, 2012 this sequence version replaced A6YR40.1.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [PTM] Contains 4 disulfide bonds. {ECO:0000305}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..86
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..86
                     /product="Mu-conotoxin-like Cal 12.1.3a"
                     /note="Conotoxin CalTx 12.1.4C; Conotoxin Cl12.2"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000414930."
     Region          43..86
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.3a. /id=PRO_0000392277."
     Site            65
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            78
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            79
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            81
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            85
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 mkltcvlvvl llllpygdli tnsyirgaar kvtpwrrnlk trdvcdslvd grcihngcfc
       61 eeskpngncc dtggcvwwwc pgtkwd
//

LOCUS       COCA_CONCL                84 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.2a; AltName: Full=Conotoxin
            CalTx 12.2.1A; AltName: Full=Conotoxin Cl12a; Flags: Precursor.
ACCESSION   A6YR42
VERSION     A6YR42.1
DBSOURCE    UniProtKB: locus COCA_CONCL, accession A6YR42;
            class: standard.
            extra accessions:P0DJC1
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644196.1, ABR92966.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR42, ConoServer:815,
            GO:0005576, GO:0008200, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Bromination; Direct protein sequencing; Disulfide bond;
            Hydroxylation; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Biggs,J.S., Watkins,M., Puillandre,N., Ownby,J.P., Lopez-Vera,E.,
            Christensen,S., Moreno,K.J., Bernaldez,J., Licea-Navarro,A.,
            Corneli,P.S. and Olivera,B.M.
  TITLE     Evolution of Conus peptide toxins: analysis of Conus californicus
            Reeve, 1844
  JOURNAL   Mol Phylogenet Evol 56 (1), 1-12 (2010)
   PUBMED   20363338
  REMARK    PROTEIN SEQUENCE OF 43-84, AND HYDROXYLATION AT PRO-48.;
            TISSUE=Venom
COMMENT     On Feb 12, 2021 this sequence version replaced P0DJC1.1.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..84
                     /product="Mu-conotoxin-like Cal 12.2a"
                     /note="Conotoxin CalTx 12.2.1A; Conotoxin Cl12a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000392279."
     Region          43..84
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.2a. /id=PRO_0000392280."
     Bond            bond(45,57)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Site            48
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000305|PubMed:20363338."
     Bond            bond(52,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(59,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(64,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            72
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            77
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            81
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 mkltcvlvvl llvlpfgdli ttsntednkr gatpwqnslk argvcstpeg scvhngcicq
       61 napcchpsgc nwanvcpgfl wdkn
//

LOCUS       6CNU_B                    31 aa            linear   INV 01-DEC-2020
DEFINITION  Chain B, JzTx-V.
ACCESSION   6CNU_B
VERSION     6CNU_B
DBSOURCE    pdb: molecule 6CNU, chain B, release Mar 4, 2020;
            deposition: Mar 9, 2018;
            class: TOXIN;
            source: Mmdb_id: 184998, Pdb_id 1: 6CNU;
            Exp. method: X-ray Diffraction.
KEYWORDS    .
SOURCE      Chilobrachys guangxiensis
  ORGANISM  Chilobrachys guangxiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Chilobrachys.
REFERENCE   1  (residues 1 to 31)
  AUTHORS   Wu,B., Murray,J.K., Andrews,K.L., Sham,K., Long,J., Aral,J.,
            Ligutti,J., Amagasu,S., Liu,D., Zou,A., Min,X., Wang,Z., Ilch,C.P.,
            Kornecook,T.J., Lin,M.J., Be,X., Miranda,L.P., Moyer,B.D. and
            Biswas,K.
  TITLE     Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V
            Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of
            Histamine-Induced Pruritis
  JOURNAL   J. Med. Chem. 61 (21), 9500-9512 (2018)
   PUBMED   30346167
REFERENCE   2  (residues 1 to 31)
  AUTHORS   Min,X. and Wang,Z.
  TITLE     Direct Submission
  JOURNAL   Submitted (09-MAR-2018)
COMMENT     On Mar 6, 2020 this sequence version replaced gi:1595432332.
            Crystal Structure of JzTX-V.
FEATURES             Location/Qualifiers
     source          1..31
                     /organism="Chilobrachys guangxiensis"
                     /db_xref="taxon:278060"
     NonStdRes       2
                     /non_std_residue="LPH"
     Bond            bond(3,17)
                     /bond_type="disulfide"
     NonStdRes       7
                     /non_std_residue="MSE"
     Bond            bond(10,22)
                     /bond_type="disulfide"
     Bond            bond(16,26)
                     /bond_type="disulfide"
     SecStr          20..23
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          25..28
                     /sec_str_type="sheet"
                     /note="strand 2"
     NonStdRes       31
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 excqkwxwtc dsaraccegl rcklwcrkei x
//

LOCUS       CM3A_CONST                73 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Mu-conotoxin SIIIA; Flags: Precursor.
ACCESSION   Q86DU6
VERSION     Q86DU6.1
DBSOURCE    UniProtKB: locus CM3A_CONST, accession Q86DU6;
            class: standard.
            created: Jan 16, 2004.
            sequence updated: Jun 1, 2003.
            annotation updated: May 3, 2023.
            xrefs: AY207469.1, AAO48588.1
            xrefs (non-sequence databases): AlphaFoldDB:Q86DU6, BMRB:Q86DU6,
            TCDB:8.B.28.1.1, ConoServer:825, GO:0005576, GO:0019871,
            GO:0090729, InterPro:IPR004214, InterPro:IPR008036, Pfam:PF02950,
            PROSITE:PS60013
KEYWORDS    Amidation; Cleavage on pair of basic residues; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin;
            Neurotoxin; Pyrrolidone carboxylic acid; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Conus striatus (striated cone)
  ORGANISM  Conus striatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Pionoconus.
REFERENCE   1  (residues 1 to 73)
  AUTHORS   Wang,C.Z., Zhang,H., Jiang,H., Lu,W., Zhao,Z.Q. and Chi,C.W.
  TITLE     A novel conotoxin from Conus striatus, mu-SIIIA, selectively
            blocking rat tetrodotoxin-resistant sodium channels
  JOURNAL   Toxicon 47 (1), 122-132 (2006)
   PUBMED   16325217
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], SYNTHESIS OF 52-71, AND FUNCTION.;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 73)
  AUTHORS   Bulaj,G., West,P.J., Garrett,J.E., Watkins,M., Zhang,M.M.,
            Norton,R.S., Smith,B.J., Yoshikami,D. and Olivera,B.M.
  TITLE     Novel conotoxins from Conus striatus and Conus kinoshitai
            selectively block TTX-resistant sodium channels
  JOURNAL   Biochemistry 44 (19), 7259-7265 (2005)
   PUBMED   15882064
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 52-73, SYNTHESIS OF 52-71, AND
            FUNCTION.;
            TISSUE=Venom duct
            Erratum:[Biochemistry. 2006 Mar 7;45(9):3116. Marsh, Maren
            [corrected to Watkins, Maren]]
REFERENCE   3  (residues 1 to 73)
  AUTHORS   Bulaj,G., West,P.J., Garrett,J.E., Watkins,M., Zhang,M.-M.,
            Norton,R.S., Smith,B.J., Yoshikami,D. and Olivera,B.M.
  JOURNAL   Biochemistry 45, 3116-3116 (2006)
  REMARK    ERRATUM OF PUBMED:15882064.
            DOI: 10.1021/bi068001c
REFERENCE   4  (residues 1 to 73)
  AUTHORS   Schroeder,C.I., Ekberg,J., Nielsen,K.J., Adams,D., Loughnan,M.L.,
            Thomas,L., Adams,D.J., Alewood,P.F. and Lewis,R.J.
  TITLE     Neuronally micro-conotoxins from Conus striatus utilize an
            alpha-helical motif to target mammalian sodium channels
  JOURNAL   J Biol Chem 283 (31), 21621-21628 (2008)
   PUBMED   18522941
  REMARK    PROTEIN SEQUENCE OF 52-71, SYNTHESIS OF 52-71, FUNCTION,
            SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY,
            PYROGLUTAMATE FORMATION AT GLN-52, AMIDATION AT CYS-71, STRUCTURE
            BY NMR OF 52-71, AND MUTAGENESIS OF GLN-52; LYS-62; TRP-63; ARG-65;
            ASP-66; HIS-67 AND ARG-69.;
            TISSUE=Venom
REFERENCE   5  (residues 1 to 73)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION ON SODIUM CHANNELS.
REFERENCE   6  (residues 1 to 73)
  AUTHORS   Schroeder,C.I., Adams,D., Thomas,L., Alewood,P.F. and Lewis,R.J.
  TITLE     N- and C-terminal extensions of mu-conotoxins increase potency and
            selectivity for neuronal sodium channels
  JOURNAL   Biopolymers 98 (2), 161-165 (2012)
   PUBMED   22733528
  REMARK    MUTAGENESIS OF GLN-52; ASP-66 AND CYS-71, AND SYNTHESIS OF 52-71.
REFERENCE   7  (residues 1 to 73)
  AUTHORS   Favreau,P., Benoit,E., Hocking,H.G., Carlier,L., D' hoedt,D.,
            Leipold,E., Markgraf,R., Schlumberger,S., Cordova,M.A.,
            Gaertner,H., Paolini-Bertrand,M., Hartley,O., Tytgat,J.,
            Heinemann,S.H., Bertrand,D., Boelens,R., Stocklin,R. and Molgo,J.
  TITLE     A novel micro-conopeptide, CnIIIC, exerts potent and preferential
            inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic
            acetylcholine receptors
  JOURNAL   Br J Pharmacol 166 (5), 1654-1668 (2012)
   PUBMED   22229737
  REMARK    FUNCTION, AND SYNTHESIS OF 52-71.
REFERENCE   8  (residues 1 to 73)
  AUTHORS   Yao,S., Zhang,M.M., Yoshikami,D., Azam,L., Olivera,B.M., Bulaj,G.
            and Norton,R.S.
  TITLE     Structure, dynamics, and selectivity of the sodium channel blocker
            mu-conotoxin SIIIA
  JOURNAL   Biochemistry 47 (41), 10940-10949 (2008)
   PUBMED   18798648
  REMARK    STRUCTURE BY NMR OF 52-71, SYNTHESIS OF 52-71, DISULFIDE BONDS, AND
            FUNCTION.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin moderately blocks rNav1.1/SCN1A, rNav1.2/SCN2A,
            rNav1.3/SCN3A, rNav1.4/SCN4A, and mNav1.6/SCN8A.
            {ECO:0000269|PubMed:15882064, ECO:0000269|PubMed:16325217,
            ECO:0000269|PubMed:18522941, ECO:0000269|PubMed:18798648,
            ECO:0000269|PubMed:21652775, ECO:0000269|PubMed:22229737}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:18522941}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000269|PubMed:18522941}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=2206.8; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:18522941}.
            [MISCELLANEOUS] Negative results: does not inhibit Nav1.5/SCN5A,
            Nav1.7/SCN9A and Nav1.8/SCN10A. {ECO:0000269|PubMed:18522941}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
            [CAUTION] All results of mutagenesis experiments are compared with
            the mutant DEL-52. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..73
                     /organism="Conus striatus"
                     /db_xref="taxon:6493"
     Protein         1..73
                     /product="Mu-conotoxin SIIIA"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..20
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          3..60
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          20..40
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          21..49
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000035057."
     Region          52..71
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin SIIIA. /id=PRO_0000035058."
     Site            52
                     /site_type="mutagenized"
                     /note="Missing: Increase of affinity at Nav1.2/SCN2A and
                     decrease of affinity at Nav1.4/SCN4A.
                     /evidence=ECO:0000269|PubMed:18522941,
                     ECO:0000269|PubMed:22733528."
     Site            52
                     /site_type="pyrrolidone-carboxylic-acid"
                     /note="Pyrrolidone carboxylic acid.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            52
                     /site_type="mutagenized"
                     /note="Q->R: Increase of affinity for both Nav1.2/SCN2A
                     and Nav1.4/SCN4A. /evidence=ECO:0000269|PubMed:18522941,
                     ECO:0000269|PubMed:22733528."
     Bond            bond(54,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:18798648."
     Bond            bond(55,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:18798648."
     Bond            bond(59,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:18798648."
     Site            62
                     /site_type="mutagenized"
                     /note="K->A: 6-fold decrease of affinity to both
                     Nav1.2/SCN2A and Nav1.4/SCN4A; when associated with
                     DEL-52. /evidence=ECO:0000269|PubMed:18522941."
     Site            62
                     /site_type="mutagenized"
                     /note="K->R: 10-fold increase of affinity at Nav1.2/SCN2A
                     without affecting Nav1.4/SCN4A affinity; when associated
                     with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            63
                     /site_type="mutagenized"
                     /note="W->A: 22- and 87-fold decrease of affinity to
                     Nav1.2/SCN2A and Nav1.4/SCN4A, respectively; when
                     associated with DEL-52.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            65
                     /site_type="mutagenized"
                     /note="R->A: Decrease of affinity to both Nav1.2/SCN2A and
                     Nav1.4/SCN4A; when associated with DEL-52.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            66
                     /site_type="mutagenized"
                     /note="D->A: 10-fold increase of affinity at Nav1.2/SCN2A
                     without affecting Nav1.4/SCN4A affinity; when associated
                     with DEL-52. 30-fold decrease of affinity to Nav1.4/SCN4A
                     without affecting Nav1.2/SCN2A affinity; when associated
                     with DEL-52 and R-67. 100,000- and 400-fold decrease in
                     affinity to Nav1.2/SCN2A and Nav1.4/SCN4A, respectively;
                     when associated with DEL-52 and D-67. Different changes
                     when associated with C-terminal extension, see mutated
                     Cys-71. /evidence=ECO:0000269|PubMed:18522941,
                     ECO:0000269|PubMed:22733528."
     Site            66
                     /site_type="mutagenized"
                     /note="D->K: Decrease of affinity to both Nav1.2/SCN2A and
                     Nav1.4/SCN4A; when associated with DEL-52.
                     /evidence=ECO:0000269|PubMed:18522941,
                     ECO:0000269|PubMed:22733528."
     Site            67
                     /site_type="mutagenized"
                     /note="H->A: Most important decrease of affinity to both
                     Nav1.2/SCN2A and Nav1.4/SCN4A; when associated with
                     DEL-52. /evidence=ECO:0000269|PubMed:18522941."
     Site            67
                     /site_type="mutagenized"
                     /note="H->D: 100,000- and 400-fold decrease in affinity to
                     Nav1.2/SCN2A and Nav1.4/SCN4A, respectively; when
                     associated with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            67
                     /site_type="mutagenized"
                     /note="H->R: 30-fold decrease of affinity at Nav1.4/SCN4A
                     without affecting Nav1.2/SCN2A affinity; when associated
                     with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            69
                     /site_type="mutagenized"
                     /note="R->A: 30- and 500-fold decrease of affinity to
                     Nav1.2/SCN2A and Nav1.4/SCN4A, respectively; when
                     associated with DEL-52.
                     /evidence=ECO:0000269|PubMed:18522941."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CA: Increase in affinity for Nav1.2/SCN2A, no
                     change in affinity for Nav1.4/SCN4A; when associated with
                     DEL-52 and A-66. /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CAA: Increase in affinity for Nav1.2/SCN2A,
                     little decrease in affinity for Nav1.4/SCN4A; when
                     associated with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CAD: Important decrease in affinity for both
                     Nav1.2/SCN2A and Nav1.4/SCN4A; when associated with DEL-52
                     and A-66. /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CAK: Little decrease in affinity for
                     Nav1.4/SCN4A, no change in affinity for Nav1.2/SCN2A; when
                     associated with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CD: The second most selective for Nav1.2/SCN2A
                     over Nav1.4/SCVN4A; when associated with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="mutagenized"
                     /note="C->CK: The most selective for Nav1.2/SCN2A over
                     Nav1.4/SCVN4A; when associated with DEL-52 and A-66.
                     /evidence=ECO:0000269|PubMed:22733528."
     Site            71
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000269|PubMed:18522941."
ORIGIN      
        1 mmsklgvllt vcpllfplta lppdgdqpad rpaermqddi ssdehplfdk rqnccnggcs
       61 skwcrdharc cgr
//

LOCUS       TXP1_PHLXX                34 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Pspp1; Short=Mu-TRTX-Pspp1; AltName:
            Full=Phlotoxin 1; Short=PhlTx1.
ACCESSION   P0DM14
VERSION     P0DM14.1
DBSOURCE    UniProtKB: locus TXP1_PHLXX, accession P0DM14;
            class: standard.
            created: May 23, 2018.
            sequence updated: May 23, 2018.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DM14, SMR:P0DM14,
            GO:0005576, GO:0008200, GO:0017080, GO:0090729, InterPro:IPR011696,
            Pfam:PF07740, SUPFAM:SSF57059
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Pharmaceutical; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Phlogiellus sp. PE-2016
  ORGANISM  Phlogiellus sp. PE-2016
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Phlogiellus.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Escoubas,P., Bosmans,F., Cuypers,E., Diochot,S., Mebs,D., Craik,D.,
            Hill,J., Maertens,C., Nakajima,T., Lazdunski,M. and Tytgat,J.
  TITLE     Phlotoxin-1, a toxin from tarantula venom, is a potent modulator of
            Nav1.7 sodium channels and a potential analgesic
  JOURNAL   Unpublished
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, AND SYNTHESIS.
REFERENCE   2  (residues 1 to 34)
  AUTHORS   Wood,J.N.
  TITLE     Synergistic combination of analgesic drugs
  JOURNAL   Patent: EP EP3046569 27-JUL-2016;
  REMARK    PHARMACEUTICAL.
REFERENCE   3  (residues 1 to 34)
  AUTHORS   Deuis,J.R., Dekan,Z., Wingerd,J.S., Smith,J.J., Munasinghe,N.R.,
            Bhola,R.F., Imlach,W.L., Herzig,V., Armstrong,D.A., Rosengren,K.J.,
            Bosmans,F., Waxman,S.G., Dib-Hajj,S.D., Escoubas,P., Minett,M.S.,
            Christie,M.J., King,G.F., Alewood,P.F., Lewis,R.J., Wood,J.N. and
            Vetter,I.
  TITLE     Pharmacological characterisation of the highly NaV1.7 selective
            spider venom peptide Pn3a
  JOURNAL   Sci Rep 7, 40883 (2017)
   PUBMED   28106092
  REMARK    HARMACEUTICAL.
            Erratum:[Sci Rep. 2017 May 26;7:46816. PMID: 28548111]
            Publication Status: Online-Only
REFERENCE   4  (residues 1 to 34)
  AUTHORS   Deuis,J.R., Dekan,Z., Wingerd,J.S., Smith,J.J., Munasinghe,N.R.,
            Bhola,R.F., Imlach,W.L., Herzig,V., Armstrong,D.A., Rosengren,K.J.,
            Bosmans,F., Waxman,S.G., Dib-Hajj,S.D., Escoubas,P., Minett,M.S.,
            Christie,M.J., King,G.F., Alewood,P.F., Lewis,R.J., Wood,J.N. and
            Vetter,I.
  TITLE     Corrigendum: Pharmacological characterisation of the highly NaV1.7
            selective spider venom peptide Pn3a
  JOURNAL   Sci Rep 7, 46816 (2017)
   PUBMED   28548111
  REMARK    ERRATUM OF PUBMED:28106092.
            Correction to:[Sci Rep. 2017 Jan 20;7:40883. PMID: 28106092]
            Publication Status: Online-Only
REFERENCE   5  (residues 1 to 34)
  AUTHORS   Nicolas,S., Zoukimian,C., Bosmans,F., Montnach,J., Diochot,S.,
            Cuypers,E., De Waard,S., Beroud,R., Mebs,D., Craik,D., Boturyn,D.,
            Lazdunski,M., Tytgat,J. and De Waard,M.
  TITLE     Chemical Synthesis, Proper Folding, Nav Channel Selectivity Profile
            and Analgesic Properties of the Spider Peptide Phlotoxin 1
  JOURNAL   Toxins (Basel) 11 (6), E367 (2019)
   PUBMED   31234412
  REMARK    FUNCTION, SYNTHESIS, AND AMIDATION AT PHE-34.
            Publication Status: Online-Only
REFERENCE   6  (residues 1 to 34)
  AUTHORS   Goncalves,T.C., Lesport,P., Kuylle,S., Stura,E., Ciolek,J.,
            Mourier,G., Servent,D., Bourinet,E., Benoit,E. and Gilles,N.
  TITLE     Evaluation of the Spider (Phlogiellus genus) Phlotoxin 1 and
            Synthetic Variants as Antinociceptive Drug Candidates
  JOURNAL   Toxins (Basel) 11 (9), E484 (2019)
   PUBMED   31443554
  REMARK    FUNCTION, SYNTHESIS, MUTAGENESIS OF ALA-1; ASP-7; SER-8; LYS-12;
            LYS-15; TRP-24; LYS-25 AND TYR-26, 3D-STRUCTURE MODELING, AND
            AMIDATION AT PHE-34.
            Publication Status: Online-Only
COMMENT     [FUNCTION] Voltage-gated sodium channel inhibitor. It is unclear if
            it selectively inhibits Nav1.7/SCN9A or shows similar potency on
            all sodium channels tested (Ref.1, PubMed:31234412,
            PubMed:31443554). According to Escoubas et al., 2006 and Nicolas et
            al., 2019, it is selective over Nav1.7/SCN9A (90% inhibition at 1
            uM), versus Nav1.4 and Nav1.6 (35% inhibition), and shows a small
            inhibition on all other sodium channels (except Nav1.8/SCN10A)
            (Ref.1, PubMed:31234412). According to Goncalves et al., 2019, it
            shows a similar inhibition on almost all sodium channels tested
            (Nav1.1/SCN1A (IC(50)=280.3 nM), Nav1.2/SCN2A (IC(50)=73.7 nM),
            Nav1.3/SCN3A (IC(50)=201.5 nM), Nav1.4/SCN4A (IC(50)>2100 nM),
            Nav1.5/SCN5A (IC(50)=710.6 nM), Nav1.6/SCN8A (IC(50)=491.2 nM), and
            Nav1.7/SCN9A (IC(50)=254.3-260 nM)), except Nav1.8/SCN10A
            (PubMed:31443554). The voltage-dependence of steady-state
            Nav1.7/SCN9A channel activation and inactivation are not affected,
            suggesting that is does not act as a gating-modifier toxin but
            rather blocks or impedes ion flux through the channel pore (Ref.1,
            PubMed:31234412). The toxin effect is partial and poorly reversible
            (PubMed:31234412). In addition to its inhibition to sodium
            channels, it also shows a small inhibition on rat Kv3.4/KCNC4
            potassium channels (20% inhibition at 1 uM) (PubMed:31234412). In
            vivo, when tested on pain models, it shows analgesic activity
            (PubMed:31234412, PubMed:31443554). {ECO:0000269|PubMed:31234412,
            ECO:0000269|PubMed:31443554, ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|Ref.1}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|Ref.1}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P84507}.
            [PHARMACEUTICAL] This toxin may represent a lead for the
            development of novel analgesic agents. When injected into mice with
            an opioid analgesic drug and/or an enkephalinase inhibitor, it
            provides an enhanced and effective therapeutic approach to the
            treatment and/or prevention of pain (PubMed:28106092, Ref.2). When
            tested on the OD1-induced mouse model of Nav1.7/SCN9A-mediated
            pain, it almost completely reverses the induced pain
            (PubMed:31443554). In addition, it reduces the response of mice in
            both the acute pain and inflammation phases induced upon formalin
            injection into the paw (PubMed:31234412).
            {ECO:0000269|PubMed:28106092, ECO:0000269|PubMed:31234412,
            ECO:0000269|PubMed:31443554, ECO:0000269|Ref.2}.
            [MISCELLANEOUS] Synthesis and folding of this linear peptide
            generates 4 peaks. Only the peak 1 shows a strong activity against
            Nav1.7/SCN9A. When analyzed in details, this peak shows two forms
            (P1' and P1''), which may be explained by the involvement of at
            least one Pro residue in a cis-trans isomerization.
            {ECO:0000305|PubMed:31234412, ECO:0000305|PubMed:31443554}.
            [MISCELLANEOUS] Negative results: does not show inhibition on
            mKv1.1/KCNA1, rKv1.2/KCNA2, rKv1.3/KCNA3, rKv1.4/KCNA4,
            mKv1.5/KCNA5, rKv1.6/KCNA6, rKv2.1, rKv2.2/KCNB2, rKv3.1/KCNC1,
            rKv3.2/KCNC2, mKv4.1/KCND1, rKv4.2/KCND2, dog Kv4.3/KCND3,
            KT3.1/KCNK3, rKir1.1/KCNJ1, mKir2.3/KCNJ4 (PubMed:31234412). Shows
            no or weak activity on Cav1.2/CACNA1C (IC(50)=5.9 uM),
            Kv11.1/KCNH2/ERG1/HERG (IC(50)>10 uM), and Nav1.8/SCN10A (IC(50)>10
            uM) (PubMed:31443554). {ECO:0000269|PubMed:31234412,
            ECO:0000269|PubMed:31443554}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Phlogiellus sp. PE-2016"
                     /db_xref="taxon:2211175"
     Protein         1..34
                     /product="Mu-theraphotoxin-Pspp1"
                     /note="Mu-TRTX-Pspp1; Phlotoxin 1; PhlTx1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Mature chain"
                     /note="Mu-theraphotoxin-Pspp1.
                     /evidence=ECO:0000269|Ref.1. /id=PRO_0000444153."
     Site            1
                     /site_type="mutagenized"
                     /note="A->Q: When modified in pyroglutamic acid; weak
                     change in ability to inhibit Nav1.7/SCN9A.
                     /evidence=ECO:0000269|PubMed:31443554."
     Bond            bond(2,17)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P84507."
     Site            7
                     /site_type="mutagenized"
                     /note="D->A: Moderate increase (about 5-fold) in ability
                     to inhibit Nav1.2/SCN2A, Nav1.5/SCN5A, and Nav1.7/SCN9A,
                     gain of ability to inhibit Nav1.8/SCN10A and important
                     increase in ability to inhibit Cav1.2/CACNA1C (7300-fold).
                     Similar analgesic activity, when tested on the OD1-induced
                     mouse model of Nav1.7/SCN9A-mediated pain.
                     /evidence=ECO:0000269|PubMed:31443554."
     Site            8
                     /site_type="mutagenized"
                     /note="S->A: Weak change in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P84507."
     Site            12
                     /site_type="mutagenized"
                     /note="K->A: Weak change in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Site            15
                     /site_type="mutagenized"
                     /note="K->A: Weak change in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Bond            bond(16,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P84507."
     Site            24
                     /site_type="mutagenized"
                     /note="W->A: 40-fold decrease in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Site            25
                     /site_type="mutagenized"
                     /note="K->A: 40-fold decrease in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Site            26
                     /site_type="mutagenized"
                     /note="Y->A: 40-fold decrease in ability to inhibit
                     Nav1.7/SCN9A. /evidence=ECO:0000269|PubMed:31443554."
     Site            34
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000305|PubMed:31234412,
                     ECO:0000305|PubMed:31443554."
ORIGIN      
        1 aclgqwdscd pkaskccpny acewkypwcr yklf
//

LOCUS       TXO1A_PELMU               84 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-theraphotoxin-Pm1a; Short=Omega-TRTX-Pm1a;
            AltName: Full=Omega-theraphotoxin-Cc1a; Short=Omega-TRTX-Cc1a;
            AltName: Full=Toxin-like GVDKE; Flags: Precursor.
ACCESSION   D5J6X1
VERSION     D5J6X1.1
DBSOURCE    UniProtKB: locus TXO1A_PELMU, accession D5J6X1;
            class: standard.
            extra accessions:D5J6X4
            created: Feb 4, 2015.
            sequence updated: Jun 15, 2010.
            annotation updated: Feb 22, 2023.
            xrefs: GU170866.1, ADF28492.1, GU170867.1, ADF28493.1, GU170868.1,
            ADF28494.1, GU170869.1, ADF28495.1
            xrefs (non-sequence databases): AlphaFoldDB:D5J6X1, SMR:D5J6X1,
            ArachnoServer:AS001640, GO:0005576, GO:0005246, GO:0008200,
            GO:0090729, InterPro:IPR011696, Pfam:PF07740, SUPFAM:SSF57059
KEYWORDS    Calcium channel impairing toxin; Direct protein sequencing;
            Disulfide bond; Ion channel impairing toxin; Knottin; Neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated calcium channel impairing
            toxin.
SOURCE      Pelinobius muticus (king baboon spider)
  ORGANISM  Pelinobius muticus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Pelinobius.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Diego-Garcia,E., Peigneur,S., Waelkens,E., Debaveye,S. and
            Tytgat,J.
  TITLE     Venom components from Citharischius crawshayi spider (Family
            Theraphosidae): exploring transcriptome, venomics, and function
  JOURNAL   Cell Mol Life Sci 67 (16), 2799-2813 (2010)
   PUBMED   20372963
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], MASS SPECTROMETRY, AND SUBCELLULAR
            LOCATION.;
            TISSUE=Venom, and Venom gland
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Klint,J.K., Berecki,G., Durek,T., Mobli,M., Knapp,O., King,G.F.,
            Adams,D.J., Alewood,P.F. and Rash,L.D.
  TITLE     Isolation, synthesis and characterization of omega-TRTX-Cc1a, a
            novel tarantula venom peptide that selectively targets L-type Cav
            channels
  JOURNAL   Biochem Pharmacol 89 (2), 276-286 (2014)
   PUBMED   24561180
  REMARK    PROTEIN SEQUENCE OF 46-84, MASS SPECTROMETRY, FUNCTION, SYNTHESIS
            OF 46-84, MUTAGENESIS OF 46-GLY--GLU-50 AND 80-TRP--VAL-84,
            SUBCELLULAR LOCATION, AND DOMAIN.;
            TISSUE=Venom
COMMENT     [FUNCTION] Omega-conotoxins act at presynaptic membranes, they bind
            and block voltage-gated calcium channels (Cav). This toxin inhibits
            barium currents (IBa) mediated by L-type voltage-gated calcium
            channels Cav1.2/CACNA1C (IC(50)=825 nM) and Cav1.3/CACNA1C
            (IC(50)=2240 nM) (PubMed:24561180). {ECO:0000269|PubMed:24561180}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:20372963,
            ECO:0000269|PubMed:24561180}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:24561180}.
            [MASS SPECTROMETRY] Mass=4267.85; Method=MALDI;
            Evidence={ECO:0000269|PubMed:20372963}.
            [MASS SPECTROMETRY] Mass=4266.27; Method=MALDI;
            Evidence={ECO:0000269|PubMed:24561180}.
            [MISCELLANEOUS] Negative results: only exhibits a weak activity on
            Nav1.5/SCN5A and Nav1.7/SCN9A voltage-gated sodium channel (at 3
            uM, reduces by 39% and 17% the peak amplitude and slows
            inactivation) (PubMed:24561180). In addition, this toxin shows a
            little inhibition on Cav2.2/CACNA1B (20% at 3 uM), but does not
            inhibit Cav2.1/CACNA1A and Cav2.3/CACNA1E (PubMed:24561180).
            {ECO:0000269|PubMed:24561180}.
            [MISCELLANEOUS] Negative results: exists as two stable, slowly
            interconverting isomers. {ECO:0000269|PubMed:24561180}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 41
            (Jztx-36) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Pelinobius muticus"
                     /db_xref="taxon:753628"
     Protein         1..84
                     /product="Omega-theraphotoxin-Pm1a"
                     /note="Omega-TRTX-Pm1a; Omega-theraphotoxin-Cc1a;
                     Toxin-like GVDKE; Omega-TRTX-Cc1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..45
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:20372963.
                     /id=PRO_0000431733."
     Region          36
                     /region_name="Conflict"
                     /note="V -> A (in Ref. 1; ADF28495).
                     /evidence=ECO:0000305."
     Region          46..84
                     /region_name="Mature chain"
                     /note="Omega-theraphotoxin-Pm1a.
                     /evidence=ECO:0000269|PubMed:24561180.
                     /id=PRO_0000431734."
     Site            46..50
                     /site_type="mutagenized"
                     /note="Missing: Small decrease in inhibition of
                     Cav1.2/CACNA1C. /evidence=ECO:0000269|PubMed:24561180."
     Region          51..80
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(52,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
     Bond            bond(59,71)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
     Bond            bond(65,78)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B1P1E3."
     Site            80..84
                     /site_type="mutagenized"
                     /note="Missing: Important decrease in inhibition of
                     Cav1.2/CACNA1C. /evidence=ECO:0000269|PubMed:24561180."
ORIGIN      
        1 mktsmlavfv alplafvlta ateerahpne lvnslvelvk ldaergvdke gckymfgscg
       61 ksddccpkla ckrtfnycaw dgsv
//

LOCUS       SC15_MESMA                85 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin BmKaTX15; AltName: Full=Alpha-neurotoxin Tx15;
            AltName: Full=BmKalphaTx15; AltName: Full=KTc; AltName: Full=Na+
            channel toxin BmKT'; Flags: Precursor.
ACCESSION   Q9GNG8
VERSION     Q9GNG8.1
DBSOURCE    UniProtKB: locus SC15_MESMA, accession Q9GNG8;
            class: standard.
            extra accessions:Q1H5L1
            created: Dec 19, 2001.
            sequence updated: Mar 1, 2001.
            annotation updated: Feb 22, 2023.
            xrefs: AF163017.1, AAG39643.1, AF163016.1, AAG39642.1, AY786186.1,
            AAX11389.1
            xrefs (non-sequence databases): AlphaFoldDB:Q9GNG8, SMR:Q9GNG8,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 85)
  AUTHORS   Zhu,S.Y., Li,W.X., Zeng,X.C., Liu,H., Jiang,D.H. and Mao,X.
  TITLE     Nine novel precursors of Buthus martensii scorpion alpha-toxin
            homologues
  JOURNAL   Toxicon 38 (12), 1653-1661 (2000)
   PUBMED   10858508
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
            Erratum:[Toxicon 2001 Jul;39(7):1093]
REFERENCE   2  (residues 1 to 85)
  AUTHORS   Zeng,X.C., Luo,F. and Li,W.X.
  TITLE     Characterization of a novel cDNA encoding a short venom peptide
            derived from venom gland of scorpion Buthus martensii Karsch:
            trans-splicing may play an important role in the diversification of
            scorpion venom peptides
  JOURNAL   Peptides 27 (4), 675-681 (2006)
   PUBMED   16150513
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].
COMMENT     On May 17, 2014 this sequence version replaced gi:122119417.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..85
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..85
                     /product="Toxin BmKaTX15"
                     /note="Alpha-neurotoxin Tx15; BmKalphaTx15; KTc; Na+
                     channel toxin BmKT'"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000250."
     Region          20..85
                     /region_name="Mature chain"
                     /note="Toxin BmKaTX15. /id=PRO_0000035250."
     Region          21..83
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(31,82)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(41,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(45,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
ORIGIN      
        1 mnylvffsla llvmtgvesv rdgyiaddkn cayfcgrnay cddeckknga esgycqwagv
       61 ygnacwcykl pdkvpirvpg kcngg
//

LOCUS       COCB_CONCL                84 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.2b; AltName: Full=Conotoxin
            CalTx 12.2.1B; Flags: Precursor.
ACCESSION   A7LI90
VERSION     A7LI90.1
DBSOURCE    UniProtKB: locus COCB_CONCL, accession A7LI90;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Sep 11, 2007.
            annotation updated: May 25, 2022.
            xrefs: EU022528.1, ABS59785.1
            xrefs (non-sequence databases): AlphaFoldDB:A7LI90, ConoServer:817,
            GO:0005576, GO:0008200, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Signal; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..84
                     /product="Mu-conotoxin-like Cal 12.2b"
                     /note="Conotoxin CalTx 12.2.1B"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000392281."
     Region          43..84
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.2b. /id=PRO_0000392282."
     Bond            bond(45,57)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(52,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(59,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(64,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            72
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            77
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            81
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 mkltcvlvvl llvlpfgdli ttsntednkr gatpwqnslk argvcstpeg scvhngcicq
       61 napcchpsgc nwvnvcpgfl wdkn
//

LOCUS       COCC_CONCL                43 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.2c; AltName: Full=Conotoxin
            CalTx 12.2.1C; Flags: Precursor.
ACCESSION   A7LI91
VERSION     A7LI91.1
DBSOURCE    UniProtKB: locus COCC_CONCL, accession A7LI91;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Sep 11, 2007.
            annotation updated: May 25, 2022.
            xrefs: EU022529.1, ABS59786.1
            xrefs (non-sequence databases): AlphaFoldDB:A7LI91, ConoServer:818,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 43)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..43
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         <1..43
                     /product="Mu-conotoxin-like Cal 12.2c"
                     /note="Conotoxin CalTx 12.2.1C"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          <1
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000392283."
     Region          2..43
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.2c. /id=PRO_0000392284."
     Bond            bond(4,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,24)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(23,35)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            31
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            36
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            40
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 rgvcstpegs cvhngcicqn apcchpsgcn wanvcpgylw dkn
//

LOCUS       COC3B_CONCL               44 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.3b; AltName:
            Full=Conotoxin CalTx 12.1.4D.
ACCESSION   A6YR41
VERSION     A6YR41.1
DBSOURCE    UniProtKB: locus COC3B_CONCL, accession A6YR41;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644195.1, ABR92965.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR41, ConoServer:814,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 44)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..44
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..44
                     /product="Mu-conotoxin-like Cal 12.1.3b"
                     /note="Conotoxin CalTx 12.1.4D"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..44
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.3b. /id=PRO_0000392278."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            36
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            39
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            43
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvdgr cihngcfcee skpngnccds ggcvwwwcpg tkwd
//

LOCUS       COC2H_CONCL               44 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2h; AltName:
            Full=Conotoxin CalTx 12.1.3G.
ACCESSION   A6YR37
VERSION     A6YR37.1
DBSOURCE    UniProtKB: locus COC2H_CONCL, accession A6YR37;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644191.1, ABR92961.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR37, ConoServer:810,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 44)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..44
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..44
                     /product="Mu-conotoxin-like Cal 12.1.2h"
                     /note="Conotoxin CalTx 12.1.3G"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..44
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2h. /id=PRO_0000392276."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            36
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            39
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            43
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggr cihngcwcer saphgnccnt ggcvwwwcpg tkwd
//

LOCUS       COC2G_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2g; AltName:
            Full=Conotoxin CalTx 12.1.3F.
ACCESSION   A6YR36
VERSION     A6YR36.1
DBSOURCE    UniProtKB: locus COC2G_CONCL, accession A6YR36;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644190.1, ABR92960.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR36, ConoServer:809,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2g"
                     /note="Conotoxin CalTx 12.1.3F"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2g. /id=PRO_0000392275."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggr cihngcycer sapngnccdt agctvlwwcp gtkfd
//

LOCUS       COC2F_CONCL               44 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2f; AltName:
            Full=Conotoxin CalTx 12.1.3D.
ACCESSION   A6YR34
VERSION     A6YR34.1
DBSOURCE    UniProtKB: locus COC2F_CONCL, accession A6YR34;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644188.1, ABR92958.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR34, ConoServer:807,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 44)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..44
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..44
                     /product="Mu-conotoxin-like Cal 12.1.2f"
                     /note="Conotoxin CalTx 12.1.3D"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..44
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2f. /id=PRO_0000392274."
     Bond            bond(3,15)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(10,27)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            16
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(17,32)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            22
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(26,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            36
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            39
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            43
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcesvagrc ihngcwcers aphgnccnts gctarwwcpg tkwd
//

LOCUS       COC2E_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2e; AltName:
            Full=Conotoxin CalTx 12.1.3C.
ACCESSION   A6YR33
VERSION     A6YR33.1
DBSOURCE    UniProtKB: locus COC2E_CONCL, accession A6YR33;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644187.1, ABR92957.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR33, ConoServer:806,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2e"
                     /note="Conotoxin CalTx 12.1.3C"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2e. /id=PRO_0000392273."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggr cihngcwcer saphgnccnt sgctatfwcp gtlfd
//

LOCUS       COC2D_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2d; AltName:
            Full=Conotoxin CalTx 12.1.3A.
ACCESSION   A6YR31
VERSION     A6YR31.1
DBSOURCE    UniProtKB: locus COC2D_CONCL, accession A6YR31;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644185.1, ABR92955.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR31, ConoServer:804,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2d"
                     /note="Conotoxin CalTx 12.1.3A"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2d. /id=PRO_0000392272."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggr cihngcwcer saphgnccnt sgctarwwcp gtkfd
//

LOCUS       COC2C_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2c; AltName:
            Full=Conotoxin CalTx 12.1.2D.
ACCESSION   A6YR30
VERSION     A6YR30.1
DBSOURCE    UniProtKB: locus COC2C_CONCL, accession A6YR30;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644184.1, ABR92954.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR30, ConoServer:803,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2c"
                     /note="Conotoxin CalTx 12.1.2D"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2c. /id=PRO_0000392271."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            44
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggr cihngcycer dapngnccnt dgctarwwcp gtkwd
//

LOCUS       COC2B_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2b; AltName:
            Full=Conotoxin CalTx 12.1.2C.
ACCESSION   A6YR29
VERSION     A6YR29.1
DBSOURCE    UniProtKB: locus COC2B_CONCL, accession A6YR29;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644183.1, ABR92953.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR29, ConoServer:802,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2b"
                     /note="Conotoxin CalTx 12.1.2C"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2b. /id=PRO_0000392270."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            44
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvdgr cihngcycer dapngnccnt dgctarwwcp gtkwd
//

LOCUS       COC2A_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.2a; AltName:
            Full=Conotoxin CalTx 12.1.2B.
ACCESSION   A6YR28
VERSION     A6YR28.1
DBSOURCE    UniProtKB: locus COC2A_CONCL, accession A6YR28;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644182.1, ABR92952.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR28, ConoServer:800,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.2a"
                     /note="Conotoxin CalTx 12.1.2B"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.2a. /id=PRO_0000392269."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            44
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvdgr cihngcfcer dapngnccdt dgctarwwcp gtkwd
//

LOCUS       COC1E_CONCL               44 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.1e; AltName:
            Full=Conotoxin CalTx 12.1.1G.
ACCESSION   A6YR26
VERSION     A6YR26.1
DBSOURCE    UniProtKB: locus COC1E_CONCL, accession A6YR26;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644180.1, ABR92950.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR26, ConoServer:799,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 44)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..44
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..44
                     /product="Mu-conotoxin-like Cal 12.1.1e"
                     /note="Conotoxin CalTx 12.1.1G"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..44
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.1e. /id=PRO_0000392268."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            36
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            39
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            43
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvggh cihngcwcdq daphgnccdt ggcvwwwcpg tkwd
//

LOCUS       COC1D_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.1d; AltName:
            Full=Conotoxin CalTx 12.1.1E.
ACCESSION   A6YR24
VERSION     A6YR24.1
DBSOURCE    UniProtKB: locus COC1D_CONCL, accession A6YR24;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644178.1, ABR92948.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR24, ConoServer:797,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Gamma-carboxyglutamic acid;
            Hydroxylation; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.1d"
                     /note="Conotoxin CalTx 12.1.1E"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.1d. /id=PRO_0000392267."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            21
                     /site_type="gamma-carboxyglutamic-acid"
                     /note="4-carboxyglutamate. /evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            44
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvegr cihngcwcde eaphgnccdt agctawwwcp gtkwd
//

LOCUS       COC1C_CONCL               45 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like Cal 12.1.1c; AltName:
            Full=Conotoxin CalTx 12.1.1D.
ACCESSION   A6YR23
VERSION     A6YR23.1
DBSOURCE    UniProtKB: locus COC1C_CONCL, accession A6YR23;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644177.1, ABR92947.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR23, ConoServer:796,
            GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Gamma-carboxyglutamic acid;
            Hydroxylation; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 45)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..45
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..45
                     /product="Mu-conotoxin-like Cal 12.1.1c"
                     /note="Conotoxin CalTx 12.1.1D"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..45
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like Cal 12.1.1c. /id=PRO_0000392266."
     Bond            bond(3,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,28)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            17
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Bond            bond(18,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            21
                     /site_type="gamma-carboxyglutamic-acid"
                     /note="4-carboxyglutamate. /evidence=ECO:0000250."
     Site            23
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Bond            bond(27,39)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            37
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            38
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            40
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
ORIGIN      
        1 dvcdslvegr cihngcwcde eaphgnccdt agctawwwcp gtkfd
//

LOCUS       COC1B_CONCL               87 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin cal12b; AltName: Full=Conotoxin Cal
            12.1.1b; AltName: Full=Conotoxin CalTx 12.1.1B; Flags: Precursor.
ACCESSION   A6YR21
VERSION     A6YR21.1
DBSOURCE    UniProtKB: locus COC1B_CONCL, accession A6YR21;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644175.1, ABR92945.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR21, ConoServer:794,
            GO:0005576, GO:0008200, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Bromination; Direct protein sequencing; Disulfide bond;
            Hydroxylation; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 87)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 43-62, FUNCTION,
            SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY,
            BROMINATION AT TRP-59; TRP-79; TRP-80 AND TRP-86, AND HYDROXYLATION
            AT PRO-65 AND PRO-82.;
            TISSUE=Venom, and Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in cephalopods
            (tested on squid giant-fiber-lobe neurons) with an inhibitor
            constant (Ki) of 15 nmol/l, with no alteration in the voltage
            dependence of sodium conductance or on the kinetics of
            inactivation. Has no effect on sodium channels of the two gastropod
            S.luhuanus and A.californica (which are not natural prey).
            {ECO:0000269|PubMed:21147978}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21147978}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000269|PubMed:21147978}.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [MASS SPECTROMETRY] Mass=5194; Method=MALDI;
            Evidence={ECO:0000269|PubMed:21147978}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..87
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..87
                     /product="Mu-conotoxin cal12b"
                     /note="Conotoxin Cal 12.1.1b; Conotoxin CalTx 12.1.1B"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:21147978.
                     /id=PRO_0000392264."
     Region          43..87
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin cal12b. /id=PRO_0000392265."
     Bond            bond(45,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(53,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            59
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Bond            bond(60,75)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            65
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:21147978."
     Bond            bond(69,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            79
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            80
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            82
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            86
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
ORIGIN      
        1 mkltcvlvvl llllpygdli tnnyirgaar kvtpwrrnlk trdvcdslvg ghcihngcwc
       61 dqdaphgncc dtdgctaaww cpgtkwd
//

LOCUS       COC1A_CONCL               87 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin cal12a; AltName: Full=Conotoxin Cal
            12.1.1a; AltName: Full=Conotoxin CalTx 12.1.1A; Flags: Precursor.
ACCESSION   A6YR20
VERSION     A6YR20.1
DBSOURCE    UniProtKB: locus COC1A_CONCL, accession A6YR20;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Aug 21, 2007.
            annotation updated: May 25, 2022.
            xrefs: EF644174.1, ABR92944.1
            xrefs (non-sequence databases): AlphaFoldDB:A6YR20, ConoServer:793,
            GO:0005576, GO:0008200, GO:0017080, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Bromination; Direct protein sequencing; Disulfide bond;
            Gamma-carboxyglutamic acid; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Signal; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 87)
  AUTHORS   Gilly,W.F., Richmond,T.A., Duda,T.F. Jr., Elliger,C., Lebaric,Z.,
            Schulz,J., Bingham,J.P. and Sweedler,J.V.
  TITLE     A diverse family of novel peptide toxins from an unusual cone
            snail, Conus californicus
  JOURNAL   J Exp Biol 214 (Pt 1), 147-161 (2011)
   PUBMED   21147978
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 43-62, FUNCTION,
            SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY,
            BROMINATION AT TRP-59; TRP-79; TRP-80 AND TRP-86,
            GAMMA-CARBOXYGLUTAMATION AT GLU-63, AND HYDROXYLATION AT PRO-65 AND
            PRO-82.;
            TISSUE=Venom, and Venom duct
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin reversibly blocks voltage-gated sodium channel in
            cephalopods (tested on squid giant-fiber-lobe neurons) with an
            inhibitor constant (Ki) of 15 nmol/l, with no alteration in the
            voltage dependence of sodium conductance or on the kinetics of
            inactivation. Has no effect on sodium channels of the two gastropod
            S.luhuanus and A.californica (which are not natural prey).
            {ECO:0000269|PubMed:21147978}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21147978}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000269|PubMed:21147978}.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
            [MASS SPECTROMETRY] Mass=5253; Method=MALDI;
            Evidence={ECO:0000269|PubMed:21147978}.
            [SIMILARITY] Belongs to the conotoxin O1 superfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..87
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         1..87
                     /product="Mu-conotoxin cal12a"
                     /note="Conotoxin Cal 12.1.1a; Conotoxin CalTx 12.1.1A"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..42
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:21147978.
                     /id=PRO_0000392262."
     Region          43..87
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin cal12a. /id=PRO_0000392263."
     Bond            bond(45,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(53,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            59
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Bond            bond(60,75)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            63
                     /site_type="gamma-carboxyglutamic-acid"
                     /note="4-carboxyglutamate.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            65
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:21147978."
     Bond            bond(69,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            79
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            80
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            82
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:21147978."
     Site            86
                     /site_type="modified"
                     /note="6'-bromotryptophan.
                     /evidence=ECO:0000269|PubMed:21147978."
ORIGIN      
        1 mkltcvlvvl llllpygdli tnnyirgaar kvtpwrrnlk trdvcdslvg ghcihngcwc
       61 dqeaphgncc dtdgctaaww cpgtkwd
//

LOCUS       1SN1_A                    64 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Protein (neurotoxin Bmk M1).
ACCESSION   1SN1_A
VERSION     1SN1_A
DBSOURCE    pdb: molecule 1SN1, chain A, release Oct 4, 2017;
            deposition: Nov 12, 1998;
            class: Toxin;
            source: Mmdb_id: 11567, Pdb_id 1: 1SN1;
            Exp. method: X-Ray Diffraction.
KEYWORDS    .
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 64)
  AUTHORS   Fontecilla-Camps,J.C., Almassy,R.J., Suddath,F.L., Watt,D.D. and
            Bugg,C.E.
  TITLE     Three-dimensional structure of a protein from scorpion venom: a new
            structural class of neurotoxins
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 77 (11), 6496-6500 (1980)
   PUBMED   6256740
REFERENCE   2  (residues 1 to 64)
  AUTHORS   Almassy,R.J., Fontecilla-Camps,J.C., Suddath,F.L. and Bu,C.E.
  TITLE     Structure Of Variant-3 Scorpion Neurotoxin From Cen Sculpturatus
            Ewing, Refined At 1.8 A Resolution
  JOURNAL   J.Mol.Biol. 170, 496 (1983)
REFERENCE   3  (residues 1 to 64)
  AUTHORS   Hu,R.Q., Wang,M., Liu,J.N. and Lei,K.J.
  TITLE     Purification And Partial Characterization Of Severa Neurotoxins
            From East- Asia Scorpion [chinese]
  JOURNAL   Dongwuxue Yanjiu 10, 185 (1989)
REFERENCE   4  (residues 1 to 64)
  AUTHORS   Zhao,B., Carson,M., Ealick,S.E. and Bugg,C.E.
  TITLE     Structure of scorpion toxin variant-3 at 1.2 A resolution
  JOURNAL   J. Mol. Biol. 227 (1), 239-252 (1992)
   PUBMED   1522588
REFERENCE   5  (residues 1 to 64)
  AUTHORS   Housset,D., Habersetzer-Rochat,C., Astier,J.P. and
            Fontecilla-Camps,J.C.
  TITLE     Crystal structure of toxin II from the scorpion Androctonus
            australis Hector refined at 1.3 A resolution
  JOURNAL   J. Mol. Biol. 238 (1), 88-103 (1994)
   PUBMED   8145259
REFERENCE   6  (residues 1 to 64)
  AUTHORS   Li,H.M., Wang,D.C., Zeng,Z.H., Jin,L. and Hu,R.Q.
  TITLE     Crystal structure of an acidic neurotoxin from scorpion Buthus
            martensii Karsch at 1.85 A resolution
  JOURNAL   J. Mol. Biol. 261 (3), 415-431 (1996)
   PUBMED   8780783
REFERENCE   7  (residues 1 to 64)
  AUTHORS   Ji,Y.H., Mansuelle,P., Terakawa,S., Kopeyan,C., Yanaihara,N.,
            Hsu,K. and Rochat,H.
  TITLE     Two neurotoxins (BmK I and BmK II) from the venom of the scorpion
            Buthus martensi Karsch: purification, amino acid sequences and
            assessment of specific activity
  JOURNAL   Toxicon 34 (9), 987-1001 (1996)
   PUBMED   8896191
REFERENCE   8  (residues 1 to 64)
  AUTHORS   He,X.L., Li,H.M., Zeng,Z.H., Liu,X.Q., Wang,M. and Wang,D.C.
  TITLE     Crystal structures of two alpha-like scorpion toxins: non-proline
            cis peptide bonds and implications for new binding site selectivity
            on the sodium channel
  JOURNAL   J. Mol. Biol. 292 (1), 125-135 (1999)
   PUBMED   10493862
REFERENCE   9  (residues 1 to 64)
  AUTHORS   He,X.L., Li,H.M., Liu,X.Q., Zeng,Z.H. and Wang,D.C.
  TITLE     Direct Submission
  JOURNAL   Submitted (12-NOV-1998)
COMMENT     Structure Of Scorpion Neurotoxin Bmk M1.
FEATURES             Location/Qualifiers
     source          1..64
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     SecStr          2..6
                     /sec_str_type="sheet"
                     /note="strand 1"
     Bond            bond(12,63)
                     /bond_type="disulfide"
     Bond            bond(16,36)
                     /bond_type="disulfide"
     SecStr          19..29
                     /sec_str_type="helix"
                     /note="helix 1"
     Bond            bond(22,46)
                     /bond_type="disulfide"
     Bond            bond(26,48)
                     /bond_type="disulfide"
     SecStr          30..39
                     /sec_str_type="sheet"
                     /note="strand 2"
     SecStr          43..52
                     /sec_str_type="sheet"
                     /note="strand 3"
ORIGIN      
        1 vrdayiakph ncvyecarne ycndlctkng aksgycqwvg kygngcwcie lpdnvpirvp
       61 gkch
//

LOCUS       SCM1_MESMA                84 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Alpha-like toxin BmK M1; Short=BmK-M1; Short=BmKM1;
            AltName: Full=BmK-I; Short=BmK I; Short=BmKI; AltName: Full=BmK1;
            Flags: Precursor.
ACCESSION   P45697
VERSION     P45697.2
DBSOURCE    UniProtKB: locus SCM1_MESMA, accession P45697;
            class: standard.
            created: Nov 1, 1995.
            sequence updated: Dec 15, 1998.
            annotation updated: May 3, 2023.
            xrefs: AF057554.1, AAC13693.1, U28659.1, AAA69557.1, 1DJT_A,
            1DJT_B, 1SN1_A, 1T7A_A, 1T7B_A, 1T7E_A, 1ZU3_A, 1ZUT_A, 1ZVE_A,
            1ZVG_A, 1ZYV_A, 1ZYW_A
            xrefs (non-sequence databases): PDBsum:1DJT, PDBsum:1SN1,
            PDBsum:1T7A, PDBsum:1T7B, PDBsum:1T7E, PDBsum:1ZU3, PDBsum:1ZUT,
            PDBsum:1ZVE, PDBsum:1ZVG, PDBsum:1ZYV, PDBsum:1ZYW,
            AlphaFoldDB:P45697, SMR:P45697, TCDB:8.B.1.1.1,
            EvolutionaryTrace:P45697, GO:0005576, GO:0019871, GO:0090729,
            GO:0006952, CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Cardiotoxin; Direct protein sequencing; Disulfide
            bond; Ion channel impairing toxin; Neurotoxin; Secreted; Signal;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Xiong,Y.M., Ling,M.H., Wang,D.C. and Chi,C.W.
  TITLE     The CDNA and genomic DNA sequences of a mammalian neurotoxin from
            the scorpion Buthus martensii Karsch
  JOURNAL   Toxicon 35 (7), 1025-1031 (1997)
   PUBMED   9248001
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Ji,Y.H., Mansuelle,P., Terakawa,S., Kopeyan,C., Yanaihara,N.,
            Hsu,K. and Rochat,H.
  TITLE     Two neurotoxins (BmK I and BmK II) from the venom of the scorpion
            Buthus martensi Karsch: purification, amino acid sequences and
            assessment of specific activity
  JOURNAL   Toxicon 34 (9), 987-1001 (1996)
   PUBMED   8896191
  REMARK    PROTEIN SEQUENCE OF 20-83, FUNCTION, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 84)
  AUTHORS   Goudet,C., Huys,I., Clynen,E., Schoofs,L., Wang,D.C., Waelkens,E.
            and Tytgat,J.
  TITLE     Electrophysiological characterization of BmK M1, an alpha-like
            toxin from Buthus martensi Karsch venom
  JOURNAL   FEBS Lett 495 (1-2), 61-65 (2001)
   PUBMED   11322948
  REMARK    FUNCTION, AND FUNCTION ON SCN5A SODIUM CHANNELS.
REFERENCE   4  (residues 1 to 84)
  AUTHORS   Wang,C.G., Gilles,N., Hamon,A., Le Gall,F., Stankiewicz,M.,
            Pelhate,M., Xiong,Y.M., Wang,D.C. and Chi,C.W.
  TITLE     Exploration of the functional site of a scorpion alpha-like toxin
            by site-directed mutagenesis
  JOURNAL   Biochemistry 42 (16), 4699-4708 (2003)
   PUBMED   12705833
  REMARK    MUTAGENESIS OF TYR-24; LYS-27; PRO-28; HIS-29; ASN-30; TYR-40;
            LYS-47; ASP-72; ARG-77; LYS-81 AND HIS-83, FUNCTION ON SCN2A AND
            SCN4A SODIUM CHANNELS, AND TOXIC DOSE.
REFERENCE   5  (residues 1 to 84)
  AUTHORS   Sun,Y.M., Bosmans,F., Zhu,R.H., Goudet,C., Xiong,Y.M., Tytgat,J.
            and Wang,D.C.
  TITLE     Importance of the conserved aromatic residues in the scorpion
            alpha-like toxin BmK M1: the hydrophobic surface region revisited
  JOURNAL   J Biol Chem 278 (26), 24125-24131 (2003)
   PUBMED   12692120
  REMARK    MUTAGENESIS OF TYR-24; TRP-57 AND TYR-61.
REFERENCE   6  (residues 1 to 84)
  AUTHORS   Bai,Z.T., Zhang,X.Y. and Ji,Y.H.
  TITLE     Fos expression in rat spinal cord induced by peripheral injection
            of BmK I, an alpha-like scorpion neurotoxin
  JOURNAL   Toxicol Appl Pharmacol 192 (1), 78-85 (2003)
   PUBMED   14554105
  REMARK    FUNCTION, AND BIOASSAY.
REFERENCE   7  (residues 1 to 84)
  AUTHORS   Liu,L.H., Bosmans,F., Maertens,C., Zhu,R.H., Wang,D.C. and
            Tytgat,J.
  TITLE     Molecular basis of the mammalian potency of the scorpion alpha-like
            toxin, BmK M1
  JOURNAL   FASEB J 19 (6), 594-596 (2005)
   PUBMED   15677695
  REMARK    FUNCTION, TOXIC DOSE, AND MUTAGENESIS OF VAL-20; ARG-21; ASP-22;
            ILE-25; PRO-28; HIS-29; GLY-53; GLY-62; LEU-70; PRO-71; ILE-76;
            VAL-78; PRO-79 AND GLY-80.
REFERENCE   8  (residues 1 to 84)
  AUTHORS   Bai,Z.T., Zhao,R., Zhang,X.Y., Chen,J., Liu,T. and Ji,Y.H.
  TITLE     The epileptic seizures induced by BmK I, a modulator of sodium
            channels
  JOURNAL   Exp Neurol 197 (1), 167-176 (2006)
   PUBMED   16229835
  REMARK    FUNCTION, AND BIOASSAY.
REFERENCE   9  (residues 1 to 84)
  AUTHORS   Zhu,M.M., Tan,M., Cheng,H.W. and Ji,Y.H.
  TITLE     The alpha-like scorpion toxin BmK I enhances membrane excitability
            via persistent sodium current by preventing slow inactivation and
            deactivation of rNav1.2a expressed in Xenopus Oocytes
  JOURNAL   Toxicol In Vitro 23 (4), 561-568 (2009)
   PUBMED   19162162
  REMARK    FUNCTION.
REFERENCE   10 (residues 1 to 84)
  AUTHORS   He,H., Liu,Z., Dong,B., Zhou,J., Zhu,H. and Ji,Y.
  TITLE     Molecular determination of selectivity of the site 3 modulator (BmK
            I) to sodium channels in the CNS: a clue to the importance of
            Nav1.6 in BmK I-induced neuronal hyperexcitability
  JOURNAL   Biochem J 431 (2), 289-298 (2010)
   PUBMED   20678086
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   11 (residues 1 to 84)
  AUTHORS   Li,H.M., Zhao,T., Jin,L., Wang,M., Zhang,Y. and Wang,D.C.
  TITLE     A series of bioactivity-variant neurotoxins from scorpion Buthus
            martensii Karsch: purification, crystallization and
            crystallographic analysis
  JOURNAL   Acta Crystallogr D Biol Crystallogr 55 (Pt 1), 341-344 (1999)
   PUBMED   10089445
  REMARK    CRYSTALLIZATION.;
            TISSUE=Venom
REFERENCE   12 (residues 1 to 84)
  AUTHORS   He,X.L., Li,H.M., Zeng,Z.H., Liu,X.Q., Wang,M. and Wang,D.C.
  TITLE     Crystal structures of two alpha-like scorpion toxins: non-proline
            cis peptide bonds and implications for new binding site selectivity
            on the sodium channel
  JOURNAL   J Mol Biol 292 (1), 125-135 (1999)
   PUBMED   10493862
  REMARK    X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 20-83.
REFERENCE   13 (residues 1 to 84)
  AUTHORS   Guan,R.J., Xiang,Y., He,X.L., Wang,C.G., Wang,M., Zhang,Y.,
            Sundberg,E.J. and Wang,D.C.
  TITLE     Structural mechanism governing cis and trans isomeric states and an
            intramolecular switch for cis/trans isomerization of a non-proline
            peptide bond observed in crystal structures of scorpion toxins
  JOURNAL   J Mol Biol 341 (5), 1189-1204 (2004)
   PUBMED   15321715
  REMARK    X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 19-83, AND MUTAGENESIS OF
            LYS-27 AND PRO-28.
REFERENCE   14 (residues 1 to 84)
  AUTHORS   Ye,X., Bosmans,F., Li,C., Zhang,Y., Wang,D.C. and Tytgat,J.
  TITLE     Structural basis for the voltage-gated Na+ channel selectivity of
            the scorpion alpha-like toxin BmK M1
  JOURNAL   J Mol Biol 353 (4), 788-803 (2005)
   PUBMED   16209876
  REMARK    X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 19-83, AND MUTAGENESIS.
COMMENT     On Oct 22, 1999 this sequence version replaced gi:1173390.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels thereby blocking neuronal transmission. This toxin is
            active against both mammals and insects, and is classified as an
            alpha-like toxin. It is active on Nav1.2/SCN2A (EC(50)=139-252 nM),
            Nav1.3/SCN3A (EC(50)=565 nM), Nav1.4/SCN4A and Nav1.5/SCN5A
            (EC(50)=195-500 nM), Nav1.6/SCN8A (EC(50)=214 nM), and drosophila
            DmNav1 (EC(50)=30 nM) (PubMed:11322948, PubMed:12705833,
            PubMed:15677695, PubMed:19162162, PubMed:20678086). In
            mNav1.6/SCN8A, the toxin induces a large increase in both transient
            and persistent currents, which correlates with a prominent
            reduction in the fast component of inactivating current
            (PubMed:20678086). In rNav1.2/SCN2A and rNav1.3/SCN3A,
            toxin-increased currents is much smaller (PubMed:19162162,
            PubMed:20678086). Moreover, the toxin only accelerates the slow
            inactivation development and delay recovery of mNav1.6/SCN8A
            through binding to the channel in the open state (PubMed:20678086).
            Is 6-fold more toxic than BmK-M2. In vivo, intrahippocampal
            injection into rat induces epileptiform responses
            (PubMed:16229835). In addition, intraplantar injection into rat
            induces spontaneous nociception and hyperalgesia (PubMed:14554105).
            {ECO:0000269|PubMed:11322948, ECO:0000269|PubMed:12705833,
            ECO:0000269|PubMed:14554105, ECO:0000269|PubMed:15677695,
            ECO:0000269|PubMed:16229835, ECO:0000269|PubMed:19162162,
            ECO:0000269|PubMed:20678086}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:8896191}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:8896191}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000269|PubMed:10493862, ECO:0000269|PubMed:15321715,
            ECO:0000269|PubMed:16209876}.
            [TOXIC DOSE] LD(50) is 0.75 mg/kg by intravenous injection into
            mice. {ECO:0000269|PubMed:12705833}.
            [TOXIC DOSE] LD(50) is 0.53 mg/kg by intravenous injection into
            tail mice. {ECO:0000269|PubMed:12705833,
            ECO:0000269|PubMed:15677695}.
            [MISCELLANEOUS] Exists in two forms, due to cis-trans isomerization
            at 28-Pro-His-29. {ECO:0000269|PubMed:15321715}.
            [MISCELLANEOUS] Has insignificant effect on Nav1.2/SCN2A.
            {ECO:0000269|PubMed:12705833, ECO:0000269|PubMed:15677695}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
            [SEQUENCE CAUTION] Sequence=AAA69557.1; Type=Erroneous initiation;
            Note=Truncated N-terminus.; Evidence={ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..84
                     /product="Alpha-like toxin BmK M1"
                     /note="BmK-M1; BmKM1; BmK-I; BmK1; BmK I; BmKI"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000269|PubMed:8896191."
     Region          20..83
                     /region_name="Mature chain"
                     /note="Alpha-like toxin BmK M1.
                     /evidence=ECO:0000269|PubMed:8896191. /id=PRO_0000035236."
     Site            20..22
                     /site_type="mutagenized"
                     /note="Missing: 7.7-fold decrease in toxicity to mice,
                     3.2-fold decrease in activity on Nav1.5/SCN5A, and
                     17.2-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            20
                     /site_type="mutagenized"
                     /note="Missing: 1.2-fold decrease in toxicity to mice,
                     8.6-fold decrease in activity on Nav1.5/SCN5A, and
                     2.5-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Region          21..83
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          21..27
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1DJT."
     Site            21
                     /site_type="mutagenized"
                     /note="R->A: 2.4-fold decrease in toxicity to mice,
                     15.2-fold decrease in activity on Nav1.5/SCN5A, and
                     43.3-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            21
                     /site_type="mutagenized"
                     /note="R->E: 2.5-fold decrease in toxicity to mice,
                     1.6-fold decrease in activity on Nav1.5/SCN5A, and
                     22.3-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            22
                     /site_type="mutagenized"
                     /note="D->A: 1.3-fold decrease in toxicity to mice,
                     16.8-fold decrease in activity on Nav1.5/SCN5A, and
                     7.5-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            22
                     /site_type="mutagenized"
                     /note="D->N: 1.4-fold increase in toxicity to mice,
                     1.4-fold increase in activity on Nav1.5/SCN5A, and
                     3.9-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            24
                     /site_type="mutagenized"
                     /note="Y->F: 25-fold decrease in toxicity to mice.
                     /evidence=ECO:0000269|PubMed:12692120,
                     ECO:0000269|PubMed:12705833."
     Site            24
                     /site_type="mutagenized"
                     /note="Y->G: Complete loss of toxicity to mice, and
                     70-fold decrease in the binding affinity for insect sodium
                     channels. /evidence=ECO:0000269|PubMed:12692120,
                     ECO:0000269|PubMed:12705833."
     Site            25
                     /site_type="mutagenized"
                     /note="I->G: >47-fold decrease in toxicity to mice,
                     2.4-fold decrease in activity on Nav1.5/SCN5A, and 70-fold
                     decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            27..28
                     /site_type="mutagenized"
                     /note="KP->DS: 43.4-fold decrease in toxicity to mice,
                     170-fold decrease in the binding affinity for insect
                     sodium channels."
     Site            27
                     /site_type="mutagenized"
                     /note="K->D: 118-fold decrease in toxicity to mice, and
                     250-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833,
                     ECO:0000269|PubMed:15321715."
     Region          28..30
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1DJT."
     Site            28..29
                     /site_type="mutagenized"
                     /note="PH->NY: 3.3-fold increase in toxicity to mice,
                     7-fold decrease in activity on Nav1.5/SCN5A, and 5.1-fold
                     decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            28
                     /site_type="mutagenized"
                     /note="P->N: 1.9-fold increase in toxicity to mice,
                     1.3-fold increase in activity on Nav1.5/SCN5A, and
                     24.1-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            28
                     /site_type="mutagenized"
                     /note="P->S: 1.8-fold decrease in toxicity to mice, and
                     1.3-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833,
                     ECO:0000269|PubMed:15321715."
     Site            29
                     /site_type="mutagenized"
                     /note="H->E: 1.7-fold decrease in toxicity to mice, and
                     0.8-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Site            29
                     /site_type="mutagenized"
                     /note="H->Y: 2.2-fold decrease in toxicity to mice,
                     6.8-fold increase in activity on Nav1.5/SCN5A, and
                     1.8-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            30
                     /site_type="mutagenized"
                     /note="N->A: Complete loss of toxicity to mice, 380-fold
                     decrease in the binding affinity for insect sodium
                     channels. /evidence=ECO:0000269|PubMed:12705833."
     Bond            bond(31,82)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0000269|PubMed:15321715, ECO:0000269|PubMed:16209876,
                     ECO:0000312|PDB:1DJT, ECO:0000312|PDB:1SN1,
                     ECO:0000312|PDB:1T7A, ECO:0000312|PDB:1T7B,
                     ECO:0000312|PDB:1T7E, ECO:0000312|PDB:1ZU3,
                     ECO:0000312|PDB:1ZUT, ECO:0000312|PDB:1ZVE,
                     ECO:0000312|PDB:1ZVG, ECO:0000312|PDB:1ZYV,
                     ECO:0000312|PDB:1ZYW."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0000269|PubMed:15321715, ECO:0000269|PubMed:16209876,
                     ECO:0000312|PDB:1DJT, ECO:0000312|PDB:1SN1,
                     ECO:0000312|PDB:1T7A, ECO:0000312|PDB:1T7B,
                     ECO:0000312|PDB:1T7E, ECO:0000312|PDB:1ZU3,
                     ECO:0000312|PDB:1ZUT, ECO:0000312|PDB:1ZVE,
                     ECO:0000312|PDB:1ZVG, ECO:0000312|PDB:1ZYV,
                     ECO:0000312|PDB:1ZYW."
     Region          38..47
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1DJT."
     Site            40
                     /site_type="mutagenized"
                     /note="Y->G: 1.9-fold decrease in toxicity to mice, and
                     1.4-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Bond            bond(41,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0000269|PubMed:15321715, ECO:0000269|PubMed:16209876,
                     ECO:0000312|PDB:1DJT, ECO:0000312|PDB:1SN1,
                     ECO:0000312|PDB:1T7A, ECO:0000312|PDB:1T7B,
                     ECO:0000312|PDB:1T7E, ECO:0000312|PDB:1ZU3,
                     ECO:0000312|PDB:1ZUT, ECO:0000312|PDB:1ZVE,
                     ECO:0000312|PDB:1ZVG, ECO:0000312|PDB:1ZYV,
                     ECO:0000312|PDB:1ZYW."
     Bond            bond(45,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0000269|PubMed:15321715, ECO:0000269|PubMed:16209876,
                     ECO:0000312|PDB:1DJT, ECO:0000312|PDB:1SN1,
                     ECO:0000312|PDB:1T7A, ECO:0000312|PDB:1T7B,
                     ECO:0000312|PDB:1T7E, ECO:0000312|PDB:1ZU3,
                     ECO:0000312|PDB:1ZUT, ECO:0000312|PDB:1ZVE,
                     ECO:0000312|PDB:1ZVG, ECO:0000312|PDB:1ZYV,
                     ECO:0000312|PDB:1ZYW."
     Site            47
                     /site_type="mutagenized"
                     /note="K->E: 4.1-fold decrease in toxicity to mice, and
                     14-fold decrease in the binding affinity for insect sodium
                     channels. /evidence=ECO:0000269|PubMed:12705833."
     Region          48
                     /region_name="Conflict"
                     /note="N -> D (in Ref. 2; AA sequence).
                     /evidence=ECO:0000305."
     Region          51..59
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1DJT."
     Site            53
                     /site_type="mutagenized"
                     /note="G->A: 38-fold decrease in toxicity to mice,
                     11.2-fold decrease in activity on Nav1.5/SCN5A, and
                     43.3-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            57
                     /site_type="mutagenized"
                     /note="W->G: More than 50-fold decrease in toxicity to
                     mice. /evidence=ECO:0000269|PubMed:12692120."
     Site            61
                     /site_type="mutagenized"
                     /note="Y->G: More than 50-fold decrease in toxicity to
                     mice. /evidence=ECO:0000269|PubMed:12692120."
     Region          62..70
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1DJT."
     Site            62
                     /site_type="mutagenized"
                     /note="G->A: >47-fold decrease in toxicity to mice, loss
                     of activity on Nav1.5/SCN5A, and 56.7-fold decrease in
                     activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            70
                     /site_type="mutagenized"
                     /note="L->G: >47-fold decrease in toxicity to mice, loss
                     of activity on Nav1.5/SCN5A, and 233.3-fold decrease in
                     activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            71
                     /site_type="mutagenized"
                     /note="P->S: Not tested in mice, 1.2-fold decrease in
                     activity on Nav1.5/SCN5A, and 16.9-fold decrease in
                     activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            72
                     /site_type="mutagenized"
                     /note="D->A: 0.6-fold decrease in toxicity to mice, and
                     0.2-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Site            76
                     /site_type="mutagenized"
                     /note="I->G: 1.1-fold decrease in toxicity to mice, loss
                     of activity on Nav1.5/SCN5A, and 2.5-fold decrease in
                     activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            77
                     /site_type="mutagenized"
                     /note="R->A: Complete loss of toxicity to mice, and
                     complete loss of affinity for insect sodium channels.
                     /evidence=ECO:0000269|PubMed:12705833."
     Site            78
                     /site_type="mutagenized"
                     /note="V->G: 1.3-fold decrease in toxicity to mice,
                     2.6-fold decrease in activity on Nav1.5/SCN5A, and
                     2.2-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            79
                     /site_type="mutagenized"
                     /note="P->A: 1.1-fold increase in toxicity to mice,
                     5.8-fold decrease in activity on Nav1.5/SCN5A, and
                     20.4-fold decrease in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            79
                     /site_type="mutagenized"
                     /note="P->G: 1.7-fold decrease in toxicity to mice,
                     1.3-fold increase in activity on Nav1.5/SCN5A, and
                     1.7-fold increase in activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            80
                     /site_type="mutagenized"
                     /note="G->A: 35-fold decrease in toxicity to mice, loss of
                     activity on Nav1.5/SCN5A, and 7.8-fold decrease in
                     activity on insect sodium channels.
                     /evidence=ECO:0000269|PubMed:15677695."
     Site            81
                     /site_type="mutagenized"
                     /note="K->E: 71.4-fold decrease in toxicity to mice, and
                     170-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Site            83
                     /site_type="mutagenized"
                     /note="H->A: 3.8-fold decrease in toxicity to mice, and
                     180-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Site            83
                     /site_type="mutagenized"
                     /note="H->D: 43.9-fold decrease in toxicity to mice, and
                     96-fold decrease in the binding affinity for insect sodium
                     channels. /evidence=ECO:0000269|PubMed:12705833."
     Site            83
                     /site_type="mutagenized"
                     /note="H->K: 1.9-fold decrease in toxicity to mice, and
                     11.5-fold decrease in the binding affinity for insect
                     sodium channels. /evidence=ECO:0000269|PubMed:12705833."
     Region          84
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000305. /id=PRO_0000035237."
ORIGIN      
        1 mnylvmisfa lllmtgvesv rdayiakphn cvyecarney cndlctknga ksgycqwvgk
       61 ygngcwciel pdnvpirvpg kchr
//

LOCUS       CM3C_CONST                22 aa            linear   INV 03-MAY-2023
DEFINITION  RecName: Full=Mu-conotoxin SIIIC; AltName: Full=Mu-conotoxin
            TIIIA-like.
ACCESSION   P0C349
VERSION     P0C349.1
DBSOURCE    UniProtKB: locus CM3C_CONST, accession P0C349;
            class: standard.
            created: May 29, 2007.
            sequence updated: May 29, 2007.
            annotation updated: May 3, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0C349, GO:0005576,
            GO:0019871, GO:0090729, InterPro:IPR008036, Pfam:PF05374
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond;
            Hydroxylation; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Conus striatus (striated cone)
  ORGANISM  Conus striatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Pionoconus.
REFERENCE   1  (residues 1 to 22)
  AUTHORS   Lewis,R.J., Schroeder,C.I., Ekberg,J., Nielsen,K.J., Loughnan,M.,
            Thomas,L., Adams,D.A., Drinkwater,R., Adams,D.J. and Alewood,P.F.
  TITLE     Isolation and structure-activity of mu-conotoxin TIIIA, a potent
            inhibitor of tetrodotoxin-sensitive voltage-gated sodium channels
  JOURNAL   Mol Pharmacol 71 (3), 676-685 (2007)
   PUBMED   17142296
  REMARK    PROTEIN SEQUENCE, FUNCTION, SYNTHESIS, HYDROXYLATION AT PRO-8 AND
            PRO-18, STRUCTURE BY NMR, DISULFIDE BONDS, MUTAGENESIS OF HIS-2;
            LYS-6; LYS-9; ARG-14; GLU-15; ARG-17; GLN-19 AND HIS-20, AND
            SUBCELLULAR LOCATION.;
            TISSUE=Venom
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            synthetic peptide reversibly inhibits the brain sodium channel
            rNav1.2/SCN2A (IC(50) is 40 nM) and the skeletal muscle sodium
            channel rNav1.4/SCN4A (IC(50) is 9 nM).
            {ECO:0000269|PubMed:17142296}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:17142296}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:17142296}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-4 branch, since 4 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MISCELLANEOUS] No cis-trans isomerization is found.
            {ECO:0000305|PubMed:17142296}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..22
                     /organism="Conus striatus"
                     /db_xref="taxon:6493"
     Protein         1..22
                     /product="Mu-conotoxin SIIIC"
                     /note="Mu-conotoxin TIIIA-like"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin SIIIC.
                     /evidence=ECO:0000269|PubMed:17142296.
                     /id=PRO_0000288944."
     Site            2
                     /site_type="mutagenized"
                     /note="H->A: Slight increase in toxicity at rat muscle.
                     /evidence=ECO:0000269|PubMed:17142296."
     Bond            bond(4,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:17142296."
     Bond            bond(5,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:17142296."
     Site            6
                     /site_type="mutagenized"
                     /note="K->A,Q: Little decrease in toxicity at both rat
                     muscle and brain level.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            8
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            9
                     /site_type="mutagenized"
                     /note="K->A,Q: Little decrease in toxicity at both rat
                     muscle and brain level.
                     /evidence=ECO:0000269|PubMed:17142296."
     Bond            bond(11,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:17142296."
     Site            14
                     /site_type="other"
                     /note="Important for activity."
     Site            14
                     /site_type="mutagenized"
                     /note="R->A,Y,Q: Important decrease of toxicity at both
                     rat muscle and brain level.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            15
                     /site_type="mutagenized"
                     /note="E->A: 10-fold increase in affinity for both rat
                     brain and muscle Navs.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            17
                     /site_type="mutagenized"
                     /note="R->A,Q: Little decrease in toxicity at both rat
                     muscle and brain level.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            18
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            19
                     /site_type="mutagenized"
                     /note="Q->A: Slight increase in toxicity at rat muscle.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            20
                     /site_type="mutagenized"
                     /note="H->A: Little decrease in toxicity at both rat
                     muscle and brain level.
                     /evidence=ECO:0000269|PubMed:17142296."
     Site            22
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P0C350."
ORIGIN      
        1 rhgcckgpkg cssrecrpqh cc
//

LOCUS       TX3_CERMR                 39 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-theraphotoxin-Cm2a; Short=Beta-TRTX-Cm2a;
            AltName: Full=Ceratotoxin-3; Short=CcoTx3.
ACCESSION   P84509
VERSION     P84509.1
DBSOURCE    UniProtKB: locus TX3_CERMR, accession P84509;
            class: standard.
            created: Oct 25, 2005.
            sequence updated: Oct 25, 2005.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P84509, SMR:P84509,
            ArachnoServer:AS000272, GO:0005615, GO:0019871, GO:0090729,
            GO:0044489, InterPro:IPR011696, Pfam:PF07740, SUPFAM:SSF57059
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Ceratogyrus marshalli
  ORGANISM  Ceratogyrus marshalli
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Ceratogyrus.
REFERENCE   1  (residues 1 to 39)
  AUTHORS   Bosmans,F., Rash,L., Zhu,S., Diochot,S., Lazdunski,M., Escoubas,P.
            and Tytgat,J.
  TITLE     Four novel tarantula toxins as selective modulators of
            voltage-gated sodium channel subtypes
  JOURNAL   Mol Pharmacol 69 (2), 419-429 (2006)
   PUBMED   16267209
  REMARK    PROTEIN SEQUENCE, FUNCTION, BIOASSAY, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND AMIDATION AT PHE-39.;
            TISSUE=Venom
COMMENT     [FUNCTION] Inhibits mammalian voltage-gated sodium channel subtypes
            Nav1.5/SCN5A and Nav1.8/SCN10A by shifting the voltage dependence
            of channel activation to more depolarized potentials and by
            blocking the inward component of the sodium current. In vivo, this
            toxin causes erect, elevated tail, initial partial ataxia, followed
            by recovery over approximately 1 hour after injection and the
            progressive development of shaking. Although paralysis subsides,
            the body tremors never cease and persist until the end of the
            experiment. {ECO:0000269|PubMed:16267209}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:16267209}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:16267209}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P56855}.
            [MASS SPECTROMETRY] Mass=4321.84; Method=MALDI;
            Evidence={ECO:0000269|PubMed:16267209}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 47
            subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..39
                     /organism="Ceratogyrus marshalli"
                     /db_xref="taxon:316287"
     Protein         1..39
                     /product="Beta-theraphotoxin-Cm2a"
                     /note="Beta-TRTX-Cm2a; Ceratotoxin-3; CcoTx3"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..39
                     /region_name="Processed active peptide"
                     /note="Beta-theraphotoxin-Cm2a.
                     /evidence=ECO:0000269|PubMed:16267209.
                     /id=PRO_0000045002."
     Bond            bond(7,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56855."
     Bond            bond(14,26)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56855."
     Bond            bond(20,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56855."
     Site            39
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000269|PubMed:16267209."
ORIGIN      
        1 gvdkegcrkl lggctidddc cphlgcnkky whcgwdgtf
//

LOCUS       SCAA2_MESMA               65 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Neurotoxin BmK AGAP-SYPU2.
ACCESSION   G4V3T9
VERSION     G4V3T9.1
DBSOURCE    UniProtKB: locus SCAA2_MESMA, accession G4V3T9;
            class: standard.
            created: May 14, 2014.
            sequence updated: Dec 14, 2011.
            annotation updated: Feb 22, 2023.
            xrefs: GU726489.1, ADR83705.1
            xrefs (non-sequence databases): AlphaFoldDB:G4V3T9, SMR:G4V3T9,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Shao,J.H., Cui,Y., Zhao,M.Y., Wu,C.F., Liu,Y.F. and Zhang,J.H.
  TITLE     Purification, characterization, and bioactivity of a new
            analgesic-antitumor peptide from Chinese scorpion Buthus martensii
            Karsch
  JOURNAL   Peptides 53, 89-96 (2014)
   PUBMED   24269605
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-12, FUNCTION,
            BIOASSAY, MASS SPECTROMETRY, 3D-STRUCTURE MODELING, AND SUBCELLULAR
            LOCATION.;
            TISSUE=Venom, and Venom gland
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            In vivo, shows analgesic activity (ED(50) is 1.42 mg/kg) and
            antitumor activity against Ehrlich ascites tumor and S-180
            fibrosarcoma models (PubMed:24269605). {ECO:0000250,
            ECO:0000269|PubMed:24269605}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:24269605}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:24269605}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7247.40; Method=MALDI;
            Evidence={ECO:0000269|PubMed:24269605}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..>65
                     /product="Neurotoxin BmK AGAP-SYPU2"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..>65
                     /region_name="Mature chain"
                     /note="Neurotoxin BmK AGAP-SYPU2.
                     /evidence=ECO:0000305|PubMed:24269605.
                     /id=PRO_0000428967."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
ORIGIN      
        1 vkdgyivddk ncayfcgrna ycddecekng aesgycqwag vygnacwcyk lpdkvpirvp
       61 grcng
//

LOCUS       CM3A_CONBU                77 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin BuIIIA; Flags: Precursor.
ACCESSION   C1J5M5
VERSION     C1J5M5.1
DBSOURCE    UniProtKB: locus CM3A_CONBU, accession C1J5M5;
            class: standard.
            created: Sep 22, 2009.
            sequence updated: May 26, 2009.
            annotation updated: Feb 22, 2023.
            xrefs: FJ240165.1, ACO50770.1
            xrefs (non-sequence databases): AlphaFoldDB:C1J5M5,
            ConoServer:3716, GO:0005576, GO:0008200, GO:0017080, GO:0090729,
            InterPro:IPR004214, Pfam:PF02950
KEYWORDS    Amidation; Cleavage on pair of basic residues; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Conus bullatus
  ORGANISM  Conus bullatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Textilia.
REFERENCE   1  (residues 1 to 77)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], SYNTHESIS OF 52-74, FUNCTION ON
            NAV1.4/SCN4A, AND AMIDATION AT CYS-74.;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 77)
  AUTHORS   Wilson,M.J., Yoshikami,D., Azam,L., Gajewiak,J., Olivera,B.M.,
            Bulaj,G. and Zhang,M.M.
  TITLE     mu-Conotoxins that differentially block sodium channels NaV1.1
            through 1.8 identify those responsible for action potentials in
            sciatic nerve
  JOURNAL   Proc Natl Acad Sci U S A 108 (25), 10302-10307 (2011)
   PUBMED   21652775
  REMARK    FUNCTION, AND SYNTHESIS OF 52-74.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This synthetic toxin potently blocks rNav1.2/SCN2A, and
            rNav1.4/SCN4A. It also moderately blocks rNav1.1/SCN1A,
            rNav1.3/SCN3A, rNav1.5/SCN5A, and mNav1.6/SCN8A. The inhibition is
            reversible. {ECO:0000269|PubMed:18950653,
            ECO:0000269|PubMed:21652775}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:18950653}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:18950653}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MISCELLANEOUS] Negative results: does not block rNav1.7/SCN9A, and
            rNav1.8/SCN10A. {ECO:0000305|PubMed:21652775}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..77
                     /organism="Conus bullatus"
                     /db_xref="taxon:89438"
     Protein         1..77
                     /product="Mu-conotoxin BuIIIA"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..51
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305. /id=PRO_0000384431."
     Region          26..46
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          28..46
                     /region_name="Compositionally biased region"
                     /note="Basic and acidic residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          52..74
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin BuIIIA.
                     /evidence=ECO:0000305|PubMed:18950653.
                     /id=PRO_0000384432."
     Bond            bond(56,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Bond            bond(57,73)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Bond            bond(63,74)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Site            74
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:18950653."
ORIGIN      
        1 mmsklgvllt iclllfplfa lpqdgdqpad rpaermqddi sseqnsllek rvtdrcckgk
       61 recgrwcrdh srccgrr
//

LOCUS       2LXG_A                    17 aa            linear   INV 24-AUG-2022
DEFINITION  Chain A, Mu-conotoxin KIIIA.
ACCESSION   2LXG_A
VERSION     2LXG_A
DBSOURCE    pdb: molecule 2LXG, chain A, release Aug 24, 2022;
            deposition: Aug 21, 2012;
            class: TOXIN;
            source: Mmdb_id: 107243, Pdb_id 1: 2LXG;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Conus kinoshitai
  ORGANISM  Conus kinoshitai
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Afonsoconus.
REFERENCE   1  (residues 1 to 17)
  AUTHORS   Khoo,K.K., Gupta,K., Green,B.R., Zhang,M.M., Watkins,M.,
            Olivera,B.M., Balaram,P., Yoshikami,D., Bulaj,G. and Norton,R.S.
  TITLE     Distinct disulfide isomers of mu-conotoxins KIIIA and KIIIB block
            voltage-gated sodium channels
  JOURNAL   Biochemistry 51 (49), 9826-9835 (2012)
   PUBMED   23167564
REFERENCE   2  (residues 1 to 17)
  AUTHORS   Khoo,K.K. and Norton,R.S.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-AUG-2012)
COMMENT     NMR solution structure of Mu-conotoxin KIIIA.
FEATURES             Location/Qualifiers
     source          1..17
                     /organism="Conus kinoshitai"
                     /db_xref="taxon:376876"
     Bond            bond(2,9)
                     /bond_type="disulfide"
     Bond            bond(4,16)
                     /bond_type="disulfide"
     SecStr          6..13
                     /sec_str_type="helix"
                     /note="helix 1"
     NonStdRes       17
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 ccncsskwcr dhsrccx
//

LOCUS       COCE_CONCL                43 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin-like CalTx 12.2.1E; Flags: Precursor.
ACCESSION   A9UH01
VERSION     A9UH01.1
DBSOURCE    UniProtKB: locus COCE_CONCL, accession A9UH01;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Feb 5, 2008.
            annotation updated: May 25, 2022.
            xrefs: EU284127.1, ABX79671.1
            xrefs (non-sequence databases): AlphaFoldDB:A9UH01,
            ConoServer:2785, GO:0005576, GO:0099106, GO:0090729
KEYWORDS    Bromination; Disulfide bond; Hydroxylation; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin.
SOURCE      Californiconus californicus
  ORGANISM  Californiconus californicus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Californiconus.
REFERENCE   1  (residues 1 to 43)
  AUTHORS   Gilly,W.F., Richmond,T.A., Elliger,C., Lebaric,Z., Schulz,J.,
            Bingham,J.P. and Sweedler,J.V.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-MAY-2007) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels. This
            toxin reversibly blocks voltage-gated sodium channel in
            cephalopods, with no alteration in the voltage dependence of sodium
            conductance or on the kinetics of inactivation (By similarity).
            {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is XII (C-C-C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..43
                     /organism="Californiconus californicus"
                     /db_xref="taxon:1736779"
     Protein         <1..43
                     /product="Mu-conotoxin-like CalTx 12.2.1E"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          <1
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000392287."
     Region          2..43
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin-like CalTx 12.2.1E.
                     /id=PRO_0000392288."
     Bond            bond(4,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000305."
     Bond            bond(11,24)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(18,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(23,35)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            31
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
     Site            36
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline. /evidence=ECO:0000250."
     Site            40
                     /site_type="modified"
                     /note="6'-bromotryptophan. /evidence=ECO:0000250."
ORIGIN      
        1 rgvcstpegs cvhngcicqn apcchesgcn wanvcpgflw dkn
//

LOCUS       NA1B_CONGI                47 aa            linear   INV 13-SEP-2023
DEFINITION  RecName: Full=Delta-actitoxin-Cgg1b; Short=Delta-AITX-Cgg1b;
            AltName: Full=Cp-1; Short=Cp I; Short=CpI; AltName:
            Full=Delta-actitoxin-Cps1a; Short=Delta-AITX-Cps1a.
ACCESSION   P0CH42
VERSION     P0CH42.1
DBSOURCE    UniProtKB: locus NA1B_CONGI, accession P0CH42;
            class: standard.
            created: Oct 5, 2010.
            sequence updated: Oct 5, 2010.
            annotation updated: Sep 13, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0CH42, SMR:P0CH42,
            GO:0005576, GO:0042151, GO:0017080, GO:0090729, Gene3D:2.20.20.10,
            InterPro:IPR023355, Pfam:PF00706, SUPFAM:SSF57392
KEYWORDS    Direct protein sequencing; Disulfide bond; Hydroxylation; Ion
            channel impairing toxin; Nematocyst; Secreted; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Condylactis gigantea (giant Caribbean anemone)
  ORGANISM  Condylactis gigantea
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Condylactis.
REFERENCE   1  (residues 1 to 47)
  AUTHORS   Shiomi,K., Lin,X.Y., Nagashima,Y. and Ishida,M.
  TITLE     Isolation and amino acid sequences of polypeptide toxins in the
            Caribbean sea anemone Condylactis passiflora
  JOURNAL   Fish. Sci. 61, 1016-1021 (1995)
  REMARK    PROTEIN SEQUENCE, AND HYDROXYLATION AT PRO-3.
REFERENCE   2  (residues 1 to 47)
  AUTHORS   Wanke,E., Zaharenko,A.J., Redaelli,E. and Schiavon,E.
  TITLE     Actions of sea anemone type 1 neurotoxins on voltage-gated sodium
            channel isoforms
  JOURNAL   Toxicon 54 (8), 1102-1111 (2009)
   PUBMED   19393679
  REMARK    REVIEW.
REFERENCE   3  (residues 1 to 47)
  AUTHORS   Oliveira,J.S., Fuentes-Silva,D. and King,G.F.
  TITLE     Development of a rational nomenclature for naming peptide and
            protein toxins from sea anemones
  JOURNAL   Toxicon 60 (4), 539-550 (2012)
   PUBMED   22683676
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Binds voltage-dependently at site 3 of sodium channels
            (Nav) and inhibits the inactivation, thereby blocking neuronal
            transmission (By similarity). The minimum lethal dose against crabs
            is 7.3 mg/kg (Ref.1). {ECO:0000250, ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted. Nematocyst {ECO:0000305}.
            [SIMILARITY] Belongs to the sea anemone sodium channel inhibitory
            toxin family. Type I subfamily. {ECO:0000305}.
            [CAUTION] Since the species C.passiflora is considered as a synonym
            of C.gigantea, the protein name was updated from
            Delta-actitoxin-Cps1a to Delta-actitoxin-Cgg1b. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..47
                     /organism="Condylactis gigantea"
                     /db_xref="taxon:47073"
     Protein         1..47
                     /product="Delta-actitoxin-Cgg1b"
                     /note="Delta-AITX-Cgg1b; Cp-1; Delta-actitoxin-Cps1a; Cp
                     I; CpI; Delta-AITX-Cps1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..47
                     /region_name="Mature chain"
                     /note="Delta-actitoxin-Cgg1b. /evidence=ECO:0000269|Ref.1.
                     /id=PRO_0000397963."
     Region          3..45
                     /region_name="Toxin_4"
                     /note="Anenome neurotoxin; pfam00706"
                     /db_xref="CDD:109750"
     Site            3
                     /site_type="hydroxylation"
                     /note="Hydroxyproline. /evidence=ECO:0000269|Ref.1."
     Bond            bond(4,44)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0C280."
     Bond            bond(6,34)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0C280."
     Bond            bond(27,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0C280."
ORIGIN      
        1 gvpcrcdsdg psvhgntlsg tvwvgscasg whkcntehni fheccke
//

LOCUS       SCX3_TITSE                86 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-mammal toxin Ts3; AltName: Full=PT-Mice-alpha
            NaTx3.1; AltName: Full=Tityustoxin IV; Short=Ts IV; Short=TsIV;
            AltName: Full=Tityustoxin IV-5; Short=Toxin IV-5; Short=TsIV-5;
            AltName: Full=Ts3(1-64); Flags: Precursor.
ACCESSION   P01496
VERSION     P01496.5
DBSOURCE    UniProtKB: locus SCX3_TITSE, accession P01496;
            class: standard.
            extra accessions:A0A218QX01,P45659,P91788
            created: Jul 21, 1986.
            sequence updated: Aug 3, 2022.
            annotation updated: Feb 22, 2023.
            xrefs: GEUW01000074.1, JAW06971.1, MT450707.1, QPD99043.1,
            S69808.1, AAB30413.1, S82286.1, AAB37719.2, NTSR4T, 5CY0_A
            xrefs (non-sequence databases): PDBsum:5CY0, AlphaFoldDB:P01496,
            SMR:P01496, GO:0005576, GO:0019871, GO:0090729, GO:0006952,
            CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Amidation; Direct protein sequencing; Disulfide bond;
            Ion channel impairing toxin; Neurotoxin; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Tityus serrulatus (Brazilian scorpion)
  ORGANISM  Tityus serrulatus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 86)
  AUTHORS   de Oliveira,U.C., Nishiyama,M.Y. Jr., Dos Santos,M.B.V.,
            Santos-da-Silva,A.P., Chalkidis,H.M., Souza-Imberg,A.,
            Candido,D.M., Yamanouye,N., Dorce,V.A.C. and
            Junqueira-de-Azevedo,I.L.M.
  TITLE     Proteomic endorsed transcriptomic profiles of venom glands from
            Tityus obscurus and T. serrulatus scorpions
  JOURNAL   PLoS One 13 (3), e0193739 (2018)
   PUBMED   29561852
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Telson
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 86)
  AUTHORS   Kalapothakis,Y., Miranda,K., Pereira,A.H., Witt,A.S.A., Marani,C.,
            Martins,A.P., Leal,H.G., Campos-Junior,E., Pimenta,A.M.C.,
            Borges,A., Chavez-Olortegui,C. and Kalapothakis,E.
  TITLE     Novel components of Tityus serrulatus venom: A transcriptomic
            approach
  JOURNAL   Toxicon 189, 91-104 (2021)
   PUBMED   33181162
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Telson
REFERENCE   3  (residues 1 to 86)
  AUTHORS   Martin-Eauclaire,M.F., Ceard,B., Ribeiro,A.M., Diniz,C.R.,
            Rochat,H. and Bougis,P.E.
  TITLE     Biochemical, pharmacological and genomic characterisation of Ts IV,
            an alpha-toxin from the venom of the South American scorpion Tityus
            serrulatus
  JOURNAL   FEBS Lett 342 (2), 181-184 (1994)
   PUBMED   8143874
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 7-86, PROTEIN SEQUENCE OF 20-49, AND
            SUBCELLULAR LOCATION.;
            TISSUE=Venom, and Venom gland
REFERENCE   4  (residues 1 to 86)
  AUTHORS   Corona,M., Zurita,M., Possani,L.D. and Becerril,B.
  TITLE     Cloning and characterization of the genomic region encoding toxin
            IV-5 from the scorpion Tityus serrulatus Lutz and Mello
  JOURNAL   Toxicon 34 (2), 251-256 (1996)
   PUBMED   8711758
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 7-86.
REFERENCE   5  (residues 1 to 86)
  AUTHORS   Possani,L.D., Martin,B.M., Fletcher,M.D. and Fletcher,P.L. Jr.
  TITLE     Discharge effect on pancreatic exocrine secretion produced by
            toxins purified from Tityus serrulatus scorpion venom
  JOURNAL   J Biol Chem 266 (5), 3178-3185 (1991)
   PUBMED   1993690
  REMARK    PROTEIN SEQUENCE OF 20-81, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   6  (residues 1 to 86)
  AUTHORS   Teixeira,C.E., Ifa,D.R., Corso,G., Santagada,V., Caliendo,G.,
            Antunes,E. and De Nucci,G.
  TITLE     Sequence and structure-activity relationship of a scorpion venom
            toxin with nitrergic activity in rabbit corpus cavernosum
  JOURNAL   FASEB J 17 (3), 485-487 (2003)
   PUBMED   12551849
  REMARK    PROTEIN SEQUENCE OF 20-44, FUNCTION, AND MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   7  (residues 1 to 86)
  AUTHORS   Possani,L.D., Martin,B.M., Mochca-Morales,J. and Svendsen,I.
  TITLE     N-terminal sequence of toxin IV-5 from the venom of the scorpion
            Tytius serrulatus
  JOURNAL   Toxicon 20, 75-76 (1982)
  REMARK    PROTEIN SEQUENCE OF 20-49.;
            TISSUE=Venom
REFERENCE   8  (residues 1 to 86)
  AUTHORS   Kirsch,G.E., Skattebol,A., Possani,L.D. and Brown,A.M.
  TITLE     Modification of Na channel gating by an alpha scorpion toxin from
            Tityus serrulatus
  JOURNAL   J Gen Physiol 93 (1), 67-83 (1989)
   PUBMED   2536799
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   9  (residues 1 to 86)
  AUTHORS   Campos,F.V., Coronas,F.I. and Beirao,P.S.
  TITLE     Voltage-dependent displacement of the scorpion toxin Ts3 from
            sodium channels and its implication on the control of inactivation
  JOURNAL   Br J Pharmacol 142 (7), 1115-1122 (2004)
   PUBMED   15249424
  REMARK    FUNCTION.;
            TISSUE=Venom
REFERENCE   10 (residues 1 to 86)
  AUTHORS   Campos,F.V., Moreira,T.H., Beirao,P.S. and Cruz,J.S.
  TITLE     Veratridine modifies the TTX-resistant Na+ channels in rat vagal
            afferent neurons
  JOURNAL   Toxicon 43 (4), 401-406 (2004)
   PUBMED   15051403
  REMARK    FUNCTION.
REFERENCE   11 (residues 1 to 86)
  AUTHORS   Cologna,C.T., Marcussi,S., Giglio,J.R., Soares,A.M. and
            Arantes,E.C.
  TITLE     Tityus serrulatus scorpion venom and toxins: an overview
  JOURNAL   Protein Pept Lett 16 (8), 920-932 (2009)
   PUBMED   19689419
  REMARK    NOMENCLATURE.
REFERENCE   12 (residues 1 to 86)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
REFERENCE   13 (residues 1 to 86)
  AUTHORS   Dang,B., Kubota,T., Mandal,K., Correa,A.M., Bezanilla,F. and
            Kent,S.B.
  TITLE     Elucidation of the covalent and tertiary structures of biologically
            active Ts3 toxin
  JOURNAL   Angew. Chem. Int. Ed. 55, 8639-8642 (2016)
   PUBMED   27244051
  REMARK    X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 20-83, FUNCTION,
            DISULFIDE BOND, AND SYNTHESIS OF 20-81; 20-83; 20-85 AND 20-86.
COMMENT     On Aug 5, 2022 this sequence version replaced P01496.4.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (PubMed:2536799,
            PubMed:15249424, PubMed:15051403). This synthetic toxin inhibits
            inactivation of rat Nav1.4/SCN4A (when tested at 201 nM)
            (PubMed:27244051). In addition, it has been shown to cause a
            persistent sodium channel activation in nitrergic inhibitory fibers
            innervating the rabbit corpus cavernosum, resulting in NO release
            and cavernosal smooth muscle relaxation (PubMed:12551849). This
            toxin is active against mammals (PubMed:2536799, PubMed:15249424,
            PubMed:15051403). {ECO:0000269|PubMed:12551849,
            ECO:0000269|PubMed:15051403, ECO:0000269|PubMed:15249424,
            ECO:0000269|PubMed:2536799, ECO:0000269|PubMed:27244051}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:1993690,
            ECO:0000269|PubMed:8143874}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:8143874}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000269|PubMed:27244051}.
            [MASS SPECTROMETRY] Mass=7427.66; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12551849}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
            [CAUTION] The longest forms Tityustoxin V (also called Ts V and
            Ts3(1-66)) and Ts3(1-67) and the shortest form Tityustoxin III
            (also called Ts III and Ts3(1-62)) show minimal effect on
            Nav1.4/SCN4A, suggesting that the wild-type toxin corresponds to
            the amidated 64-residues long peptide (PubMed:8143874,
            PubMed:27244051). {ECO:0000269|PubMed:27244051,
            ECO:0000303|PubMed:8143874}.
FEATURES             Location/Qualifiers
     source          1..86
                     /organism="Tityus serrulatus"
                     /db_xref="taxon:6887"
     Protein         1..86
                     /product="Alpha-mammal toxin Ts3"
                     /note="PT-Mice-alpha NaTx3.1; Tityustoxin IV; Tityustoxin
                     IV-5; Ts3(1-64); Ts IV; TsIV; Toxin IV-5; TsIV-5"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          7
                     /region_name="Conflict"
                     /note="L -> M (in Ref. 4; AAB37719).
                     /evidence=ECO:0000305."
     Region          20..83
                     /region_name="Mature chain"
                     /note="Alpha-mammal toxin Ts3.
                     /evidence=ECO:0000305|PubMed:1993690,
                     ECO:0000305|PubMed:8143874, ECO:0000305|Ref.7.
                     /id=PRO_0000035299."
     Region          21..82
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..73
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          21..23
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Region          25..27
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Region          28..30
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Bond            bond(31,81)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:27244051,
                     ECO:0000312|PDB:5CY0."
     Bond            bond(35,57)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:27244051,
                     ECO:0000312|PDB:5CY0."
     Region          40..49
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Bond            bond(43,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:27244051,
                     ECO:0000312|PDB:5CY0."
     Bond            bond(47,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:27244051,
                     ECO:0000312|PDB:5CY0."
     Region          53..58
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Region          59..62
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Region          63..69
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:5CY0."
     Region          76..79
                     /region_name="Conflict"
                     /note="KTNG -> GST (in Ref. 5; AA sequence).
                     /evidence=ECO:0000305."
     Site            83
                     /site_type="amidation"
                     /note="Serine amide.
                     /evidence=ECO:0000250|UniProtKB:P01484."
ORIGIN      
        1 mnyfillvvv clltagtegk kdgypveydn cayicwnydn aycdklckdk kadsgycywv
       61 hilcycyglp dseptktngk cksgkk
//

LOCUS       CM3A_CONTS                67 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin TsIIIA; Flags: Precursor.
ACCESSION   H2BKS9
VERSION     H2BKS9.1
DBSOURCE    UniProtKB: locus CM3A_CONTS, accession H2BKS9;
            class: standard.
            created: Apr 12, 2017.
            sequence updated: Mar 21, 2012.
            annotation updated: Feb 22, 2023.
            xrefs: JF510914.1, AEX60400.1
            xrefs (non-sequence databases): AlphaFoldDB:H2BKS9, GO:0005576,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Cleavage on pair of basic residues; Disulfide bond; Ion channel
            impairing toxin; Secreted; Signal; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Conus tessulatus
  ORGANISM  Conus tessulatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Tesselliconus.
REFERENCE   1  (residues 1 to 67)
  AUTHORS   Zhou,M., Wang,L., Wu,Y., Zhu,X., Feng,Y., Chen,Z., Li,Y., Sun,D.,
            Ren,Z. and Xu,A.
  TITLE     Characterizing the evolution and functions of the M-superfamily
            conotoxins
  JOURNAL   Toxicon 76, 150-159 (2013)
   PUBMED   24080356
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom duct
REFERENCE   2  (residues 1 to 67)
  AUTHORS   Yang,M., Zhao,S., Min,X., Shao,M., Chen,Y., Chen,Z. and Zhou,M.
  TITLE     A novel mu-conotoxin from worm-hunting Conus tessulatus that
            selectively inhibit rat TTX-resistant sodium currents
  JOURNAL   Toxicon 130, 11-18 (2017)
   PUBMED   28219625
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SYNTHESIS OF 49-67.;
            TISSUE=Venom duct
REFERENCE   3  (residues 1 to 67)
  AUTHORS   Yang,M. and Zhou,M.
  TITLE     mu-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated
            sodium channel hNav1.8
  JOURNAL   Toxicon 186, 29-34 (2020)
   PUBMED   32758497
  REMARK    FUNCTION, AND SYNTHESIS OF 49-67.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            This toxin specifically inhibits mammalian Nav1.8/SCN10A sodium
            currents (IC(50)=2.11 uM) without inducing a shift in the
            current-voltage relationship of this channel (PubMed:32758497). In
            vivo, shows potent analgesic activity in a mice hotplate analgesic
            assay (PubMed:28219625). In addition, this toxin has better
            analgesic effects than Ziconotide, an analgesic drug
            (PubMed:28219625). {ECO:0000269|PubMed:28219625,
            ECO:0000269|PubMed:32758497}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:24080356,
            ECO:0000305|PubMed:28219625}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:24080356, ECO:0000305|PubMed:28219625}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-4 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MISCELLANEOUS] Negative results: has no effects (10 uM tested) on
            the human tetrodotoxin-sensitive Nav1.1/SCN1A, Nav1.2/SCN2A,
            Nav1.3/SCN3A, Nav1.4/SCN4A, Nav1.6/SCN8A and Nav1.7/SCN9A, as well
            as human tetrodotoxin-resistant Nav1.5/SCN7A.
            {ECO:0000269|PubMed:32758497}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..67
                     /organism="Conus tessulatus"
                     /db_xref="taxon:101317"
     Protein         1..67
                     /product="Mu-conotoxin TsIIIA"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..20
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          3..60
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          21..48
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:28219625.
                     /id=PRO_0000439628."
     Region          49..67
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin TsIIIA.
                     /evidence=ECO:0000305|PubMed:28219625.
                     /id=PRO_5003560264."
     Bond            bond(50,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01523,
                     ECO:0000305|PubMed:28219625."
     Bond            bond(51,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01523,
                     ECO:0000305|PubMed:28219625."
     Bond            bond(55,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01523,
                     ECO:0000305|PubMed:28219625."
ORIGIN      
        1 mmsklgvllt iclllfplta vpldgdqpad qpaerkqneq hplfdqkrgc crwpcpsrcg
       61 marccss
//

LOCUS       TXH3_CYRSC                87 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-theraphotoxin-Hs1a; Short=Mu-TRTX-Hs1a; AltName:
            Full=Huwentoxin-3; AltName: Full=Huwentoxin-III; Short=HwTx-III;
            Contains: RecName: Full=U2-theraphotoxin-Hs1b; Short=U2-TRTX-Hs1b;
            AltName: Full=HWTX-IIIa; AltName: Full=Mutant of huwentoxin-3;
            AltName: Full=Mutant of huwentoxin-III; Short=mHWTX-III; Flags:
            Precursor.
ACCESSION   P61103
VERSION     P61103.2
DBSOURCE    UniProtKB: locus TXH3_CYRSC, accession P61103;
            class: standard.
            created: Apr 26, 2004.
            sequence updated: Nov 23, 2004.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P61103, SMR:P61103,
            ArachnoServer:AS000331, ArachnoServer:AS000754, GO:0005576,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR011696,
            InterPro:IPR013140, Pfam:PF07740, SUPFAM:SSF57059, PROSITE:PS60021
KEYWORDS    Cleavage on pair of basic residues; Direct protein sequencing;
            Disulfide bond; Ion channel impairing toxin; Knottin; Neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Cyriopagopus schmidti (Selenocosmia huwena)
  ORGANISM  Cyriopagopus schmidti
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Cyriopagopus.
REFERENCE   1  (residues 1 to 87)
  AUTHORS   Diao,J., Lin,Y., Tang,J. and Liang,S.
  TITLE     cDNA sequence analysis of seven peptide toxins from the spider
            Selenocosmia huwena
  JOURNAL   Toxicon 42 (7), 715-723 (2003)
   PUBMED   14757201
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 87)
  AUTHORS   Huang,R.H., Liu,Z.H. and Liang,S.P.
  TITLE     Purification and characterization of a neurotoxic peptide
            huwentoxin-III and a natural inactive mutant from the venom of the
            spider Selenocosmia huwena Wang (Ornithoctonus huwena Wang)
  JOURNAL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35 (11),
            976-980 (2003)
   PUBMED   14614533
  REMARK    PROTEIN SEQUENCE OF 53-85, FUNCTION, DISULFIDE BONDS, TOXIC DOSE,
            MASS SPECTROMETRY, DISRUPTION PHENOTYPE, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 87)
  AUTHORS   Wang,R.L., Yi,S. and Liang,S.P.
  TITLE     Mechanism of action of two insect toxins huwentoxin-III and
            hainantoxin-VI on voltage-gated sodium channels
  JOURNAL   J Zhejiang Univ Sci B 11 (6), 451-457 (2010)
   PUBMED   20506577
  REMARK    FUNCTION.
COMMENT     On Nov 23, 2004 this sequence version replaced gi:46577328.
            [FUNCTION] [Mu-theraphotoxin-Hs1a]: Probable sodium channel pore
            blocker that dose-dependently inhibits voltage-gated sodium
            channels (VGSC) on DUM neurons in a way similar to tetrodotoxin
            (PubMed:20506577). Has no effect on the kinetics of activation and
            inactivation (PubMed:20506577). Seems not to interact with VGSC in
            an inactivated state (PubMed:20506577). In vivo, reversibly
            paralyzes cockroaches, and can enhance the muscular contraction
            elicited by stimulating its nerve (PubMed:14614533).
            {ECO:0000269|PubMed:14614533, ECO:0000269|PubMed:20506577}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:14614533}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MASS SPECTROMETRY] [Mu-theraphotoxin-Hs1a]: Mass=3853.35;
            Method=MALDI; Evidence={ECO:0000269|PubMed:14614533}.
            [MASS SPECTROMETRY] [U2-theraphotoxin-Hs1b]: Mass=3667.40;
            Method=MALDI; Evidence={ECO:0000269|PubMed:14614533}.
            [DISRUPTION PHENOTYPE] The natural mutant mHwTx-III does not
            reversibly paralyze cockroaches. {ECO:0000269|PubMed:14614533}.
            [TOXIC DOSE] PD(50) of HwTx-III is 192.95 +/- 120.84 mg/kg to
            locusts. {ECO:0000269|PubMed:14614533}.
            [MISCELLANEOUS] Negative results: does not inhibit sodium channels
            of adult rat DRG neurons (PubMed:20506577). Neither HwTx-III, nor
            mHwTx-III agglutinate erythrocytes (PubMed:14614533).
            {ECO:0000269|PubMed:14614533, ECO:0000269|PubMed:20506577}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 51
            (Hntx-8) subfamily. Hntx-8 sub-subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..87
                     /organism="Cyriopagopus schmidti"
                     /db_xref="taxon:29017"
     Protein         1..87
                     /product="Mu-theraphotoxin-Hs1a"
                     /note="Mu-TRTX-Hs1a; Huwentoxin-3; Huwentoxin-III;
                     HwTx-III"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..24
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          25..52
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:14614533.
                     /id=PRO_0000035564."
     Region          53..85
                     /region_name="Mature chain"
                     /note="Mu-theraphotoxin-Hs1a.
                     /evidence=ECO:0000269|PubMed:14614533.
                     /id=PRO_0000035565."
     Region          53..84
                     /region_name="Mature chain"
                     /note="U2-theraphotoxin-Hs1b. /id=PRO_0000035566."
     Region          53..81
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(54,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B3FIS6."
     Bond            bond(61,72)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B3FIS6."
     Bond            bond(66,79)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:B3FIS6."
ORIGIN      
        1 mvnmkasmfl tfaglvllfv vcyaseseek efpkemlssi favdndfkqe erdcagymre
       61 ckeklccsgy vcssrwkwcv lpapwrr
//

LOCUS       TXP1_PARSR                29 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Kappa-theraphotoxin-Ps1a; Short=Kappa-TRTX-Ps1a;
            AltName: Full=PaTx1; AltName: Full=Phrixotoxin-1.
ACCESSION   P61230
VERSION     P61230.1
DBSOURCE    UniProtKB: locus TXP1_PARSR, accession P61230;
            class: standard.
            created: May 10, 2004.
            sequence updated: May 10, 2004.
            annotation updated: Feb 22, 2023.
            xrefs: 1V7F_A
            xrefs (non-sequence databases): PDBsum:1V7F, AlphaFoldDB:P61230,
            SMR:P61230, ArachnoServer:AS000399, EvolutionaryTrace:P61230,
            GO:0005576, GO:0015459, GO:0090729, SUPFAM:SSF57059
KEYWORDS    3D-structure; Amidation; Direct protein sequencing; Disulfide bond;
            Ion channel impairing toxin; Knottin; Neurotoxin; Potassium channel
            impairing toxin; Secreted; Toxin; Voltage-gated potassium channel
            impairing toxin.
SOURCE      Paraphysa scrofa
  ORGANISM  Paraphysa scrofa
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Paraphysa.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Diochot,S., Drici,M.D., Moinier,D., Fink,M. and Lazdunski,M.
  TITLE     Effects of phrixotoxins on the Kv4 family of potassium channels and
            implications for the role of Ito1 in cardiac electrogenesis
  JOURNAL   Br J Pharmacol 126 (1), 251-263 (1999)
   PUBMED   10051143
  REMARK    PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, AND SUBCELLULAR
            LOCATION.
REFERENCE   2  (residues 1 to 29)
  AUTHORS   Park,J.H., Carlin,K.P., Wu,G., Ilyin,V.I., Musza,L.L., Blake,P.R.
            and Kyle,D.J.
  TITLE     Studies examining the relationship between the chemical structure
            of protoxin II and its activity on voltage gated sodium channels
  JOURNAL   J Med Chem 57 (15), 6623-6631 (2014)
   PUBMED   25026046
  REMARK    FUNCTION ON NAV1.7/SCN9A, AND MUTAGENESIS OF ALA-12; LEU-19 AND
            28-ILE-ILE-29.
REFERENCE   3  (residues 1 to 29)
  AUTHORS   Chagot,B., Escoubas,P., Villegas,E., Bernard,C., Ferrat,G.,
            Corzo,G., Lazdunski,M. and Darbon,H.
  TITLE     Solution structure of Phrixotoxin 1, a specific peptide inhibitor
            of Kv4 potassium channels from the venom of the theraphosid spider
            Phrixotrichus auratus
  JOURNAL   Protein Sci 13 (5), 1197-1208 (2004)
   PUBMED   15096626
  REMARK    STRUCTURE BY NMR, SYNTHESIS, DISULFIDE BONDS, AND AMIDATION AT
            ILE-29.
COMMENT     [FUNCTION] Potent and specific blocker of Kv4.2/KCND2 (IC(50)=5 nM)
            and Kv4.3/KCND3 (IC(50)=28 nM) potassium channels
            (PubMed:10051143). Acts by altering the gating properties of these
            channels (PubMed:10051143). Also shows moderate inhibition on human
            voltage-gated sodium channel Nav1.7/SCN9A activation (IC(50)=423
            nM) (PubMed:25026046). {ECO:0000269|PubMed:10051143,
            ECO:0000269|PubMed:25026046}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:10051143}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:10051143}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000269|PubMed:15096626}.
            [MASS SPECTROMETRY] Mass=3547.60; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:10051143}.
            [MISCELLANEOUS] Negative results: does not inhibit Kv1/KCNA,
            Kv2/KCNB, Kv3/KCNC, and Kv11/KCNH channels (PubMed:10051143). It
            weakly blocks the neuronal TTX-sensitive sodium currents of
            neuroblastoma cells (13% inhibition at 100 nM) (PubMed:10051143).
            Does not inhibit sodium channel Nav1.2/SCN2A (PubMed:25026046).
            {ECO:0000269|PubMed:10051143, ECO:0000269|PubMed:25026046}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Paraphysa scrofa"
                     /db_xref="taxon:269635"
     Protein         1..29
                     /product="Kappa-theraphotoxin-Ps1a"
                     /note="Kappa-TRTX-Ps1a; PaTx1; Phrixotoxin-1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..29
                     /region_name="Processed active peptide"
                     /note="Kappa-theraphotoxin-Ps1a.
                     /evidence=ECO:0000269|PubMed:10051143.
                     /id=PRO_0000044555."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15096626,
                     ECO:0007744|PDB:1V7F."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15096626,
                     ECO:0007744|PDB:1V7F."
     Site            12
                     /site_type="mutagenized"
                     /note="A->E: No change in ability to inhibit Nav1.7/SCN9A,
                     and gain of ability to inhibit Nav1.2/SCN2A (IC(50)=919
                     nM); when associated with M-19.
                     /evidence=ECO:0000269|PubMed:25026046."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15096626,
                     ECO:0007744|PDB:1V7F."
     Site            19
                     /site_type="mutagenized"
                     /note="L->M: No change in ability to inhibit Nav1.7/SCN9A,
                     and gain of ability to inhibit Nav1.2/SCN2A (IC(50)=919
                     nM); when associated with E-12.
                     /evidence=ECO:0000269|PubMed:25026046."
     Region          20..26
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1V7F."
     Site            28..29
                     /site_type="mutagenized"
                     /note="II->KLW: 400-fold increase in ability to inhibit
                     Nav1.7/SCN9A; and important gain of ability to inhibit
                     Nav1.2/SCN2A (IC(50)=24 nM).
                     /evidence=ECO:0000269|PubMed:25026046."
     Site            29
                     /site_type="amidation"
                     /note="Isoleucine amide.
                     /evidence=ECO:0000269|PubMed:15096626."
ORIGIN      
        1 ycqkwmwtcd sarkcceglv crlwckkii
//

LOCUS       CM4B_CONPE                70 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin PnIVB; Flags: Precursor.
ACCESSION   P58927
VERSION     P58927.2
DBSOURCE    UniProtKB: locus CM4B_CONPE, accession P58927;
            class: standard.
            extra accessions:Q9BH61,Q9BP54
            created: Jul 26, 2002.
            sequence updated: Mar 23, 2010.
            annotation updated: May 25, 2022.
            xrefs: AF214931.1, AAG60359.1, AF215093.1, AAG60514.1, AF215094.1,
            AAG60515.1
            xrefs (non-sequence databases): AlphaFoldDB:P58927,
            ConoServer:1559, ConoServer:618, ConoServer:771, GO:0005576,
            GO:0008200, GO:0017080, GO:0090729, InterPro:IPR004214,
            Pfam:PF02950
KEYWORDS    Cleavage on pair of basic residues; Direct protein sequencing;
            Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Conus pennaceus
  ORGANISM  Conus pennaceus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Darioconus.
REFERENCE   1  (residues 1 to 70)
  AUTHORS   Conticello,S.G., Gilad,Y., Avidan,N., Ben-Asher,E., Levy,Z. and
            Fainzilber,M.
  TITLE     Mechanisms for evolving hypervariability: the case of conopeptides
  JOURNAL   Mol Biol Evol 18 (2), 120-131 (2001)
   PUBMED   11158371
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
REFERENCE   2  (residues 1 to 70)
  AUTHORS   Fainzilber,M., Nakamura,T., Gaathon,A., Lodder,J.C., Kits,K.S.,
            Burlingame,A.L. and Zlotkin,E.
  TITLE     A new cysteine framework in sodium channel blocking conotoxins
  JOURNAL   Biochemistry 34 (27), 8649-8656 (1995)
   PUBMED   7612605
  REMARK    PROTEIN SEQUENCE OF 54-70, MASS SPECTROMETRY, AND SUBCELLULAR
            LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 70)
  AUTHORS   Hasson,A., Fainzilber,M., Zlotkin,E. and Spira,M.
  TITLE     Electrophysiological characterization of a novel conotoxin that
            blocks molluscan sodium channels
  JOURNAL   Eur J Neurosci 7 (4), 815-818 (1995)
   PUBMED   7620628
  REMARK    FUNCTION.
COMMENT     On or before Mar 30, 2010 this sequence version replaced
            gi:74848178, gi:74848499, P58927.1.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            Blocks reversibly sodium channels in molluskan neurons, but has no
            effect on sodium currents in bovine chromaffin cells or in rat
            brain synaptosomes. Induces paralysis in bivalve mollusks
            (Mytilus). No effect are observed on fish (Gambusia) and fly larvae
            (Sarcophaga). Is approximately 6 times more potent than PnIVA in
            blockade of the sodium current in Lymnaea neurons.
            {ECO:0000269|PubMed:7620628}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is IV (CC-C-C-C-C).
            [PTM] Contains 3 disulfide bonds (By similarity). They are not
            added, since framework IV presents two different connectivities
            (I-V, II-III, IV-VI and I-III, II-V, IV-VI). {ECO:0000250}.
            [MASS SPECTROMETRY] Mass=1862.8; Method=LSI;
            Evidence={ECO:0000269|PubMed:7612605}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..70
                     /organism="Conus pennaceus"
                     /db_xref="taxon:37335"
     Protein         1..70
                     /product="Mu-conotoxin PnIVB"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..20
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          <19..66
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          21..51
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:7612605.
                     /id=PRO_0000392725."
     Region          54..70
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin PnIVB.
                     /evidence=ECO:0000269|PubMed:7612605. /id=PRO_0000044497."
     Site            57
                     /site_type="other"
                     /note="Important for binding and activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mmsklgvlli iclllcplta vpqdgdqpad qpaermqddi ssehhpffdp vkrcckygwt
       61 cwlgcspcgc
//

LOCUS       2LOC_A                    25 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-conotoxin BuIIIB.
ACCESSION   2LOC_A
VERSION     2LOC_A
DBSOURCE    pdb: molecule 2LOC, chain A, release Feb 19, 2014;
            deposition: Jan 21, 2012;
            class: TOXIN;
            source: Mmdb_id: 106820, Pdb_id 1: 2LOC;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Conus bullatus
  ORGANISM  Conus bullatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Textilia.
REFERENCE   1  (residues 1 to 25)
  AUTHORS   Kuang,Z., Zhang,M.M., Gupta,K., Gajewiak,J., Gulyas,J., Balaram,P.,
            Rivier,J.E., Olivera,B.M., Yoshikami,D., Bulaj,G. and Norton,R.S.
  TITLE     Mammalian neuronal sodium channel blocker mu-conotoxin BuIIIB has a
            structured N-terminus that influences potency
  JOURNAL   ACS Chem. Biol. 8 (6), 1344-1351 (2013)
   PUBMED   23557677
REFERENCE   2  (residues 1 to 25)
  AUTHORS   Kuang,Z.
  TITLE     Direct Submission
  JOURNAL   Submitted (21-JAN-2012)
COMMENT     Conotoxin analogue [D-Ala2]BuIIIB.
FEATURES             Location/Qualifiers
     source          1..25
                     /organism="Conus bullatus"
                     /db_xref="taxon:89438"
     NonStdRes       2
                     /non_std_residue="DAL"
     Bond            bond(5,17)
                     /bond_type="disulfide"
     Bond            bond(6,23)
                     /bond_type="disulfide"
     Bond            bond(13,24)
                     /bond_type="disulfide"
     NonStdRes       25
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 vxercckngk rgcgrwcrdh srccx
//

LOCUS       2LO9_A                    25 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Mu-conotoxin BuIIIB.
ACCESSION   2LO9_A
VERSION     2LO9_A
DBSOURCE    pdb: molecule 2LO9, chain A, release Feb 19, 2014;
            deposition: Jan 20, 2012;
            class: TOXIN;
            source: Mmdb_id: 106819, Pdb_id 1: 2LO9;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Conus bullatus
  ORGANISM  Conus bullatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Textilia.
REFERENCE   1  (residues 1 to 25)
  AUTHORS   Kuang,Z., Zhang,M.M., Gupta,K., Gajewiak,J., Gulyas,J., Balaram,P.,
            Rivier,J.E., Olivera,B.M., Yoshikami,D., Bulaj,G. and Norton,R.S.
  TITLE     Mammalian neuronal sodium channel blocker mu-conotoxin BuIIIB has a
            structured N-terminus that influences potency
  JOURNAL   ACS Chem. Biol. 8 (6), 1344-1351 (2013)
   PUBMED   23557677
REFERENCE   2  (residues 1 to 25)
  AUTHORS   Kuang,Z.
  TITLE     Direct Submission
  JOURNAL   Submitted (20-JAN-2012)
COMMENT     NMR solution structure of Mu-contoxin BuIIIB.
FEATURES             Location/Qualifiers
     source          1..25
                     /organism="Conus bullatus"
                     /db_xref="taxon:89438"
     Bond            bond(5,17)
                     /bond_type="disulfide"
     Bond            bond(6,23)
                     /bond_type="disulfide"
     Bond            bond(13,24)
                     /bond_type="disulfide"
     NonStdRes       25
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 vgercckngk rgcgrwcrdh srccx
//

LOCUS       SCXA_MESMA                84 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Neurotoxin BmK-M10; AltName: Full=Alpha-neurotoxin
            TX9; AltName: Full=BmK AngM1; AltName: Full=BmK-X; Short=BmKX;
            AltName: Full=BmK10; AltName: Full=BmKalphaTx9; AltName: Full=Bmk
            M10; Short=BmkM10; AltName: Full=Neurotoxin M10; Flags: Precursor.
ACCESSION   O61705
VERSION     O61705.1
DBSOURCE    UniProtKB: locus SCXA_MESMA, accession O61705;
            class: standard.
            created: Dec 15, 1998.
            sequence updated: Aug 1, 1998.
            annotation updated: Feb 22, 2023.
            xrefs: AF062563.1, AAC16697.1, AF164203.1, AAK06898.1, 2KBK_A
            xrefs (non-sequence databases): PDBsum:2KBK, AlphaFoldDB:O61705,
            SMR:O61705, EvolutionaryTrace:O61705, GO:0005576, GO:0019870,
            GO:0019871, GO:0090729, GO:0006952, GO:0044489, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Xiong,Y.-M., Ling,M.-H., Wang,D.-C. and Chi,C.-W.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-APR-1998) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Zhu,S.Y., Li,W.X., Zeng,X.C., Liu,H., Jiang,D.H. and Mao,X.
  TITLE     Nine novel precursors of Buthus martensii scorpion alpha-toxin
            homologues
  JOURNAL   Toxicon 38 (12), 1653-1661 (2000)
   PUBMED   10858508
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
            Erratum:[Toxicon 2001 Jul;39(7):1093]
REFERENCE   3  (residues 1 to 84)
  AUTHORS   Cao,Z.Y., Mi,Z.M., Cheng,G.F., Shen,W.Q., Xiao,X., Liu,X.M.,
            Liang,X.T. and Yu,D.Q.
  TITLE     Purification and characterization of a new peptide with analgesic
            effect from the scorpion Buthus martensi Karch
  JOURNAL   J Pept Res 64 (1), 33-41 (2004)
   PUBMED   15200476
  REMARK    PROTEIN SEQUENCE OF 20-83, FUNCTION, SUBCELLULAR LOCATION, AND MASS
            SPECTROMETRY.
COMMENT     [FUNCTION] Binds to voltage-dependent sodium channels (Nav) and
            voltage-dependent delayed rectifier potassium channels and inhibits
            the inactivation of the activated channels, thereby blocking
            neuronal transmission. Administration to mice at a dosage of 0.8
            mg/kg produces an analgesic effect. {ECO:0000269|PubMed:15200476}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:15200476}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:15200476}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7040.5; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:15200476}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..84
                     /product="Neurotoxin BmK-M10"
                     /note="Alpha-neurotoxin TX9; BmK AngM1; BmK-X; BmK10;
                     BmKalphaTx9; Bmk M10; Neurotoxin M10; BmKX; BmkM10"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000269|PubMed:15200476."
     Region          20..83
                     /region_name="Mature chain"
                     /note="Neurotoxin BmK-M10.
                     /evidence=ECO:0000269|PubMed:15200476.
                     /id=PRO_0000035240."
     Region          21..83
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          21..23
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Region          28..30
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Bond            bond(31,82)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0007744|PDB:2KBK."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0007744|PDB:2KBK."
     Region          36..38
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Bond            bond(41,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0007744|PDB:2KBK."
     Region          41..48
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Bond            bond(45,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0007744|PDB:2KBK."
     Region          51..59
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Region          62..70
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBK."
     Region          84
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase. /id=PRO_0000035241."
ORIGIN      
        1 mnylvmisfa lllmkgvesv rdayiakpen cvyecgitqd cnklctenga esgycqwggk
       61 ygnacwcikl pdsvpirvpg kcqr
//

LOCUS       CM4A_CONPE                17 aa            linear   INV 25-MAY-2022
DEFINITION  RecName: Full=Mu-conotoxin PnIVA.
ACCESSION   P58926
VERSION     P58926.1
DBSOURCE    UniProtKB: locus CM4A_CONPE, accession P58926;
            class: standard.
            created: Jul 26, 2002.
            sequence updated: Jul 26, 2002.
            annotation updated: May 25, 2022.
            xrefs (non-sequence databases): AlphaFoldDB:P58926,
            ConoServer:1560, GO:0005576, GO:0017080, GO:0090729
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Conus pennaceus
  ORGANISM  Conus pennaceus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Darioconus.
REFERENCE   1  (residues 1 to 17)
  AUTHORS   Fainzilber,M., Nakamura,T., Gaathon,A., Lodder,J.C., Kits,K.S.,
            Burlingame,A.L. and Zlotkin,E.
  TITLE     A new cysteine framework in sodium channel blocking conotoxins
  JOURNAL   Biochemistry 34 (27), 8649-8656 (1995)
   PUBMED   7612605
  REMARK    PROTEIN SEQUENCE, AND MASS SPECTROMETRY.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            Blocks reversibly sodium channels in molluskan neurons, but has no
            effect on sodium currents in bovine chromaffin cells or in rat
            brain synaptosomes. Induces paralysis in bivalve mollusks
            (Mytilus). No effect are observed on fish (Gambusia) and fly larvae
            (Sarcophaga). PnIVB is approximately 6 times more potent than PnIVA
            in blockade of the sodium current in Lymnaea neurons.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The cysteine framework is IV (CC-C-C-C-C).
            [PTM] Contains 3 disulfide bonds (By similarity). They are not
            added, since framework IV presents two different connectivities
            (I-V, II-III, IV-VI and I-III, II-V, IV-VI). {ECO:0000250}.
            [MASS SPECTROMETRY] Mass=1789.5; Method=LSI;
            Evidence={ECO:0000269|PubMed:7612605}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..17
                     /organism="Conus pennaceus"
                     /db_xref="taxon:37335"
     Protein         1..17
                     /product="Mu-conotoxin PnIVA"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..17
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin PnIVA. /id=PRO_0000044496."
     Site            4
                     /site_type="other"
                     /note="Important for binding and activity."
ORIGIN      
        1 cckygwtcll gcspcgc
//

LOCUS       5TCZ_A                    32 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, Beta/omega-theraphotoxin-Tp2a.
ACCESSION   5TCZ_A
VERSION     5TCZ_A
DBSOURCE    pdb: molecule 5TCZ, chain A, release Jan 18, 2017;
            deposition: Sep 16, 2016;
            class: TOXIN;
            source: Mmdb_id: 146611, Pdb_id 1: 5TCZ;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Thrixopelma pruriens
  ORGANISM  Thrixopelma pruriens
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Thrixopelma.
REFERENCE   1  (residues 1 to 32)
  AUTHORS   Flinspach,M., Xu,Q., Piekarz,A.D., Fellows,R., Hagan,R., Gibbs,A.,
            Liu,Y., Neff,R.A., Freedman,J., Eckert,W.A., Zhou,M., Bonesteel,R.,
            Pennington,M.W., Eddinger,K.A., Yaksh,T.L., Hunter,M., Swanson,R.V.
            and Wickenden,A.D.
  TITLE     Insensitivity to pain induced by a potent selective closed-state
            Nav1.7 inhibitor
  JOURNAL   Sci Rep 7, 39662 (2017)
   PUBMED   28045073
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 32)
  AUTHORS   Gibbs,A.C. and Wickenden,A.D.
  TITLE     Direct Submission
  JOURNAL   Submitted (16-SEP-2016)
COMMENT     NMR solution structure of engineered Protoxin-II analog.
FEATURES             Location/Qualifiers
     source          1..32
                     /organism="Thrixopelma pruriens"
                     /db_xref="taxon:213387"
     Bond            bond(4,18)
                     /bond_type="disulfide"
     Bond            bond(11,23)
                     /bond_type="disulfide"
     Bond            bond(17,27)
                     /bond_type="disulfide"
     SecStr          21..24
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          25..29
                     /sec_str_type="sheet"
                     /note="strand 2"
ORIGIN      
        1 gpycqkwmqt cdserkcceg mvcrlwckkk ll
//

LOCUS       1NIX_A                    34 aa            linear   INV 01-DEC-2020
DEFINITION  Chain A, HAINANTOXIN-I.
ACCESSION   1NIX_A
VERSION     1NIX_A
DBSOURCE    pdb: molecule 1NIX, chain A, release Nov 29, 2017;
            deposition: Dec 29, 2002;
            class: TOXIN;
            source: Mmdb_id: 74088, Pdb_id 1: 1NIX;
            Exp. method: Solution NMR.
KEYWORDS    .
SOURCE      Haplopelma hainanum
  ORGANISM  Haplopelma hainanum
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Haplopelma.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Li,D., Xiao,Y., Hu,W., Xie,J., Bosmans,F., Tytgat,J. and Liang,S.
  TITLE     Function and solution structure of hainantoxin-I, a novel insect
            sodium channel inhibitor from the Chinese bird spider Selenocosmia
            hainana
  JOURNAL   FEBS Lett. 555 (3), 616-622 (2003)
   PUBMED   14675784
REFERENCE   2  (residues 1 to 34)
  AUTHORS   Li,D. and Liang,S.
  TITLE     Direct Submission
  JOURNAL   Submitted (29-DEC-2002)
COMMENT     On Jul 10, 2009 this sequence version replaced gi:159162746.
            THREE DIMENSIONAL SOLUTION STRUCTURE OF HAINANTOXIN-I BY 2D 1H-NMR.
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Haplopelma hainanum"
                     /db_xref="taxon:209901"
     Bond            bond(2,17)
                     /bond_type="disulfide"
     Bond            bond(9,22)
                     /bond_type="disulfide"
     Bond            bond(16,29)
                     /bond_type="disulfide"
     SecStr          20..25
                     /sec_str_type="sheet"
                     /note="strand 1"
     SecStr          26..31
                     /sec_str_type="sheet"
                     /note="strand 2"
     NonStdRes       34
                     /non_std_residue="NH2 COOH"
ORIGIN      
        1 eckgfgkscv pgkneccsgy acnsrdkwck vllx
//

LOCUS       TX2C_EUCCO                29 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Lambda-theraphotoxin-Ec2c; Short=Lambda-TRTX-Ec2c;
            AltName: Full=Kappa-theraphotoxin-Ec2c; Short=Kappa-TRTX-Ec2c.
ACCESSION   P0DQO7
VERSION     P0DQO7.1
DBSOURCE    UniProtKB: locus TX2C_EUCCO, accession P0DQO7;
            class: standard.
            created: Feb 10, 2021.
            sequence updated: Feb 10, 2021.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DQO7, SMR:P0DQO7,
            GO:0005576, GO:0015459, GO:0090729, SUPFAM:SSF57059
KEYWORDS    Calcium-activated potassium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin;
            Neurotoxin; Potassium channel impairing toxin; Secreted; Toxin.
SOURCE      Eucratoscelus constrictus
  ORGANISM  Eucratoscelus constrictus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Eucratoscelus.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Windley,M.J., Escoubas,P., Valenzuela,S.M. and Nicholson,G.M.
  TITLE     A novel family of insect-selective peptide neurotoxins targeting
            insect large-conductance calcium-activated K+ channels isolated
            from the venom of the theraphosid spider Eucratoscelus constrictus
  JOURNAL   Mol Pharmacol 80 (1), 1-13 (2011)
   PUBMED   21447641
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND TOXIC DOSE.;
            TISSUE=Venom
COMMENT     [FUNCTION] Both insecticidal and vertebrate neurotoxin that
            potently blocks insect calcium-activated potassium (BKCa) channels
            (Slo-type) in cockroach dorsal unpaired median (DUM) neurons
            (IC(50)=24.6 nM) (PubMed:21447641). This occurs in the absence of
            any shifts in the voltage dependence of activation
            (PubMed:21447641). May interact with the turret and/or loop region
            of the external entrance to the channel and does not project deeply
            into the pore of the channel (Probable). Also shows toxicity to
            mice by introcerebroventicular injection (PubMed:21447641).
            {ECO:0000269|PubMed:21447641, ECO:0000305|PubMed:21447641}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21447641}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:21447641}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P83476}.
            [MASS SPECTROMETRY] Mass=3627.16; Method=MALDI; Note=Monoisotopic
            mass.; Evidence={ECO:0000269|PubMed:21447641}.
            [TOXIC DOSE] Intrathoracical injection into juvenile crickets
            (Gryllus bimaculatus) of this toxin (at a dose of ca. 1100 pmol/g
            (4 ug/g)) causes a rapid insecticidal activity, with complete
            paralysis within 5 minutes and death within 15 minutes.
            {ECO:0000269|PubMed:21447641}.
            [TOXIC DOSE] Intracerebroventricular injection into mice of this
            toxin (at a dose of 1.8 ug per mice) causes strong neurotoxicity
            symptoms, including convulsions, tonic paralysis, general ataxia,
            extension of legs and toes, tail erection, and respiratory
            paralysis resulting in very marked cyanosis of the animal. These
            symptoms are reversible. {ECO:0000269|PubMed:21447641}.
            [MISCELLANEOUS] Negative results: At concentrations up to 330 nM,
            does not show activity on transient 'A-type' Kv, delayed-rectifier
            Kv, voltage-gated sodium channel (Nav) and both HVA and M-LVA Cav
            channels in cockroach DUM neurons. {ECO:0000269|PubMed:21447641}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
            [CAUTION] This toxin has the prefix lambda in its name (instead of
            kappa), since lambda is the Greek letter attributed to
            calcium-activated potassium (KCa) channel impairing toxins
            (according to the nomenclature of King et al., 2008).
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Eucratoscelus constrictus"
                     /db_xref="taxon:2771863"
     Protein         1..29
                     /product="Lambda-theraphotoxin-Ec2c"
                     /note="Lambda-TRTX-Ec2c; Kappa-theraphotoxin-Ec2c;
                     Kappa-TRTX-Ec2c"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..29
                     /region_name="Processed active peptide"
                     /note="Lambda-theraphotoxin-Ec2c. /id=PRO_0000451988."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
ORIGIN      
        1 ycqfkmwtcd serkccedmv crlwcklnl
//

LOCUS       TX2B_EUCCO                29 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Lambda-theraphotoxin-Ec2b; Short=Lambda-TRTX-Ec2b;
            AltName: Full=Kappa-theraphotoxin-Ec2b; Short=Kappa-TRTX-Ec2b.
ACCESSION   P0DQO6
VERSION     P0DQO6.1
DBSOURCE    UniProtKB: locus TX2B_EUCCO, accession P0DQO6;
            class: standard.
            created: Feb 10, 2021.
            sequence updated: Feb 10, 2021.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DQO6, SMR:P0DQO6,
            GO:0005576, GO:0015459, GO:0090729, SUPFAM:SSF57059
KEYWORDS    Calcium-activated potassium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin;
            Neurotoxin; Potassium channel impairing toxin; Secreted; Toxin.
SOURCE      Eucratoscelus constrictus
  ORGANISM  Eucratoscelus constrictus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Eucratoscelus.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Windley,M.J., Escoubas,P., Valenzuela,S.M. and Nicholson,G.M.
  TITLE     A novel family of insect-selective peptide neurotoxins targeting
            insect large-conductance calcium-activated K+ channels isolated
            from the venom of the theraphosid spider Eucratoscelus constrictus
  JOURNAL   Mol Pharmacol 80 (1), 1-13 (2011)
   PUBMED   21447641
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND TOXIC DOSE.;
            TISSUE=Venom
COMMENT     [FUNCTION] Insect-selective neurotoxin that potently blocks insect
            calcium-activated potassium (BKCa) channels (Slo-type) in cockroach
            dorsal unpaired median (DUM) neurons (IC(50)=25.3 nM)
            (PubMed:21447641). This occurs in the absence of any shifts in the
            voltage dependence of activation (PubMed:21447641). May interact
            with the turret and/or loop region of the external entrance to the
            channel and does not project deeply into the pore of the channel
            (Probable). In vivo, does not show toxicity in mice after
            intracerebroventricular injection of up to 25 pmol/g (1.8 ug/20 g
            mouse) (PubMed:21447641). {ECO:0000269|PubMed:21447641,
            ECO:0000305|PubMed:21447641}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21447641}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:21447641}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P83476}.
            [MASS SPECTROMETRY] Mass=3676.71; Method=MALDI; Note=Monoisotopic
            mass.; Evidence={ECO:0000269|PubMed:21447641}.
            [TOXIC DOSE] Intrathoracical injection into juvenile crickets
            (Gryllus bimaculatus) of this toxin (at a dose of ca. 1100 pmol/g
            (4 ug/g)) causes a rapid insecticidal activity, with complete
            paralysis within 5 minutes and death within 15 minutes.
            {ECO:0000269|PubMed:21447641}.
            [MISCELLANEOUS] Negative results: At concentrations up to 330 nM,
            does not show activity on transient 'A-type' Kv, delayed-rectifier
            Kv, voltage-gated sodium channel (Nav) and both HVA and M-LVA Cav
            channels in cockroach DUM neurons. {ECO:0000269|PubMed:21447641}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
            [CAUTION] This toxin has the prefix lambda in its name (instead of
            kappa), since lambda is the Greek letter attributed to
            calcium-activated potassium (KCa) channel impairing toxins
            (according to the nomenclature of King et al., 2008).
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Eucratoscelus constrictus"
                     /db_xref="taxon:2771863"
     Protein         1..29
                     /product="Lambda-theraphotoxin-Ec2b"
                     /note="Lambda-TRTX-Ec2b; Kappa-theraphotoxin-Ec2b;
                     Kappa-TRTX-Ec2b"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..29
                     /region_name="Processed active peptide"
                     /note="Lambda-theraphotoxin-Ec2b. /id=PRO_0000451987."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
ORIGIN      
        1 ycqkflwtcd terkccedmv celwckyke
//

LOCUS       TX2A_EUCCO                29 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Lambda-theraphotoxin-Ec2a; Short=Lambda-TRTX-Ec2a;
            AltName: Full=Kappa-theraphotoxin-Ec2a; Short=Kappa-TRTX-Ec2a.
ACCESSION   P0DQO5
VERSION     P0DQO5.1
DBSOURCE    UniProtKB: locus TX2A_EUCCO, accession P0DQO5;
            class: standard.
            created: Feb 10, 2021.
            sequence updated: Feb 10, 2021.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0DQO5, SMR:P0DQO5,
            GO:0005576, GO:0015459, GO:0090729, SUPFAM:SSF57059
KEYWORDS    Calcium-activated potassium channel impairing toxin; Direct protein
            sequencing; Disulfide bond; Ion channel impairing toxin;
            Neurotoxin; Potassium channel impairing toxin; Secreted; Toxin.
SOURCE      Eucratoscelus constrictus
  ORGANISM  Eucratoscelus constrictus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Eucratoscelus.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Windley,M.J., Escoubas,P., Valenzuela,S.M. and Nicholson,G.M.
  TITLE     A novel family of insect-selective peptide neurotoxins targeting
            insect large-conductance calcium-activated K+ channels isolated
            from the venom of the theraphosid spider Eucratoscelus constrictus
  JOURNAL   Mol Pharmacol 80 (1), 1-13 (2011)
   PUBMED   21447641
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MASS
            SPECTROMETRY, AND TOXIC DOSE.;
            TISSUE=Venom
COMMENT     [FUNCTION] Insect-selective neurotoxin that potently blocks insect
            calcium-activated potassium (BKCa) channels (Slo-type) in cockroach
            dorsal unpaired median (DUM) neurons (IC(50)=3.7 nM)
            (PubMed:21447641). This occurs in the absence of any shifts in the
            voltage dependence of activation (PubMed:21447641). At high
            concentrations (330 nM), it partially inhibits cockroach
            delayed-rectifier potassium channels (Kv) currents
            (PubMed:21447641). May interact with the turret and/or loop region
            of the external entrance to the channel and does not project deeply
            into the pore of the channel (Probable). In vivo, does not show
            toxicity in mice after intracerebroventricular injection of up to
            25 pmol/g (1.8 ug/20 g mouse) (PubMed:21447641).
            {ECO:0000269|PubMed:21447641, ECO:0000305|PubMed:21447641}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:21447641}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:21447641}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P83476}.
            [MASS SPECTROMETRY] Mass=3626.73; Method=MALDI; Note=Monoisotopic
            mass.; Evidence={ECO:0000269|PubMed:21447641}.
            [TOXIC DOSE] Intrathoracical injection into juvenile crickets
            (Gryllus bimaculatus) of this toxin (at a dose of ca. 1100 pmol/g
            (4 ug/g)) causes a rapid insecticidal activity, with complete
            paralysis within 5 minutes and death within 15 minutes.
            {ECO:0000269|PubMed:21447641}.
            [MISCELLANEOUS] Negative results: does not show activity on insect
            voltage-gated sodium channel (Nav) or insect calcium channels (Cav)
            in cockroach DUM neurons. {ECO:0000250|UniProtKB:P0DQO6}.
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
            [CAUTION] This toxin has the prefix lambda in its name (instead of
            kappa), since lambda is the Greek letter attributed to
            calcium-activated potassium (KCa) channel impairing toxins
            (according to the nomenclature of King et al., 2008).
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Eucratoscelus constrictus"
                     /db_xref="taxon:2771863"
     Protein         1..29
                     /product="Lambda-theraphotoxin-Ec2a"
                     /note="Lambda-TRTX-Ec2a; Kappa-theraphotoxin-Ec2a;
                     Kappa-TRTX-Ec2a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..29
                     /region_name="Processed active peptide"
                     /note="Lambda-theraphotoxin-Ec2a. /id=PRO_0000451986."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P83476."
ORIGIN      
        1 ycqkflwtcd terkccedmv celwcklek
//

LOCUS       TO1F_ATRRO                78 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1f; Short=Omega-HXTX-Ar1f; AltName:
            Full=Omega-atracotoxin-Ar1f; Short=Omega-ACTX-Ar1f; Flags:
            Precursor.
ACCESSION   A5A3H5
VERSION     A5A3H5.1
DBSOURCE    UniProtKB: locus TO1F_ATRRO, accession A5A3H5;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: May 29, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: EF523499.1, ABP63658.1
            xrefs (non-sequence databases): AlphaFoldDB:A5A3H5, BMRB:A5A3H5,
            SMR:A5A3H5, ArachnoServer:AS000025, GO:0005576, GO:0019855,
            GO:0017080, GO:0090729, GO:0006952, InterPro:IPR009415,
            InterPro:IPR018071, Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 78)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=XenFW135; TISSUE=Venom gland
COMMENT     [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets (By
            similarity). {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] This toxin comes from a male specimen. It is
            observed that propeptide sequences coming from male specimen are
            identical but have only limited homology with the female paralogs,
            but the reason is unknown.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..78
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..78
                     /product="Omega-hexatoxin-Ar1f"
                     /note="Omega-HXTX-Ar1f; Omega-atracotoxin-Ar1f;
                     Omega-ACTX-Ar1f"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..41
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000379916."
     Region          42..78
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          42..78
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1f. /id=PRO_0000379917."
     Bond            bond(45,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            51
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(52,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(58,77)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            68
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            76
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgvial lvlatvigci eaedtradlq ggeaaekvfr rsptcipsgq pcpynenccs
       61 qsctfkenet gntvkrcd
//

LOCUS       TO1E_ATRRO                78 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1e; Short=Omega-HXTX-Ar1e; AltName:
            Full=Omega-atracotoxin-Ar1e; Short=Omega-ACTX-Ar1e; Flags:
            Precursor.
ACCESSION   A5A3H4
VERSION     A5A3H4.1
DBSOURCE    UniProtKB: locus TO1E_ATRRO, accession A5A3H4;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: May 29, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: EF523498.1, ABP63657.1
            xrefs (non-sequence databases): AlphaFoldDB:A5A3H4, SMR:A5A3H4,
            ArachnoServer:AS000024, GO:0005576, GO:0019855, GO:0017080,
            GO:0090729, GO:0006952, InterPro:IPR009415, InterPro:IPR018071,
            Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 78)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=XenFW139; TISSUE=Venom gland
COMMENT     [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets (By
            similarity). {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] This toxin comes from a male specimen. It is
            observed that propeptide sequences coming from male specimen are
            identical but have only limited homology with the female paralogs,
            but the reason is unknown.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..78
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..78
                     /product="Omega-hexatoxin-Ar1e"
                     /note="Omega-HXTX-Ar1e; Omega-atracotoxin-Ar1e;
                     Omega-ACTX-Ar1e"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..41
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000379914."
     Region          42..78
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          42..78
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1e. /id=PRO_0000379915."
     Bond            bond(45,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            51
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(52,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(58,77)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            68
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            76
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgvial lvlatvigci eaedtradlq ggeaaekvfr rsptcipsgq pcpynenccs
       61 ksctykenen gntvqrcd
//

LOCUS       TO1D_ATRRO                78 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1d; Short=Omega-HXTX-Ar1d; AltName:
            Full=Omega-atracotoxin-Ar1d; Short=Omega-ACTX-Ar1d; Flags:
            Precursor.
ACCESSION   A5A3H3
VERSION     A5A3H3.1
DBSOURCE    UniProtKB: locus TO1D_ATRRO, accession A5A3H3;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: May 29, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: EF523497.1, ABP63656.1
            xrefs (non-sequence databases): AlphaFoldDB:A5A3H3, BMRB:A5A3H3,
            SMR:A5A3H3, ArachnoServer:AS000023, GO:0005576, GO:0019855,
            GO:0017080, GO:0090729, GO:0006952, InterPro:IPR009415,
            InterPro:IPR018071, Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 78)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=XenFW141; TISSUE=Venom gland
COMMENT     [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets (By
            similarity). {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] This toxin comes from a male specimen. It is
            observed that propeptide sequences coming from male specimen are
            identical but have only limited homology with the female paralogs,
            but the reason is unknown.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..78
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..78
                     /product="Omega-hexatoxin-Ar1d"
                     /note="Omega-HXTX-Ar1d; Omega-atracotoxin-Ar1d;
                     Omega-ACTX-Ar1d"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..41
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000379912."
     Region          42..78
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          42..78
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1d. /id=PRO_0000379913."
     Bond            bond(45,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            51
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(52,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(58,77)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            68
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            76
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgvial lvlatvigci eaedtradlq ggeaaekvfr rsptcipsgq pcpynenccs
       61 qsctfkenen gntvkrcd
//

LOCUS       TO1B_ATRRO                73 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1b; Short=Omega-HXTX-Ar1b; AltName:
            Full=Omega-atracotoxin-Ar1b; Short=Omega-ACTX-Ar1b; Flags:
            Precursor.
ACCESSION   A5A3H1
VERSION     A5A3H1.1
DBSOURCE    UniProtKB: locus TO1B_ATRRO, accession A5A3H1;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: May 29, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: EF523495.1, ABP63654.1
            xrefs (non-sequence databases): AlphaFoldDB:A5A3H1, SMR:A5A3H1,
            ArachnoServer:AS000021, GO:0005576, GO:0019855, GO:0017080,
            GO:0090729, GO:0006952, InterPro:IPR009415, Pfam:PF06357,
            SUPFAM:SSF57059
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 73)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=XenFW208; TISSUE=Venom gland
COMMENT     [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets (By
            similarity). {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] This toxin comes from a female specimen. It is
            observed that propeptide sequences coming from female specimen have
            only limited homology with the male paralogs, but the reason is
            unknown.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..73
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..73
                     /product="Omega-hexatoxin-Ar1b"
                     /note="Omega-HXTX-Ar1b; Omega-atracotoxin-Ar1b;
                     Omega-ACTX-Ar1b"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..37
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000379908."
     Region          38..73
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1b. /id=PRO_0000379909."
     Region          40..72
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Bond            bond(40,54)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            46
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(47,58)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(53,72)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            63
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            71
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgfivl lvlatvlgci eageshvred amgrarrgac tptgqpcpyn esccsgscqe
       61 qlnenghtvk rcv
//

LOCUS       TO1A_ATRRO                85 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1a; Short=Omega-HXTX-Ar1a; AltName:
            Full=Omega-atracotoxin-Ar1a; Short=Omega-AcTx-Ar1a; Flags:
            Precursor.
ACCESSION   P83580
VERSION     P83580.2
DBSOURCE    UniProtKB: locus TO1A_ATRRO, accession P83580;
            class: standard.
            extra accessions:A5A3H0
            created: Jun 27, 2003.
            sequence updated: Jul 28, 2009.
            annotation updated: Feb 22, 2023.
            xrefs: EF523494.1, ABP63653.1
            xrefs (non-sequence databases): AlphaFoldDB:P83580, SMR:P83580,
            ArachnoServer:AS000020, GO:0005576, GO:0019855, GO:0017080,
            GO:0090729, GO:0006952, InterPro:IPR009415, InterPro:IPR018071,
            Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Secreted; Signal; Toxin;
            Voltage-gated calcium channel impairing toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 85)
  AUTHORS   Chong,Y., Hayes,J.L., Sollod,B., Wen,S., Wilson,D.T., Hains,P.G.,
            Hodgson,W.C., Broady,K.W., King,G.F. and Nicholson,G.M.
  TITLE     The omega-atracotoxins: selective blockers of insect M-LVA and HVA
            calcium channels
  JOURNAL   Biochem Pharmacol 74 (4), 623-638 (2007)
   PUBMED   17610847
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 49-85, FUNCTION,
            SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY, AND
            TOXIC DOSE.;
            STRAIN=XenFW194; TISSUE=Venom, and Venom gland
COMMENT     On Jul 28, 2009 this sequence version replaced P83580.1.
            [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets.
            {ECO:0000269|PubMed:17610847}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:17610847,
            ECO:0000305}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:17610847, ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MASS SPECTROMETRY] Mass=4002.8; Mass_error=1.0;
            Method=Electrospray; Evidence={ECO:0000269|PubMed:17610847}.
            [TOXIC DOSE] LD(50) is 236+-28 pmol/g in house crickets (Acheta
            domesticus) (at 48 hours post-injection).
            {ECO:0000269|PubMed:17610847}.
            [TOXIC DOSE] LD(50) is l43+-10 pmol/g in house crickets (Acheta
            domesticus) (at 72 hours post-injection).
            {ECO:0000269|PubMed:17610847}.
            [TOXIC DOSE] PD(50) is 147+-16 pmol/g in house crickets (Acheta
            domesticus) (at 48 hours post-injection).
            {ECO:0000269|PubMed:17610847}.
            [TOXIC DOSE] PD(50) is 124+-12 pmol/g in house crickets (Acheta
            domesticus) (at 72 hours post-injection).
            {ECO:0000269|PubMed:17610847}.
            [MISCELLANEOUS] This toxin comes from a female specimen. It is
            observed that propeptide sequences coming from female specimen have
            only limited homology with the male paralogs, but the reason is
            unknown.
            [MISCELLANEOUS] Negative results: does not inhibit potassium
            channel currents. Has no activity in vertebrate smooth and skeletal
            nerve-muscle preparations (PubMed:17610847).
            {ECO:0000305|PubMed:17610847}.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..85
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..85
                     /product="Omega-hexatoxin-Ar1a"
                     /note="Omega-HXTX-Ar1a; Omega-atracotoxin-Ar1a;
                     Omega-AcTx-Ar1a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..48
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000269|PubMed:17610847.
                     /id=PRO_0000379907."
     Region          49..85
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          49..85
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1a. /id=PRO_0000044994."
     Bond            bond(52,66)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            58
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(59,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(65,84)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            75
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            83
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgfivl lvlatvlgai eaedavpdfe ggfashared tvggkirrss vcipsgqpcp
       61 ynehccsgsc tykenengnt vqrcd
//

LOCUS       CM3C_CONBU                80 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin BuIIIC; Flags: Precursor.
ACCESSION   C1J5M7
VERSION     C1J5M7.1
DBSOURCE    UniProtKB: locus CM3C_CONBU, accession C1J5M7;
            class: standard.
            created: Sep 22, 2009.
            sequence updated: May 26, 2009.
            annotation updated: Feb 22, 2023.
            xrefs: FJ240167.1, ACO50772.1, 2LU6_1
            xrefs (non-sequence databases): PDBsum:2LU6, AlphaFoldDB:C1J5M7,
            BMRB:C1J5M7, SMR:C1J5M7, ConoServer:3714, GO:0005576, GO:0008200,
            GO:0017080, GO:0090729, InterPro:IPR004214, Pfam:PF02950
KEYWORDS    3D-structure; Amidation; Cleavage on pair of basic residues;
            Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Conus bullatus
  ORGANISM  Conus bullatus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Textilia.
REFERENCE   1  (residues 1 to 80)
  AUTHORS   Holford,M., Zhang,M.M., Gowd,K.H., Azam,L., Green,B.R., Watkins,M.,
            Ownby,J.P., Yoshikami,D., Bulaj,G. and Olivera,B.M.
  TITLE     Pruning nature: Biodiversity-derived discovery of novel sodium
            channel blocking conotoxins from Conus bullatus
  JOURNAL   Toxicon 53 (1), 90-98 (2009)
   PUBMED   18950653
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], SYNTHESIS OF 52-77, FUNCTION, AND
            AMIDATION AT CYS-77.
REFERENCE   2  (residues 1 to 80)
  AUTHORS   Stevens,M., Peigneur,S., Dyubankova,N., Lescrinier,E., Herdewijn,P.
            and Tytgat,J.
  TITLE     Design of bioactive peptides from naturally occurring mu-conotoxin
            structures
  JOURNAL   J Biol Chem 287 (37), 31382-31392 (2012)
   PUBMED   22773842
  REMARK    STRUCTURE BY NMR OF MUTANT R2-MIDI BUIIIC, FUNCTION OF MUTANT
            R2-MIDI BUIIIC, MUTAGENESIS OF 64-ARG-GLY-65 AND CYS-70, AND
            DISULFIDE BOND OF MUTANT R2-MIDI BUIIIC.
COMMENT     [FUNCTION] Mu-conotoxins block voltage-gated sodium channels.
            Extremely potent inhibitor of Nav1.4/SCN4A (96% inhibition at 1
            uM). The inhibition is very slowly reversible.
            {ECO:0000269|PubMed:18950653}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:18950653}.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            {ECO:0000305|PubMed:18950653}.
            [DOMAIN] The cysteine framework is III (CC-C-C-CC). Classified in
            the M-5 branch, since 5 residues stand between the fourth and the
            fifth cysteine residues. {ECO:0000305}.
            [MISCELLANEOUS] The analog R2-Midi BuIIIC is a potent inhibitor of
            Nav1.2/SCN2A (IC(50)=34.1 nM) (PubMed:22773842). It also inhibits
            Nav1.3/SCN3A (10% inhibition at 75 nM), Nav1.4/SCN4A (45%
            inhibition at 75 nM), Nav1.6/SCN8A (45% inhibition at 75 nM), but
            does not inhibit Nav1.5/SCN5A and Nav1.8/SCN10A (75 nM tested)
            (PubMed:22773842). The inhibition is slowly reversible
            (PubMed:22773842). {ECO:0000269|PubMed:22773842}.
            [SIMILARITY] Belongs to the conotoxin M superfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..80
                     /organism="Conus bullatus"
                     /db_xref="taxon:89438"
     Protein         1..80
                     /product="Mu-conotoxin BuIIIC"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          <23..78
                     /region_name="Conotoxin"
                     /note="pfam02950"
                     /db_xref="CDD:367269"
     Region          23..51
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000384435."
     Region          52..77
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin BuIIIC.
                     /evidence=ECO:0000305|PubMed:18950653.
                     /id=PRO_0000384436."
     Site            52..63
                     /site_type="mutagenized"
                     /note="Missing: In R2-Midi BuIIIC; potently and
                     selectively inhibits Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:22773842."
     Bond            bond(56,70)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Bond            bond(57,76)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Site            64..65
                     /site_type="mutagenized"
                     /note="RG->CN: In R2-Midi BuIIIC; potently and selectively
                     inhibits Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:22773842."
     Bond            bond(66,77)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:C1J5M6."
     Site            70
                     /site_type="mutagenized"
                     /note="C->A: In R2-Midi BuIIIC; potently and selectively
                     inhibits Nav1.2/SCN2A.
                     /evidence=ECO:0000269|PubMed:22773842."
     Site            77
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000305|PubMed:18950653."
ORIGIN      
        1 mmsklgvllt iclllfplfa lpqdgdqpad rpaermqddl sseqhplfek rivdrccnkg
       61 ngkrgcsrwc rdhsrccgrr
//

LOCUS       TXHM1_HERML               37 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-thomitoxin-Hme1a; Short=Mu-TMTX-Hme1a; AltName:
            Full=Neurotoxin Hm-1.
ACCESSION   P85505
VERSION     P85505.1
DBSOURCE    UniProtKB: locus TXHM1_HERML, accession P85505;
            class: standard.
            created: Oct 14, 2008.
            sequence updated: Oct 14, 2008.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P85505, SMR:P85505,
            ArachnoServer:AS000759, GO:0005576, GO:0017080, GO:0090729
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Secreted; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Heriaeus mellotteei
  ORGANISM  Heriaeus mellotteei
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Entelegynae; Dionycha; Thomisidae;
            Heriaeus.
REFERENCE   1  (residues 1 to 37)
  AUTHORS   Billen,B., Vassilevski,A., Nikolsky,A., Tytgat,J. and Grishin,E.
  TITLE     Two novel sodium channel inhibitors from Heriaeus melloteei spider
            venom differentially interacting with mammalian channel's isoforms
  JOURNAL   Toxicon 52 (2), 309-317 (2008)
   PUBMED   18606177
  REMARK    PROTEIN SEQUENCE, FUNCTION, DISULFIDE BONDS, MASS SPECTROMETRY, AND
            AMIDATION AT PHE-37.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 37)
  AUTHORS   Nikolsky,A., Billen,B., Vassilevski,A., Filkin,S., Tytgat,J. and
            Grishin,E.
  TITLE     Voltage-gated sodium channels are targets for toxins from the venom
            of the spider Heriaeus melloteei
  JOURNAL   Biochemistry (Mosc.) Suppl. Series A 3, 245-253 (2009)
  REMARK    PROTEIN SEQUENCE, FUNCTION, DISULFIDE BONDS, MASS SPECTROMETRY, AND
            AMIDATION AT PHE-37.;
            TISSUE=Venom
            DOI: 10.1134/S1990747809030027
COMMENT     [FUNCTION] Blocks the Nav1.2/SCN2A, Nav1.4/SCN4A, and Nav1.6/SCN8A
            sodium channels. Reduces the peak amplitude of the sodium current
            and negatively shifts the steady-state inactivation process. Does
            not shift the threshold potential of activation or the voltage
            corresponding to maximal current. Does not change the reversal
            potential of the sodium current. May act on site 1 of the receptor.
            {ECO:0000269|PubMed:18606177, ECO:0000269|Ref.2}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:18606177}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P31328}.
            [PTM] Contains 3 disulfide bonds.
            [MASS SPECTROMETRY] Mass=4171.9; Method=MALDI;
            Evidence={ECO:0000269|PubMed:18606177}.
            [MISCELLANEOUS] Negative results: does not inhibit the sodium
            channel Nav1.8/SCN10A sodium channel.
            [SIMILARITY] Belongs to the neurotoxin 01 (U2-agtx) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..37
                     /organism="Heriaeus mellotteei"
                     /db_xref="taxon:2337432"
     Protein         1..37
                     /product="Mu-thomitoxin-Hme1a"
                     /note="Mu-TMTX-Hme1a; Neurotoxin Hm-1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..37
                     /region_name="Processed active peptide"
                     /note="Mu-thomitoxin-Hme1a. /id=PRO_0000352650."
     Bond            bond(2,18)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P31328."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P31328."
     Bond            bond(17,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P31328."
     Site            37
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000269|PubMed:18606177, ECO:0000269|Ref.2."
ORIGIN      
        1 gcipygktce fwsgpwccag kcklnvwsmt lsctrnf
//

LOCUS       U6GS_CONGE                34 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-conotoxin GS; Short=CGS.
ACCESSION   P15472
VERSION     P15472.1
DBSOURCE    UniProtKB: locus U6GS_CONGE, accession P15472;
            class: standard.
            created: Apr 1, 1990.
            sequence updated: Apr 1, 1990.
            annotation updated: Feb 22, 2023.
            xrefs: A31043, 1AG7_A
            xrefs (non-sequence databases): PDBsum:1AG7, AlphaFoldDB:P15472,
            SMR:P15472, ConoServer:1268, EvolutionaryTrace:P15472, GO:0005576,
            GO:0019871, GO:0090729, InterPro:IPR012629, Pfam:PF08094,
            SUPFAM:SSF57059
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond;
            Gamma-carboxyglutamic acid; Hydroxylation; Ion channel impairing
            toxin; Knottin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Conus geographus (geography cone)
  ORGANISM  Conus geographus
            Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
            Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus;
            Gastridium.
REFERENCE   1  (residues 1 to 34)
  AUTHORS   Yanagawa,Y., Abe,T., Satake,M., Odani,S., Suzuki,J. and Ishikawa,K.
  TITLE     A novel sodium channel inhibitor from Conus geographus:
            purification, structure, and pharmacological properties
  JOURNAL   Biochemistry 27 (17), 6256-6262 (1988)
   PUBMED   2851318
  REMARK    PROTEIN SEQUENCE, HYDROXYLATION AT PRO-10 AND PRO-11,
            GAMMA-CARBOXYGLUTAMATION AT GLU-32, AND FUNCTION.
REFERENCE   2  (residues 1 to 34)
  AUTHORS   Hill,J.M., Alewood,P.F. and Craik,D.J.
  TITLE     Solution structure of the sodium channel antagonist conotoxin GS: a
            new molecular caliper for probing sodium channel geometry
  JOURNAL   Structure 5 (4), 571-583 (1997)
   PUBMED   9115446
  REMARK    STRUCTURE BY NMR, AND DISULFIDE BONDS.
COMMENT     On Apr 12, 2005 this sequence version replaced gi:84532.
            [FUNCTION] Mu-conotoxins block voltage-gated sodium channels (Nav).
            No effect was observed upon injections into mice and goldfish (25
            ug). {ECO:0000269|PubMed:2851318}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom duct.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            [DOMAIN] The cysteine framework is VI/VII (C-C-CC-C-C).
FEATURES             Location/Qualifiers
     source          1..34
                     /organism="Conus geographus"
                     /db_xref="taxon:6491"
     Protein         1..34
                     /product="Mu-conotoxin GS"
                     /note="CGS"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..34
                     /region_name="Processed active peptide"
                     /note="Mu-conotoxin GS. /id=PRO_0000044878."
     Region          1..33
                     /region_name="Toxin_24"
                     /note="Conotoxin TVIIA/GS family; pfam08094"
                     /db_xref="CDD:311850"
     Bond            bond(2,14)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:9115446."
     Bond            bond(9,19)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:9115446."
     Region          9..11
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AG7."
     Site            10
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:2851318."
     Site            11
                     /site_type="hydroxylation"
                     /note="4-hydroxyproline.
                     /evidence=ECO:0000269|PubMed:2851318."
     Bond            bond(13,27)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:9115446."
     Region          17..20
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AG7."
     Region          22..24
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AG7."
     Region          26..29
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1AG7."
     Site            32
                     /site_type="gamma-carboxyglutamic-acid"
                     /note="4-carboxyglutamate.
                     /evidence=ECO:0000269|PubMed:2851318."
ORIGIN      
        1 acsgrgsrcp pqccmglrcg rgnpqkciga hedv
//

LOCUS       TO1C_ATRRO                78 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-hexatoxin-Ar1c; Short=Omega-HXTX-Ar1c; AltName:
            Full=Omega-atracotoxin-Ar1c; Short=Omega-ACTX-Ar1c; Flags:
            Precursor.
ACCESSION   A5A3H2
VERSION     A5A3H2.1
DBSOURCE    UniProtKB: locus TO1C_ATRRO, accession A5A3H2;
            class: standard.
            created: Jul 28, 2009.
            sequence updated: May 29, 2007.
            annotation updated: Feb 22, 2023.
            xrefs: EF523496.1, ABP63655.1
            xrefs (non-sequence databases): AlphaFoldDB:A5A3H2, SMR:A5A3H2,
            ArachnoServer:AS000022, GO:0005576, GO:0019855, GO:0017080,
            GO:0090729, GO:0006952, InterPro:IPR009415, InterPro:IPR018071,
            Pfam:PF06357, SUPFAM:SSF57059, PROSITE:PS60016
KEYWORDS    Calcium channel impairing toxin; Cleavage on pair of basic
            residues; Disulfide bond; Ion channel impairing toxin; Knottin;
            Neurotoxin; Secreted; Signal; Toxin; Voltage-gated calcium channel
            impairing toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Atrax robustus
  ORGANISM  Atrax robustus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Hexathelidae; Atrax.
REFERENCE   1  (residues 1 to 78)
  AUTHORS   Sollod,B.L., Wilson,D.T., Drinkwater,R.D. and King,G.F.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-APR-2007) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            STRAIN=XenFW137; TISSUE=Venom gland
COMMENT     [FUNCTION] Insecticidal toxin that reversibly and
            voltage-independently blocks both mid-low- (M-LVA) and
            high-voltage-activated (HVA) calcium channels (Cav) in cockroach
            DUM neurons. Also causes a modest block of insect sodium channel
            currents (Nav). Induces potent excitatory symptoms, followed by
            flaccid paralysis leading to death in house crickets (By
            similarity). {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [MISCELLANEOUS] This toxin comes from a male specimen. It is
            observed that propeptide sequences coming from male specimen are
            identical but have only limited homology with the female paralogs,
            but the reason is unknown.
            [SIMILARITY] Belongs to the neurotoxin 08 (Shiva) family. 01 (omega
            toxin) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..78
                     /organism="Atrax robustus"
                     /db_xref="taxon:6903"
     Protein         1..78
                     /product="Omega-hexatoxin-Ar1c"
                     /note="Omega-HXTX-Ar1c; Omega-atracotoxin-Ar1c;
                     Omega-ACTX-Ar1c"
                     /UniProtKB_evidence="Evidence at transcript level"
     Region          1..22
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          23..41
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250. /id=PRO_0000379910."
     Region          42..78
                     /region_name="Omega-toxin"
                     /note="Omega-atracotoxin; pfam06357"
                     /db_xref="CDD:253691"
     Region          42..78
                     /region_name="Processed active peptide"
                     /note="Omega-hexatoxin-Ar1c. /id=PRO_0000379911."
     Bond            bond(45,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            51
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Bond            bond(52,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Site            68
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
     Site            76
                     /site_type="other"
                     /note="Critical for insecticidal activity.
                     /evidence=ECO:0000250."
ORIGIN      
        1 mntatgvial lvlatvigci eaedtradlq ggeaaekvfr rsptcipsgq pcpynenycs
       61 qsctfkenen antvkrcd
//

LOCUS       KAX2D_CENSU               38 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Potassium channel toxin alpha-KTx 2.13; AltName:
            Full=Toxin Css20.
ACCESSION   P85529
VERSION     P85529.1
DBSOURCE    UniProtKB: locus KAX2D_CENSU, accession P85529;
            class: standard.
            created: Dec 16, 2008.
            sequence updated: Dec 16, 2008.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P85529, SMR:P85529,
            GO:0005576, GO:0008200, GO:0015459, GO:0090729, Gene3D:3.30.30.10,
            InterPro:IPR036574, InterPro:IPR001947, Pfam:PF00451,
            PRINTS:PR00286, SUPFAM:SSF57095, PROSITE:PS01138
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Potassium channel impairing toxin; Secreted;
            Toxin; Voltage-gated potassium channel impairing toxin.
SOURCE      Centruroides suffusus (Mexican scorpion)
  ORGANISM  Centruroides suffusus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Centruroides.
REFERENCE   1  (residues 1 to 38)
  AUTHORS   Corzo,G., Papp,F., Varga,Z., Barraza,O., Espino-Solis,P.G.,
            Rodriguez de la Vega,R.C., Gaspar,R., Panyi,G. and Possani,L.D.
  TITLE     A selective blocker of Kv1.2 and Kv1.3 potassium channels from the
            venom of the scorpion Centruroides suffusus suffusus
  JOURNAL   Biochem Pharmacol 76 (9), 1142-1154 (2008)
   PUBMED   18786511
  REMARK    PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, SUBCELLULAR
            LOCATION, AND ACTIVITY PROFILE.;
            TISSUE=Venom
COMMENT     [FUNCTION] Selective inhibitor of voltage-gated potassium channels,
            blocks the Kv1.2/KCNA2 (Kd=1.3 nM) and Kv1.3/KCNA3 (Kd=7.2 nM)
            channels. Association and dissociation rates of the toxin are
            slower for Kv1.2/KCNA2 than for Kv1.3/KCNA3.
            {ECO:0000269|PubMed:18786511}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:18786511}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:18786511}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to a beta-sheet by disulfide bonds (CSalpha/beta).
            {ECO:0000250|UniProtKB:P40755}.
            [MASS SPECTROMETRY] Mass=4000.3; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:18786511}.
            [MISCELLANEOUS] Negative results: does not inhibit the potassium
            channels Kv1.1/KCNA1, Kv1.4/KCNA4, Kv1.5/KCNA5, Kv2.1/KCNB1,
            Kv11.1/KCNH2, KCa3.1/KCNN4, KCa1.1/KCNMA1 and the sodium channel
            Nav1.5/SCN5A. {ECO:0000305|PubMed:18786511}.
            [SIMILARITY] Belongs to the short scorpion toxin superfamily.
            Potassium channel inhibitor family. Alpha-KTx 02 subfamily.
            {ECO:0000255}.
FEATURES             Location/Qualifiers
     source          1..38
                     /organism="Centruroides suffusus"
                     /db_xref="taxon:6880"
     Protein         1..38
                     /product="Potassium channel toxin alpha-KTx 2.13"
                     /note="Toxin Css20"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..38
                     /region_name="Processed active peptide"
                     /note="Potassium channel toxin alpha-KTx 2.13.
                     /evidence=ECO:0000269|PubMed:18786511.
                     /id=PRO_0000358604."
     Region          5..37
                     /region_name="Toxin_2"
                     /note="Scorpion short toxin, BmKK2; pfam00451"
                     /db_xref="CDD:278858"
     Bond            bond(7,29)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P40755."
     Bond            bond(13,34)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P40755."
     Bond            bond(17,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P40755."
     Site            28
                     /site_type="other"
                     /note="Basic residue of the functional dyad.
                     /evidence=ECO:0000250."
     Site            37
                     /site_type="other"
                     /note="Aromatic residue of the functional dyad.
                     /evidence=ECO:0000250."
ORIGIN      
        1 ifinvkcssp qqclkpckaa fgisaggkci ngkckcyp
//

LOCUS       TX482_HYSGI               41 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Omega-theraphotoxin-Hg1a; Short=Omega-TRTX-Hg1a;
            AltName: Full=Toxin SNX-482; Short=SNX482.
ACCESSION   P56854
VERSION     P56854.1
DBSOURCE    UniProtKB: locus TX482_HYSGI, accession P56854;
            class: standard.
            created: May 30, 2000.
            sequence updated: May 30, 2000.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P56854, SMR:P56854,
            ArachnoServer:AS000281, GO:0005576, GO:0005246, GO:0008200,
            GO:0017080, GO:0090729, InterPro:IPR011696, Pfam:PF07740,
            SUPFAM:SSF57059
KEYWORDS    Calcium channel impairing toxin; Direct protein sequencing;
            Disulfide bond; Ion channel impairing toxin; Knottin; Neurotoxin;
            Secreted; Toxin; Voltage-gated calcium channel impairing toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Hysterocrates gigas
  ORGANISM  Hysterocrates gigas
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Hysterocrates.
REFERENCE   1  (residues 1 to 41)
  AUTHORS   Newcomb,R., Szoke,B., Palma,A., Wang,G., Chen,Xh., Hopkins,W.,
            Cong,R., Miller,J., Urge,L., Tarczy-Hornoch,K., Loo,J.A.,
            Dooley,D.J., Nadasdi,L., Tsien,R.W., Lemos,J. and Miljanich,G.
  TITLE     Selective peptide antagonist of the class E calcium channel from
            the venom of the tarantula Hysterocrates gigas
  JOURNAL   Biochemistry 37 (44), 15353-15362 (1998)
   PUBMED   9799496
  REMARK    PROTEIN SEQUENCE, AND FUNCTION.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 41)
  AUTHORS   Bourinet,E., Stotz,S.C., Spaetgens,R.L., Dayanithi,G., Lemos,J.,
            Nargeot,J. and Zamponi,G.W.
  TITLE     Interaction of SNX482 with domains III and IV inhibits activation
            gating of alpha(1E) (Ca(V)2.3) calcium channels
  JOURNAL   Biophys J 81 (1), 79-88 (2001)
   PUBMED   11423396
  REMARK    FUNCTION.
REFERENCE   3  (residues 1 to 41)
  AUTHORS   Arroyo,G., Aldea,M., Fuentealba,J., Albillos,A. and Garcia,A.G.
  TITLE     SNX482 selectively blocks P/Q Ca2+ channels and delays the
            inactivation of Na+ channels of chromaffin cells
  JOURNAL   Eur J Pharmacol 475 (1-3), 11-18 (2003)
   PUBMED   12954354
  REMARK    FUNCTION.
COMMENT     [FUNCTION] Toxin that blocks vertebrate P/Q-type (Cav2.1/CACNA1A)
            and R-type (Cav2.3/CACNA1E) voltage-gated calcium channels. Also
            inhibits sodium channels (Nav) in bovine chromaffin cells by
            delaying sodium channel inactivation. {ECO:0000269|PubMed:11423396,
            ECO:0000269|PubMed:12954354, ECO:0000269|PubMed:9799496}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin. {ECO:0000250}.
            [SIMILARITY] Belongs to the neurotoxin 10 (Hwtx-1) family. 56
            (SNX-482) subfamily. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..41
                     /organism="Hysterocrates gigas"
                     /db_xref="taxon:118972"
     Protein         1..41
                     /product="Omega-theraphotoxin-Hg1a"
                     /note="Omega-TRTX-Hg1a; Toxin SNX-482; SNX482"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..41
                     /region_name="Mature chain"
                     /note="Omega-theraphotoxin-Hg1a. /id=PRO_0000087673."
     Region          6..35
                     /region_name="Toxin_12"
                     /note="Ion channel inhibitory toxin; pfam07740"
                     /db_xref="CDD:400201"
     Bond            bond(7,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(14,26)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
     Bond            bond(20,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250."
ORIGIN      
        1 gvdkagcrym fggcsvnddc cprlgchslf sycawdltfs d
//

LOCUS       SCX8_ANDCR                66 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Sodium channel alpha-toxin Acra8; Flags: Precursor.
ACCESSION   M1JMR8
VERSION     M1JMR8.1
DBSOURCE    UniProtKB: locus SCX8_ANDCR, accession M1JMR8;
            class: standard.
            created: Apr 1, 2015.
            sequence updated: May 1, 2013.
            annotation updated: Feb 22, 2023.
            xrefs: JQ975130.1, AGE83107.1
            xrefs (non-sequence databases): AlphaFoldDB:M1JMR8, SMR:M1JMR8,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Disulfide bond; Ion channel impairing toxin; Neurotoxin;
            Secreted; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Androctonus crassicauda
  ORGANISM  Androctonus crassicauda
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
REFERENCE   1  (residues 1 to 66)
  AUTHORS   Caliskan,F., Quintero-Hernandez,V., Restano-Cassulini,R.,
            Coronas-Valderrama,F.I., Corzo,G. and Possani,L.D.
  TITLE     Molecular cloning and biochemical characterization of the first
            Na(+)-channel alpha-type toxin peptide (Acra4) from Androctonus
            crassicauda scorpion venom
  JOURNAL   Biochimie 95 (6), 1216-1222 (2013)
   PUBMED   23395751
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission.
            {ECO:0000250|UniProtKB:P01481}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..66
                     /organism="Androctonus crassicauda"
                     /db_xref="taxon:122909"
     Protein         1..66
                     /product="Sodium channel alpha-toxin Acra8"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..64
                     /region_name="Mature chain"
                     /note="Sodium channel alpha-toxin Acra8.
                     /id=PRO_5001113115."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            64
                     /site_type="amidation"
                     /note="Asparagine amide.
                     /evidence=ECO:0000250|UniProtKB:P01481."
     Region          65..66
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01481.
                     /id=PRO_0000432480."
ORIGIN      
        1 vrdgyivddk nctffcgrna ycndeckkkg gesgycqwas pygnacwcyk lpdrvpikek
       61 grcngr
//

LOCUS       SCX4_ANDCR                65 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Sodium channel alpha-toxin Acra4; Flags: Precursor.
ACCESSION   M1JBC0
VERSION     M1JBC0.1
DBSOURCE    UniProtKB: locus SCX4_ANDCR, accession M1JBC0;
            class: standard.
            created: Apr 1, 2015.
            sequence updated: May 1, 2013.
            annotation updated: Feb 22, 2023.
            xrefs: JQ975126.1, AGE83103.1
            xrefs (non-sequence databases): AlphaFoldDB:M1JBC0, SMR:M1JBC0,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Androctonus crassicauda
  ORGANISM  Androctonus crassicauda
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Caliskan,F., Quintero-Hernandez,V., Restano-Cassulini,R.,
            Coronas-Valderrama,F.I., Corzo,G. and Possani,L.D.
  TITLE     Molecular cloning and biochemical characterization of the first
            Na(+)-channel alpha-type toxin peptide (Acra4) from Androctonus
            crassicauda scorpion venom
  JOURNAL   Biochimie 95 (6), 1216-1222 (2013)
   PUBMED   23395751
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 7-65, PROTEIN SEQUENCE OF 1-14,
            SUBCELLULAR LOCATION, MASS SPECTROMETRY, AND TOXIC DOSE.;
            TISSUE=Venom, and Venom gland
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission.
            Electrophysiological studies of this were performed using
            sodium-channels expressed in F11 cell culture, by patch-clamp
            recordings. Affinity of this toxin toward sodium channels in F11
            cell line is in the order of 1 uM concentration.
            {ECO:0000269|PubMed:23395751}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:23395751}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=6937; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:23395751}.
            [TOXIC DOSE] LD(50) is 2.5 ug/kg when intracranially injected into
            mice. {ECO:0000269|PubMed:23395751}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Androctonus crassicauda"
                     /db_xref="taxon:122909"
     Protein         1..65
                     /product="Sodium channel alpha-toxin Acra4"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..64
                     /region_name="Mature chain"
                     /note="Sodium channel alpha-toxin Acra4.
                     /id=PRO_5001113087."
     Region          2..63
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..53
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,34)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(20,44)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(24,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          65
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000250|UniProtKB:P01480.
                     /id=PRO_0000432477."
ORIGIN      
        1 vrdgyivddk ncvyhcippc dglckknggk sgscsflvps glacwckalp dnvpikdpsy
       61 kchkr
//

LOCUS       TXHM2_HERML               40 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Mu-thomitoxin-Hme1b; Short=Mu-TMTX-Hme1b; AltName:
            Full=Neurotoxin Hm-2.
ACCESSION   P85506
VERSION     P85506.1
DBSOURCE    UniProtKB: locus TXHM2_HERML, accession P85506;
            class: standard.
            created: Oct 14, 2008.
            sequence updated: Oct 14, 2008.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P85506, SMR:P85506,
            ArachnoServer:AS000760, GO:0005576, GO:0017080, GO:0090729
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Knottin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Heriaeus mellotteei
  ORGANISM  Heriaeus mellotteei
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Araneomorphae; Entelegynae; Dionycha; Thomisidae;
            Heriaeus.
REFERENCE   1  (residues 1 to 40)
  AUTHORS   Billen,B., Vassilevski,A., Nikolsky,A., Tytgat,J. and Grishin,E.
  TITLE     Two novel sodium channel inhibitors from Heriaeus melloteei spider
            venom differentially interacting with mammalian channel's isoforms
  JOURNAL   Toxicon 52 (2), 309-317 (2008)
   PUBMED   18606177
  REMARK    PROTEIN SEQUENCE, FUNCTION, DISULFIDE BONDS, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 40)
  AUTHORS   Nikolsky,A., Billen,B., Vassilevski,A., Filkin,S., Tytgat,J. and
            Grishin,E.
  TITLE     Voltage-gated sodium channels are targets for toxins from the venom
            of the spider Heriaeus melloteei
  JOURNAL   Biochemistry (Mosc.) Suppl. Series A 3, 245-253 (2009)
  REMARK    PROTEIN SEQUENCE, FUNCTION, DISULFIDE BONDS, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom
            DOI: 10.1134/S1990747809030027
COMMENT     [FUNCTION] Blocks the Nav1.2/SCN2A, Nav1.4/SCN4A, Nav1.5/SCN5A and
            Nav1.6/SCN8A sodium channels. Shows a slight preference for the
            Nav1.2 and Nav1.4 channels. Reduces the peak amplitude of the
            sodium current and negatively shifts the steady-state inactivation
            process. Does not shift the threshold potential of activation or
            the voltage corresponding to maximal current. Does not change the
            reversal potential of the sodium current. May act on site 1 of the
            receptor. {ECO:0000269|PubMed:18606177, ECO:0000269|Ref.2}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:18606177}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:P56714}.
            [PTM] Contains 3 disulfide bonds.
            [MASS SPECTROMETRY] Mass=4555.3; Method=MALDI;
            Evidence={ECO:0000269|PubMed:18606177}.
            [MISCELLANEOUS] Negative results: does not inhibit the sodium
            channel Nav1.8/SCN10A.
            [SIMILARITY] Belongs to the neurotoxin 19 (CSTX) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..40
                     /organism="Heriaeus mellotteei"
                     /db_xref="taxon:2337432"
     Protein         1..40
                     /product="Mu-thomitoxin-Hme1b"
                     /note="Mu-TMTX-Hme1b; Neurotoxin Hm-2"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..40
                     /region_name="Processed active peptide"
                     /note="Mu-thomitoxin-Hme1b. /id=PRO_0000352651."
     Bond            bond(2,18)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56714."
     Bond            bond(9,22)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56714."
     Bond            bond(17,33)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P56714."
ORIGIN      
        1 gcipsfgeca wfsgescctg ickwvfftsk fmcrrvwgkd
//

LOCUS       SCX7_MESMA                66 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-like toxin BmK-M7; Short=BmKM7; Short=Bmk M7.
ACCESSION   P59854
VERSION     P59854.1
DBSOURCE    UniProtKB: locus SCX7_MESMA, accession P59854;
            class: standard.
            created: Sep 19, 2003.
            sequence updated: Sep 19, 2003.
            annotation updated: Feb 22, 2023.
            xrefs: 1KV0_A, 1KV0_B
            xrefs (non-sequence databases): PDBsum:1KV0, AlphaFoldDB:P59854,
            SMR:P59854, EvolutionaryTrace:P59854, GO:0005576, GO:0019871,
            GO:0090729, GO:0006952, CDD:cd00107, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 66)
  AUTHORS   Guan,R.J., Xiang,Y., He,X.L., Wang,C.G., Wang,M., Zhang,Y.,
            Sundberg,E.J. and Wang,D.C.
  TITLE     Structural mechanism governing cis and trans isomeric states and an
            intramolecular switch for cis/trans isomerization of a non-proline
            peptide bond observed in crystal structures of scorpion toxins
  JOURNAL   J Mol Biol 341 (5), 1189-1204 (2004)
   PUBMED   15321715
  REMARK    PROTEIN SEQUENCE, X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS), AND MASS
            SPECTROMETRY.
REFERENCE   2  (residues 1 to 66)
  AUTHORS   Guan,R.J., He,X.L., Wang,M., Ye-Xiang, Li,G.P. and Wang,D.C.
  TITLE     Purification, crystallization and initial structural solution of a
            new alpha-like toxin with cardiac toxicity from scorpion Buthus
            martensii Karsch
  JOURNAL   Protein Pept Lett 9 (5), 441-449 (2002)
   PUBMED   12370033
  REMARK    FUNCTION, AND CRYSTALLIZATION.;
            TISSUE=Venom
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. This toxin is
            active on both mammals and insects. It can be considered as a
            cardiotoxin, as it can bind to human cardiac sodium channel and
            modify its normal properties. {ECO:0000269|PubMed:12370033}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7237.4; Method=MALDI;
            Evidence={ECO:0000269|PubMed:15321715}.
            [MISCELLANEOUS] Exists in two forms, due to cis-trans isomerization
            at 9-Pro-His-10.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..66
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..66
                     /product="Alpha-like toxin BmK-M7"
                     /note="BmKM7; Bmk M7"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..66
                     /region_name="Mature chain"
                     /note="Alpha-like toxin BmK-M7. /id=PRO_0000066752."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          2..8
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1KV0."
     Region          9..11
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1KV0."
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          19..28
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1KV0."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          32..38
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1KV0."
     Region          40..51
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1KV0."
ORIGIN      
        1 vrdgyialph ncaygclnne ycnnlctkdg akigycnivg kygnacwciq lpdnvpirvp
       61 grchpa
//

LOCUS       SCX4_MESMA                64 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-like toxin BmK-M4; Short=BmK4; Short=BmKM4;
            Short=Bmk M4; AltName: Full=BmK-IV.
ACCESSION   P58328
VERSION     P58328.1
DBSOURCE    UniProtKB: locus SCX4_MESMA, accession P58328;
            class: standard.
            created: Oct 24, 2001.
            sequence updated: Oct 24, 2001.
            annotation updated: Feb 22, 2023.
            xrefs: 1SN4_A
            xrefs (non-sequence databases): PDBsum:1SN4, AlphaFoldDB:P58328,
            SMR:P58328, EvolutionaryTrace:P58328, GO:0005576, GO:0019871,
            GO:0090729, GO:0006952, CDD:cd00107, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 64)
  AUTHORS   Luo,M.J., Xiong,Y.M., Wang,M., Wang,D.C. and Chi,C.W.
  TITLE     Purification and sequence determination of a new neutral mammalian
            neurotoxin from the scorpion Buthus martensii Karsch
  JOURNAL   Toxicon 35 (5), 723-731 (1997)
   PUBMED   9203297
  REMARK    PROTEIN SEQUENCE, TOXIC DOSE, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 64)
  AUTHORS   Li,H.M., Zhao,T., Jin,L., Wang,M., Zhang,Y. and Wang,D.C.
  TITLE     A series of bioactivity-variant neurotoxins from scorpion Buthus
            martensii Karsch: purification, crystallization and
            crystallographic analysis
  JOURNAL   Acta Crystallogr D Biol Crystallogr 55 (Pt 1), 341-344 (1999)
   PUBMED   10089445
  REMARK    CRYSTALLIZATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 64)
  AUTHORS   He,X.L., Li,H.M., Zeng,Z.H., Liu,X.Q., Wang,M. and Wang,D.C.
  TITLE     Crystal structures of two alpha-like scorpion toxins: non-proline
            cis peptide bonds and implications for new binding site selectivity
            on the sodium channel
  JOURNAL   J Mol Biol 292 (1), 125-135 (1999)
   PUBMED   10493862
  REMARK    X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS).
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. This toxin is
            active against mammals.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:9203297}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:9203297}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000269|PubMed:10493862}.
            [TOXIC DOSE] LD(50) is 4 mg/kg +/- 0.25 by intravenous injection
            into mice. {ECO:0000269|PubMed:9203297}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..64
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..64
                     /product="Alpha-like toxin BmK-M4"
                     /note="BmK4; BmKM4; Bmk M4; BmK-IV"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..64
                     /region_name="Mature chain"
                     /note="Alpha-like toxin BmK-M4.
                     /evidence=ECO:0000269|PubMed:9203297. /id=PRO_0000066751."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          2..8
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1SN4."
     Region          9..11
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:1SN4."
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0007744|PDB:1SN4."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0007744|PDB:1SN4."
     Region          19..28
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1SN4."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0007744|PDB:1SN4."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:10493862,
                     ECO:0007744|PDB:1SN4."
     Region          32..40
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1SN4."
     Region          43..51
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1SN4."
ORIGIN      
        1 vrdayiakpe ncvyhcagne gcnklctdng aesgycqwgg rygnacwcik lpddvpirvp
       61 gkch
//

LOCUS       SCX1_BUTOC                65 aa            linear   INV 13-SEP-2023
DEFINITION  RecName: Full=Alpha-toxin Bot1; AltName: Full=Bot I; Short=BotI;
            AltName: Full=Neurotoxin 1; AltName: Full=Neurotoxin I.
ACCESSION   P01488
VERSION     P01488.2
DBSOURCE    UniProtKB: locus SCX1_BUTOC, accession P01488;
            class: standard.
            created: Jul 21, 1986.
            sequence updated: Apr 1, 1990.
            annotation updated: Sep 13, 2023.
            xrefs: NTSR1B
            xrefs (non-sequence databases): AlphaFoldDB:P01488, SMR:P01488,
            ABCD:P01488, GO:0005576, GO:0019871, GO:0090729, GO:0006952,
            CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284,
            SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Buthus occitanus tunetanus (Tunisian scorpion)
  ORGANISM  Buthus occitanus tunetanus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Buthus.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Gregoire,J. and Rochat,H.
  TITLE     Covalent structure of toxins I and II from the scorpion Buthus
            occitanus tunetanus
  JOURNAL   Toxicon 21 (1), 153-162 (1983)
   PUBMED   6845379
  REMARK    PROTEIN SEQUENCE, SUBCELLULAR LOCATION, AND AMIDATION AT PHE-65.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 65)
  AUTHORS   Vargas,O., Gregoire,J., Martin,M.-F., Bechis,G. and Rochat,H.
  TITLE     Neurotoxins from the venoms of two scorpions: Buthus occitanus
            tunetanus and Buthus occitanus mardochei
  JOURNAL   Toxicon 20, 79-79 (1982)
  REMARK    PROTEIN SEQUENCE, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 65)
  AUTHORS   Rodriguez de la Vega,R.C. and Possani,L.D.
  TITLE     Overview of scorpion toxins specific for Na+ channels and related
            peptides: biodiversity, structure-function relationships and
            evolution
  JOURNAL   Toxicon 46 (8), 831-844 (2005)
   PUBMED   16274721
  REMARK    REVIEW.
COMMENT     On Oct 11, 2005 this sequence version replaced gi:69534.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:6845379,
            ECO:0000269|Ref.2}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:6845379, ECO:0000305|Ref.2}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Buthus occitanus tunetanus"
                     /sub_species="tunetanus"
                     /db_xref="taxon:6871"
     Protein         1..65
                     /product="Alpha-toxin Bot1"
                     /note="Bot I; Neurotoxin 1; Neurotoxin I; BotI"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..65
                     /region_name="Mature chain"
                     /note="Alpha-toxin Bot1.
                     /evidence=ECO:0000269|PubMed:6845379, ECO:0000269|Ref.2.
                     /id=PRO_0000066732."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..55
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          29
                     /region_name="Conflict"
                     /note="N -> D (in Ref. 2; AA sequence).
                     /evidence=ECO:0000305."
     Site            65
                     /site_type="amidation"
                     /note="Phenylalanine amide.
                     /evidence=ECO:0000269|PubMed:6845379."
ORIGIN      
        1 grdayiaqpe ncvyecaqns ycndlctkng atsgycqwlg kygnacwckd lpdnvpirip
       61 gkchf
//

LOCUS       KA23N_VAEMS               65 aa            linear   INV 28-JUN-2023
DEFINITION  RecName: Full=Toxin VmKTx1; AltName: Full=Toxin sVmKTx; Flags:
            Precursor.
ACCESSION   P0DW84
VERSION     P0DW84.1
DBSOURCE    UniProtKB: locus KA23N_VAEMS, accession P0DW84;
            class: standard.
            created: Oct 12, 2022.
            sequence updated: Oct 12, 2022.
            annotation updated: Jun 28, 2023.
            xrefs: JZ818447.1
            xrefs (non-sequence databases): SMR:P0DW84, GO:0005576, GO:0008200,
            GO:0015459, GO:0090729, Gene3D:3.30.30.10, InterPro:IPR036574,
            InterPro:IPR001947, Pfam:PF00451, PRINTS:PR00286, SUPFAM:SSF57095,
            PROSITE:PS01138
KEYWORDS    Amidation; Disulfide bond; Ion channel impairing toxin; Potassium
            channel impairing toxin; Secreted; Signal; Toxin; Voltage-gated
            potassium channel impairing toxin.
SOURCE      Vaejovis smithi
  ORGANISM  Vaejovis smithi
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Iurida; Chactoidea; Vaejovidae; Vaejovis.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Quintero-Hernandez,V., Ramirez-Carreto,S., Romero-Gutierrez,M.T.,
            Valdez-Velazquez,L.L., Becerril,B., Possani,L.D. and Ortiz,E.
  TITLE     Transcriptome analysis of scorpion species belonging to the
            Vaejovis genus
  JOURNAL   PLoS One 10 (2), e0117188 (2015)
   PUBMED   25659089
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 65)
  AUTHORS   Csoti,A., Del Carmen Najera Meza,R., Bogar,F., Tajti,G.,
            Szanto,T.G., Varga,Z., Gurrola,G.B., Toth,G.K., Possani,L.D. and
            Panyi,G.
  TITLE     sVmKTx, a transcriptome analysis-based synthetic peptide analogue
            of Vm24, inhibits Kv1.3 channels of human T cells with improved
            selectivity
  JOURNAL   Biochem Pharmacol 199, 115023 (2022)
   PUBMED   35358481
  REMARK    FUNCTION, SYNTHESIS OF 29-65, 3D-STRUCTURE MODELING, AND PROBABLE
            AMIDATION AT CYS-64.
COMMENT     [FUNCTION] Voltage-gated potassium channel inhibitor. Selectively
            and reversibly binds (Kd=0.77 nM) and blocks hKv1.3/KCNA3 potassium
            channels of human T-lymphocytes. Also shows a very weak effect on
            hKv1.2/KCNA2 (Kd=7.1 uM). Also reduces the fraction of CD40L
            expressing T cells that are stimulated by alphaCD3/alphaCD28.
            {ECO:0000269|PubMed:35358481}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305|PubMed:35358481}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:35358481}.
            [DOMAIN] Has the CSalpha/beta fold, which comprises one or two
            short alpha helices connected to anti-parallel beta-sheets
            stabilized by three or four disulfide bonds.
            {ECO:0000250|UniProtKB:P0DJ31}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000250|UniProtKB:P0DJ31}.
            [MISCELLANEOUS] Has very weak or no effect on many potassium
            channels (hKCa1.1/KCNMA1, hKCa3.1/KCNN4/IK/SK4, hKv1.1/KCNA1,
            hKv1.4/KCNA4, hKv1.5/KCNA5, rKv2.1/KCNB1, and hKv11.1/KCNH2/ERG1),
            and on the tested sodium channel (hNav1.5/SCN5A).
            {ECO:0000269|PubMed:35358481}.
            [SIMILARITY] Belongs to the short scorpion toxin superfamily.
            Potassium channel inhibitor family. Alpha-KTx 23 subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Vaejovis smithi"
                     /db_xref="taxon:1562928"
     Protein         1..65
                     /product="Toxin VmKTx1"
                     /note="Toxin sVmKTx"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..21
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          22..28
                     /region_name="Propeptide"
                     /note="/evidence=ECO:0000305|PubMed:35358481.
                     /id=PRO_0000456413."
     Region          29..64
                     /region_name="Mature chain"
                     /note="Toxin VmKTx1.
                     /evidence=ECO:0000305|PubMed:35358481.
                     /id=PRO_0000456414."
     Region          32..62
                     /region_name="Toxin_2"
                     /note="Scorpion short toxin, BmKK2; pfam00451"
                     /db_xref="CDD:278858"
     Bond            bond(34,54)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DJ31."
     Bond            bond(40,59)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DJ31."
     Bond            bond(44,61)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DJ31."
     Bond            bond(49,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P0DJ31."
     Site            53
                     /site_type="other"
                     /note="Basic residue of the functional dyad.
                     /evidence=ECO:0000250|UniProtKB:P0DJ31."
     Site            62
                     /site_type="other"
                     /note="Aromatic residue of the functional dyad.
                     /evidence=ECO:0000250|UniProtKB:P0DJ31."
     Site            64
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P0DJ31,
                     ECO:0000305|PubMed:35358481."
ORIGIN      
        1 mktsclltil llsflvavav aegersaraa aiscvgspec ppkcraqgck ngkcmnrkck
       61 cyycg
//

LOCUS       TXB2A_PTEMU               29 aa            linear   INV 28-JUN-2023
DEFINITION  RecName: Full=Beta/kappa-theraphotoxin-Pmu2a;
            Short=Beta/kappa-TRTX-Pmu2a; AltName:
            Full=Beta/kappa-theraphotoxin-Pm2a; Short=Beta/kappa-TRTX-Pm2a;
            AltName: Full=Pterinotoxin-2.
ACCESSION   B3EWN1
VERSION     B3EWN1.1
DBSOURCE    UniProtKB: locus TXB2A_PTEMU, accession B3EWN1;
            class: standard.
            created: Sep 5, 2012.
            sequence updated: Sep 5, 2012.
            annotation updated: Jun 28, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:B3EWN1, SMR:B3EWN1,
            ArachnoServer:AS001496, GO:0005576, GO:0015459, GO:0017080,
            GO:0090729, SUPFAM:SSF57059
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Knottin; Neurotoxin; Potassium channel impairing
            toxin; Secreted; Toxin; Voltage-gated potassium channel impairing
            toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Pterinochilus murinus
  ORGANISM  Pterinochilus murinus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Araneae; Mygalomorphae; Theraphosidae; Pterinochilus.
REFERENCE   1  (residues 1 to 29)
  AUTHORS   Meir,A., Cherki,R.S., Kolb,E., Langut,Y. and Bajayo,N.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-MAY-2012) to UniProtKB
  REMARK    PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, AND AMIDATION AT
            LEU-29.;
            TISSUE=Venom {ECO:0000269|Ref.1}
COMMENT     [FUNCTION] Spider venom neurotoxin that blocks voltage-gated sodium
            channel Nav1.3/SCN3A in human (IC(50)=1 uM) and rat (IC(50)=1 uM).
            Partially inhibits human Kv11.1/KCNH2/ERG (40% at 10 uM).
            {ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|Ref.1}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] The presence of a 'disulfide through disulfide knot'
            structurally defines this protein as a knottin.
            {ECO:0000250|UniProtKB:D2Y1X6}.
            [MASS SPECTROMETRY] Mass=3636.6; Method=MALDI;
            Evidence={ECO:0000269|Ref.1}.
            [MISCELLANEOUS] Negative results: has no effect on human and rat
            Nav1.8/SCN10A (Ref.1).
            [SIMILARITY] Belongs to the neurotoxin 30 (phrixotoxin) family.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..29
                     /organism="Pterinochilus murinus"
                     /db_xref="taxon:1184495"
     Protein         1..29
                     /product="Beta/kappa-theraphotoxin-Pmu2a"
                     /note="Beta/kappa-TRTX-Pmu2a;
                     Beta/kappa-theraphotoxin-Pm2a; Pterinotoxin-2;
                     Beta/kappa-TRTX-Pm2a"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..29
                     /region_name="Processed active peptide"
                     /note="Beta/kappa-theraphotoxin-Pmu2a.
                     /id=PRO_0000419138."
     Bond            bond(2,16)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:D2Y1X6."
     Bond            bond(9,21)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:D2Y1X6."
     Bond            bond(15,25)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:D2Y1X6."
     Site            29
                     /site_type="amidation"
                     /note="Leucine amide. /evidence=ECO:0000269|Ref.1."
ORIGIN      
        1 ycqeflwtcd eerkccgdmv crlwckkrl
//

LOCUS       BDS16_BUNCN               38 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin Bcg III 31.16; Short=Toxin Bcg 31.16.
ACCESSION   P86461
VERSION     P86461.1
DBSOURCE    UniProtKB: locus BDS16_BUNCN, accession P86461;
            class: standard.
            created: Mar 23, 2010.
            sequence updated: Mar 23, 2010.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P86461, SMR:P86461,
            GO:0005576, GO:0042151, GO:0008200, GO:0017080, GO:0090729,
            Gene3D:2.20.20.10, InterPro:IPR012414, InterPro:IPR023355,
            Pfam:PF07936
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Nematocyst; Neurotoxin; Secreted; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Bunodosoma cangicum
  ORGANISM  Bunodosoma cangicum
            Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
            Actiniidae; Bunodosoma.
REFERENCE   1  (residues 1 to 38)
  AUTHORS   Zaharenko,A.J., Ferreira,W.A. Jr., Oliveira,J.S., Richardson,M.,
            Pimenta,D.C., Konno,K., Portaro,F.C. and de Freitas,J.C.
  TITLE     Proteomics of the neurotoxic fraction from the sea anemone
            Bunodosoma cangicum venom: novel peptides belonging to new classes
            of toxins
  JOURNAL   Comp. Biochem. Physiol. 3D, 219-225 (2008)
   PUBMED   20483220
  REMARK    PROTEIN SEQUENCE, FUNCTION, AND MASS SPECTROMETRY.
COMMENT     [FUNCTION] Possible modulator of crustacean voltage-gated sodium
            channels (Nav). {ECO:0000269|PubMed:20483220}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000305}. Nematocyst
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=4371.1; Method=MALDI;
            Evidence={ECO:0000269|PubMed:20483220}.
            [MISCELLANEOUS] Despite this toxin having similarity to members of
            a potassium channel toxin family, the effect seen on crab leg nerve
            was similar to that of sodium channel toxins.
            {ECO:0000269|PubMed:20483220, ECO:0000305}.
            [SIMILARITY] Belongs to the sea anemone type 3 (BDS) potassium
            channel toxin family. {ECO:0000255}.
FEATURES             Location/Qualifiers
     source          1..38
                     /organism="Bunodosoma cangicum"
                     /db_xref="taxon:138296"
     Protein         1..>38
                     /product="Toxin Bcg III 31.16"
                     /note="Toxin Bcg 31.16"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..>38
                     /region_name="Mature chain"
                     /note="Toxin Bcg III 31.16. /id=PRO_0000392959."
     Region          2..35
                     /region_name="Defensin_4"
                     /note="Potassium-channel blocking toxin; pfam07936"
                     /db_xref="CDD:254527"
     Bond            bond(4,37)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P61541."
     Bond            bond(6,30)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P61541."
     Bond            bond(20,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P61541."
ORIGIN      
        1 gttcycgstl giywfavssc psgrgytghc gyflglcc
//

LOCUS       SCX16_CENTE               84 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Beta-toxin Ct16; Flags: Precursor.
ACCESSION   P0DUI1
VERSION     P0DUI1.1
DBSOURCE    UniProtKB: locus SCX16_CENTE, accession P0DUI1;
            class: standard.
            created: Apr 7, 2021.
            sequence updated: Apr 7, 2021.
            annotation updated: Feb 22, 2023.
            xrefs: JZ122280.1
            xrefs (non-sequence databases): AlphaFoldDB:P0DUI1, SMR:P0DUI1,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Signal; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Centruroides tecomanus
  ORGANISM  Centruroides tecomanus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Centruroides.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Valdez-Velazquez,L.L., Quintero-Hernandez,V.,
            Romero-Gutierrez,M.T., Coronas,F.I. and Possani,L.D.
  TITLE     Mass fingerprinting of the venom and transcriptome of venom gland
            of scorpion Centruroides tecomanus
  JOURNAL   PLoS One 8 (6), e66486 (2013)
   PUBMED   23840487
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 20-47, PROBABLE
            AMIDATION AT THR-82, MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom, and Venom gland
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Valdez-Velazquez,L.L., Romero-Gutierrez,M.T., Delgado-Enciso,I.,
            Dobrovinskaya,O., Melnikov,V., Quintero-Hernandez,V.,
            Ceballos-Magana,S.G., Gaitan-Hinojosa,M.A., Coronas,F.I.,
            Puebla-Perez,A.M., Zamudio,F., De la Cruz-Garcia,I.,
            Vazquez-Vuelvas,O.F., Soriano-Hernandez,A.D. and Possani,L.D.
  TITLE     Comprehensive analysis of venom from the scorpion Centruroides
            tecomanus reveals compounds with antimicrobial, cytotoxic, and
            insecticidal activities
  JOURNAL   Toxicon 118, 95-103 (2016)
   PUBMED   27130039
  REMARK    FUNCTION.;
            TISSUE=Venom
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            Is possibly toxic to mice (PubMed:27130039).
            {ECO:0000250|UniProtKB:F8UWP3, ECO:0000269|PubMed:27130039}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:23840487}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:23840487}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7292; Method=Electrospray; Note=Average
            mass.; Evidence={ECO:0000269|PubMed:23840487}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Centruroides tecomanus"
                     /db_xref="taxon:1028682"
     Protein         1..84
                     /product="Beta-toxin Ct16"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000305|PubMed:23840487."
     Region          20..82
                     /region_name="Mature chain"
                     /note="Beta-toxin Ct16.
                     /evidence=ECO:0000305|PubMed:23840487.
                     /id=PRO_0000452428."
     Region          21..80
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..71
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(31,79)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01496."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01496."
     Bond            bond(41,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01496."
     Bond            bond(45,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000250|UniProtKB:P01496."
     Site            82
                     /site_type="amidation"
                     /note="Threonine amide.
                     /evidence=ECO:0000305|PubMed:23840487."
ORIGIN      
        1 mnyfillfva tfllldvnck kdgypvdann ckfecwkney cdelckakra esgycyklkl
       61 scwceglpdd eptktsdrcy gtgr
//

LOCUS       SCX6_ANDCR                60 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Putative insect toxin Acra6.
ACCESSION   M1INJ1
VERSION     M1INJ1.1
DBSOURCE    UniProtKB: locus SCX6_ANDCR, accession M1INJ1;
            class: standard.
            created: Apr 1, 2015.
            sequence updated: May 1, 2013.
            annotation updated: Feb 22, 2023.
            xrefs: JQ975128.1, AGE83105.1
            xrefs (non-sequence databases): AlphaFoldDB:M1INJ1, SMR:M1INJ1,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Androctonus crassicauda
  ORGANISM  Androctonus crassicauda
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Androctonus.
REFERENCE   1  (residues 1 to 60)
  AUTHORS   Caliskan,F., Quintero-Hernandez,V., Restano-Cassulini,R.,
            Coronas-Valderrama,F.I., Corzo,G. and Possani,L.D.
  TITLE     Molecular cloning and biochemical characterization of the first
            Na(+)-channel alpha-type toxin peptide (Acra4) from Androctonus
            crassicauda scorpion venom
  JOURNAL   Biochimie 95 (6), 1216-1222 (2013)
   PUBMED   23395751
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
COMMENT     [FUNCTION] Depressant insect toxins cause a transient contraction
            paralysis followed by a slow flaccid paralysis. They bind
            voltage-independently to sodium channels (Nav) and block action
            potentials, primarily by depolarizing the axonal membrane and
            suppressing the sodium current. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Beta subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..60
                     /organism="Androctonus crassicauda"
                     /db_xref="taxon:122909"
     Protein         1..60
                     /product="Putative insect toxin Acra6"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..60
                     /region_name="Mature chain"
                     /note="Putative insect toxin Acra6. /id=PRO_5001112291."
     Region          2..60
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..52
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(16,37)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(23,44)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(27,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
ORIGIN      
        1 vrdgyirrkd efkfkcyvdg kdcddvckse ggsagyctal gflcycaglp ddkawkptss
//

LOCUS       SCU1_MESMA                66 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Neurotoxin BmK AGP-SYPU1; Flags: Precursor.
ACCESSION   E7CAU3
VERSION     E7CAU3.1
DBSOURCE    UniProtKB: locus SCU1_MESMA, accession E7CAU3;
            class: standard.
            created: Oct 19, 2011.
            sequence updated: Mar 8, 2011.
            annotation updated: Feb 22, 2023.
            xrefs: GU726488.1, ADR83605.1
            xrefs (non-sequence databases): AlphaFoldDB:E7CAU3, SMR:E7CAU3,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, GO:0044465,
            CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Direct protein sequencing; Disulfide bond; Ion channel impairing
            toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium channel
            impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 66)
  AUTHORS   Wang,Y., Wang,L., Cui,Y., Song,Y.B., Liu,Y.F., Zhang,R., Wu,C.F.
            and Zhang,J.H.
  TITLE     Purification, characterization and functional expression of a new
            peptide with an analgesic effect from Chinese scorpion Buthus
            martensii Karsch (BmK AGP-SYPU1)
  JOURNAL   Biomed Chromatogr 25 (7), 801-807 (2011)
   PUBMED   20945457
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-20, AND MASS
            SPECTROMETRY.;
            TISSUE=Venom {ECO:0000269|PubMed:20945457}
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            This toxin has a strong analgesic effect when administered to mice
            by intraperitoneal injection. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:20945457}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:20945457}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7545.4131; Method=MALDI;
            Evidence={ECO:0000269|PubMed:20945457}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000255}.
FEATURES             Location/Qualifiers
     source          1..66
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     gene            1..66
                     /gene="AGP-SYPU1"
     Protein         <1..66
                     /product="Neurotoxin BmK AGP-SYPU1"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..64
                     /region_name="Mature chain"
                     /note="Neurotoxin BmK AGP-SYPU1.
                     /evidence=ECO:0000269|PubMed:20945457.
                     /id=PRO_0000413469."
     Region          2..64
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..54
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,36)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(22,46)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(26,48)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          65..66
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000250|UniProtKB:Q9GQW3.
                     /id=PRO_0000413470."
ORIGIN      
        1 grdayiaqny ncvyhcfrdd ycnglcteng adsgycylag kyghacwcin lpddkpirip
       61 gkchrr
//

LOCUS       SCNA8_TITDI               85 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin TdNa8; AltName: Full=P*T-alpha* NaTx3.6; Flags:
            Precursor.
ACCESSION   C9X4K6
VERSION     C9X4K6.1
DBSOURCE    UniProtKB: locus SCNA8_TITDI, accession C9X4K6;
            class: standard.
            created: Apr 20, 2010.
            sequence updated: Nov 24, 2009.
            annotation updated: Feb 22, 2023.
            xrefs: FN392284.1, CAY61941.1
            xrefs (non-sequence databases): AlphaFoldDB:C9X4K6, SMR:C9X4K6,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Amidation; Disulfide bond; Ion channel impairing toxin; Neurotoxin;
            Secreted; Signal; Toxin; Voltage-gated sodium channel impairing
            toxin.
SOURCE      Tityus discrepans
  ORGANISM  Tityus discrepans
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 85)
  AUTHORS   D'Suze,G., Schwartz,E.F., Garcia-Gomez,B.I., Sevcik,C. and
            Possani,L.D.
  TITLE     Molecular cloning and nucleotide sequence analysis of genes from a
            cDNA library of the scorpion Tityus discrepans
  JOURNAL   Biochimie 91 (8), 1010-1019 (2009)
   PUBMED   19470401
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 85)
  AUTHORS   Batista,C.V., D'Suze,G., Gomez-Lagunas,F., Zamudio,F.Z.,
            Encarnacion,S., Sevcik,C. and Possani,L.D.
  TITLE     Proteomic analysis of Tityus discrepans scorpion venom and amino
            acid sequence of novel toxins
  JOURNAL   Proteomics 6 (12), 3718-3727 (2006)
   PUBMED   16705749
  REMARK    MASS SPECTROMETRY.
REFERENCE   3  (residues 1 to 85)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7090.8; Method=MALDI; Note=very likely
            corresponds to the mass found for the peptide eluting at 35.93
            minutes.; Evidence={ECO:0000269|PubMed:16705749}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..85
                     /organism="Tityus discrepans"
                     /db_xref="taxon:57059"
     Protein         1..85
                     /product="Toxin TdNa8"
                     /note="P*T-alpha* NaTx3.6"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000250."
     Region          20..82
                     /region_name="Mature chain"
                     /note="Toxin TdNa8. /id=PRO_5000525372."
     Region          21..81
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..72
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(31,80)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(35,56)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(42,63)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(46,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            82
                     /site_type="amidation"
                     /note="Proline amide. /evidence=ECO:0000250."
ORIGIN      
        1 mnyltliaaa slltagtesk kdgypvkegd cafpcgydna ycdklckerk adsgycywgn
       61 ilcycyglpd kaaikgygrc rpgkk
//

LOCUS       SCX3_TITST                64 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin Tst3; AltName: Full=P-alpha* NaTx3.5; Flags:
            Precursor.
ACCESSION   P0C8X5
VERSION     P0C8X5.1
DBSOURCE    UniProtKB: locus SCX3_TITST, accession P0C8X5;
            class: standard.
            created: Mar 3, 2009.
            sequence updated: Mar 3, 2009.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P0C8X5, SMR:P0C8X5,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Tityus stigmurus
  ORGANISM  Tityus stigmurus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 64)
  AUTHORS   Batista,C.V.F., Roman-Gonzalez,S.A., Salas-Castillo,S.P.,
            Zamudio,F.Z., Gomez-Lagunas,F. and Possani,L.D.
  TITLE     Proteomic analysis of the venom from the scorpion Tityus stigmurus:
            biochemical and physiological comparison with other Tityus species
  JOURNAL   Comp. Biochem. Physiol. 146C, 147-157 (2007)
   PUBMED   17270501
  REMARK    PROTEIN SEQUENCE, AND MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 64)
  AUTHORS   Becerril,B., Corona,M., Coronas,F.I., Zamudio,F.,
            Calderon-Aranda,E.S., Fletcher,P.L. Jr., Martin,B.M. and
            Possani,L.D.
  TITLE     Toxic peptides and genes encoding toxin gamma of the Brazilian
            scorpions Tityus bahiensis and Tityus stigmurus
  JOURNAL   Biochem J 313 (Pt 3), 753-760 (1996)
   PUBMED   8611151
  REMARK    PROTEIN SEQUENCE OF 1-30, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 64)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. {ECO:0000250}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:17270501}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:17270501}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7407.0; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:17270501}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..64
                     /organism="Tityus stigmurus"
                     /db_xref="taxon:50344"
     Protein         1..64
                     /product="Toxin Tst3"
                     /note="P-alpha* NaTx3.5"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..62
                     /region_name="Mature chain"
                     /note="Toxin Tst3. /id=PRO_0000366114."
     Region          2..63
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..54
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(24,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(28,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            62
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P56612."
     Region          63..64
                     /region_name="Propeptide"
                     /note="Removed in mature form. /evidence=ECO:0000255.
                     /id=PRO_0000441710."
ORIGIN      
        1 kkdgypveyd ncayicwnyd naycdklckd kkadsgycyw ahitcycygl pdseptktng
       61 kcks
//

LOCUS       SCX2_TITST                62 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin Tst2; AltName: Full=P-Mice-beta* NaTx5.2;
            AltName: Full=Tityustoxin II; Short=TsTX-II; AltName: Full=Toxin
            III-8.
ACCESSION   P68411
VERSION     P68411.1
DBSOURCE    UniProtKB: locus SCX2_TITST, accession P68411;
            class: standard.
            extra accessions:P23814
            created: Nov 23, 2004.
            sequence updated: Nov 23, 2004.
            annotation updated: Feb 22, 2023.
            xrefs: S62866
            xrefs (non-sequence databases): AlphaFoldDB:P68411, SMR:P68411,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Tityus stigmurus
  ORGANISM  Tityus stigmurus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 62)
  AUTHORS   Becerril,B., Corona,M., Coronas,F.I., Zamudio,F.,
            Calderon-Aranda,E.S., Fletcher,P.L. Jr., Martin,B.M. and
            Possani,L.D.
  TITLE     Toxic peptides and genes encoding toxin gamma of the Brazilian
            scorpions Tityus bahiensis and Tityus stigmurus
  JOURNAL   Biochem J 313 (Pt 3), 753-760 (1996)
   PUBMED   8611151
  REMARK    PROTEIN SEQUENCE, AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 62)
  AUTHORS   Batista,C.V.F., Roman-Gonzalez,S.A., Salas-Castillo,S.P.,
            Zamudio,F.Z., Gomez-Lagunas,F. and Possani,L.D.
  TITLE     Proteomic analysis of the venom from the scorpion Tityus stigmurus:
            biochemical and physiological comparison with other Tityus species
  JOURNAL   Comp. Biochem. Physiol. 146C, 147-157 (2007)
   PUBMED   17270501
  REMARK    PROTEIN SEQUENCE, AND MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   3  (residues 1 to 62)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
COMMENT     On Jan 24, 2006 this sequence version replaced gi:2148091.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            Is toxic to mice (PubMed:8611151). {ECO:0000250,
            ECO:0000269|PubMed:8611151}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=6989.2; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:17270501}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Beta subfamily.
            {ECO:0000305}.
            [CAUTION] This toxin is functionally similar to alpha toxins and
            structurally similar to beta toxins. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..62
                     /organism="Tityus stigmurus"
                     /db_xref="taxon:50344"
     Protein         1..62
                     /product="Toxin Tst2"
                     /note="P-Mice-beta* NaTx5.2; Tityustoxin II; Toxin III-8;
                     TsTX-II"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..62
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          1..62
                     /region_name="Mature chain"
                     /note="Toxin Tst2. /id=PRO_0000066825."
     Region          1..52
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(11,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(15,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(23,43)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(27,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            62
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P56612."
ORIGIN      
        1 kegyamdheg ckfscfirpa gfcdgyckth lkassgycaw pacycygvpd hikvwdyatn
       61 kc
//

LOCUS       SCX12_CENNO               67 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-toxin Cn12.
ACCESSION   P63019
VERSION     P63019.1
DBSOURCE    UniProtKB: locus SCX12_CENNO, accession P63019;
            class: standard.
            created: Aug 31, 2004.
            sequence updated: Aug 31, 2004.
            annotation updated: Feb 22, 2023.
            xrefs: 1PE4_A
            xrefs (non-sequence databases): PDBsum:1PE4, AlphaFoldDB:P63019,
            BMRB:P63019, SMR:P63019, TCDB:8.B.1.1.13, EvolutionaryTrace:P63019,
            GO:0005576, GO:0019871, GO:0090729, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR036574, InterPro:IPR002061,
            Pfam:PF00537, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated
            sodium channel impairing toxin.
SOURCE      Centruroides noxius (Mexican scorpion)
  ORGANISM  Centruroides noxius
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Centruroides.
REFERENCE   1  (residues 1 to 67)
  AUTHORS   del Rio-Portilla,F., Hernandez-Marin,E., Pimienta,G., Coronas,F.V.,
            Zamudio,F.Z., Rodriguez de la Vega,R.C., Wanke,E. and Possani,L.D.
  TITLE     NMR solution structure of Cn12, a novel peptide from the Mexican
            scorpion Centruroides noxius with a typical beta-toxin sequence but
            with alpha-like physiological activity
  JOURNAL   Eur J Biochem 271 (12), 2504-2516 (2004)
   PUBMED   15182366
  REMARK    PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, STRUCTURE BY NMR,
            DISULFIDE BONDS, AND SUBCELLULAR LOCATION.;
            TISSUE=Venom
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. This toxin binds,
            in vitro, to sodium channels and inhibits the inactivation of the
            activated channels. Seems not toxic to mice, crickets and
            sweet-water shrimps. {ECO:0000269|PubMed:15182366}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:15182366}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:15182366}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7139.5; Method=Unknown;
            Evidence={ECO:0000269|PubMed:15182366}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Beta subfamily.
            {ECO:0000305}.
            [CAUTION] This toxin sequence resembles the beta scorpion toxin
            class, although patch-clamp experiments shows the induction of
            supplementary slow inactivation of sodium channels, which means
            that it behaves like an alpha scorpion toxin. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..67
                     /organism="Centruroides noxius"
                     /db_xref="taxon:6878"
     Protein         1..67
                     /product="Alpha-toxin Cn12"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..67
                     /region_name="Mature chain"
                     /note="Alpha-toxin Cn12.
                     /evidence=ECO:0000269|PubMed:15182366.
                     /id=PRO_0000066772."
     Region          1..66
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          8..10
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Bond            bond(11,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15182366,
                     ECO:0007744|PDB:1PE4."
     Region          12..14
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Bond            bond(15,40)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15182366,
                     ECO:0007744|PDB:1PE4."
     Bond            bond(25,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15182366,
                     ECO:0007744|PDB:1PE4."
     Region          25..31
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Bond            bond(29,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000269|PubMed:15182366,
                     ECO:0007744|PDB:1PE4."
     Region          41..44
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Region          46..49
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Region          51..53
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
     Region          63..65
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:1PE4."
ORIGIN      
        1 rdgyplasng ckfgcsglge nnptcnhvce kkagsdygyc yawtcycehv aegtvlwgds
       61 gtgpcrs
//

LOCUS       SCX4_LEIHE                65 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin Lqh4; AltName: Full=Lqh IV; Short=LqhIV;
            AltName: Full=Toxin IV.
ACCESSION   P83644
VERSION     P83644.1
DBSOURCE    UniProtKB: locus SCX4_LEIHE, accession P83644;
            class: standard.
            created: Dec 15, 2003.
            sequence updated: Oct 1, 2003.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P83644, SMR:P83644,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, GO:0035821,
            CDD:cd00107, Gene3D:3.30.30.10, InterPro:IPR044062,
            InterPro:IPR003614, InterPro:IPR036574, InterPro:IPR018218,
            InterPro:IPR002061, Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284,
            SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Leiurus quinquestriatus hebraeus
  ORGANISM  Leiurus quinquestriatus hebraeus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Leiurus.
REFERENCE   1  (residues 1 to 65)
  AUTHORS   Corzo,G., Villegas,E. and Nakajima,T.
  TITLE     Isolation and structural characterization of a peptide from the
            venom of scorpion with toxicity towards invertebrates and
            vertebrates
  JOURNAL   Protein Pept. Lett. 8, 385-393 (2001)
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, TOXIC DOSE, MASS SPECTROMETRY, AMIDATION AT ARG-65,
            CIRCULAR DICHROISM ANALYSIS, AND 3D-STRUCTURE MODELING.;
            TISSUE=Venom {ECO:0000305}
REFERENCE   2  (residues 1 to 65)
  AUTHORS   Nascimento,D.G., Rates,B., Santos,D.M., Verano-Braga,T.,
            Barbosa-Silva,A., Dutra,A.A., Biondi,I., Martin-Eauclaire,M.F., De
            Lima,M.E. and Pimenta,A.M.
  TITLE     Moving pieces in a taxonomic puzzle: venom 2D-LC/MS and data
            clustering analyses to infer phylogenetic relationships in some
            scorpions from the Buthidae family (Scorpiones)
  JOURNAL   Toxicon 47 (6), 628-639 (2006)
   PUBMED   16551474
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY.
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            Intracerebroventricular injection into mice induces immediate
            convulsions and urination followed by death. Is toxic to insects
            and mice. {ECO:0000250, ECO:0000269|Ref.1}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|Ref.1, ECO:0000305}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|Ref.1, ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=7211.3; Method=MALDI;
            Evidence={ECO:0000269|Ref.1}.
            [TOXIC DOSE] LD(50) is 20.3 +/- 3.0 mg/kg to the insect S.litura.
            {ECO:0000269|Ref.1}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..65
                     /organism="Leiurus quinquestriatus hebraeus"
                     /sub_species="hebraeus"
                     /db_xref="taxon:6884"
     Protein         1..65
                     /product="Toxin Lqh4"
                     /note="Lqh IV; Toxin IV; LqhIV"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..65
                     /region_name="Mature chain"
                     /note="Toxin Lqh4. /id=PRO_0000066785."
     Region          3..65
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          3..56
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(13,64)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(17,37)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(23,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(27,49)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            65
                     /site_type="amidation"
                     /note="Arginine amide. /evidence=ECO:0000269|Ref.1."
ORIGIN      
        1 gvrdayiadd kncvytcgan sycntectkn gaesgycqwf gkygnacwci klpdkvpiri
       61 pgkcr
//

LOCUS       SCX4_TITFA                62 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Alpha-toxin Tf4; AltName: Full=Neurotoxin 4; AltName:
            Full=P-Frog-alpha NaTx4.4.
ACCESSION   P83435
VERSION     P83435.1
DBSOURCE    UniProtKB: locus SCX4_TITFA, accession P83435;
            class: standard.
            created: Nov 1, 2002.
            sequence updated: Oct 1, 2002.
            annotation updated: Feb 22, 2023.
            xrefs (non-sequence databases): AlphaFoldDB:P83435, SMR:P83435,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, Gene3D:3.30.30.10,
            InterPro:IPR044062, InterPro:IPR003614, InterPro:IPR036574,
            InterPro:IPR018218, InterPro:IPR002061, Pfam:PF00537,
            PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Tityus fasciolatus
  ORGANISM  Tityus fasciolatus
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 62)
  AUTHORS   Wagner,S., Castro,M.S., Barbosa,J.A., Fontes,W., Schwartz,E.N.,
            Sebben,A., Rodrigues Pires,O. Jr., Sousa,M.V. and Schwartz,C.A.
  TITLE     Purification and primary structure determination of Tf4, the first
            bioactive peptide isolated from the venom of the Brazilian scorpion
            Tityus fasciolatus
  JOURNAL   Toxicon 41 (7), 737-745 (2003)
   PUBMED   12782073
  REMARK    PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, TISSUE
            SPECIFICITY, AND MASS SPECTROMETRY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 62)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
COMMENT     [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (PubMed:12782073).
            This toxin is toxic to frogs but non-toxic to insect larvae
            (T.molitor), mammals (rats) and crustaceans (crabs) at the doses
            assayed (PubMed:12782073). {ECO:0000269|PubMed:12782073}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:12782073,
            ECO:0000305}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000269|PubMed:12782073}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MASS SPECTROMETRY] Mass=6614.30; Method=Electrospray;
            Evidence={ECO:0000269|PubMed:12782073}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..62
                     /organism="Tityus fasciolatus"
                     /db_xref="taxon:203543"
     Protein         1..62
                     /product="Alpha-toxin Tf4"
                     /note="Neurotoxin 4; P-Frog-alpha NaTx4.4"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..62
                     /region_name="Mature chain"
                     /note="Alpha-toxin Tf4.
                     /evidence=ECO:0000269|PubMed:12782073.
                     /id=PRO_0000066827."
     Region          2..62
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..52
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(24,43)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(28,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            62
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P0DQH6."
ORIGIN      
        1 gkegypadsk gckvtcfftg vgycdteckl kkassgycaw pacycyglpd sasvwdsatn
       61 kc
//

LOCUS       SCXB_MESMA                84 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Neurotoxin BmK-M11; Short=BmK11; Short=Bmk M11;
            Short=BmkM11; AltName: Full=Alpha-neurotoxin TX14;
            Short=BmalphaTX14; AltName: Full=BmK M4'; AltName: Full=BmK-XI;
            Flags: Precursor.
ACCESSION   Q9N682
VERSION     Q9N682.1
DBSOURCE    UniProtKB: locus SCXB_MESMA, accession Q9N682;
            class: standard.
            created: Dec 19, 2001.
            sequence updated: Oct 1, 2000.
            annotation updated: Feb 22, 2023.
            xrefs: AF114025.1, AAF34872.1, AF156169.1, AAF29462.1, AF156595.1,
            AAK06897.1, JE0143
            xrefs (non-sequence databases): AlphaFoldDB:Q9N682, SMR:Q9N682,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Disulfide bond; Ion channel impairing toxin; Neurotoxin; Secreted;
            Signal; Toxin; Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Zeng,X.C., Li,W.X., Zhu,S.Y., Peng,F., Jiang,D.H., Yang,F.H. and
            Wu,K.L.
  TITLE     Cloning and characterization of the cDNA sequences of two venom
            peptides from Chinese scorpion Buthus martensii Karsch (BmK)
  JOURNAL   Toxicon 38 (7), 893-899 (2000)
   PUBMED   10728828
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Zhu,S.Y., Li,W.X., Zeng,X.C., Liu,H., Jiang,D.H. and Mao,X.
  TITLE     Nine novel precursors of Buthus martensii scorpion alpha-toxin
            homologues
  JOURNAL   Toxicon 38 (12), 1653-1661 (2000)
   PUBMED   10858508
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
            Erratum:[Toxicon 2001 Jul;39(7):1093]
REFERENCE   3  (residues 1 to 84)
  AUTHORS   Dai,H., Yin,S., Li,T., Cao,Z., Ji,Y., Wu,Y. and Li,W.
  TITLE     Recombinant expression, purification, and characterization of
            scorpion toxin BmalphaTX14
  JOURNAL   Protein Expr Purif 82 (2), 325-331 (2012)
   PUBMED   22343065
  REMARK    FUNCTION.
COMMENT     On Jul 17, 2007 this sequence version replaced gi:7438619.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission. This recombinant
            toxin selectively inhibits the fast inactivation of mNav1.4/SCN4A
            (EC(50)=82.3 nM) (tested in HEK293 cells).
            {ECO:0000269|PubMed:22343065}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000250}.
            [TISSUE SPECIFICITY] Expressed by the venom gland. {ECO:0000305}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MISCELLANEOUS] Negative results: does not inhibit rNav1.2/SCN2A
            (EC(50) is >30000 nM) channels. {ECO:0000269|PubMed:22343065}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..84
                     /product="Neurotoxin BmK-M11"
                     /note="BmK11; Bmk M11; BmkM11; Alpha-neurotoxin TX14; BmK
                     M4'; BmK-XI; BmalphaTX14"
                     /UniProtKB_evidence="Inferred from homology"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000250."
     Region          20..83
                     /region_name="Mature chain"
                     /note="Neurotoxin BmK-M11. /id=PRO_0000035242."
     Region          21..83
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(31,82)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(41,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(45,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          84
                     /region_name="Propeptide"
                     /note="Removed by a carboxypeptidase.
                     /evidence=ECO:0000305. /id=PRO_0000035243."
ORIGIN      
        1 mnylvmisfa lllmtgvesv rdayiakpen cvyhcatneg cnklctdnga esgycqwggk
       61 ygnacwcikl pddvpirvpg kchr
//

LOCUS       SC11_MESMA                85 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=BmK AGP-SYPU2; AltName: Full=Alpha-neurotoxin Tx11;
            AltName: Full=Alpha-toxin 2; AltName: Full=BmKalpha2; AltName:
            Full=BmKalphaTx11; AltName: Full=BmKalphaTx11'; AltName: Full=Toxin
            BmTX11'; AltName: Full=Toxin Bmka2; Flags: Precursor.
ACCESSION   Q9NJC7
VERSION     Q9NJC7.1
DBSOURCE    UniProtKB: locus SC11_MESMA, accession Q9NJC7;
            class: standard.
            extra accessions:Q49S26,Q9NJP8
            created: Dec 19, 2001.
            sequence updated: Oct 1, 2000.
            annotation updated: Feb 22, 2023.
            xrefs: AF155364.1, AAF31478.1, AF132974.1, AAF31295.1, AF288608.1,
            AAG00581.1, AY647171.1, AAV64255.1, 2KBH_A, 2KBJ_A
            xrefs (non-sequence databases): PDBsum:2KBH, PDBsum:2KBJ,
            AlphaFoldDB:Q9NJC7, SMR:Q9NJC7, EvolutionaryTrace:Q9NJC7,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, PRINTS:PR00284, SMART:SM00505,
            SUPFAM:SSF57095, PROSITE:PS51863
KEYWORDS    3D-structure; Direct protein sequencing; Disulfide bond; Ion
            channel impairing toxin; Neurotoxin; Secreted; Signal; Toxin;
            Voltage-gated sodium channel impairing toxin.
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 85)
  AUTHORS   Zhu,S.Y., Li,W.X., Zeng,X.C., Liu,H., Jiang,D.H. and Mao,X.
  TITLE     Nine novel precursors of Buthus martensii scorpion alpha-toxin
            homologues
  JOURNAL   Toxicon 38 (12), 1653-1661 (2000)
   PUBMED   10858508
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
            Erratum:[Toxicon 2001 Jul;39(7):1093]
REFERENCE   2  (residues 1 to 85)
  AUTHORS   Ye,J.G., Chen,J., Zuo,X.P. and Ji,Y.H.
  TITLE     Cloning and characterization of cDNA sequences encoding two novel
            alpha-like-toxin precursors from the Chinese scorpion Buthus
            martensii Karsch
  JOURNAL   Toxicon 39 (8), 1191-1194 (2001)
   PUBMED   11306129
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].;
            TISSUE=Venom gland
REFERENCE   3  (residues 1 to 85)
  AUTHORS   Xu,X., Cao,Z., Sheng,J., Wu,W., Luo,F., Sha,Y., Mao,X., Liu,H.,
            Jiang,D. and Li,W.
  TITLE     Genomic sequence analysis and organization of BmKalphaTx11 and
            BmKalphaTx15 from Buthus martensii Karsch: molecular evolution of
            alpha-toxin genes
  JOURNAL   J Biochem Mol Biol 38 (4), 386-390 (2005)
   PUBMED   16053704
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ISOFORM TX11P
            4-LEU--PHE-7.;
            TISSUE=Venom gland
REFERENCE   4  (residues 1 to 85)
  AUTHORS   Zhang,R., Yang,Z., Liu,Y.F., Cui,Y. and Zhang,J.H.
  TITLE     Purification, characterization and cDNA cloning of an analgesic
            peptide from the Chinese scorpion Buthus martensii Karsch (BmK
            AGP-SYPU2)
  JOURNAL   Mol Biol (Mosk) 45 (6), 956-962 (2011)
   PUBMED   22295565
  REMARK    NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND
            FUNCTION.;
            TISSUE=Venom, and Venom gland
REFERENCE   5  (residues 1 to 85)
  AUTHORS   Zhang,R., Cui,Y., Zhang,X., Yang,Z., Zhao,Y., Song,Y., Wu,C. and
            Zhang,J.
  TITLE     Soluble expression, purification and the role of C-terminal glycine
            residues in scorpion toxin BmK AGP-SYPU2
  JOURNAL   BMB Rep 43 (12), 801-806 (2010)
   PUBMED   21189156
  REMARK    FUNCTION, BIOASSAY, SITES GLY-84 AND GLY-85, AND MUTAGENESIS OF
            84-GLY-GLY-85 AND GLY-85.
REFERENCE   6  (residues 1 to 85)
  AUTHORS   Zhu,J., Tong,X., Cao,C., Wu,G., Zhang,N. and Wu,H.
  TITLE     Solution structure of BmKalphaTx11, a toxin from the venom of the
            Chinese scorpion Buthus martensii Karsch
  JOURNAL   Biochem Biophys Res Commun 391 (1), 627-633 (2010)
   PUBMED   19932686
  REMARK    STRUCTURE BY NMR OF 20-85, AND DISULFIDE BONDS.
COMMENT     On May 17, 2014 this sequence version replaced gi:122013221.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            Shows analgesic activity when intraperitoneally injected into mice.
            {ECO:0000250, ECO:0000269|PubMed:21189156,
            ECO:0000269|PubMed:22295565}.
            [SUBCELLULAR LOCATION] Secreted.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [MISCELLANEOUS] Exists only in one form, with a trans isomerization
            at 28-Asp-Arg-29. The cis isomere does not exist (PubMed:19932686).
            {ECO:0000305|PubMed:19932686}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..85
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..85
                     /product="BmK AGP-SYPU2"
                     /note="Alpha-neurotoxin Tx11; Alpha-toxin 2; BmKalpha2;
                     BmKalphaTx11; BmKalphaTx11'; Toxin BmTX11'; Toxin Bmka2"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000250."
     Region          4..7
                     /region_name="Variant"
                     /note="MVII -> LVFF (in isoform TX11P)."
     Region          13
                     /region_name="Variant"
                     /note="V -> L (in isoform TX11P)."
     Region          20..85
                     /region_name="Mature chain"
                     /note="BmK AGP-SYPU2. /id=PRO_0000035245."
     Region          21..83
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Region          21..25
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBH."
     Bond            bond(31,82)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:19932686."
     Bond            bond(35,55)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:19932686."
     Region          38..47
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:2KBH."
     Bond            bond(41,65)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:19932686."
     Bond            bond(45,67)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210,
                     ECO:0000269|PubMed:19932686."
     Region          51..70
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBH."
     Region          79..83
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:2KBJ."
     Site            84..85
                     /site_type="mutagenized"
                     /note="Missing: Important decrease in analgesic activity.
                     /evidence=ECO:0000269|PubMed:21189156."
     Site            84
                     /site_type="other"
                     /note="Important for analgesic activity."
     Site            85
                     /site_type="other"
                     /note="Important for analgesic activity."
     Site            85
                     /site_type="mutagenized"
                     /note="Missing: Significant decrease in analgesic
                     activity. /evidence=ECO:0000269|PubMed:21189156."
ORIGIN      
        1 mnymviisla llvmtgvesv kdgyiaddrn cpyfcgrnay cdgeckknra esgycqwask
       61 ygnacwcykl pddarimkpg rcngg
//

LOCUS       SCX3_TITBA                62 aa            linear   INV 22-FEB-2023
DEFINITION  RecName: Full=Toxin Tb3; AltName: Full=P-Mice-alpha* NaTx3.3;
            AltName: Full=TbTx IV-5.
ACCESSION   P56608
VERSION     P56608.1
DBSOURCE    UniProtKB: locus SCX3_TITBA, accession P56608;
            class: standard.
            created: Dec 15, 1998.
            sequence updated: Dec 15, 1998.
            annotation updated: Feb 22, 2023.
            xrefs: S62863
            xrefs (non-sequence databases): AlphaFoldDB:P56608, SMR:P56608,
            GO:0005576, GO:0019871, GO:0090729, GO:0006952, CDD:cd00107,
            Gene3D:3.30.30.10, InterPro:IPR044062, InterPro:IPR003614,
            InterPro:IPR036574, InterPro:IPR018218, InterPro:IPR002061,
            Pfam:PF00537, PRINTS:PR00285, SMART:SM00505, SUPFAM:SSF57095,
            PROSITE:PS51863
KEYWORDS    Amidation; Direct protein sequencing; Disulfide bond; Ion channel
            impairing toxin; Neurotoxin; Secreted; Toxin; Voltage-gated sodium
            channel impairing toxin.
SOURCE      Tityus bahiensis
  ORGANISM  Tityus bahiensis
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Tityus.
REFERENCE   1  (residues 1 to 62)
  AUTHORS   Becerril,B., Corona,M., Coronas,F.I., Zamudio,F.,
            Calderon-Aranda,E.S., Fletcher,P.L. Jr., Martin,B.M. and
            Possani,L.D.
  TITLE     Toxic peptides and genes encoding toxin gamma of the Brazilian
            scorpions Tityus bahiensis and Tityus stigmurus
  JOURNAL   Biochem J 313 (Pt 3), 753-760 (1996)
   PUBMED   8611151
  REMARK    PROTEIN SEQUENCE, SUBCELLULAR LOCATION, AND BIOASSAY.;
            TISSUE=Venom
REFERENCE   2  (residues 1 to 62)
  AUTHORS   Guerrero-Vargas,J.A., Mourao,C.B., Quintero-Hernandez,V.,
            Possani,L.D. and Schwartz,E.F.
  TITLE     Identification and phylogenetic analysis of Tityus pachyurus and
            Tityus obscurus novel putative Na+-channel scorpion toxins
  JOURNAL   PLoS One 7 (2), e30478 (2012)
   PUBMED   22355312
  REMARK    NOMENCLATURE.
COMMENT     On Jan 20, 2006 this sequence version replaced gi:2148092.
            [FUNCTION] Alpha toxins bind voltage-independently at site-3 of
            sodium channels (Nav) and inhibit the inactivation of the activated
            channels, thereby blocking neuronal transmission (By similarity).
            Is lethal to mice (PubMed:8611151). {ECO:0000250,
            ECO:0000269|PubMed:8611151}.
            [SUBCELLULAR LOCATION] Secreted {ECO:0000269|PubMed:8611151}.
            [TISSUE SPECIFICITY] Expressed by the venom gland.
            {ECO:0000305|PubMed:8611151}.
            [DOMAIN] Has the structural arrangement of an alpha-helix connected
            to antiparallel beta-sheets by disulfide bonds (CS-alpha/beta).
            {ECO:0000305}.
            [SIMILARITY] Belongs to the long (4 C-C) scorpion toxin
            superfamily. Sodium channel inhibitor family. Alpha subfamily.
            {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..62
                     /organism="Tityus bahiensis"
                     /db_xref="taxon:50343"
     Protein         1..62
                     /product="Toxin Tb3"
                     /note="P-Mice-alpha* NaTx3.3; TbTx IV-5"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..62
                     /region_name="Mature chain"
                     /note="Toxin Tb3. /evidence=ECO:0000269|PubMed:8611151.
                     /id=PRO_0000066793."
     Region          2..62
                     /region_name="Domain"
                     /note="LCN-type CS-alpha/beta.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Region          2..54
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     Bond            bond(12,62)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(16,38)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(24,45)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Bond            bond(28,47)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU01210."
     Site            62
                     /site_type="amidation"
                     /note="Cysteine amide.
                     /evidence=ECO:0000250|UniProtKB:P56611."
ORIGIN      
        1 kkdgypvead ncafvcfgyd naycdklcgd kkadsgycyw vhilcycygl pdneptktng
       61 kc
//

LOCUS       ABL62808                  84 aa            linear   INV 01-OCT-2008
DEFINITION  neurotoxin BmK9-1 precursor [Mesobuthus martensii].
ACCESSION   ABL62808
VERSION     ABL62808.1
DBSOURCE    accession DQ981787.1
KEYWORDS    .
SOURCE      Mesobuthus martensii (Buthus martensii)
  ORGANISM  Mesobuthus martensii
            Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
            Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
REFERENCE   1  (residues 1 to 84)
  AUTHORS   Shao,J. and Zhang,J.
  TITLE     Characterization of two novel peptides purified from Chinese
            scorpion
  JOURNAL   Unpublished
REFERENCE   2  (residues 1 to 84)
  AUTHORS   Shao,J. and Zhang,J.
  TITLE     Direct Submission
  JOURNAL   Submitted (03-SEP-2006) School of Pharmaceutical Engineering,
            Shenyang Pharmaceutical University, Wen Hua Lu, Shenyang, Liaoning
            110016, China
COMMENT     Method: conceptual translation supplied by author.
FEATURES             Location/Qualifiers
     source          1..84
                     /organism="Mesobuthus martensii"
                     /db_xref="taxon:34649"
     Protein         1..84
                     /product="neurotoxin BmK9-1 precursor"
                     /name="alpha toxin subfamily"
     Region          21..74
                     /region_name="Toxin_3"
                     /note="Scorpion toxin-like domain; pfam00537"
                     /db_xref="CDD:395428"
     CDS             1..84
                     /coded_by="DQ981787.1:24..278"
                     /note="specifically prolongs the action potential by
                     blocking the sodium channel inactivation; the interaction
                     of alpha-toxin is voltage dependent; bind to the receptor
                     at site 3 of the sodium channel"
ORIGIN      
        1 mnylvmisfa lllmtgvesv rdayiakpen cvyhcatneg cnklctdnga esgycqwggr
       61 ygnacwcikl pdsvpirvpg kchr
//

